WorldWideScience

Sample records for bifidobacterium dentium bd1

  1. The Bifidobacterium dentium Bd1 genome sequence reflects its genetic adaptation to the human oral cavity.

    Directory of Open Access Journals (Sweden)

    Marco Ventura

    2009-12-01

    Full Text Available Bifidobacteria, one of the relatively dominant components of the human intestinal microbiota, are considered one of the key groups of beneficial intestinal bacteria (probiotic bacteria. However, in addition to health-promoting taxa, the genus Bifidobacterium also includes Bifidobacterium dentium, an opportunistic cariogenic pathogen. The genetic basis for the ability of B. dentium to survive in the oral cavity and contribute to caries development is not understood. The genome of B. dentium Bd1, a strain isolated from dental caries, was sequenced to completion to uncover a single circular 2,636,368 base pair chromosome with 2,143 predicted open reading frames. Annotation of the genome sequence revealed multiple ways in which B. dentium has adapted to the oral environment through specialized nutrient acquisition, defences against antimicrobials, and gene products that increase fitness and competitiveness within the oral niche. B. dentium Bd1 was shown to metabolize a wide variety of carbohydrates, consistent with genome-based predictions, while colonization and persistence factors implicated in tissue adhesion, acid tolerance, and the metabolism of human saliva-derived compounds were also identified. Global transcriptome analysis demonstrated that many of the genes encoding these predicted traits are highly expressed under relevant physiological conditions. This is the first report to identify, through various genomic approaches, specific genetic adaptations of a Bifidobacterium taxon, Bifidobacterium dentium Bd1, to a lifestyle as a cariogenic microorganism in the oral cavity. In silico analysis and comparative genomic hybridization experiments clearly reveal a high level of genome conservation among various B. dentium strains. The data indicate that the genome of this opportunistic cariogen has evolved through a very limited number of horizontal gene acquisition events, highlighting the narrow boundaries that separate commensals from

  2. Metabolism of rutin and poncirin by human intestinal microbiota and cloning of their metabolizing α-L-rhamnosidase from Bifidobacterium dentium.

    Science.gov (United States)

    Bang, Seo-Hyeon; Hyun, Yang-Jin; Shim, Juwon; Hong, Sung-Woon; Kim, Dong-Hyun

    2015-01-01

    To understand the metabolism of flavonoid rhamnoglycosides by human intestinal microbiota, we measured the metabolic activity of rutin and poncirin (distributed in many functional foods and herbal medicine) by 100 human stool specimens. The average α-Lrhamnosidase activities on the p-nitrophenyl-α-L-rhamnopyranoside, rutin, and poncirin subtrates were 0.10 ± 0.07, 0.25 ± 0.08, and 0.15 ± 0.09 pmol/min/mg, respectively. To investigate the enzymatic properties, α-L-rhamnosidase-producing bacteria were isolated from the specimens, and the α-L-rhamnosidase gene was cloned from a selected organism, Bifidobacterium dentium, and expressed in E. coli. The cloned α-L-rhamnosidase gene contained a 2,673 bp sequcence encoding 890 amino acid residues. The cloned gene was expressed using the pET 26b(+) vector in E. coli BL21, and the expressed enzyme was purified using Ni(2+)-NTA and Q-HP column chromatography. The specific activity of the purified α-L-rhamnosidase was 23.3 μmol/min/mg. Of the tested natural product constituents, the cloned α-L-rhamnosidase hydrolyzed rutin most potently, followed by poncirin, naringin, and ginsenoside Re. However, it was unable to hydrolyze quercitrin. This is the first report describing the cloning, expression, and characterization of α-L-rhamnosidase, a flavonoid rhamnoglycosidemetabolizing enzyme, from bifidobacteria. Based on these findings, the α-L-rhamnosidase of intestinal bacteria such as B. dentium seem to be more effective in hydrolyzing (1-->6) bonds than (1-->2) bonds of rhamnoglycosides, and may play an important role in the metabolism and pharmacological effect of rhamnoglycosides.

  3. Genomics and ecological overview of the genus Bifidobacterium.

    Science.gov (United States)

    Turroni, Francesca; van Sinderen, Douwe; Ventura, Marco

    2011-09-01

    Members of the genus Bifidobacterium are high G+C Gram positive bacteria belonging to the phylum Actinobacteria, and represent common inhabitants of the gastro-intestinal tract (GIT) of mammals, birds and certain cold-blooded animals. The overall microbial population that resides in the GIT, referred to as the "gut microbiota", is an extremely complex community of microorganisms whose functions are believed to have a significant impact on human physiology. Different ecological relationships between bifidobacteria and their host can be developed, ranging from opportunistic pathogenic interactions (e.g. in the case of Bifidobacterium dentium) to a commensal or even health-promoting relationship (e.g. in the case of Bifidobacterium bifidum and Bifidobacterium breve species). Among the known health-promoting or probiotic microorganisms, bifidobacteria represent one of the most dominant group and some bifidobacterial species are frequently used as the probiotic ingredient in many functional foods. However, despite the generally accepted importance of bifidobacteria as constituents of the human microbiota, there is only limited information available on their phylogeny, physiology and genetics. Moreover, host-microbiota interactions and cross-talk between different members of the gut microbiota are far from completely understood although they represent a crucial factor in the development and maintenance of human physiology and immune system. The aim of this review is to highlight the genetic and functional features of bifidobacteria residing in the human GIT using genomic and ecology-based information.

  4. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii.

    Science.gov (United States)

    Ramirez-Farias, Carlett; Slezak, Kathleen; Fuller, Zoë; Duncan, Alan; Holtrop, Grietje; Louis, Petra

    2009-02-01

    Prebiotics are food ingredients that improve health by modulating the colonic microbiota. The bifidogenic effect of the prebiotic inulin is well established; however, it remains unclear which species of Bifidobacterium are stimulated in vivo and whether bacterial groups other than lactic acid bacteria are affected by inulin consumption. Changes in the faecal microbiota composition were examined by real-time PCR in twelve human volunteers after ingestion of inulin (10 g/d) for a 16-d period in comparison with a control period without any supplement intake. The prevalence of most bacterial groups examined did not change after inulin intake, although the low G+C % Gram-positive species Faecalibacterium prausnitzii exhibited a significant increase (10.3% for control period v. 14.5% during inulin intake, P=0.019). The composition of the genus Bifidobacterium was studied in four of the volunteers by clone library analysis. Between three and five Bifidobacterium spp. were found in each volunteer. Bifidobacterium adolescentis and Bifidobacterium longum were present in all volunteers, and Bifidobacterium pseudocatenulatum, Bifidobacterium animalis, Bifidobacterium bifidum and Bifidobacterium dentium were also detected. Real-time PCR was employed to quantify the four most prevalent Bifidobacterium spp., B. adolescentis, B. longum, B. pseudocatenulatum and B. bifidum, in ten volunteers carrying detectable levels of bifidobacteria. B. adolescentis showed the strongest response to inulin consumption, increasing from 0.89 to 3.9% of the total microbiota (P=0.001). B. bifidum was increased from 0.22 to 0.63% (P<0.001) for the five volunteers for whom this species was present.

  5. Genetic analysis and morphological identification of pilus-like structures in members of the genus Bifidobacterium

    LENUS (Irish Health Repository)

    2011-08-30

    Abstract Background Cell surface pili in Gram positive bacteria have been reported to orchestrate the colonization of host tissues, evasion of immunity and the development of biofilms. So far, little if any information is available on the presence of pilus-like structures in human gut commensals like bifidobacteria. Results and discussion In this report, Atomic Force Microscopy (AFM) of various bifidobacterial strains belonging to Bifidobacterium bifidum, Bifidobacterium longum subsp. longum, Bifidobacterium dentium, Bifidobacterium adolescentis and Bifidobacterium animalis subsp. lactis revealed the existence of appendages resembling pilus-like structures. Interestingly, these microorganisms harbour two to six predicted pilus gene clusters in their genome, with each organized in an operon encompassing the major pilin subunit-encoding gene (designated fimA or fimP) together with one or two minor pilin subunit-encoding genes (designated as fimB and\\/or fimQ), and a gene encoding a sortase enzyme (strA). Quantitative Real Time (qRT)-PCR analysis and RT-PCR experiments revealed a polycistronic mRNA, encompassing the fimA\\/P and fimB\\/Q genes, which are differentially expressed upon cultivation of bifidobacteria on various glycans.

  6. Characterization of fructose 6 phosphate phosphoketolases purified from Bifidobacterium species.

    Science.gov (United States)

    Grill, J P; Crociani, J; Ballongue, J

    1995-07-01

    Fructose 6 phosphate phosphoketolases (F6PPKs) were purified from Bifidobacterium longum BB536, B. dentium ATCC 27534, B. globosum ATCC 25864, and Bifidobacterium animalis ATCC 25527. Concerning ions (Cu++, Zn++, Ca++, Mg++, Fe++, Co++, Mn++) and common enzyme inhibitors (fructose, ammonium sulfate, iodoacetate, and parachloromercuribenzoic acid), no difference appeared between the enzymes. Cu++, parachloromercuribenzoic acid (pCMB), and mercuric acetate induced high enzymatic inhibition. The study of pCMB demonstrated a noncompetitive inhibition. Additional results showed that the sulfhydryl group was not involved in catalytic reaction. Photooxidation experiments and determination of ionizable group pKas (5.16-7.17) suggested the presence of one or more histidines necessary for the catalytic reaction and explained the inhibition observed with pCMB. In light of the noncompetitive inhibition, this group was not directly involved in substrate binding. Determination of Km demonstrated that the affinities for fructose 6 phosphate in the case of animal and human origin strains were close. In addition, the same enzymatic efficiency (Kcat/Km) was obtained for each strain. The F6PPK activity was regulated by sodium pyrophosphate, ATP, and especially by ADP.

  7. Imbalances in faecal and duodenal Bifidobacterium species composition in active and non-active coeliac disease

    Directory of Open Access Journals (Sweden)

    Sanz Yolanda

    2008-12-01

    Full Text Available Abstract Background Gut bifidobacteria are believed to influence immune-related diseases. The objective of this study was to assess the possible relationships between the gut bifidobacteria composition and coeliac disease (CD in children. A total of 48 faecal samples (30 and 18 samples from active and no active CD patients, respectively and 33 duodenal biopsy specimens of CD patients (25 and 8 samples from active and non-active CD patients, respectively were analysed. Samples (30 faecal samples and 8 biopsies from a control age-matched group of children were also included for comparative purposes. Gut Bifidobacterium genus and species were analyzed by real-time PCR. Results Active and non-active CD patients showed lower numbers of total Bifidobacterium and B. longum species in faeces and duodenal biopsies than controls, and these differences were particularly remarkable between active CD patients and controls. B. catenulatum prevalence was higher in biopsies of controls than in those of active and non-active CD patients, whereas B. dentium prevalence was higher in faeces of non-active CD patients than in controls. Correlations between levels of Bifidobacterium and B. longum species in faecal and biopsy samples were detected in both CD patients and controls. Conclusion Reductions in total Bifidobacterium and B. longum populations were associated with both active and non-active CD when compared to controls. These bacterial groups could constitute novel targets for adjuvant dietary therapies although the confirmation of this hypothesis would require further investigations.

  8. Constructed a cell line to express hBD1 stablly and detected the antimicrobial activity of hBD1 to multidrug resistant bacterial strains%hBD1稳定表达细胞株的建立及其表达产物对多重耐药菌的活性检测

    Institute of Scientific and Technical Information of China (English)

    崔南; 陈新年; 魏莲花; 李娟; 邹凤梅

    2011-01-01

    目的 构建人β防御素1( hBD1)稳定表达细胞株并检测其对多种多重耐药菌的抗菌活性.方法 将重组质粒pCMV-hBD1通过阳离子脂质体转染于非洲绿猴SV40转化的肾细胞(COS-7细胞),经过G418压力筛选后获得单克隆细胞株;提取细胞总RNA,用RT-PCR检测目的基因在转录水平的表达;收集细胞培养上清液,用Western blot检测hBD1基因蛋白的表达;将含有表达产物hBD1的细胞培养上清液分别同各耐药菌液混合,37℃孵育不同时间后涂布于LB平板,以各实验组和对照组的菌落数的比值作为该耐药菌的存活率.结果 经过G418压力筛选所得到的稳定表达细胞株,在转录水平和蛋白水平均检测到目的基因hBD1的表达,在表达产物hBD1的作用下,多重耐药鲍氏不动杆菌、多重耐药大肠埃希菌存活率和多重耐药肺炎克雷伯杆菌的存活率可以分别降至9%、22%和50%,多重耐药嗜麦芽窄食单胞菌的存活率同对照组没有明显差异.结论 成功获得hBD1稳定表达细胞株,目的基因hBD1的表达产物对多种多重耐药菌均具有抗菌活性.%Objective To established a cell line that expresses hBD1 stably,and detected the antimicrobial activity of the hBD1 to the muhidrug resistant bacterial strains.Methods Recombinant plasmid was introduced into COS-7 cells by lipofectamine,cells were selected in culture medium containing G418 to acquired the monoclonal cell lines,total RNA were extracted from the cultured cells,expression levels of hBD1 mRNA was identified by RT-PCR,collected the supernatant solution of the cultured cell,expression levels of protein was identified by Western blot.Put the expression products and resistant organisms mixed together,after incubation in different times in 37℃,coating the mixtures in LB flat,then obtained the ratios between colonies number of experimental groups and colonies number of control groups,put those ratios as the survival rate of the drug

  9. GABA production and structure of gadB/gadC genes in Lactobacillus and Bifidobacterium strains from human microbiota.

    Science.gov (United States)

    Yunes, R A; Poluektova, E U; Dyachkova, M S; Klimina, K M; Kovtun, A S; Averina, O V; Orlova, V S; Danilenko, V N

    2016-12-01

    Gamma-amino butyric acid (GABA) is an active biogenic substance synthesized in plants, fungi, vertebrate animals and bacteria. Lactic acid bacteria are considered the main producers of GABA among bacteria. GABA-producing lactobacilli are isolated from food products such as cheese, yogurt, sourdough, etc. and are the source of bioactive properties assigned to those foods. The ability of human-derived lactobacilli and bifidobacteria to synthesize GABA remains poorly characterized. In this paper, we screened our collection of 135 human-derived Lactobacillus and Bifidobacterium strains for their ability to produce GABA from its precursor monosodium glutamate. Fifty eight strains were able to produce GABA. The most efficient GABA-producers were Bifidobacterium strains (up to 6 g/L). Time profiles of cell growth and GABA production as well as the influence of pyridoxal phosphate on GABA production were studied for L. plantarum 90sk, L. brevis 15f, B. adolescentis 150 and B. angulatum GT102. DNA of these strains was sequenced; the gadB and gadC genes were identified. The presence of these genes was analyzed in 14 metagenomes of healthy individuals. The genes were found in the following genera of bacteria: Bacteroidetes (Bacteroides, Parabacteroides, Alistipes, Odoribacter, Prevotella), Proteobacterium (Esherichia), Firmicutes (Enterococcus), Actinobacteria (Bifidobacterium). These data indicate that gad genes as well as the ability to produce GABA are widely distributed among lactobacilli and bifidobacteria (mainly in L. plantarum, L. brevis, B. adolescentis, B. angulatum, B. dentium) and other gut-derived bacterial species. Perhaps, GABA is involved in the interaction of gut microbiota with the macroorganism and the ability to synthesize GABA may be an important feature in the selection of bacterial strains - psychobiotics.

  10. Characterization of the NTPR and BD1 interacting domains of the human PICH-BEND3 complex

    DEFF Research Database (Denmark)

    Pitchai, Ganesha P; Hickson, Ian D; Streicher, Werner

    2016-01-01

    Chromosome integrity depends on DNA structure-specific processing complexes that resolve DNA entanglement between sister chromatids. If left unresolved, these entanglements can generate either chromatin bridging or ultrafine DNA bridging in the anaphase of mitosis. These bridge structures...... are defined by the presence of the PICH protein, which interacts with the BEND3 protein in mitosis. To obtain structural insights into PICH-BEND3 complex formation at the atomic level, their respective NTPR and BD1 domains were cloned, overexpressed and crystallized using 1.56 M ammonium sulfate...

  11. Construction of Eukaryotic Expression Vector with mBD1-mBD3 Fusion Genes and Exploring Its Activity against Influenza A Virus

    Directory of Open Access Journals (Sweden)

    Wanyi Li

    2014-03-01

    Full Text Available Influenza (flu pandemics have exhibited a great threat to human health throughout history. With the emergence of drug-resistant strains of influenza A virus (IAV, it is necessary to look for new agents for treatment and transmission prevention of the flu. Defensins are small (2–6 kDa cationic peptides known for their broad-spectrum antimicrobial activity. Beta-defensins (β-defensins are mainly produced by barrier epithelial cells and play an important role in attacking microbe invasion by epithelium. In this study, we focused on the anti-influenza A virus activity of mouse β-defensin 1 (mBD1 and β defensin-3 (mBD3 by synthesizing their fusion peptide with standard recombinant methods. The eukaryotic expression vectors pcDNA3.1(+/mBD1-mBD3 were constructed successfully by overlap-PCR and transfected into Madin-Darby canine kidney (MDCK cells. The MDCK cells transfected by pcDNA3.1(+/mBD1-mBD3 were obtained by G418 screening, and the mBD1-mBD3 stable expression pattern was confirmed in MDCK cells by RT-PCR and immunofluorescence assay. The acquired stable transfected MDCK cells were infected with IAV (A/PR/8/34, H1N1, 0.1 MOI subsequently and the virus titers in cell culture supernatants were analyzed by TCID50 72 h later. The TCID50 titer of the experimental group was clearly lower than that of the control group (p < 0.001. Furthermore, BALB/C mice were injected with liposome-encapsulated pcDNA3.1(+/mBD1-mBD3 through muscle and then challenged with the A/PR/8/34 virus. Results showed the survival rate of 100% and lung index inhibitory rate of 32.6% in pcDNA3.1(+/mBD1-mBD3group; the TCID50 titer of lung homogenates was clearly lower than that of the control group (p < 0.001. This study demonstrates that mBD1-mBD3 expressed by the recombinant plasmid pcDNA3.1(+/mBD1-mBD3 could inhibit influenza A virus replication both in vitro and in vivo. These observations suggested that the recombinant mBD1-mBD3 might be developed into an agent for

  12. In vivo Cigarette Smoke Exposure Decreases CCL20, SLPI, and BD-1 Secretion by Human Primary Nasal Epithelial Cells

    Science.gov (United States)

    Jukosky, James; Gosselin, Benoit J.; Foley, Leah; Dechen, Tenzin; Fiering, Steven; Crane-Godreau, Mardi A.

    2016-01-01

    Smokers and individuals exposed to second-hand cigarette smoke have a higher risk of developing chronic sinus and bronchial infections. This suggests that cigarette smoke (CS) has adverse effects on immune defenses against pathogens. Epithelial cells are important in airway innate immunity and are the first line of defense against infection. Airway epithelial cells not only form a physical barrier but also respond to the presence of microbes by secreting antimicrobials, cytokines, and chemokines. These molecules can lyse infectious microorganisms and/or provide signals critical to the initiation of adaptive immune responses. We examined the effects of CS on antimicrobial secretions of primary human nasal epithelial cells (PHNECs). Compared to non-CS-exposed individuals, PHNEC from in vivo CS-exposed individuals secreted less chemokine ligand (C-C motif) 20 (CCL20), Beta-defensin 1 (BD-1), and SLPI apically, less BD-1 and SLPI basolaterally, and more CCL20 basolaterally. Cigarette smoke extract (CSE) exposure in vitro decreased the apical secretion of CCL20 and beta-defensin 1 by PHNEC from non-CS-exposed individuals. Exposing PHNEC from non-CS exposed to CSE also significantly decreased the levels of many mRNA transcripts that are involved in immune signaling. Our results show that in vivo or in vitro exposure to CS alters the secretion of key antimicrobial peptides from PHNEC, but that in vivo CS exposure is a much more important modifier of antimicrobial peptide secretion. Based on the gene expression data, it appears that CSE disrupts multiple immune signaling pathways in PHNEC. Our results provide mechanistic insight into how CS exposure alters the innate immune response and increases an individual’s susceptibility to pathogen infection. PMID:26793127

  13. Svingningsteori, Bd. 1

    DEFF Research Database (Denmark)

    Nielsen, Søren R. K.

    Nærværende lærebog er skrevet med henblik på undervisningen i lineær svingingsteori på konstruktionsliniens 8. semester på Aalborg Universitetscenter. Det pågældende kursus danner grundlaget for efterfølgende undervisning i ikke-lineær svingningsteori, hvilket har påvirket fremstillingens form. D...

  14. High level expression of human epithelial β-defensins (hBD-1, 2 and 3 in papillomavirus induced lesions

    Directory of Open Access Journals (Sweden)

    Chong Kong T

    2006-09-01

    Full Text Available Abstract Background Epithelial defensins including human β-defensins (hBDs and α-defensins (HDs are antimicrobial peptides that play important roles in the mucosal defense system. However, the role of defensins in papillomavirus induced epithelial lesions is unknown. Results Papilloma tissues were prospectively collected from 15 patients with recurrent respiratory papillomatosis (RRP and analyzed for defensins and chemokine IL-8 expression by quantitative, reverse-transcriptase polymerase chain reaction (RT-PCR assays. HBD-1, -2 and -3 mRNAs were detectable in papilloma samples from all RRP patients and the levels were higher than in normal oral mucosal tissues from healthy individuals. Immunohistochemical analysis showed that both hBD-1 and 2 were localized in the upper epithelial layers of papilloma tissues. Expression of hBD-2 and hBD-3 appeared to be correlated as indicated by scatter plot analysis (r = 0.837, p Conclusion Human β-defensins are upregulated in respiratory papillomas. This novel finding suggests that hBDs might contribute to innate and adaptive immune responses targeted against papillomavirus-induced epithelial lesions.

  15. Immune effects of the probiotic Bifidobacterium breve

    NARCIS (Netherlands)

    Ezendam J; van Loveren H; TOX

    2007-01-01

    Bifidobacterium breve, een probiotische bacterie, heeft gunstige effecten op zowel allergieen als autoimmuniteit - een afweerreactie op lichaamseigen bestanddelen - bij proefdieren. Probiotica worden in reclameboodschappen ook wel 'goede bacterien' genoemd. Fabrikanten claimen een positi

  16. Molecular Docking Study Characterization of Rare Flavonoids at the Nac-Binding Site of the First Bromodomain of BRD4 (BRD4 BD1

    Directory of Open Access Journals (Sweden)

    Karthik Dhananjayan

    2015-01-01

    Full Text Available ε-N-Acetylation of lysine residues (Kac is one of the most frequently occurring posttranslational modifications (PTMs which control gene transcription and a vast array of diverse cellular functions. Bromodomains are epigenetic regulators involved in posttranslational modification. In silico docking studies were carried out to evaluate the binding potential of selected rare flavonoids on to Nac binding site of BD1 domain of BRD4 BET family proteins. Rare flavonoids like 3-O-acetylpinobanksin, naringenin triacetate, and kaempferol tetraacetate were found to occupy the WPF shelf and at the same time they exhibited a better binding affinity with multiple crystal structures of first bromodomain BRD4 (BRD4 BD1 when compared with the known inhibitors.

  17. Bifidobacterium reuteri sp. nov., Bifidobacterium callitrichos sp. nov., Bifidobacterium saguini sp. nov., Bifidobacterium stellenboschense sp. nov. and Bifidobacterium biavatii sp. nov. isolated from faeces of common marmoset (Callithrix jacchus) and red-handed tamarin (Saguinus midas).

    Science.gov (United States)

    Endo, Akihito; Futagawa-Endo, Yuka; Schumann, Peter; Pukall, Rüdiger; Dicks, Leon M T

    2012-03-01

    Five strains of bifidobacteria were isolated from faeces of a common marmoset (Callithrix jacchus) and a red-handed tamarin (Saguinus midas). The five isolates clustered inside the phylogenetic group of the genus Bifidobacterium but did not show high sequence similarities between the isolates and to known species in the genus by phylogenetic analysis based on 16S rRNA gene sequences. Sequence analyses of dnaJ1 and hsp60 also indicated their independent phylogenetic positions to each other in the Bifidobacterium cluster. DNA G+C contents of the species ranged from 57.3 to 66.3 mol%, which is within the values recorded for Bifidobacterium species. All isolates showed fructose-6-phosphate phosphoketolase activity. Based on the data provided, the five isolates represent five novel species, for which the names Bifidobacterium reuteri sp. nov. (type strain: AFB22-1(T) = JCM 17295(T) = DSM 23975(T)), Bifidobacterium callitrichos sp. nov. (type strain: AFB22-5(T) = JCM 17296(T) = DSM 23973(T)), Bifidobacterium saguini sp. nov. (type strain: AFB23-1(T) = JCM 17297(T) = DSM 23967(T)), Bifidobacterium stellenboschense sp. nov. (type strain: AFB23-3(T) = JCM 17298(T) = DSM 23968(T)) and Bifidobacterium biavatii sp. nov. (type strain: AFB23-4(T) = JCM 17299(T) = DSM 23969(T)) are proposed.

  18. Fritz-Peter Hager/Daniel Tröhler (Hrsg.): Neue Pestalozzi-Studien. Bd. 1: Anna Pestalozzis Tagebuch - Käte Silber: Anna Pestalozzi und der Frauenkreis um Pestalozzi. Bern/Stuttgart: Haupt 1993 [Rezension

    OpenAIRE

    Liedtke, Max

    1994-01-01

    Rezension von: Fritz-Peter Hager/Daniel Tröhler (Hrsg.): Neue Pestalozzi-Studien. Bd. 1: Anna Pestalozzis Tagebuch - Käte Silber: Anna Pestalozzi und der Frauenkreis um Pestalozzi. Bern/Stuttgart: Haupt 1993, 242 S.

  19. Comparative genomics of the Bifidobacterium breve taxon

    NARCIS (Netherlands)

    Bottacini, Francesca; O'Connell Motherway, Mary; Kuczynski, Justin; O'Connell, Kerry Joan; Serafini, Fausta; Duranti, Sabrina; Milani, Christian; Turroni, Francesca; Lugli, Gabriele Andrea; Zomer, Aldert; Zhurina, Daria; Riedel, Christian; Ventura, Marco; van Sinderen, Douwe

    2014-01-01

    BACKGROUND: Bifidobacteria are commonly found as part of the microbiota of the gastrointestinal tract (GIT) of a broad range of hosts, where their presence is positively correlated with the host's health status. In this study, we assessed the genomes of thirteen representatives of Bifidobacterium br

  20. Bile salt hydrolase of Bifidobacterium longum - Biochemical and genetic characterization

    NARCIS (Netherlands)

    Tanaka, H; Hashiba, Honoo; Kok, Jan; Mierau, Igor

    2000-01-01

    A bile salt hydrolase (BSH) was isolated from Bifidobacterium longum SBT2928, purified, and characterized, Furthermore, we describe for the first time cloning and analysis of the gene encoding BSII (bsh) in a member of the genus Bifidobacterium. The enzyme has a native molecular weight of 125,000 to

  1. Expression of beta-defensins pBD-1 and pBD-2 along the small tract of the pig: Lack of upregulation in vivo upon Salmonella typhimurium infection

    NARCIS (Netherlands)

    Veldhuizen, E.J.; Dijk, van A.; Tersteeg, M.H.; Kalkhove, S.I.; Meulen, van der J.; Niewold, T.A.; Haagsman, H.P.

    2007-01-01

    Defensins are antimicrobial peptides that play an important role in the innate immune response in the intestine. Up to date, only one ß-defensin (pBD-1), has been described in pig, which was found to be expressed at low levels in the intestine. We set-up a quantitative PCR method to detect the gene

  2. Hypocholesterolaemic effect of yoghurt containing Bifidobacterium pseudocatenulatum G4 or Bifidobacterium longum BB536.

    Science.gov (United States)

    Al-Sheraji, Sadeq Hasan; Ismail, Amin; Manap, Mohd Yazid; Mustafa, Shuhaimi; Yusof, Rokiah Mohd; Hassan, Fouad Abdulrahman

    2012-11-15

    The effect of a yoghurt supplement containing Bifidobacterium pseudocatenulatum G4 or Bifidobacterium longum BB536 on plasma lipids, lipid peroxidation and the faecal excretion of bile acids was examined in rats fed a cholesterol-enriched diet. After 8 weeks, the rats in the positive control (PC) group who were fed the cholesterol-enriched diet showed significant increases in plasma total cholesterol (TC), low-density lipoprotein (LDL) cholesterol, and malondialdehyde (MDA). However, groups fed a cholesterol-enriched diet supplemented with yoghurt containing B. pseudocatenulatum G4 or B. longum BB536 had significantly lower plasma TC, LDL-C, very-low-density lipoprotein (VLDL) cholesterol, and MDA than had the PC group after 8 weeks of treatment. In addition, faecal excretion of bile acids was markedly increased in the rats fed the yoghurt containing B. pseudocatenulatum G4 or B. longum BB536 as compared to the PC and NC groups.

  3. Comparative genomics of bifidobacterium, lactobacillus and related probiotic genera

    DEFF Research Database (Denmark)

    Lukjancenko, Oksana; Ussery, David; Wassenaar, Trudy M.

    2012-01-01

    Six bacterial genera containing species commonly used as probiotics for human consumption or starter cultures for food fermentation were compared and contrasted, based on publicly available complete genome sequences. The analysis included 19 Bifidobacterium genomes, 21 Lactobacillus genomes, 4...

  4. Bile resistance mechanisms in Lactobacillus and Bifidobacterium

    Directory of Open Access Journals (Sweden)

    Lorena eRuiz

    2013-12-01

    Full Text Available Probiotics are live microorganisms which when administered in adequate amounts confer a health benefit on the host. Most of the probiotic bacteria currently available in the market belong to the genera Lactobacillus and Bifidobacterium, and specific health-promoting activities, such as treatment of diarrhea or amelioration of gastrointestinal discomfort, have been attributed to them. In order to be able to survive the gastrointestinal transit and transiently colonise our gut, these bacteria must be able to counteract the deleterious action of bile salts, which are the main components of bile. Bile salts are detergent-like biological substances synthesised in the liver from cholesterol. Host enzymes conjugate the newly synthesised free bile acids in the liver with the amino acids glycine or taurine, generating conjugated bile salts. These compounds are stored in the gall bladder and they are released into the duodenum during digestion to perform their physiological function, which is the solubilisation of fat coming from diet. These bile salts possess strong antimicrobial activity, since they are able to disorganize the structure of the cell membrane, as well as trigger DNA damage. This means that bacteria inhabiting our intestinal tract must have intrinsic resistance mechanisms to cope with bile salts. To do that, Lactobacillus and Bifidobacterium display a variety of proteins devoted to the efflux of bile salts or protons, to modify sugar metabolism or to prevent protein misfolding. In this manuscript, we review and discuss specific bile resistance mechanisms, as well as the processes responsible for the adaptation of bifidobacteria and lactobacilli to bile.

  5. [Jörg Zägel (in Zusammenarbeit mit Reiner Steinweg). Vergangenheitsdiskurse in der Ostseeregion. Bd. 1. Auseinandersetzungen in den nordischen Staaten über Krieg. Völkermord, Diktatur, Besatzung und Vertreibung; B. 2 : Die Sicht auf Krieg, Diktat

    Index Scriptorium Estoniae

    Hecker-Stampehl, Jan

    2011-01-01

    Arvustus : Jörg Zägel (in Zusammenarbeit mit Reiner Steinweg). Vergangenheitsdiskurse in der Ostseeregion. Bd. 1. Auseinandersetzungen in den nordischen Staaten über Krieg. Völkermord, Diktatur, Besatzung und Vertreibung. Berlin : LIT Verlag, 2007. (Kieler Schriften zur Friedenswissenschaft. 14); Bd. 2 : Die Sicht auf Krieg, Diktatur, Völkermord, Besatsung und Vertreibung in Russland, Polen und den baltischen Staaten. Berlin: Lit Verlag, 2007. (Kieler Schriften zur Friedenswissenschaft. 15)

  6. Recoding of the stop codon UGA to glycine by a BD1-5/SN-2 bacterium and niche partitioning between Alpha- and Gammaproteobacteria in a tidal sediment microbial community naturally selected in a laboratory chemostat

    Energy Technology Data Exchange (ETDEWEB)

    Hanke, Anna [Max Planck Institute for Marine Microbiology; Hamann, Emmo [Max Planck Institute for Marine Microbiology; Sharma, Ritin [ORNL; Geelhoed, Jeanine [Max Planck Institute for Marine Microbiology; Hargesheimer, Theresa [Max Planck Institute for Marine Microbiology; Kraft, Beate [Max Planck Institute for Marine Microbiology; Meyer, Volker [Max Planck Institute for Marine Microbiology; Lenk, Sabine [Max Planck Institute for Marine Microbiology; Osmers, Harald [Max Planck Institute for Marine Microbiology; Wu, Rong [Delft University of Technology, Delft, Netherlands; Makinwa, Kofi [Delft University of Technology, Delft, Netherlands; Hettich, Robert {Bob} L [ORNL; Banfield, Jillian F. [University of California, Berkeley; Tegetmeyer, Halina [Max Planck Institute for Marine Microbiology; Strouss, Marc [University of Calgary, ALberta, Canada

    2014-01-01

    Sandy coastal sediments are global hot spots for microbial mineralization of organic matter and denitrification. These sediments are characterized by advective pore water flow, tidal cycling and an active and complex microbial community. Metagenomic sequencing of microbial communities sampled from such sediments showed that potential sulfuroxidizing Gammaproteobacteria and members of the enigmaticBD1-5/ SN-2 candidatephylumwereabundantinsitu (>10% and 2% respectively). By mimicking the dynamic oxic/anoxic environmental conditions of the sedimentin a laboratory chemostat, a simplified microbial community was selected from the more complex inoculum. Metagenomics, proteomics and fluorescenceinsituhybridization showed that this simplified community contained both a potential sulfuroxidizing Gamma proteobacteria (at 24 2% abundance) and a member of the BD1-5 / SN-2candidatephylum (at 7 6%abundance). Despite the abundant supply of organic substrates to the chemostat, proteomic analysis suggested that the selected gamma proteobacterium grew partially auto trophically and performed hydrogen/formate oxidation. The enrichment of a member of the BD1-5/SN-2candidatephylum enabled, for the first time, direct microscopic observation by fluorescent insitu hybridization and the experimental validation of the previously predicted translation of the stop codon UGA into glycine.

  7. [Surface proteins of bacteria of the genus Bifidobacterium].

    Science.gov (United States)

    Dylus, Ewa; Buda, Barbara; Górska-Frączek, Sabina; Brzozowska, Ewa; Gamian, Andrzej

    2013-05-13

    Beneficial effects due to the presence of probiotic bacteria of the genus Bifidobacterium in the human intestinal tract are still an interesting object of study. So far activities have been confirmed of bifidobacteria in stimulation of the host immune system, stimulation of tumor cell apoptosis, improvement of bowel motility, alleviation of symptoms of lactose intolerance, cholesterol lowering capacity, prevention and treatment of diarrhea and irritable bowel syndrome, alleviation of allergy or atopic dermatitis, maintenance of homeostasis of the intestine, and stimulation of the development of normal intestinal microflora in infants. A multitude of therapeutic properties encourages researchers to investigate the possibility of using the potential of Bifidobacterium in the prevention and treatment of other conditions such as rheumatoid arthritis and depression. Although it is known that the beneficial effects are due to intestinal mucosal colonization by these bacteria, the cell components responsible for the colonization are still not determined. In addition to the beneficial effects of probiotic administration, there were also negative effects including sepsis. Therefore research has been directed to identify specific components of Bifidobacterium responsible for probiotic effects. Currently researchers are focused on identifying, isolating and evaluating the properties of surface proteins that are probably involved in the adhesion of bacterial cells to the intestinal epithelium, improving colonization. This paper is an overview of current knowledge on Bifidobacterium surface proteins. The ways of transport and anchoring proteins in Gram-positive bacterial cells, the assembly of cell wall, and a description of the genus Bifidobacterium are presented.

  8. Transcriptional analysis of oligosaccharide utilization by Bifidobacterium lactis Bl-04

    DEFF Research Database (Denmark)

    Andersen, Joakim Mark; Barrangou, Rodolphe; Abou Hachem, Maher

    2013-01-01

    transcriptomes of Bifidobacterium animalis subsp. lactis Bl-04, induced by 11 potential prebiotic oligosaccharides were analyzed to identify the genetic loci involved in the uptake and catabolism of α- and β-linked hexoses, and β-xylosides. RESULTS: The overall transcriptome was modulated dependent on the type...... in the breadth and selectivity of prebiotic utilization by bifidobacteria. CONCLUSION: This study identified the differential gene expression for utilization of potential prebiotics highlighting the extensive capabilities of Bifidobacterium lactis Bl-04 to utilize oligosaccharides. Results provide insights...

  9. Mupirocin-mucin agar for selective enumeration of Bifidobacterium bifidum.

    Science.gov (United States)

    Pechar, Radko; Rada, Vojtech; Parafati, Lucia; Musilova, Sarka; Bunesova, Vera; Vlkova, Eva; Killer, Jiri; Mrazek, Jakub; Kmet, Vladimir; Svejstil, Roman

    2014-11-17

    Bifidobacterium bifidum is a bacterial species exclusively found in the human intestinal tract. This species is becoming increasingly popular as a probiotic organism added to lyophilized products. In this study, porcine mucin was used as the sole carbon source for the selective enumeration of B. bifidum in probiotic food additives. Thirty-six bifidobacterial strains were cultivated in broth with mucin. Only 13 strains of B. bifidum utilized the mucin to produce acids. B. bifidum was selectively enumerated in eight probiotic food supplements using agar (MM agar) containing mupirocin (100 mg/L) and mucin (20 g/L) as the sole carbon source. MM agar was fully selective if the B. bifidum species was presented together with Bifidobacterium animalis subsp. lactis, Bifidobacterium breve, and Bifidobacterium longum subsp. longum species and with lactic acid bacteria (lactobacilli, streptococci). Isolated strains of B. bifidum were identified using biochemical, PCR, MALDI-TOF procedures and 16S rRNA gene sequencing. The novel selective medium was also suitable for the isolation of B. bifidum strains from human fecal samples.

  10. Crystal structure of sucrose phosphorylase from Bifidobacterium adolescentis

    DEFF Research Database (Denmark)

    Sprogøe, Desiree; van den Broek, Lambertus A M; Mirza, Osman

    2004-01-01

    phosphorylase from Bifidobacterium adolescentis (BiSP) refined at 1.77 A resolution. It represents the first 3D structure of a sucrose phosphorylase and is the first structure of a phosphate-dependent enzyme from the glycoside hydrolase family 13. The structure of BiSP is composed of the four domains A, B, B...

  11. Complete genome sequence of Bifidobacterium bifidum S17.

    NARCIS (Netherlands)

    Zhurina, D.; Zomer, A.L.; Gleinser, M.; Brancaccio, V.F.; Auchter, M.; Waidmann, M.S.; Westermann, C.; Sinderen, D. van; Riedel, C.U.

    2011-01-01

    Here, we report on the first completely annotated genome sequence of a Bifidobacterium bifidum strain. B. bifidum S17, isolated from feces of a breast-fed infant, was shown to strongly adhere to intestinal epithelial cells and has potent anti-inflammatory activity in vitro and in vivo. The genome se

  12. Glycosyl hydrolases from Bifidobacterium adolescentis DSM20083. An overview

    NARCIS (Netherlands)

    Broek, van den L.A.M.; Hinz, S.W.A.; Beldman, G.; Doeswijk-Voragen, C.H.L.; Vincken, J.P.; Voragen, A.G.J.

    2005-01-01

    It is claimed that bifidobacteria have several health-promoting effects. To increase the amount of bifidobacteria in the colon the concept of probiotics and/or prebiotics can be applied. Bifidobacterium adolescentis is one of the main species of bifidobacteria in the gastro-intestinal tract of human

  13. Surface proteins of bacteria of the genus Bifidobacterium 

    Directory of Open Access Journals (Sweden)

    Ewa Dylus

    2013-05-01

    Full Text Available Beneficial effects due to the presence of probiotic bacteria of the genus Bifidobacterium in the human intestinal tract are still an interesting object of study. So far activities have been confirmed of bifidobacteria in stimulation of the host immune system, stimulation of tumor cell apoptosis, improvement of bowel motility, alleviation of symptoms of lactose intolerance, cholesterol lowering capacity, prevention and treatment of diarrhea and irritable bowel syndrome, alleviation of allergy or atopic dermatitis, maintenance of homeostasis of the intestine, and stimulation of the development of normal intestinal microflora in infants. A multitude of therapeutic properties encourages researchers to investigate the possibility of using the potential of Bifidobacterium in the prevention and treatment of other conditions such as rheumatoid arthritis and depression. Although it is known that the beneficial effects are due to intestinal mucosal colonization by these bacteria, the cell components responsible for the colonization are still not determined. In addition to the beneficial effects of probiotic administration, there were also negative effects including sepsis. Therefore research has been directed to identify specific components of Bifidobacterium responsible for probiotic effects. Currently researchers are focused on identifying, isolating and evaluating the properties of surface proteins that are probably involved in the adhesion of bacterial cells to the intestinal epithelium, improving colonization. This paper is an overview of current knowledge on Bifidobacterium surface proteins. The ways of transport and anchoring proteins in Gram-positive bacterial cells, the assembly of cell wall, and a description of the genus Bifidobacterium are presented.

  14. Resistance determinant erm(X) is borne by transposon Tn5432 in Bifidobacterium thermophilum and Bifidobacterium animals subsp. lactis

    NARCIS (Netherlands)

    Hoek, van A.H.A.M.; Mayrhofer, S.; Domig, K.J.; Aarts, H.J.M.

    2008-01-01

    The erm(X) gene from erythromycin- and clindamycin-resistant Bifidobacterium strains was characterised by polymerase chain reaction and sequence analysis, including flanking regions. Results suggest that the resistance determinant was part of transposon Tn5432 that has been described in several oppo

  15. Cloning and sequence analysis of Wadi sheep defensin sBD-1 gene and establishment and application of SYBR green Ⅰ real-time fluorescence quantitative PCR method%洼地绵羊防御素sBD-1基因克隆、序列分析及SYBR Green Ⅰ实时荧光定量检测方法的建立与应用

    Institute of Scientific and Technical Information of China (English)

    王金良; 郭显坡; 沈志强; 李敏; 任艳玲

    2011-01-01

    根据GenBank上登录的绵羊防御素基因序列,经多重比较后,设计1对引物,从洼地绵羊舌上皮组织中扩增到防御素sBD-1基因,克隆到pMD18-T载体中进行测序.结果表明,扩增基因全长215 bp,编码64个氨基酸.基因进化树分析表明,与蒙古绵羊sBD-1基因有较近的亲缘关系,核苷酸同源性为98.5%;而与黄牛的亲缘关系最远,核苷酸同源性84.6%.氨基酸序列分析表明,序列内无信号肽区域,具有3个潜在的抗原表位.以pMD18-T/sBD-1质粒为模板建立了sBD-1基因SYBR Green Ⅰ荧光定量PCR检测方法,核酸电泳、扩增动力学曲线、溶解曲线及重复性试验表明,检测方法具有良好的稳定性和特异性,得到的回归方程(R2=0.998)表明PCR产物量的对数值与起始模板量之间存在良好的线性关系,从舌、盲肠及输卵管等组织中可以进行有效的检测,检测灵敏度为83.9 copies/μL.该方法为进一步研究防御素sBD-1基因在洼地绵羊抗逆性过程中的作用奠定了基础.%According to the published gene sequences of defensin gene of sheep on GenBank,one pair of primers were designed and defensin Sbd-1 gene was amplified by RT-PCR from tongue epithelial tissue of Wadi sheep. PCR product was cloned into the Pmd18-T vector and sequenced. The results showed that gene amplication of full-length was 215 bp, encoding 64 amino acids. Phylogenetic tree analysis showed that Wadi sheep and Menggu sheep had close phylogenetic relationship,nucleotide homology was 98. 5%;kinship with the Bos taurus as far as the nucleotide ho-mology of 84. 6%. Amino acid sequence analysis showed no signal peptide amino acid sequence in the region, with three potential antigenic epitopes. Sbd-1 gene SYBR Green I fluorescence quantitative PCR method was set up u-sing Pmd18-T/Sbd-l plasmid as a template. Nucleic acid electrophoresis,amplification kinetics,dissolution curve and repeatability tests showed that the methods had good stability and

  16. Genomic encyclopedia of type strains of the genus Bifidobacterium.

    Science.gov (United States)

    Milani, Christian; Lugli, Gabriele Andrea; Duranti, Sabrina; Turroni, Francesca; Bottacini, Francesca; Mangifesta, Marta; Sanchez, Borja; Viappiani, Alice; Mancabelli, Leonardo; Taminiau, Bernard; Delcenserie, Véronique; Barrangou, Rodolphe; Margolles, Abelardo; van Sinderen, Douwe; Ventura, Marco

    2014-10-01

    Bifidobacteria represent one of the dominant microbial groups that are present in the gut of various animals, being particularly prevalent during the suckling stage of life of humans and other mammals. However, the overall genome structure of this group of microorganisms remains largely unexplored. Here, we sequenced the genomes of 42 representative (sub)species across the Bifidobacterium genus and used this information to explore the overall genetic picture of this bacterial group. Furthermore, the genomic data described here were used to reconstruct the evolutionary development of the Bifidobacterium genus. This reconstruction suggests that its evolution was substantially influenced by genetic adaptations to obtain access to glycans, thereby representing a common and potent evolutionary force in shaping bifidobacterial genomes.

  17. Bovine milk osteopontin - Targeting bacterial adhesion for biofilm control

    DEFF Research Database (Denmark)

    Kristensen, Mathilde Frost; Meyer, Rikke Louise; Schlafer, Sebastian

    performed in technical and biological duplicates. Bifidobacterium dentium, Rothia dentocariosa and Streptococcus mutans did not adhere to the flow cell, irrespective of the presence of osteopontin. Osteopontin reduced the adhesion of Actinomyces naeslundii, Actinomyces viscosus, Lactobacillus paracasei...

  18. Purification and Characterization of Conjugated Bile Salt Hydrolase from Bifidobacterium longum BB536

    OpenAIRE

    Grill, J; Schneider, F.; Crociani, J.; Ballongue, J.

    1995-01-01

    Bifidobacterium species deconjugate taurocholic, taurodeoxycholic, taurochenodeoxycholic, glycocholic, glycodeoxycholic, and glycochenodeoxycholic acids. The enzyme level increases in the growth phase. No increase in activity is observed for the cytoplasmic enzyme after addition of conjugated bile acids to a stationary-phase culture. Conjugated bile salt hydrolase (BSH) was purified from Bifidobacterium longum BB536. Its apparent molecular mass in denaturing polyacrylamide gel electrophoresis...

  19. A Bifidobacterium mixed-species microarray for high resolution discrimination between intestinal bifidobacteria

    NARCIS (Netherlands)

    Boesten, R.J.; Schuren, F.H.; Vos, de W.M.

    2009-01-01

    A genomic DNA-based microarray was constructed containing over 6000 randomly cloned genomic fragments of approximately 1-2 kb from six mammalian intestinal Bifidobacterium spp. including B. adolescentis, B. animalis, B. bifidum, B. catenulatum, B. longum and B. pseudolongum. This Bifidobacterium Mix

  20. A convenient and reproducible method to genetically transform bacteria of the genus Bifidobacterium

    NARCIS (Netherlands)

    Argnani, A.; Leer, R.J.; Luijk, N. van; Pouwels, P.H.

    1996-01-01

    A protocol was developed for the introduction of foreign plasmid DNA into various Bifidobacterium strains. The method, which is applicable to all Bifidobacterium species tested so far, is based on electroporation of bacteria made competent by preincubation in electroporation buffer for several hours

  1. Bioconversion of soy isoflavones daidzin and daidzein by Bifidobacterium strains.

    Science.gov (United States)

    Raimondi, Stefano; Roncaglia, Lucia; De Lucia, Marzia; Amaretti, Alberto; Leonardi, Alan; Pagnoni, Ugo Maria; Rossi, Maddalena

    2009-01-01

    Twenty-two strains of Bifidobacterium, representative of eight major species of human origin, were screened for their ability to transform the isoflavones daidzin and daidzein. Most of the strains released the aglycone from daidzin and 12 gave yields higher than 90%. The kinetics of growth, daidzin consumption, and daidzein production indicated that the hydrolytic activity occurred during the growth. The supernatant of the majority of the strains did not release the aglycone from daidzin, suggesting that cell-associated beta-glucosidases (beta-Glu) are mainly responsible for the metabolism of soybean glyco-conjugates. Cell-associated beta-Glu was mainly intracellular and significantly varied among the species and the strains. The lack of beta-Glu was correlated with the inability to hydrolyze daidzin. Although S-equol production by anaerobic intestinal bacteria has been established, information on S-equol-producing bifidobacteria is contradictory. In this study, 22 bifidobacteria failed to transform daidzein into reduced metabolites under all the experimental conditions, excluding any role in the reductive pathway of daidzein toward the production of S-equol. These results suggest that selected probiotic strains of Bifidobacterium can be used to speed up the release of daidzein, improving its bioavailability for absorption by colonic mucosa and/or biotransformation to S-equol by other intestinal microorganisms.

  2. Emulsifying, rheological and physicochemical properties of exopolysaccharide produced by Bifidobacterium longum subsp. infantis CCUG 52486 and Bifidobacterium infantis NCIMB 702205.

    Science.gov (United States)

    Prasanna, P H P; Bell, A; Grandison, A S; Charalampopoulos, D

    2012-09-01

    The rheological, emulsification and certain physicochemical properties of purified exopolysaccharides (EPS) of Bifidobacterium longum subsp. infantis CCUG 52486 and Bifidobacterium infantis NCIMB 702205 were studied and compared with those of guar gum and xanthan gum. The two strains were grown in skim milk supplemented with 1.5% (w/v) casein hydrolysate at 37 °C for 24h; they both produced heteropolysaccharides with different molecular mass and composition. The carbohydrate content of both polymers was more than 92% and no protein was detected. The EPS of B. longum subsp. infantis CCUG 52486 showed highly branched entangled porous structure under scanning electron microscopy. Higher intrinsic viscosity was observed for the EPS of B. longum subsp. infantis CCUG 52486 compared to the EPS of B. infantis NCIMB 702205 and guar gum. Both polymers showed pseudoplastic non-Newtonian fluid behaviour in an aqueous solution. The EPS of B. infantis NCIMB 702205 and B. longum subsp. infantis CCUG 52486 produced more stable emulsions with orange oil, sunflower seed oil, coconut oil and xylene compared to guar and xanthan gum. The EPS of B. longum subsp. infantis CCUG 52486 is the most promising one for applications in the food industry, as it had higher intrinsic viscosity, higher apparent viscosity in aqueous solution, porous dense entangled structure and good emulsification activity.

  3. A genome-based identification approach for members of the genus Bifidobacterium.

    Science.gov (United States)

    Ferrario, Chiara; Milani, Christian; Mancabelli, Leonardo; Lugli, Gabriele Andrea; Turroni, Francesca; Duranti, Sabrina; Mangifesta, Marta; Viappiani, Alice; Sinderen, Douwe van; Ventura, Marco

    2015-03-01

    During recent years, the significant and increasing interest in novel bifidobacterial strains with health-promoting characteristics has catalyzed the development of methods for efficient and reliable identification of Bifidobacterium strains at (sub) species level. We developed an assay based on recently acquired bifidobacterial genomic data and involving 98 primer pairs, called the Bifidobacterium-ampliseq panel. This panel includes multiplex PCR primers that target both core and variable genes of the pangenome of this genus. Our results demonstrate that the employment of the Bifidobacterium-ampliseq panel allows rapid and specific identification of the so far recognized 48 (sub)species harboring the Bifidobacterium genus, and thus represents a cost- and time-effective bifidobacterial screening methodology.

  4. Inhibitory activity of Bifidobacterium adolescent combined with cisplatin on melanoma in mice and its mechanism

    Institute of Scientific and Technical Information of China (English)

    2008-01-01

    The aim of this study is to explore inhibitory activity of Bifidobacterium adolescent combined with cisplatin on the growth of melanoma(B16)in mice and the underlying mechanism.C57 mice were inoculated with B16 cancer cells to construct mouse model of melanoma and treated with bifidobacterium adolescent combined with cisplatin.Ratios of inhibitory activity on the growth of melanoma(B 16)were calculated.Pathology changes of the tumor were observed by HE staining.B 16 cell cycles were examined on a flow cytometer.Lymphocyte proliferation was measured with MTT assay and the T-cell subset was measured by double marked fluorescence.When bifidobacterium of 1010 cfu/L was injected,the ratio of inhibitory activity on the growth of melanoma(B16)reached 54%,which was similar to that of cisplatin group.The ratio of inhibitory activity reached 74.45% when the mice were treated by bifidobacterium combined with cisplatin,HE staining shows that bifidobacterium inhibited B16 cell proliferation and enhanced the cisplati(n)s killing activity on B16 cells.The results of flow cytometry demonstrated that B16 cell proliferation was arrested at G1 stage after treatment with bifidobacterium.The B16 cell proliferation was arrested at S stage after treatment with cisplatin.The CD4+ percentage increased and the difference was significant compared with the normal group after treatment with bifidobacterium,indicating that T-cell immune activity was enhanced.Treatment with bifidobacterium combined with cisplatin can enhance the inhibitory activity on the growth of melanoma(B16)of cisplatin.The mechanism of the inhibitory activity on B 16 cell proliferation is correlated with the enhanced immune activity in mice.

  5. Bifidobacterium in the gut microbiota confer resilience to chronic social defeat stress in mice.

    Science.gov (United States)

    Yang, Chun; Fujita, Yuko; Ren, Qian; Ma, Min; Dong, Chao; Hashimoto, Kenji

    2017-04-03

    Accumulating evidence suggests that abnormalities in the composition of the gut microbiota may play a role in the pathogenesis of depression. Although approximately 30% mice are resilient to chronic social defeat stress (CSDS), the role of gut microbiota in this stress resilience is unknown. In this study, male C57BL/6 mice were exposed to a different CD1 aggressor mouse for 10 min on 10 consecutive days. A social interaction test was applied to distinguish between resilient and susceptible mice. Using 16S rRNA analysis, we examined the composition of gut microbiota in feces from control, resilient, and susceptible mice. The marked appearance of Bifidobacterium was detected in the resilient mice, whereas in the control and susceptible mice, Bifidobacterium were below the detection limit. Oral intake of Bifidobacterium significantly increased the number of resilient mice after CSDS compared with vehicle-treated mice. These findings suggest that Bifidobacterium may confer resilience to CSDS. Therefore, supplementation of Bifidobacterium may prevent the onset of depression from stress in humans. In addition, supplementation of Bifidobacterium may prevent or minimize relapse from remission induced by inflammation and/or stress in depressed patients.

  6. Bifidobacterium in the gut microbiota confer resilience to chronic social defeat stress in mice

    Science.gov (United States)

    Yang, Chun; Fujita, Yuko; Ren, Qian; Ma, Min; Dong, Chao; Hashimoto, Kenji

    2017-01-01

    Accumulating evidence suggests that abnormalities in the composition of the gut microbiota may play a role in the pathogenesis of depression. Although approximately 30% mice are resilient to chronic social defeat stress (CSDS), the role of gut microbiota in this stress resilience is unknown. In this study, male C57BL/6 mice were exposed to a different CD1 aggressor mouse for 10 min on 10 consecutive days. A social interaction test was applied to distinguish between resilient and susceptible mice. Using 16S rRNA analysis, we examined the composition of gut microbiota in feces from control, resilient, and susceptible mice. The marked appearance of Bifidobacterium was detected in the resilient mice, whereas in the control and susceptible mice, Bifidobacterium were below the detection limit. Oral intake of Bifidobacterium significantly increased the number of resilient mice after CSDS compared with vehicle-treated mice. These findings suggest that Bifidobacterium may confer resilience to CSDS. Therefore, supplementation of Bifidobacterium may prevent the onset of depression from stress in humans. In addition, supplementation of Bifidobacterium may prevent or minimize relapse from remission induced by inflammation and/or stress in depressed patients. PMID:28368029

  7. Performances of new isolates of Bifidobacterium on fermentation of soymilk.

    Science.gov (United States)

    Havas, Petra; Kun, Szilárd; Perger-Mészáros, Izabell; Rezessy-Szabó, Judit M; Nguyen, Quang D

    2015-12-01

    Growth and metabolic activity of several new, human origin isolates of Bifidobacterium strains were investigated. All tested bifidobacteria strains were grown well on the native soymilk medium without any additional nutrients. The fermentation processes cultured with initial cell concentrations in 10⁵ -10⁷ cfu/ml resulted in 10⁸ cfu/ml after 8-12 h of incubation in soymilk, and were kept viable up to the end of fermentation (48 h). Volumetric productivities of B. bifidum B3.2, B. bifidum B7.1 and B. breve B9.14 were 1.6 × 10¹⁰ cfu/L.h, 4.5 × 10¹⁰ cfu/L.h and 7.6 × 10⁹ cfu/L.h, respectively, whereas these values of B. lactis Bb-12 and B. longum Bb-46 probiotic strains were 2.7 × 10⁹ cfu/L.h and 1.0 x 10¹⁰ cfu/L.h. The α-galactosidase activities were also detected in the intracellular fraction of the disrupted cells. Productions of lactic and acetic acids were in the range of 23-60 mmol/L and 2.4-5.6 mmol/L, respectively. Molar ratios of acetate to lactate in all tested strains varied from 0.05-0.1 that are very promising for further technological development of probiotic fermented soy-based food products.

  8. Exploring amino acid auxotrophy in Bifidobacterium bifidum PRL2010

    Directory of Open Access Journals (Sweden)

    Chiara eFerrario

    2015-11-01

    Full Text Available The acquisition and assimilation strategies followed by members of the infant gut microbiota to retrieve nitrogen from the gut lumen are still largely unknown. In particular, no information on these metabolic processes is available regarding bifidobacteria, which are among the first microbial colonizers of the human intestine. Here, evaluation of amino acid auxotrophy and prototrophy of Bifidobacterium bifidum, with particular emphasis on B. bifidum strain PRL2010 (LMG S-28692, revealed a putative auxotrophy for cysteine. In addition, we hypothesized that cysteine plays a role in the oxidative stress response in B. bifidum. The use of glutathione as an alternative reduced sulfur compound did not alleviate cysteine auxotrophy of this strain, though it was shown to stimulate expression of the genes involved in cysteine biosynthesis, reminiscent of oxidative stress response. When PRL2010 was grown on a medium containing complex substrates, such as whey proteins or casein hydrolysate, we noticed a distinct growth-promoting effect of these compounds. Transcriptional analysis involving B. bifidum PRL2010 cultivated on whey proteins or casein hydrolysate revealed that the biosynthetic pathways for cysteine and methionine are modulated by the presence of casein hydrolysate. Such findings support the notion that certain complex substrates may act as potential prebiotics for bifidobacteria in their ecological niche.

  9. Feruloyl oligosaccharides stimulate the growth of Bifidobacterium bifidum.

    Science.gov (United States)

    Yuan, Xiaoping; Wang, Jing; Yao, Huiyuan

    2005-08-01

    Insoluble dietary fiber from wheat bran contains some feruloyl groups linked to the arabinose residues in the cell wall arabinoxylan. Treatment of wheat bran insoluble dietary fiber with xylanase from Bacillus subtilis yielded feruloyl oligosacchairdes, which were purified with Amberlite XAD-2. Saponification of the feruloyl oligosaccharides released ferulic acid and arabinoxylan oligosaccharides which consist of arabinose and xylose. The effect of the feruloyl oligosacchairdes on the growth of Bifidobacterium bifidum F-35 was investigated in vitro. The B. bifidum produced acid when cultivated anaerobically in TPY broth with 0.5% feruloyl oligosacchairdes as the carbohydrate source. The biomass yield of the B. bifidum increased with increasing the concentration of feruloyl oligosaccharides in TPY broth. The maximum cell growth was increased by 50% in TPY broth supplemented with 0.1% feruloyl oligosaccharides compared to TPY broth. These results indicated that the growth of B. bifidum F-35 was promoted by the feruloyl oligosaccharides from wheat bran insoluble dietary fiber, and not suppressed by the ferulic acid moiety of them.

  10. Antioxidative properties and inhibitory effect of Bifidobacterium adolescentis on melanogenesis.

    Science.gov (United States)

    Huang, Huey-Chun; Chang, Tsong-Min

    2012-09-01

    Melanin is a dark pigment produced by melanocytes. Tyrosinase is a key enzyme which catalyzes the rate-limiting step of melanogenesis. However, accumulation of melanin leads to various skin hyperpigmentation disorders. To find a novel skin-whitening agent, the antioxidant capacity of Bifidobacterium adolescentis culture filtrate and inhibitory effect on melanogenesis were investigated. The antioxidant effects of B. adolescentis culture filtrate include 2,2-diphenyl-1-picryl-hydrazyl (DPPH) radical scavenging capacity, 2,2'-azino-bis (3-ethylbenzthiazoline-6-sulphonic acid)(ABTS) radical cation scavenging activity and reducing power were measured spectrophotometrically. The reducing power is a useful index for the evaluation of potential antioxidants which carry out reduction of ferricyanide to ferrocyanide. Furthermore, the inhibitory effects of the bacterial culture filtrate on mushroom tyrosinase, B16F10 intracellular tyrosinase activity and melanin content were also determined. The results revealed that B. adolescentis culture filtrate (2.5, 5.0 and 7.5 %; v/v) effectively scavenged DPPH and ABTS radicals, and lower concentrations of the bacterial culture filtrates (0.5, 1.0 and 1.5 %; v/v) showed potent reducing power in a dose-dependent pattern. Additionally, the bacterial culture filtrate suppressed murine tyrosinase activity and decreased the amount of melanin in a dose-dependent manner. Our results demonstrated that B. adolescentis culture filtrate decreases the melanogenesis process of melanoma cells by inhibiting tyrosinase activity, which we suggest may be mediated through its antioxidant activity.

  11. Multiparametric flow cytometry and cell sorting for the assessment of viable, injured, and dead bifidobacterium cells during bile salt stress

    NARCIS (Netherlands)

    Ben Amor, K.; Breeuwer, P.; Verbaarschot, P.; Rombouts, F.M.; Akkermans, A.D.L.; Vos, de W.M.; Abee, T.

    2002-01-01

    Using a flow cytometry-based approach, we assessed the viability of Bifidobacterium lactis DSM 10140 and Bifidobacterium adolescentis DSM 20083 during exposure to bile salt stress. Carboxyfluorescein diacetate (cFDA), propidium iodide (PI), and oxonol [DiBAC4(3)] were used to monitor esterase activi

  12. Bifidobacterium asteroides PRL2011 genome analysis reveals clues for colonization of the insect gut.

    Directory of Open Access Journals (Sweden)

    Francesca Bottacini

    Full Text Available Bifidobacteria are known as anaerobic/microaerophilic and fermentative microorganisms, which commonly inhabit the gastrointestinal tract of various animals and insects. Analysis of the 2,167,301 bp genome of Bifidobacterium asteroides PRL2011, a strain isolated from the hindgut of Apis mellifera var. ligustica, commonly known as the honey bee, revealed its predicted capability for respiratory metabolism. Conservation of the latter gene clusters in various B. asteroides strains enforces the notion that respiration is a common metabolic feature of this ancient bifidobacterial species, which has been lost in currently known mammal-derived Bifidobacterium species. In fact, phylogenomic based analyses suggested an ancient origin of B. asteroides and indicates it as an ancestor of the genus Bifidobacterium. Furthermore, the B. asteroides PRL2011 genome encodes various enzymes for coping with toxic products that arise as a result of oxygen-mediated respiration.

  13. Bifidobacterium asteroides PRL2011 genome analysis reveals clues for colonization of the insect gut.

    Science.gov (United States)

    Bottacini, Francesca; Milani, Christian; Turroni, Francesca; Sánchez, Borja; Foroni, Elena; Duranti, Sabrina; Serafini, Fausta; Viappiani, Alice; Strati, Francesco; Ferrarini, Alberto; Delledonne, Massimo; Henrissat, Bernard; Coutinho, Pedro; Fitzgerald, Gerald F; Margolles, Abelardo; van Sinderen, Douwe; Ventura, Marco

    2012-01-01

    Bifidobacteria are known as anaerobic/microaerophilic and fermentative microorganisms, which commonly inhabit the gastrointestinal tract of various animals and insects. Analysis of the 2,167,301 bp genome of Bifidobacterium asteroides PRL2011, a strain isolated from the hindgut of Apis mellifera var. ligustica, commonly known as the honey bee, revealed its predicted capability for respiratory metabolism. Conservation of the latter gene clusters in various B. asteroides strains enforces the notion that respiration is a common metabolic feature of this ancient bifidobacterial species, which has been lost in currently known mammal-derived Bifidobacterium species. In fact, phylogenomic based analyses suggested an ancient origin of B. asteroides and indicates it as an ancestor of the genus Bifidobacterium. Furthermore, the B. asteroides PRL2011 genome encodes various enzymes for coping with toxic products that arise as a result of oxygen-mediated respiration.

  14. Determination of Bifidobacterium and Lactobacillus in breast milk of healthy women by digital PCR.

    Science.gov (United States)

    Qian, L; Song, H; Cai, W

    2016-09-01

    Breast milk is one of the most important sources of postnatal microbes. Quantitative real-time polymerase chain reaction (qRT-PCR) is currently used for the quantitative analysis of bacterial 16S rRNA genes in breast milk. However, this method relies on the use of standard curves and is imprecise when quantitating target DNA of low abundance. In contrast, droplet digital PCR (DD-PCR) provides an absolute quantitation without the need for calibration curves. A comparison between DD-PCR and qRT-PCR was conducted for the quantitation of Bifidobacterium and Lactobacillus 16S RNA genes in human breast milk, and the impacts of selected maternal factors were studied on the composition of these two bacteria in breast milk. From this study, DD-PCR reported between 0-34,460 16S rRNA gene copies of Bifidobacterium genera and between 1,108-634,000 16S rRNA gene copies of Lactobacillus genera in 1 ml breast milk. The 16S rRNA gene copy number of Lactobacillus genera was much greater than that of Bifidobacterium genera in breast milk. DD-PCR showed a 10-fold lower limit of quantitation as compared to qRT-PCR. A higher correlation and agreement was observed between qRT-PCR and DD-PCR in Lactobacillus quantitation as compared to Bifidobacterium quantitation. Based on our DD-PCR quantitation, a low abundance of Bifidobacterium bacteria in breast milk was correlated to higher pre-pregnancy body mass index (BMI). However, no significant difference was observed for these two bacteria in breast milk between mothers who had vaginal deliveries and caesarean deliveries. This study suggests that DD-PCR is a better tool to quantitate the bacterial load of breast milk compared to the conventional qRT-PCR method. The number of breast milk Bifidobacterium bacteria is influenced by maternal pre-pregnancy BMI.

  15. A probiotic treatment containing Lactobacillus, Bifidobacterium and Enterococcus improves IBS symptoms in an open label trial

    Institute of Scientific and Technical Information of China (English)

    FAN Yu-jing; CHEN Shu-jie; YU Ying-cong; SI Jian-min; LIU Bin

    2006-01-01

    Objective: To evaluate the efficacy and safety of live combined Bifidobacterium, Lactobacillus and Enterococcus capsules in treatment of irritable bowel syndrome. Methods: Eighty-five patients [male 32, female 53; age (45.31±11.72) years]were given live combined Bifidobacterium, Lactobacillus and Enterococcus capsules 1260 mg/d t.i.d.×4 weeks. Syndrome scales were used to evaluate the efficacy in gastrointestinal syndrome. Fecal flora was also measured before and after the treatment. Six bacteria were cultured and the colony forming units were counted in stool. SPSS was used for data analysis. Results: Seventy-four patients finished the follow-up. No side-effect was found. For treatment of irritable bowel syndrome, the effective rate of live combined Bifidobacterium, Lactobacillus and Enterococcus capsules was 56.8% in the second week, 74.3% in the fourth week and 73.0% in the sixth week. Single symptom was improved, especially in abdominal pain and stool character. The probiotica containing live combined Bifidobacterium, Lactobacillus and Enterococcus could increase bifidobacterium count (P<0.01) and lactobacillus count (P<0.05); decrease bacteroides count (P<0.05) and enterococci count (P<0.01); No obvious changes were observed in clostridium difficile colonitis and enterobacteriaceae (P>0.05). Conclusion: The result of the study indicated that the administration of live combined Bifidobacterium, Lactobacillus and Enterococcus improved the symptom of irritable bowel syndrome and that there was a gradual increase of this effect. Thereafter conditions remained stable for 2 weeks. That improvement may be associated with alterations in gastrointestinal flora.

  16. Viability of Two Freeze-dried Strains of Bifidobacterium Preparations at Various Temperatures during Prolonged Storage

    Institute of Scientific and Technical Information of China (English)

    DU Peng; DU Li-hui; HUO Gui-cheng

    2005-01-01

    Viability of bifidobacteria in freeze-dried probiotic products at various temperatures during prolonged storage was assessed. Bifidobacterium longum and Bifidobacterium infantis were freeze-dried. The freeze-dried preparations were stored at -18,4, and 20℃. Cell counts were enumerated using BS agar at 37℃ for 48 h under anaerobic conditions at 0, 45 and 120 days. Storage at 20℃ showed the greatest decline in the viability of bifidobacteria, whereas that at -18℃ showed the least decrease.

  17. Bifidobacterium animalis AHC7 protects against pathogen-induced NF-kappaB activation in vivo

    LENUS (Irish Health Repository)

    O'Mahony, David

    2010-12-22

    Abstract Background Bifidobacteria and lactobacilli are among the early and important colonizers of the gastrointestinal tract and are generally considered to be part of a normal, healthy microbiota. It is believed that specific strains within the microbiota can influence host immune-reactivity and may play a role in protection from infection and aberrant inflammatory activity. One such strain, Bifidobacterium animalis AHC7, has been previously shown to protect against Salmonella typhimurium infection in mice and helps resolve acute idiopathic diarrhea in dogs. The aim of this study was to investigate the potential molecular and cellular mechanisms underpinning the Bifidobacterium animalis AHC7 protective effect. Results Following 4 hours of infection with Salmonella typhimurium, NF-κB activation was significantly elevated in vivo in placebo and Enterococcus faecium-fed animals while Bifidobacterium animalis AHC7 consumption significantly attenuated the NF-κB response. In vitro anti-CD3\\/CD28 stimulated Peyer\\'s patch cells secreted significantly less TNF-α and IFN-γ following Bifidobacterium animalis AHC7 consumption. Stimulated cells released more IL-12p70 but this difference did not reach statistical significance. No alteration in mucosal IL-6, IL-10 or MCP-1 levels were observed. No statistically significant change in the cytokine profile of mesenteric lymph node cells was noted. In vitro, Bifidobacterium animalis AHC7 was bound by dendritic cells and induced secretion of both IL-10 and IL-12p70. In addition, co-culture of CD4+ T cells with Bifidobacterium animalis AHC7-stimulated dendritic cells resulted in a significant increase in CD25+Foxp3+ T cell numbers. Conclusion Bifidobacterium animalis AHC7 exerts an anti-inflammatory effect via the attenuation of pro-inflammatory transcription factor activation in response to an infectious insult associated with modulation of pro-inflammatory cytokine production within the mucosa. The cellular mechanism

  18. Bifidobacterium animalis AHC7 protects against pathogen-induced NF-κB activation in vivo

    Directory of Open Access Journals (Sweden)

    Scully Paul

    2010-12-01

    Full Text Available Abstract Background Bifidobacteria and lactobacilli are among the early and important colonizers of the gastrointestinal tract and are generally considered to be part of a normal, healthy microbiota. It is believed that specific strains within the microbiota can influence host immune-reactivity and may play a role in protection from infection and aberrant inflammatory activity. One such strain, Bifidobacterium animalis AHC7, has been previously shown to protect against Salmonella typhimurium infection in mice and helps resolve acute idiopathic diarrhea in dogs. The aim of this study was to investigate the potential molecular and cellular mechanisms underpinning the Bifidobacterium animalis AHC7 protective effect. Results Following 4 hours of infection with Salmonella typhimurium, NF-κB activation was significantly elevated in vivo in placebo and Enterococcus faecium-fed animals while Bifidobacterium animalis AHC7 consumption significantly attenuated the NF-κB response. In vitro anti-CD3/CD28 stimulated Peyer's patch cells secreted significantly less TNF-α and IFN-γ following Bifidobacterium animalis AHC7 consumption. Stimulated cells released more IL-12p70 but this difference did not reach statistical significance. No alteration in mucosal IL-6, IL-10 or MCP-1 levels were observed. No statistically significant change in the cytokine profile of mesenteric lymph node cells was noted. In vitro, Bifidobacterium animalis AHC7 was bound by dendritic cells and induced secretion of both IL-10 and IL-12p70. In addition, co-culture of CD4+ T cells with Bifidobacterium animalis AHC7-stimulated dendritic cells resulted in a significant increase in CD25+Foxp3+ T cell numbers. Conclusion Bifidobacterium animalis AHC7 exerts an anti-inflammatory effect via the attenuation of pro-inflammatory transcription factor activation in response to an infectious insult associated with modulation of pro-inflammatory cytokine production within the mucosa. The cellular

  19. Use of modified Lactobacillus selective medium and Bifidobacterium iodoacetate medium for differential enumeration of Lactobacillus acidophilus and Bifidobacterium spp. in powdered nutritional products.

    Science.gov (United States)

    Ingham, S C

    1999-01-01

    Modified Lactobacillus selective agar (APT agar + sodium acetate and glacial acetic acid; mLBS) was compared to selective modified Lactobacillus selective medium (LBS agar + tomato juice and acetic acid; mLSM) and nonselective de Man Rogosa Sharpe (MRS) agar for the enumeration of Lactobacillus acidophilus in probiotic-containing powdered nutritional products. The mLBS agar was equivalent to MRS agar and superior to the mLSM agar for enumerating L. acidophilus in products stored in sealed cans at 22 degrees C. When samples were analyzed for L. acidophilus concentration after high temperature storage in sealed cans or storage in open cans at high relative humidity, the mLBS and MRS agars were highly correlated (r2 = 0.93). Modified Bifidobacterium iodoacetate medium (12.5 mg iodoacetic acid/liter; mBIM) was compared to MRS agar + bile, cysteine, and dicloxacillin (MRS + BCD) for enumerating Bifidobacterium infantis or Bifidobacterium lactis in the nutritional products. The two media were equivalent for enumerating B. infantis in product stored at 22 degrees C in sealed cans. However, the two media were poorly correlated (r2nutritional products stored under high temperature and/or high relative humidity conditions.

  20. Bifidobacterium moukalabense sp. nov., isolated from the faeces of wild west lowland gorilla (Gorilla gorilla gorilla).

    Science.gov (United States)

    Tsuchida, Sayaka; Takahashi, Shunsuke; Nguema, Pierre Philippe Mbehang; Fujita, Shiho; Kitahara, Maki; Yamagiwa, Juichi; Ngomanda, Alfred; Ohkuma, Moriya; Ushida, Kazunari

    2014-02-01

    Gram-staining-positive anaerobic rods were isolated from the faeces of a wild lowland gorilla (Gorilla gorilla gorilla) in Moukalaba-Doudou National Park, Gabon, and strain GG01(T) was taxonomically investigated. Based on phylogenetic analyses and specific phenotypic characteristics, the strain belonged to the genus Bifidobacterium. Phylogenetic analysis of its 16S rRNA gene sequence revealed that strain GG01(T) formed a single monophyletic cluster and had a distinct line of descent. Based on 16S rRNA gene sequence similarity, the type strains of Bifidobacterium catenulatum JCM 1194(T) (98.3%) and Bifidobacterium pseudocatenulatum (98.1%) JCM 1200(T) were the most closely related to this novel strain, although it was clear that they belonged to different species. hsp60 sequences also supported these relationships. The DNA G+C content of this novel strain was 60.1 mol%. Bifidobacterium moukalabense sp. nov. (type strain GG01(T) = JCM 18751(T) = DSM 27321(T)) is proposed.

  1. Influence of bifidobacterium quadruple preparations on immunity function and cytokine of neonatal hyperbilirubinemia

    Institute of Scientific and Technical Information of China (English)

    Juan Zhang; Xiao-Qin Liang

    2016-01-01

    Objective:To investigate the influence of bifidobacterium quadruple preparations on immunity function and cytokine of neonatal hyperbilirubinemia.Methods:A total of 92 neonates with hyperbilirubinemia were randomly divided into observation group and control group with 46 cases of each group. The control group received conventional therapy, and the observation group was treated with bifidobacterium quadruple preparations on the basis of the control group. The influence of bifidobacterium quadruple preparations on immunity function and cytokine of the two groups were compared.Results:There was no significantly difference in Bilirubin before the treatment between the two groups (P>0.05), but the observation group was significantly lower than the control group 3, 5, 7 d after the treatment (P<0.01); CD3, CD4, CD4/CD8, IL-6, IL-8 of the observation group were higher than the control group after the treatment (P<0.01), but CD8 was lower than the control group (P<0.01).Conclusions:Bifidobacterium quadruple preparations can improve the immune function, and reduce serum bilirubin levels in neonates with hyperbilirubinemia.

  2. Bifidobacterium bifidum Actively Changes the Gene Expression Profile Induced by Lactobacillus acidophilus in Murine Dendritic Cells

    DEFF Research Database (Denmark)

    Weiss, Gudrun Margarethe; Rasmussen, Simon; Fink, Lisbeth Nielsen

    2010-01-01

    cytokine IL-12 in DC, whereas bifidobacteria do not induce IL-12 but inhibit the IL-12 production induced by lactobacilli. In the present study, genome-wide microarrays were used to investigate the gene expression pattern of murine DC stimulated with Lactobacillus acidophilus NCFM and Bifidobacterium...

  3. Structural rearrangements of sucrose phosphorylase from Bifidobacterium adolescentis during sucrose conversion

    DEFF Research Database (Denmark)

    Mirza, Osman; Henriksen, Lars Skov; Sprogøe, Desiree

    2006-01-01

    The reaction mechanism of sucrose phosphorylase from Bifidobacterium adolescentis (BiSP) was studied by site-directed mutagenesis and x-ray crystallography. An inactive mutant of BiSP (E232Q) was co-crystallized with sucrose. The structure revealed a substrate-binding mode comparable with that seen...

  4. Specific detection and analysis of a probiotic Bifidobacterium strain in infant feces

    NARCIS (Netherlands)

    Kok, RG; DeWaal, A; Schut, F; Welling, GW; Weenk, G; Hellingwerf, KJ

    1996-01-01

    For specific detection of the probiotic Bifidobacterium sp. strain LW420 in infant feces and for rapid quality control of this strain in culture, three strain-specific 16S rRNA gene-targeted primers have been developed. These primers allow specific detection of the organism via PCR. Specificity of t

  5. Insights into physiological traits of Bifidobacterium animalis subsp. lactis BB-12 through membrane proteome analysis

    DEFF Research Database (Denmark)

    Gilad, Ofir; Hjernø, Karin; Østerlund, Eva Christina

    2012-01-01

    Bifidobacterium animalis subsp. lactis BB-12 is a widely used probiotic strain associated with a variety of health-promoting traits. There is, however, only limited knowledge available regarding the membrane proteome and the proteins involved in oligosaccharide transport in BB-12. We applied two...

  6. Discovering novel bile protection systems in Bifidobacterium breve UCC2003 through functional genomics.

    NARCIS (Netherlands)

    Ruiz, L.; Zomer, A.L.; O'Connell-Motherway, M.; Sinderen, D. van; Margolles, A.

    2012-01-01

    Tolerance of gut commensals to bile salt exposure is an important feature for their survival in and colonization of the intestinal environment. A transcriptomic approach was employed to study the response of Bifidobacterium breve UCC2003 to bile, allowing the identification of a number of bile-induc

  7. Susceptibility of human and probiotic Bifidobacterium spp. to selected antibiotics as determined by the Etest method

    NARCIS (Netherlands)

    Matto, J.; Hoek, van A.H.A.M.; Domig, K.J.; Saarela, M.; Flórez, A.B.; Brockmann, E.; Amtmann, E.; Mayo, B.; Aarts, H.J.M.; Danielsen, M.

    2007-01-01

    This study reports the antibiotic susceptibility of 203 strains representing human or probiotic associated Bifidobacterium species as determined by the Etest method. Strains showing minimum inhibitory concentration (MIC) for tetracycline >= 16 mu g mL(-1) were detected in all studied Bifidobacter

  8. Applications of Microencapsulated Bifidobacterium Longum with Eleutherine Americana in Fresh Milk Tofu and Pineapple Juice

    OpenAIRE

    Atchara N Phoem; Suphitchaya Chanthachum; Supayang P Voravuthikunchai

    2015-01-01

    Bifidobacterium longum was microencapsulated by extrusion technique and added in fresh milk tofu and pineapple juice. Microencapsulation of B. longum with Eleutherine americana extract, oligosaccharides extract, and commercial fructo-oligosaccharides was assessed for the bacterial survival after sequential exposure to simulated gastric and intestinal juices, and refrigeration storage. Microencapsulated B. longum with the extract and oligosaccharides extract in the food products showed better ...

  9. Bifidobacterium breve - HT-29 cell line interaction: modulation of TNF-a induced gene expression

    NARCIS (Netherlands)

    Boesten, R.J.; Vos, de W.M.; Schuren, F.H.J.; Willemsen, L.E.M.; Knol, J.

    2011-01-01

    To provide insight in the molecular basis for intestinal host-microbe interactions, we determined the genome-wide transcriptional response of human intestinal epithelial cells following exposure to cells of Bifidobacterium breve. To select an appropriate test system reflecting inflammatory condition

  10. Bifidobacterium breve-HT-29 cell line interaction: Modulation of TNF-a induced gene expression

    NARCIS (Netherlands)

    Boesten, R.J.; Schuren, F.H.J.; Willemsen, L.E.M.; Vriesema, A.; Knol, J.; Vos, W.M. de

    2011-01-01

    To provide insight in the molecular basis for intestinal host-microbe interactions, we determined the genome-wide transcriptional response of human intestinal epithelial cells following exposure to cells of Bifidobacterium breve. To select an appropriate test system reflecting inflammatory condition

  11. Physico-chemical and transglucosylation properties of recombinant sucrose phosphorylase from Bifidobacterium adolescentis DSM20083.

    NARCIS (Netherlands)

    Broek, van den L.A.M.; Boxtel, van E.L.; Kievit, R.P.; Verhoef, R.P.; Beldman, G.; Voragen, A.G.J.

    2004-01-01

    Clones of a genomic library of Bifidobacterium adolescentis were grown in minimal medium with sucrose as sole carbon source. An enzymatic fructose dehydrogenase assay was used to identify sucrose-degrading enzymes. Plasmids were isolated from the positive colonies and sequence analysis revealed that

  12. Rapid detection of human fecal contamination in estuarine environments by PCR targeting of Bifidobacterium adolescentis

    NARCIS (Netherlands)

    King, Eric L.; Bachoon, Dave S.; Gates, Keith W.

    2007-01-01

    Detection of Bifidobacterium adolescentis was used as an effective genetic marker of human fecal contamination in Georgia estuaries. Enterococci enumerations on mEI media indicated that a tributary to the Little Satilla River with 516 CFU/100 ml was the most polluted of all the rivers tested. Extrac

  13. Occurrence and Diversity of CRISPR-Cas Systems in the Genus Bifidobacterium.

    Directory of Open Access Journals (Sweden)

    Alexandra E Briner

    Full Text Available CRISPR-Cas systems constitute adaptive immune systems for antiviral defense in bacteria. We investigated the occurrence and diversity of CRISPR-Cas systems in 48 Bifidobacterium genomes to gain insights into the diversity and co-evolution of CRISPR-Cas systems within the genus and investigate CRISPR spacer content. We identified the elements necessary for the successful targeting and inference of foreign DNA in select Type II CRISPR-Cas systems, including the tracrRNA and target PAM sequence. Bifidobacterium species have a very high frequency of CRISPR-Cas occurrence (77%, 37 of 48. We found that many Bifidobacterium species have unusually large and diverse CRISPR-Cas systems that contain spacer sequences showing homology to foreign genetic elements like prophages. A large number of CRISPR spacers in bifidobacteria show perfect homology to prophage sequences harbored in the chromosomes of other species of Bifidobacterium, including some spacers that self-target the chromosome. A correlation was observed between strains that lacked CRISPR-Cas systems and the number of times prophages in that chromosome were targeted by other CRISPR spacers. The presence of prophage-targeting CRISPR spacers and prophage content may shed light on evolutionary processes and strain divergence. Finally, elements of Type II CRISPR-Cas systems, including the tracrRNA and crRNAs, set the stage for the development of genome editing and genetic engineering tools.

  14. Multiparametric Flow Cytometry and Cell Sorting for the Assessment of Viable, Injured, and Dead Bifidobacterium Cells during Bile Salt Stress

    OpenAIRE

    2002-01-01

    Using a flow cytometry-based approach, we assessed the viability of Bifidobacterium lactis DSM 10140 and Bifidobacterium adolescentis DSM 20083 during exposure to bile salt stress. Carboxyfluorescein diacetate (cFDA), propidium iodide (PI), and oxonol [DiBAC4(3)] were used to monitor esterase activity, membrane integrity, and membrane potential, respectively, as indicators of bacterial viability. Single staining with these probes rapidly and noticeably reflected the behavior of the two strain...

  15. Bifidobacterium aesculapii sp. nov., from the faeces of the baby common marmoset (Callithrix jacchus).

    Science.gov (United States)

    Modesto, M; Michelini, S; Stefanini, I; Ferrara, A; Tacconi, S; Biavati, B; Mattarelli, P

    2014-08-01

    Six Gram-positive-staining, microaerophilic, non-spore-forming, fructose-6-phosphate phosphoketolase-positive bacterial strains with a peculiar morphology were isolated from faecal samples of baby common marmosets (Callithrix jacchus). Cells of these strains showed a morphology not reported previously for a bifidobacterial species, which resembled a coiled snake, always coiled or ring shaped or forming a 'Y' shape. Strains MRM 3/1(T) and MRM 4/2 were chosen as representative strains and characterized further. The bacteria utilized a wide range of carbohydrates and produced urease. Glucose was fermented to acetate and lactate. Strain MRM 3/1(T) showed a peptidoglycan type unique among members of the genus Bifidobacterium. The DNA base composition was 64.7 mol% G+C. Almost-complete 16S rRNA, hsp60, clpC and rpoB gene sequences were obtained and phylogenetic relationships were determined. Comparative analysis of 16S rRNA gene sequences showed that strains MRM 3/1(T) and MRM 4/2 had the highest similarities to Bifidobacterium scardovii DSM 13734(T) (94.6%) and Bifidobacterium stellenboschense DSM 23968(T) (94.5%). Analysis of hsp60 showed that both strains were closely related to B. stellenboschense DSM 23968(T) (97.5% similarity); however, despite this high degree of similarity, our isolates could be distinguished from B. stellenboschense DSM 23968(T) by low levels of DNA-DNA relatedness (30.4% with MRM 3/1(T)). Strains MRM 3/1(T) and MRM 4/2 were located in an actinobacterial cluster and were more closely related to the genus Bifidobacterium than to other genera in the family Bifidobacteriaceae. On the basis of these results, strains MRM 3/1(T) and MRM 4/2 represent a novel species within the genus Bifidobacterium, for which the name Bifidobacterium aesculapii sp. nov. is proposed; the type strain is MRM 3/1(T) ( = DSM 26737(T) = JCM 18761(T)).

  16. Molecular and phenotypic traits of in-vitro-selected mutants of Bifidobacterium resistant to rifaximin.

    Science.gov (United States)

    Vitali, Beatrice; Turroni, Silvia; Serina, Stefania; Sosio, Margherita; Vannini, Lucia; Candela, Marco; Guerzoni, Maria Elisabetta; Brigidi, Patrizia

    2008-06-01

    Nucleotide mutations inside a core region of the rpoB gene, encoding the beta subunit of RNA polymerase, were found in rifaximin-resistant mutants of Bifidobacterium. Five different missense mutations of codons 513, 516, 522 and 529 were identified. Further aspects of rifaximin resistance were investigated, using Bifidobacterium infantis BI07 as a model strain. Partial resistance of RNA polymerase of a BI07 mutant at a rifaximin concentration >10 microg/mL was observed by cell-free transcription assay. Mass spectrometry detection of rifaximin in the cellular pellet of the BI07 resistant mutant, as well as changes in biosynthesis of saturated and cyclopropane fatty acids during growth, suggested a reduction in membrane permeability for the antibiotic moiety.

  17. Microencapsulation and Fermentation of Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12

    Directory of Open Access Journals (Sweden)

    Maryam Yari

    2015-09-01

    Full Text Available Because of poor survival of probiotic bacteria, microencapsulation evolved from the immobilized cell culture technology used in the biotechnological industry. Two probiotic strains, Bifidobacterium (BB-12 and Lactobacillus acidophilus (LA-5 were immobilized in calcium alginate by extrusion method. Encapsulation parameters and efficacy of this method were evaluated. Growth factors of these two bacteria were also measured by culturing in 10-L fermenter. Growth curves were obtained with respect to optical density and dry biomass weight. Encapsulation yield was over than 60% in each experiment. Scanning electron microscopy (SEM of Entrapment of cells in alginate matrix and cross-sections of dried bead were obtained and illustrated. Bifidobacterium have been shown better biotechnological properties.

  18. Optimizing the Chemical Compositions of Protective Agents for Freeze-drying Bifidobacterium longum BIOMA 5920

    Institute of Scientific and Technical Information of China (English)

    杨婵媛; 朱晓丽; 范代娣; 米钰; 骆艳娥; 惠俊峰; 苏然

    2012-01-01

    Freeze drying has a deleterious effect on the viability of microorganisms. In front of this difficulty, the present study adopts response surface methodology to optimize the chemical compositions of protective agents to seek for maximum viability of Bifidobacterium longum BIOMA 5920 during freeze-drying. Through the compara- tive analysis of single protectant, the complex protective agents show better effect on the Bifidobacterium viability. Human-like collagen (HLC), trehalose and glycerol are confirmed as significant factors by Box-Behnken Design. The optimized formula for these three variables is tested as follows: HLC 1.23%, trehalose 11.50% and glycerol 4.65%. Under this formula, the viability is 88.23%, 39.67% higher in comparison to the control. The viable count is 1.07×10 9 cfu·g-1 , greatly exceeding the minimum viable count requirement (10 6 cfu·g-1 ).

  19. POSSIBLE ROLE OF PROBIOTIC MICROORGANISMS OF BIFIDOBACTERIUM AND LACTOBACILLUS GENUS IN PATHOGENESIS OF AUTOIMMUNE THYROID DISEASES

    Directory of Open Access Journals (Sweden)

    E. P. Kiseleva

    2010-01-01

    Full Text Available It was revealed, that, in blood samples of the patients with autoimmune thyroid diseases, serum antibodies against cell-free fraction of Bifidobacterium bifidum 791 and Lactobacillus plantarum B-01 were detected, respectively, in 71 and 63% of cases, that being two-fold higher than appropriate frequencies in healthy blood donors. An evidence was obtained that presence of some components specifically reacting with autoantibodies against thyroid peroxidase and thyroglobulin on the surface of the microorganisms cells and competing for binding of these immunoglobulins with thyroid antigens. One may also suggest a presence of bacterial components, interacting with thyroid peroxidase. The data obtained let us suggest that probiotic microorganisms of Bifidobacterium and Lactobacillus genus could take part in pathogenesis of autoimmune thyroid diseases, by means of molecular mimicry mechanisms.

  20. Efficacy of oral Bifidobacterium bifidum ATCC 29521 on microflora and antioxidant in mice.

    Science.gov (United States)

    Wang, Bao-gui; Xu, Hai-bo; Xu, Feng; Zeng, Zhe-ling; Wei, Hua

    2016-03-01

    This study aimed to examine whether Bifidobacterium bifidum ATCC 29521, a species of colonic microflora in humans, is involved in the intestinal tract of mice. This study was also conducted to determine the antioxidant activity of this species by evaluating different microbial populations and reactive oxygen species isolated from feces and intestinal contents for 28 days of oral administration. Microbial diversities were assessed through bacterial culture techniques, PCR-DGGE, and real-time PCR. This study showed that the intake of B. bifidum ATCC 29521 significantly (p stress were also determined. Results indicated that B. bifidum ATCC 29521 elicits a beneficial effect on murine gut microbiota and antioxidant activities compared with the control samples. This species can be considered as a potential bioresource antioxidant to promote health. Bifidobacterium bifidum ATCC 29521 may also be used as a promising material in microbiological and food applications.

  1. In Vitro Kinetic Analysis of Oligofructose Consumption by Bacteroides and Bifidobacterium spp. Indicates Different Degradation Mechanisms

    OpenAIRE

    Van der Meulen, Roel; Makras, Lefteris; Verbrugghe, Kristof; Adriany, Tom; De Vuyst, Luc

    2006-01-01

    The growth of pure cultures of Bacteroides thetaiotaomicron LMG 11262 and Bacteroides fragilis LMG 10263 on fructose and oligofructose was examined and compared to that of Bifidobacterium longum BB536 through in vitro laboratory fermentations. Gas chromatography (GC) analysis was used to determine the different fractions of oligofructose and their degradation during the fermentation process. Both B. thetaiotaomicron LMG 11262 and B. fragilis LMG 10263 were able to grow on oligofructose as fas...

  2. Probiotic Bifidobacterium longum alters gut luminal metabolism through modification of the gut microbial community

    OpenAIRE

    Hirosuke Sugahara; Toshitaka Odamaki; Shinji Fukuda; Tamotsu Kato; Jin-zhong Xiao; Fumiaki Abe; Jun Kikuchi; Hiroshi Ohno

    2015-01-01

    Probiotics are well known as health-promoting agents that modulate intestinal microbiota. However, the molecular mechanisms underlying this effect remain unclear. Using gnotobiotic mice harboring 15 strains of predominant human gut-derived microbiota (HGM), we investigated the effects of Bifidobacterium longum BB536 (BB536-HGM) supplementation on the gut luminal metabolism. Nuclear magnetic resonance (NMR)-based metabolomics showed significantly increased fecal levels of pimelate, a precursor...

  3. Effect of Bifidobacterium longum BB536 yogurt administration on the intestinal environment of healthy adults.

    OpenAIRE

    Ogata, T; Kingaku, M; Yaeshima, T.; Teraguchi, S; Fukuwatari, Y; Ishibashi, N.(Department of Physics, Osaka University, Toyonaka, Osaka 560-0043, Japan); Hayasawa, H.; Fujisawa, T.; Iino, H.

    2011-01-01

    A yogurt supplemented with B. longum BB536 was administered at 250 ml per day for 2 weeks to six healthy volunteers. The effects on the fecal microflora, fecal putrefactive substances, fecal enzymatic activities and fecal properties were examined and compared with the effects of standard yogurt. A significant increase (p<0.05) in the proportion of Bifidobacterium in the fecal microflora was observed following ingestion of yogurt containing B. longum BB536. The numbers of Lactobacillus also...

  4. Influence of whole peptidoglycan of bifidobacterium on cytotoxic effectors produced by mouse peritoneal macrophages

    Institute of Scientific and Technical Information of China (English)

    Li Sheng Wang; Hui Ming Zhu; Dian Yuan Zhou; Yu Lin Wang; Wan Dai Zhang

    2001-01-01

    @@ INTRODUCTION Bifidobacteria are physiologically beneficial bacteria which are perdominant in human intestine ,and possess the most important functions .They play an important role in maintaining microbial balance of the intestine .Furthermore , their presence is thought to be an important indication of health of the body [1-4].Whole peptidoglycan ( WPG) is the major component in the cell wall of bifidobacterium ,which is also a biological responsemodifier with nontoxic side dffcets.

  5. Protection against Influenza Virus Infection of Mice Fed Bifidobacterium breve YIT4064

    OpenAIRE

    1999-01-01

    Mice fed Bifidobacterium breve YIT4064 and immunized orally with influenza virus were more strongly protected against influenza virus infection of the lower respiratory tract than ones immunized with influenza virus only. The number of mice with enhanced anti-influenza virus immunoglobulin G (IgG) in serum upon oral administration of B. breve YIT4064 and oral immunization with influenza virus was significantly greater than that upon oral immunization with influenza...

  6. Metabolismo di oligosaccaridi prebiotici in Bifidobacterium per il potenziale sviluppo di nuovi prodotti alimentari funzionali

    OpenAIRE

    Zanoni, Simona

    2008-01-01

    The growth and the metabolism of Bifidobacterium adolescentis MB 239 fermenting GOS, lactose, galactose, and glucose were investigated. An unstructerd unsegregated model for growth of B. adolescentis MB 239 in batch cultures was developed and kinetic parameters were calculated with a Matlab algorithm. Galactose was the best carbon source; lactose and GOS led to lower growth rate and cellular yield, but glucose was the poorest carbon source. Lactate, acetate and ethanol yields a...

  7. Immune Modulating Capability of Two Exopolysaccharide-Producing Bifidobacterium Strains in a Wistar Rat Model

    Directory of Open Access Journals (Sweden)

    Nuria Salazar

    2014-01-01

    Full Text Available Fermented dairy products are the usual carriers for the delivery of probiotics to humans, Bifidobacterium and Lactobacillus being the most frequently used bacteria. In this work, the strains Bifidobacterium animalis subsp. lactis IPLA R1 and Bifidobacterium longum IPLA E44 were tested for their capability to modulate immune response and the insulin-dependent glucose homeostasis using male Wistar rats fed with a standard diet. Three intervention groups were fed daily for 24 days with 10% skimmed milk, or with 109 cfu of the corresponding strain suspended in the same vehicle. A significant increase of the suppressor-regulatory TGF-β cytokine occurred with both strains in comparison with a control (no intervention group of rats; the highest levels were reached in rats fed IPLA R1. This strain presented an immune protective profile, as it was able to reduce the production of the proinflammatory IL-6. Moreover, phosphorylated Akt kinase decreased in gastroctemius muscle of rats fed the strain IPLA R1, without affecting the glucose, insulin, and HOMA index in blood, or levels of Glut-4 located in the membrane of muscle and adipose tissue cells. Therefore, the strain B. animalis subsp. lactis IPLA R1 is a probiotic candidate to be tested in mild grade inflammation animal models.

  8. Alterations in Fecal Lactobacillus and Bifidobacterium Species in Type 2 Diabetic Patients in Southern China Population

    Directory of Open Access Journals (Sweden)

    Kim-Anne eLê

    2013-01-01

    Full Text Available Background: The connection between gut microbiota and metabolism and its role in the pathogenesis of diabetes are increasingly recognized. The objective of this study was to quantitatively measure Bifidobacterium and Lactobacillus species, members of commensal bacteria found in human gut, in type 2 diabetic patients (T2D patients from Southern China. Methods: Fifty patients with T2D and thirty control individuals of similar BMI were recruited from Southern China. T2D and control subjects were confirmed with both oral glucose tolerance test (OGTT and HbA1c measurements. Bifidobacterium and Lactobacillus species in feces were measured by real-time quantitative PCR. Data were analyzed with STATA 11.0 statistical software.Results: In comparison to control subjects T2D patients had significantly more total Lactobacillus (+18%, L. bugaricus (+13%, L. rhamnosum (+37% and L. acidophilus (+48% (P <0.05. In contrast, T2D patients had less amounts of total Bifidobacteria (-7% and B. adolescentis (-12% (P <0.05. Cluster analysis showed that gut microbiota pattern of T2D patients is characterized by greater numbers of L. rhamnosus and L. acidophillus, together with lesser numbers of B. adolescentis (P <0.05. Conclusion: The gut microflora in T2D patients is characterized by greater numbers of Lactobacillus and lesser numbers of Bifidobacterium species.

  9. Membrane filter method to study the effects of Lactobacillus acidophilus and Bifidobacterium longum on fecal microbiota.

    Science.gov (United States)

    Shimizu, Hidenori; Benno, Yoshimi

    2015-11-01

    A large number of commensal bacteria inhabit the intestinal tract, and interbacterial communication among gut microbiota is thought to occur. In order to analyze symbiotic relationships between probiotic strains and the gut microbiota, a ring with a membrane filter fitted to the bottom was used for in vitro investigations. Test strains comprising probiotic nitto strains (Lactobacillus acidophilus NT and Bifidobacterium longum NT) and type strains (L. acidophilus JCM1132(T) and B. longum JCM1217(T) ) were obtained from diluted fecal samples using the membrane filter to simulate interbacterial communication. Bifidobacterium spp., Streptococcus pasteurianus, Collinsella aerofaciens, and Clostridium spp. were the most abundant gut bacteria detected before coculture with the test strains. Results of the coculture experiments indicated that the test strains significantly promote the growth of Ruminococcus gnavus, Ruminococcus torques, and Veillonella spp. and inhibit the growth of Sutterella wadsworthensis. Differences in the relative abundances of gut bacterial strains were furthermore observed after coculture of the fecal samples with each test strain. Bifidobacterium spp., which was detected as the dominant strain in the fecal samples, was found to be unaffected by coculture with the test strains. In the present study, interbacterial communication using bacterial metabolites between the test strains and the gut microbiota was demonstrated by the coculture technique. The detailed mechanisms and effects of the complex interbacterial communications that occur among the gut microbiota are, however, still unclear. Further investigation of these relationships by coculture of several fecal samples with probiotic strains is urgently required.

  10. Antitumor effect of cytosine deaminase/5-fluorocytosine suicide gene therapy system mediated by Bifidobacterium infantis on melanoma

    Institute of Scientific and Technical Information of China (English)

    Cheng YI; Ying HUANG; Zhi-ying GUO; Shu-ren WANG

    2005-01-01

    Aim: To construct a Bifidobacterium infantis/CD targeting gene therapy system and observe the antitumor effect of cytosine deaminase/5-fluorocytosine (CD/5-FC) suicide gene therapy system mediated by Bifidobacterium infantis on melanoma in vitro and in vivo. Methods: A recombinant CD/pGEX- 1LamdaT plasmid was transfected into Bifidobacterium infantis by electroporation. Bifidobac terium infantis transfected by recombinant CD/pGEX-1LamdaT plasmid was in cubated with 5-FC anaerobically. Then the supernatant fluid was collected and added to melanoma B16-F10 cells to observe the killing effect for B16-F10 cells.Mice were inoculated with melanoma B 16-F10 cells to establish animal models.The mice were then injected with 5-FC and Bifidobacterium infantis transfected by recombinant CD/pGEX-1LamdaT plasmid. Results:Two segments of approxi mate 4.9 kb and 1.3 kb were extracted from the 6.2 kb recombinant plasmid, which were equal to the size of the pGEX-1LamdaT plasmid and CD gene, respectively.Sequencing results showed that the full length and sequence of nucleotide acid of the inserted gene in extracted recombinant plasmid was completely identical to the CD gene. In vitro, B 16-F10 cells treated by supernatant fluid were remarkably damaged morphologically, and the cell growth was significantly inhibited. Experi ments on the mice melanoma model showed that after treatment with a combination of transfected Bifidobacterium infantis and 5-FC, the tumor volume was significantly inhibited compared with controls. Conclusion: The foreign gene,CD gene, was correctly inserted into pGEX-1LambdaT plasmid and transferred into Bifidobacterium infantis. CD/5-FC suicide gene therapy system mediated by Bifidobacterium infantis demonstrated a good antitumor effect on melanoma in vitro and in vivo.

  11. Effect of Pre-Stressing on the Acid-Stress Response in Bifidobacterium Revealed Using Proteomic and Physiological Approaches.

    Directory of Open Access Journals (Sweden)

    Junhua Jin

    Full Text Available Weak acid resistance limits the application of Bifidobacteria as a probiotic in food. The acid tolerance response (ATR, caused by pre-stressing cells at a sublethal pH, could improve the acid resistance of Bifidobacteria to subsequent acid stress. In this study, we used Bifidobacterium longum sub. longum BBMN68 to investigate the effect of the ATR on the acid stress response (ASR, and compared the difference between the ATR and the ASR by analyzing the two-dimensional-PAGE protein profiles and performing physiological tests. The results revealed that a greater abundance of proteins involved in carbohydrate metabolism and protein protection was present after the ASR than after the ATR in Bifidobacterium. Pre-stressing cells increased the abundance of proteins involved in energy production, amino acid metabolism, and peptidoglycan synthesis during the ASR of Bifidobacterium. Moreover, after the ASR, the content of ATP, NH3, thiols, and peptidoglycan, the activity of H+-ATPase, and the maintenance of the intracellular pH in the pre-stressed Bifidobacterium cells was significantly higher than in the uninduced cells. These results provide the first explanation as to why the resistance of Bifidobacterium to acid stress improved after pre-stressing.

  12. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to a combination of Lactobacillus gasseri PA 16/8, Bifidobacterium bifidum M 20/5 and Bifidobacterium longum SP 07/3 and maintenance of upper respiratory tract defence

    DEFF Research Database (Denmark)

    Tetens, Inge

    of Lactobacillus gasseri PA 16/8, Bifidobacterium bifidum M 20/5 and Bifidobacterium longum SP 07/3 and maintenance of upper respiratory tract defence against pathogens. The food constituent that is the subject of the claim, a combination of Lactobacillus gasseri PA 16/8, Bifidobacterium bifidum M 20....../5 and Bifidobacterium longum SP 07/3, is sufficiently characterised. The claimed effect, maintenance of upper respiratory tract defence against pathogens, is a beneficial physiological effect. The proposed target population is the general adult population. The Panel notes that the only human intervention study provided...... did not show an effect of consumption of a combination of Lactobacillus gasseri PA 16/8, Bifidobacterium bifidum M 20/5 and Bifidobacterium longum SP 07/3 on defence against pathogens in the upper respiratory tract. On the basis of the data presented, the Panel concludes that a cause and effect...

  13. Analysis of infant isolates of Bifidobacterium breve by comparative genome hybridization indicates the existence of new subspecies with marked infant specificity

    NARCIS (Netherlands)

    Boesten, R.; Schuren, F.; Wind, R.D.; Knol, J.; Vos, W.M. de

    2011-01-01

    A total of 20 Bifidobacterium strains were isolated from fecal samples of 4 breast- and bottle-fed infants and all were characterized as Bifidobacterium breve based on 16S rRNA gene sequence and metabolic analysis. These isolates were further characterized and compared to the type strains of B. brev

  14. The extracellular proteome of Bifidobacterium animalis subsp. lactis BB‐12 reveals proteins with putative roles in probiotic effects

    DEFF Research Database (Denmark)

    Gilad, Ofir; Svensson, Birte; Viborg, Alexander Holm

    2011-01-01

    Probiotics are live microorganisms that exert health‐promoting effects on the human host, as demonstrated for numerous strains of the genus Bifidobacterium. To unravel the proteins involved in the interactions between the host and the extensively used and well‐studied probiotic strain Bifidobacte......Probiotics are live microorganisms that exert health‐promoting effects on the human host, as demonstrated for numerous strains of the genus Bifidobacterium. To unravel the proteins involved in the interactions between the host and the extensively used and well‐studied probiotic strain...... Bifidobacterium animalis subsp. lactis BB‐12, proteins secreted by the bacterium, i.e. belonging to the extracellular proteome present in the culture medium, were identified by 2‐DE coupled with MALDI‐TOF MS. Among the 74 distinct proteins identified, 31 are predicted to carry out their physiological role either...

  15. Effect of Bifidobacterium upon Clostridium difficile growth and toxicity when co-cultured in different prebiotic substrates

    Directory of Open Access Journals (Sweden)

    Lorena Valdés Varela

    2016-05-01

    Full Text Available The intestinal overgrowth of Clostridium difficile, often after disturbance of the gut microbiota by antibiotic treatment, leads to C. difficile infection (CDI which manifestation ranges from mild diarrhoea to life-threatening conditions. The increasing CDI incidence, not only in compromised subjects but also in traditionally considered low-risk populations, together with the frequent relapses of the disease, has attracted the interest for prevention/therapeutic options. Among these, probiotics, prebiotics or synbiotics constitute a promising approach. In this study we determined the potential of selected Bifidobacterium strains for the inhibition of C. difficile growth and toxicity in different carbon sources. We conducted co-cultures of the toxigenic strain C. difficile LMG21717 with four Bifidobacterium strains (Bifidobacterium longum IPLA20022, Bifidobacterium breve IPLA20006, Bifidobacterium bifidum IPLA20015, and Bifidobacterium animalis subsp. lactis Bb12 in the presence of various prebiotic substrates (Inulin, Synergy and Actilight or glucose, and compared the results with those obtained for the corresponding mono-cultures. C. difficile and bifidobacteria levels were quantified by qPCR; the pH and the production of short chain fatty acids was also determined. Moreover, supernatants of the cultures were collected to evaluate their toxicity using a recently developed model. Results showed that co-culture with B. longum IPLA20022 and B. breve IPLA20006 in the presence of short-chain fructooligosaccharides, but not of Inulin, as carbon source significantly reduced the growth of the pathogen. With the sole exception of B. animalis Bb12, whose growth was enhanced, the presence of C. difficile did not show major effects upon the growth of the bifidobacteria. In accordance with the growth data, B. longum and B. breve were the strains showing higher reduction in the toxicity of the co-culture supernatants.

  16. Experimental study on producing tomato vinegar by Bifidobacterium%双歧番茄醋的实验研究

    Institute of Scientific and Technical Information of China (English)

    王春耀; 张德纯; 张名均; 李金玲; 刘明方

    2011-01-01

    Objective To use tomato as main material,and study the fermentation process of tomato vinegar by Bifidobacterium and Acetobacter pasteurianus.Method The optimal process was selected by Orthogonal test.Result The final acidlty of Bifidobacterium vinegar was 27 g/L; The total count of Bifidobacterium was 1.9 × 1011 CFU/mL; Viable count of Bifidobacterium was 5.5 × 107 CFU/mL in five days.The product had a brown color and good gloss, with smell of ripe tomato and moderate taste.Conclusion Bifidobacterium and Acetobacter pasteurianus can survive together in tomato juice and it is feasible to use them to produce Bifidobacterium tomato vinegar.%目的 以番茄为主要原料,对双歧杆菌和醋酸杆菌共同发酵研制双歧番茄醋的工艺进行研究.方法 通过正交试验筛选最适工艺.结果 双歧番茄醋的最终醋酸度为27 g/L,含双歧杆菌总菌为1.9×1011 CFU/mL,5 d内双歧杆菌活菌为5.5×107 CFU/mL.双歧番茄醋棕黄色,光泽度好,有成熟番茄香味,入口酸甜适中.结论 双歧杆菌与醋酸杆菌在可以番茄汁中共生,此方法制备双歧番茄醋可行.

  17. Classification of a moderately oxygen-tolerant isolate from baby faeces as Bifidobacterium thermophilum

    Directory of Open Access Journals (Sweden)

    Fliss Ismaïl

    2007-08-01

    Full Text Available Abstract Background Bifidobacteria are found at varying prevalence in human microbiota and seem to play an important role in the human gastrointestinal tract (GIT. Bifidobacteria are highly adapted to the human GIT which is reflected in the genome sequence of a Bifidobacterim longum isolate. The competitiveness against other bacteria is not fully understood yet but may be related to the production of antimicrobial compounds such as bacteriocins. In a previous study, 34 Bifidobacterium isolates have been isolated from baby faeces among which six showed proteinaceous antilisterial activity against Listeria monocytogenes. In this study, one of these isolates, RBL67, was further identified and characterized. Results Bifidobacterium isolate RBL67 was classified and characterized using a polyphasic approach. RBL67 was classified as Bifidobacterium thermophilum based on phenotypic and DNA-DNA hybridization characteristics, although 16S rDNA analyses and partial groEL sequences showed higher homology with B. thermacidophilum subsp. porcinum and B. thermacidophilum subsp. thermacidophilum, respectively. RBL67 was moderately oxygen-tolerant and was able to grow at pH 4 and at a temperature of 47°C. Conclusion In order to assign RBL67 to a species, a polyphasic approach was used. This resulted in the classification of RBL67 as a Bifidobacterium thermophilum strain. To our knowledge, this is the first report about B. thermophilum isolated from baby faeces since the B. thermophilum strains were related to ruminants and swine faeces before. B. thermophilum was previously only isolated from animal sources and was therefore suggested to be used as differential species between animal and human contamination. Our findings may disapprove this suggestion and further studies are now conducted to determine whether B. thermophilum is distributed broader in human faeces. Furthermore, the postulated differentiation between human and animal strains by growth above 45

  18. Adhesion and immunomodulatory effects of Bifidobacterium lactis HN019 on intestinal epithelial cells INT-407

    Institute of Scientific and Technical Information of China (English)

    2010-01-01

    AIM:To elucidate the adherence and immunomodulatory properties of a probiotic strain Bifidobacterium lactis(B.lactis) HN019.METHODS:Adhesion assays of B.lactis HN019 and Salmonella typhimurium(S.typhimurium) ATCC 14028 to INT-407 cells were carried out by detecting copies of species-specific genes with real-time polymerase chain reaction.Morphological study was further conducted by transmission electron microscopy.Interleukin-1β(IL-1β),interleukin-8,and tumor necrosis factor-α(TNF-α) gene expression were as...

  19. Bifidobacterium bifidum Actively Changes the Gene Expression Profile Induced by Lactobacillus acidophilus in Murine Dendritic Cells

    DEFF Research Database (Denmark)

    Weiss, Gudrun Margarethe; Rasmussen, Simon; Fink, Lisbeth Nielsen;

    2010-01-01

    Dendritic cells (DC) play a pivotal regulatory role in activation of both the innate as well as the adaptive immune system by responding to environmental microorganisms. We have previously shown that Lactobacillus acidophilus induces a strong production of the pro-inflammatory and Th1 polarizing...... cytokine IL-12 in DC, whereas bifidobacteria do not induce IL-12 but inhibit the IL-12 production induced by lactobacilli. In the present study, genome-wide microarrays were used to investigate the gene expression pattern of murine DC stimulated with Lactobacillus acidophilus NCFM and Bifidobacterium...

  20. Prebiotic Effects of Agave salmiana Fructans in Lactobacillus acidophilus and Bifidobacterium lactis Cultures.

    Science.gov (United States)

    Castro-Zavala, Adriana; Juárez-Flores, Bertha I; Pinos-Rodríguez, Juan M; Delgado-Portales, Rosa E; Aguirre-Rivera, Juan R; Alcocer-Gouyonnet, Francisco

    2015-11-01

    Agave salmiana is a fructan rich species that is widely distributed in Mexico. The aim of this investigation was to extract the fructans of A. salmiana and evaluate their prebiotic effect in 48 hours in vitro cultures of Bifidobacterium lactis and Lactobacillus acidophilus and to compare this effect with other available fructan sources. A significant difference in pH, optical density and biomass was found in the cultures depending on the source of fructans and the type of bacteria. It was possible to determine a dose-response effect of the A. salmiana fructans and the growth of the studied strains.

  1. Predominant genera of fecal microbiota in children with atopic dermatitis are not altered by intake of probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium animalis subsp.lactis Bi-07

    DEFF Research Database (Denmark)

    Larsen, Nadejda Nikolajevna; Vogensen, Finn Kvist; Gøbel, Rikke Juul

    2011-01-01

    The effect of probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 on the composition of the Lactobacillus group, Bifidobacterium and the total bacterial population in feces from young children with atopic dermatitis was investigated. The study included 50 children...... as Lactobacillus gasseri, Lactobacillus fermentum, Lactobacillus oris, Leuconostoc mesenteroides, while the bifidobacterial community included Bifidobacterium adolescentis, Bifidobacterium bifidum, Bifidobacterium longum and Bifidobacterium catenulatum. The fecal numbers of L. acidophilus and B. lactis increased...... significantly after intervention, indicating survival of the ingested bacteria. The levels of Bifidobacterium correlated positively (P = 0.03), while the levels of the Lactobacillus group negatively (P = 0.01) with improvement of atopic eczema evaluated by the Severity Scoring of Atopic Dermatitis index...

  2. Purification and Characterization of Conjugated Bile Salt Hydrolase from Bifidobacterium longum BB536.

    Science.gov (United States)

    Grill, J; Schneider, F; Crociani, J; Ballongue, J

    1995-07-01

    Bifidobacterium species deconjugate taurocholic, taurodeoxycholic, taurochenodeoxycholic, glycocholic, glycodeoxycholic, and glycochenodeoxycholic acids. The enzyme level increases in the growth phase. No increase in activity is observed for the cytoplasmic enzyme after addition of conjugated bile acids to a stationary-phase culture. Conjugated bile salt hydrolase (BSH) was purified from Bifidobacterium longum BB536. Its apparent molecular mass in denaturing polyacrylamide gel electrophoresis was ca. 40,000 Da. The intact enzyme had a relative molecular weight of ca. 250,000 as determined by gel filtration chromatography, suggesting that the native BSH of B. longum is probably a hexamer. The purified enzyme is active towards both glycine and taurine conjugates of cholate, deoxycholate, and chenodeoxycholate. The pH optimum is in the range of 5.5 to 6.5. A loss of BSH activity is observed after incubation at temperatures higher than 42(deg)C; at 60(deg)C, 50% of the BSH activity is lost. The importance of free sulfhydryl groups at the enzyme active center is suggested. For B. longum BB536, no significant difference in the initial rate of deconjugation and enzymatic efficiency appears between bile salts. The enzymatic efficiency is higher for B. longum BB536 than for other genera. In this paper, a new method which permits a display of BSH activity directly on polyacrylamide gels is described; this method confirms the molecular weight obtained for B. longum BB536 BSH.

  3. In vitro kinetic analysis of oligofructose consumption by Bacteroides and Bifidobacterium spp. indicates different degradation mechanisms.

    Science.gov (United States)

    Van der Meulen, Roel; Makras, Lefteris; Verbrugghe, Kristof; Adriany, Tom; De Vuyst, Luc

    2006-02-01

    The growth of pure cultures of Bacteroides thetaiotaomicron LMG 11262 and Bacteroides fragilis LMG 10263 on fructose and oligofructose was examined and compared to that of Bifidobacterium longum BB536 through in vitro laboratory fermentations. Gas chromatography (GC) analysis was used to determine the different fractions of oligofructose and their degradation during the fermentation process. Both B. thetaiotaomicron LMG 11262 and B. fragilis LMG 10263 were able to grow on oligofructose as fast as on fructose, succinic acid being the major metabolite produced by both strains. B. longum BB536 grew slower on oligofructose than on fructose. Acetic acid and lactic acid were the main metabolites produced when fructose was used as the sole energy source. Increased amounts of formic acid and ethanol were produced when oligofructose was used as an energy source at the cost of lactic acid. Detailed kinetic analysis revealed a preferential metabolism of the short oligofructose fractions (e.g., F2 and F3) for B. longum BB536. After depletion of the short fractions, the larger oligofructose fractions (e.g., F4, GF4, F5, GF5, and F6) were metabolized, too. Both Bacteroides strains did not display such a preferential metabolism and degraded all oligofructose fractions simultaneously, transiently increasing the fructose concentration in the medium. This suggests a different mechanism for oligofructose breakdown between the strain of Bifidobacterium and both strains of Bacteroides, which helps to explain the bifidogenic nature of inulin-type fructans.

  4. Creation of the Probiotic Consortium on the Base of Strains of Bifidobacterium spp.

    Directory of Open Access Journals (Sweden)

    Kozhakhmetov, S. S.

    2009-01-01

    Full Text Available Nowadays, a widespread circulation of disbiotic conditions among the population of all ages in Kazakhstan requires an active development in industry for both preparations and products with probiotic properties. The gained bacterial isolates, Bifidobacterium adolescentis 180, B. breve 204, B. breve 584 and B. breve 587 were used in our researches and screening showed they possess high probiotic properties. The consortium possesses strong antimicrobial activity to pathogenic and potentially-pathogenic microflora, insulated during disbacteriosis, as well as from vagina and urea. They are able to produce vitamin B12 and also have antimutagenic activity. As a result, the consortium on the base of strains of Bifidobacterium spp. was received, possessing the following advantages: contains live mass of microbial, antagonistically active strains B. breve and B. adolescentis; contains more than 10^9 alive Bifidobacteria; does not contain plasmids, which means that it could not be a carrier of antibiotic stability for Gram-positive receptive pathogenic and potentially-pathogenic microflora.

  5. Effects of cigarette smoke condensate on the production and characterization of exopolysaccharides by Bifidobacterium

    Directory of Open Access Journals (Sweden)

    Jinqiang Hu

    2015-06-01

    Full Text Available The aim of the study was to investigate the effect of cigarette smoke on the production and characterization of exopolysaccharides (EPSs produced by Bifidobacterium. Cigarettes of Shanhua brand (nicotine: 1.1 mg, tar: 11 mg were utilized to prepare a cigarette smoke condensate (CSC. The standard strain of Bifidobacterium animalis was cultured in MRS media under anaerobic addition of CSC. The results showed that CSC significantly decreased the growth of B. animalis as well as EPSs and acetic acid production. Furthermore, two EPSs fractions (Fr-I and Fr-II were isolated and purified for chemical and molecular determination. By comparison with control, CSC was found to be of great impact on EPSs carbohydrate composition. The molecular weight mass of Fr-I changed from 3.33×105 g/mol (without CSC to 2.99×105 (with CSC. In conclusion, in vitro studies revealed that CSC was directly able to affect the production of metabolites for B. animalis, which could be an essential factor in certain pathological disorders.

  6. Enhancing bile tolerance improves survival and persistence of Bifidobacterium and Lactococcus in the murine gastrointestinal tract

    Directory of Open Access Journals (Sweden)

    Hill Colin

    2008-10-01

    Full Text Available Abstract Background The majority of commensal gastrointestinal bacteria used as probiotics are highly adapted to the specialised environment of the large bowel. However, unlike pathogenic bacteria; they are often inadequately equipped to endure the physicochemical stresses of gastrointestinal (GI delivery in the host. Herein we outline a patho-biotechnology strategy to improve gastric delivery and host adaptation of a probiotic strain Bifidobacterium breve UCC2003 and the generally regarded as safe (GRAS organism Lactococcus lactis NZ9000. Results In vitro bile tolerance of both strains was significantly enhanced (P Listeria monocytogenes bile resistance mechanism BilE. Strains harbouring bilE were also recovered at significantly higher levels (P n = 5, following oral inoculation. Furthermore, a B. breve strain expressing bilE demonstrated increased efficacy relative to the wild-type strain in reducing oral L. monocytogenes infection in mice. Conclusion Collectively the data indicates that bile tolerance can be enhanced in Bifidobacterium and Lactococcus species through rational genetic manipulation and that this can significantly improve delivery to and colonisation of the GI tract.

  7. Predominant genera of fecal microbiota in children with atopic dermatitis are not altered by intake of probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium animalis subsp. lactis Bi-07.

    Science.gov (United States)

    Larsen, Nadja; Vogensen, Finn K; Gøbel, Rikke; Michaelsen, Kim F; Abu Al-Soud, Waleed; Sørensen, Søren J; Hansen, Lars H; Jakobsen, Mogens

    2011-03-01

    The effect of probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 on the composition of the Lactobacillus group, Bifidobacterium and the total bacterial population in feces from young children with atopic dermatitis was investigated. The study included 50 children randomized to intake of one of the probiotic strain or placebo. Microbial composition was characterized by denaturing gradient gel electrophoresis, quantitative PCR and, in a subset of subjects, by pyrosequencing of the 16S rRNA gene. The core population of the Lactobacillus group was identified as Lactobacillus gasseri, Lactobacillus fermentum, Lactobacillus oris, Leuconostoc mesenteroides, while the bifidobacterial community included Bifidobacterium adolescentis, Bifidobacterium bifidum, Bifidobacterium longum and Bifidobacterium catenulatum. The fecal numbers of L. acidophilus and B. lactis increased significantly after intervention, indicating survival of the ingested bacteria. The levels of Bifidobacterium correlated positively (P=0.03), while the levels of the Lactobacillus group negatively (P=0.01) with improvement of atopic eczema evaluated by the Severity Scoring of Atopic Dermatitis index. This correlation was observed across the whole study cohort and not attributed to the probiotic intake. The main conclusion of the study is that administration of L. acidophilus NCFM and B. lactis Bi-07 does not affect the composition and diversity of the main bacterial populations in feces.

  8. EFFECT OF THE CONSUMPTION OF A CHEESE ENRICHED WITH PROBIOTIC ORGANISMS (BIFIDOBACTERIUM LACTIS BI-07 IN IMPROVING SYMPTOMS OF CONSTIPATION

    Directory of Open Access Journals (Sweden)

    Diane Cassia FAVRETTO

    2013-09-01

    Full Text Available Context Constipation is a very common symptom in the general population. One way of non-pharmacological treatment of constipation is through the addition of probiotics to food. Obectives The aim of this study was to evaluate de effect of the consumption of a fresh cheese, enriched with Bifidobacterium lactis Bi-07 on the symptoms of constipated women. Methods A randomized controlled trial, carried out in the Basic Health Units of Guaporé's City – RS/Brazil, between january and may 2012, with 30 constipated women. The patients were randomized into two groups whom received, for 30 days, 30 g of fresh cheese enriched with Bifidobacterium lactis Bi-07 (n = 15 or regular fresh cheese (n = 15. Constipation symptoms were evaluated according to ROMA III Consensus, before and after the nutritional intervention. Also, data of clinical and anthropometric characteristics of the individuals were collected. Accepted level of significance 5% (P≤0,05. Results The medium age of the studied population was 37,5±14,4 years in the intervention group and 40,8±12,8 years in the control group. After 30 days we observed that the ingestion of fresh cheese enriched with Bifidobacterium lactis Bi-07 promoted benefic effects on the symptoms of strength to evacuate. Conclusion The consumption of 30g/day of a fresh cheese enriched with Bifidobacterium lactis Bi-07 has beneficial effects on constipation symptoms.

  9. Stimulation of the growth of two probiotic bacteria, Lactobacillus Acidophilus NCFM and Bifidobacterium Lactis BL-04, by selected prebiotic canditates

    DEFF Research Database (Denmark)

    van Zanten, Gabriella Christina; Knudsen, Anne; Bandsholm, O.

    2009-01-01

    Prebiotics have been shown to support the growth of probiotic bacteria thereby having a beneficial effect on human health. The aim of this work was to evaluate selected and structurally different carbohydrate prebiotic candidate by measuring their capability to stimulate the growth of the two pro...... probiotic bacteria Lactobacillus acdophilus NCFM and Bifidobacterium lactis BL-04....

  10. Analysis of the human intestinal epithelial cell transcriptional response to Lactobacillus acidophilus, Lactobacillus salivarius, Bifidobacterium lactis and Escherichia coli

    DEFF Research Database (Denmark)

    Putaala, H; Barrangou, R; Leyer, G J

    2010-01-01

    a comparative analysis of the global in vitro transcriptional response of human intestinal epithelial cells to Lactobacillus acidophilus NCFM™, Lactobacillus salivarius Ls-33, Bifidobacterium animalis subsp. lactis 420, and enterohaemorrhagic Escherichia coli O157:H7 (EHEC). Interestingly, L. salivarius Ls-33...

  11. Comparative genomic analysis of 45 type strains of the genus Bifidobacterium: a snapshot of its genetic diversity and evolution.

    Directory of Open Access Journals (Sweden)

    Zhihong Sun

    Full Text Available Bifidobacteria are well known for their human health-promoting effects and are therefore widely applied in the food industry. Members of the Bifidobacterium genus were first identified from the human gastrointestinal tract and were then found to be widely distributed across various ecological niches. Although the genetic diversity of Bifidobacterium has been determined based on several marker genes or a few genomes, the global diversity and evolution scenario for the entire genus remain unresolved. The present study comparatively analyzed the genomes of 45 type strains. We built a robust genealogy for Bifidobacterium based on 402 core genes and defined its root according to the phylogeny of the tree of bacteria. Our results support that all human isolates are of younger lineages, and although species isolated from bees dominate the more ancient lineages, the bee was not necessarily the original host for bifidobacteria. Moreover, the species isolated from different hosts are enriched with specific gene sets, suggesting host-specific adaptation. Notably, bee-specific genes are strongly associated with respiratory metabolism and are potential in helping those bacteria adapt to the oxygen-rich gut environment in bees. This study provides a snapshot of the genetic diversity and evolution of Bifidobacterium, paving the way for future studies on the taxonomy and functional genomics of the genus.

  12. In vitro study of the prebiotic xylooligosaccharide (XOS) on the growth of Bifidobacterium spp and Lactobacillus spp.

    Science.gov (United States)

    Li, Zhaoping; Summanen, Paula H; Komoriya, Tomoe; Finegold, Sydney M

    2015-01-01

    We recently demonstrated that XOS increased the counts of Bifidobacterium in vivo without increasing Lactobacillus in healthy adults. In the current study, we evaluated the effect of XOS on the growth of 35 Bifidobacterium and 29 Lactobacillus strains in in vitro conditions. Bacteria were identified by 16S rRNA sequence analysis. The growth stimulation was determined by agar dilution technique on plates containing two-fold serial dilutions of XOS (100-0.1 mg/ml). The growth of 86% of Bifidobacterium strains was stimulated at 1.56 mg/ml XOS and 100% at 6.25 mg/ml XOS. The growth of 38% of Lactobacillus strains was stimulated at 1.56 mg/ml XOS and 62% at 6.25 mg/ml XOS; 31% of Lactobacillus were not stimulated by XOS. Our results further suggest that XOS may be beneficial in stimulating intestinal Bifidobacterium without having much effect on Lactobacillus. The potential role for XOS in managing obesity should be investigated further.

  13. Post-sensitization administration of non-digestible oligosaccharides and Bifidobacterium breve M-16V reduces allergic symptoms in mice

    NARCIS (Netherlands)

    van Esch, Betty C A M; Abbring, Suzanne; Diks, Mara A P; Dingjan, Gemma M; Harthoorn, Lucien F; Vos, A Paul; Garssen, Johan

    2016-01-01

    To support dietary management of severe cow's milk allergic infants, a synbiotic mixture of non-digestible oligosaccharides and Bifidobacterium breve M-16V (B. breve) was designed from source materials that are completely cow's milk-free. It was investigated whether this specific synbiotic concept c

  14. Stimulation of the growth of two probiotic bacteria, Lactobacillus Acidophilus NCFM and Bifidobacterium Lactis BL-04, by selected prebiotic canditates

    DEFF Research Database (Denmark)

    van Zanten, Gabriella Christina; Knudsen, Anne; Bandsholm, O.;

    2009-01-01

    Prebiotics have been shown to support the growth of probiotic bacteria thereby having a beneficial effect on human health. The aim of this work was to evaluate selected and structurally different carbohydrate prebiotic candidate by measuring their capability to stimulate the growth of the two...... probiotic bacteria Lactobacillus acdophilus NCFM and Bifidobacterium lactis BL-04....

  15. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of a health claim related to a combination of Lactobacillus helveticus CNCM I-1722, Bifidobacterium longum subsp. infantis CNCM I-3424, Bifidobacterium bifidum CNCM I-3426 and fructo

    DEFF Research Database (Denmark)

    Tetens, Inge

    of Lactobacillus helveticus CNCM I-1722, Bifidobacterium longum subsp. infantis CNCM I-3424, Bifidobacterium bifidum CNCM I-3426 and fructo-oligosaccharides from sucrose and immune defence against pathogens. The food constituent that is the subject of the health claim, a combination of L. helveticus CNCM I-1722, B...

  16. Antigen-presenting cells exposed to Lactobacillus acidophilus NCFM, Bifidobacterium bifidum BI-98, and BI-504 reduce regulatory T cell activity

    DEFF Research Database (Denmark)

    Schmidt, Esben Gjerløff Wedebye; Claesson, Mogens Helweg; Jensen, Simon Skjøde

    2010-01-01

    BACKGROUND:: The effect in vitro of six different probiotic strains including Lactobacillus acidophilus NCFM, Lactobacillus salivarius Ls-33, Lactobacillus paracasei subsp. paracasei YS8866441, Lactobacillus plantarum Lp-115, Bifidobacterium bifidum BI-504 and BI-98 was studied on splenic...

  17. The effect of soymilk intake on the fecal microbiota, particularly Bifidobacterium species, and intestinal environment of healthy adults: a pilot study.

    Science.gov (United States)

    Fujisawa, Tomohiko; Ohashi, Yuji; Shin, Ryoichi; Narai-Kanayama, Asako; Nakagaki, Takenori

    2017-01-01

    The influence of soymilk on the fecal microbiota, particularly Bifidobacterium species, and metabolic activities were investigated in eight healthy adult humans. During the soymilk intake period, the number of bifidobacteria in feces was significantly higher (penvironment.

  18. Effects of Bifidobacterium longum BB536 on lipid profile and histopathological changes in hypercholesterolaemic rats.

    Science.gov (United States)

    Al-Sheraji, S H; Amin, I; Azlan, A; Manap, M Y; Hassan, F A

    2015-01-01

    The present study investigated the effects of Bifidobacterium longum BB536 on lipid profile, liver and kidney function, and body fat in hypercholesterolaemic rats. 40 Sprague-Dawley rats were randomly divided into five groups. The negative control group received a standard diet. The positive control group received a cholesterol-enriched diet, whereas the intervention groups received a cholesterol-enriched diet supplemented with B. longum BB536 alone or in combination with inulin or Mangifera pajang fibrous polysaccharides. After 8 weeks, plasma lipids, and liver and kidney function were tested. Intake of the cholesterol-enriched diet increased total cholesterol, alanine aminotransferase, gamma-glutamyl transferase, creatinine, urea, liver weight, adipose tissue weight, liver lipid deposition and adipocyte size. B. longum BB536 supplementation significantly reduced total cholesterol, liver lipid deposition and adipocyte size, and positively affected liver and kidney function. These effects were significantly increased in the presence of inulin and M. pajang fibrous polysaccharides.

  19. Characterization and Application of BiLA, a Psychrophilic α-Amylase from Bifidobacterium longum.

    Science.gov (United States)

    Lee, Hye-Won; Jeon, Hye-Yeon; Choi, Hye-Jeong; Kim, Na-Ri; Choung, Woo-Jae; Koo, Ye-Seul; Ko, Dam-Seul; You, SangGuan; Shim, Jae-Hoon

    2016-04-06

    In this study, a novel α-amylase was cloned from Bifidobacterium longum and named BiLA. The enzyme exhibited optimal activity at 20 °C and a pH value of 5.0. Kinetic analysis using various carbohydrate substrates revealed that BiLA had the highest k(cat/)K(m) value for amylose. Interestingly, analysis of the enzymatic reaction products demonstrated that BiLA specifically catalyzed the hydrolysis of oligosaccharides and starches up to G5 from the nonreducing ends. To determine whether BiLA can be used to generate slowly digestible starch (SDS), starch was treated with BiLA, and the kinetic parameters were analyzed using porcine pancreatic α-amylase (PPA) and amyloglucosidase (AMG). Compared to normal starch, BiLA-treated starch showed lower k(cat)/K(m) values with PPA and AMG, suggesting that BiLA is a potential candidate for the production of SDS.

  20. Optimization of nitrogen source for Bifidobacterium bifidum using response surface methodology

    Directory of Open Access Journals (Sweden)

    Chen He

    2016-06-01

    Full Text Available In order to improve the viable counts of Bifidobacterium bifidum BB01 in the liquid medium, the Central Composite Design (CCD was used to optimize the nitrogen source in the medium of B. bifidum BB01. The results showed that the nitrogen source composition of B. bifidum BB01 was: peptone 0.9%, yeast extracts 0.3%, beef paste 0.7%. Under the optimal conditions, the viable counts of B. bifidum BB01 reached (2.49±0.06×109CFU/mL after cultured at 18h, which was 42.97% higher than MRS (lactose, and 12.85% higher than the optimized MRS medium (carbon source and prebiotics were optimized. Therefore, the CCD used in this study is workable for promoting the growth of B. bifidum BB01.

  1. Genetic analyses of the antibiotic resistance of Bifidobacterium bifidum strain Yakult YIT 4007.

    Science.gov (United States)

    Sato, Takashi; Iino, Tohru

    2010-02-28

    Bifidobacterium bifidum strain Yakult YIT 4007 (abbreviated as B. bifidum YIT 4007) is a commercial strain and resistant to erythromycin, neomycin, and streptomycin. Resistances to these antibiotics were endowed by sequential isolation of resistant mutants from its susceptible progenitor strain YIT 4001. Comparison of nucleotide sequences of various candidate genes of both strains led us to find that B. bifidum YIT 4007 had mutations on three copies of 23S ribosomal RNA genes, an 8 bp deletion of the rluD gene for pseudouridine synthase, and a mutation on the rpsL gene for ribosomal protein S12. The responsibility of these mutations to antibiotic resistances was supported by analyses of newly isolated mutants resistant to these antibiotics. The antibiotic resistances of B. bifidum YIT 4007 were evidently acquired by mutations of the structural genes on the chromosome and not associated with mobile genetic elements like insertion sequences, phages, and plasmids.

  2. Applications of microencapsulated Bifidobacterium longum with Eleutherine americana in fresh milk tofu and pineapple juice.

    Science.gov (United States)

    Phoem, Atchara N; Chanthachum, Suphitchaya; Voravuthikunchai, Supayang P

    2015-04-01

    Bifidobacterium longum was microencapsulated by extrusion technique and added in fresh milk tofu and pineapple juice. Microencapsulation of B. longum with Eleutherine americana extract, oligosaccharides extract, and commercial fructo-oligosaccharides was assessed for the bacterial survival after sequential exposure to simulated gastric and intestinal juices, and refrigeration storage. Microencapsulated B. longum with the extract and oligosaccharides extract in the food products showed better survival than free cells under adverse conditions. Sensory analysis demonstrated that the products containing co-encapsulated bacterial cells were more acceptable by consumers than free cells. Pineapple juice prepared with co-encapsulated cells had lower values for over acidification, compared with the juice with free cells added. This work suggested that microencapsulated B. longum with E. americana could enhance functional properties of fresh milk tofu and pineapple juice.

  3. Applications of Microencapsulated Bifidobacterium Longum with Eleutherine Americana in Fresh Milk Tofu and Pineapple Juice

    Directory of Open Access Journals (Sweden)

    Atchara N. Phoem

    2015-04-01

    Full Text Available Bifidobacterium longum was microencapsulated by extrusion technique and added in fresh milk tofu and pineapple juice. Microencapsulation of B. longum with Eleutherine americana extract, oligosaccharides extract, and commercial fructo-oligosaccharides was assessed for the bacterial survival after sequential exposure to simulated gastric and intestinal juices, and refrigeration storage. Microencapsulated B. longum with the extract and oligosaccharides extract in the food products showed better survival than free cells under adverse conditions. Sensory analysis demonstrated that the products containing co-encapsulated bacterial cells were more acceptable by consumers than free cells. Pineapple juice prepared with co-encapsulated cells had lower values for over acidification, compared with the juice with free cells added. This work suggested that microencapsulated B. longum with E. americana could enhance functional properties of fresh milk tofu and pineapple juice.

  4. CRECIMIENTO, SOBREVIVENCIA Y ADAPTACIÓN DE Bifidobacterium infantis A CONDICIONES ÁCIDAS

    OpenAIRE

    L. Mayorga-Reyes; P. Bustamante-Camilo; A. Gutiérrez-Nava; E. Barranco-Florido; A. Azaola-Espinosa

    2009-01-01

    La acidez es una condición ambiental comúnmente encontrada por las bacterias presentes en productos lácteos fermentados y el tracto gastrointestinal. En este estudio, las células de Bifidobacterium infantis de 24 h de fermentación se inocularon en medios de cultivo con pH iniciales de 7.0, 4.0, 3.0 y 2.0 durante 24 h. Conforme el pH inicial disminuye, la población celular activa disminuyó hasta tres órdenes de magnitud. A pH 4.0 las células se mostraron estables durante las primeras 5 h de fe...

  5. Improved adhesive properties of recombinant bifidobacteria expressing the Bifidobacterium bifidum-specific lipoprotein BopA

    Directory of Open Access Journals (Sweden)

    Gleinser Marita

    2012-06-01

    Full Text Available Abstract Background Bifidobacteria belong to one of the predominant bacterial groups in the intestinal microbiota of infants and adults. Several beneficial effects on the health status of their human hosts have been demonstrated making bifidobacteria interesting candidates for probiotic applications. Adhesion of probiotics to the intestinal epithelium is discussed as a prerequisite for colonisation of and persistence in the gastrointestinal tract. Results In the present study, 15 different strains of bifidobacteria were tested for adhesion. B. bifidum was identified as the species showing highest adhesion to all tested intestinal epithelial cell (IEC lines. Adhesion of B. bifidum S17 to IECs was strongly reduced after treatment of bacteria with pronase. These results strongly indicate that a proteinaceous cell surface component mediates adhesion of B. bifidum S17 to IECs. In silico analysis of the currently accessible Bifidobacterium genomes identified bopA encoding a lipoprotein as a B. bifidum-specific gene previously shown to function as an adhesin of B. bifidum MIMBb75. The in silico results were confirmed by Southern Blot analysis. Furthermore, Northern Blot analysis demonstrated that bopA is expressed in all B. bifidum strains tested under conditions used to cultivate bacteria for adhesion assays. The BopA gene was successfully expressed in E. coli and purified by Ni-NTA affinity chromatography as a C-terminal His6-fusion. Purified BopA had an inhibitory effect on adhesion of B. bifidum S17 to IECs. Moreover, bopA was successfully expressed in B. bifidum S17 and B. longum/infantis E18. Strains overexpressing bopA showed enhanced adhesion to IECs, clearly demonstrating a role of BopA in adhesion of B. bifidum strains. Conclusions BopA was identified as a B. bifidum-specific protein involved in adhesion to IECs. Bifidobacterium strains expressing bopA show enhanced adhesion. Our results represent the first report on recombinant

  6. Intraspecies Genomic Diversity and Long-Term Persistence of Bifidobacterium longum.

    Directory of Open Access Journals (Sweden)

    Andrei V Chaplin

    Full Text Available Members of genus Bifidobacterium are Gram-positive bacteria, representing a large part of the human infant microbiota and moderately common in adults. However, our knowledge about their diversity, intraspecific phylogeny and long-term persistence in humans is still limited. Bifidobacterium longum is generally considered to be the most common and prevalent species in the intestinal microbiota. In this work we studied whole genome sequences of 28 strains of B. longum, including 8 sequences described in this paper. Part of these strains were isolated from healthy children during a long observation period (up to 10 years between isolation from the same patient. The three known subspecies (longum, infantis and suis could be clearly divided using sequence-based phylogenetic methods, gene content and the average nucleotide identity. The profiles of glycoside hydrolase genes reflected the different ecological specializations of these three subspecies. The high impact of horizontal gene transfer on genomic diversity was observed, which is possibly due to a large number of prophages and rapidly spreading plasmids. The pan-genome characteristics of the subspecies longum corresponded to the open pan-genome model. While the major part of the strain-specific genetic loci represented transposons and phage-derived regions, a large number of cell envelope synthesis genes were also observed within this category, representing high variability of cell surface molecules. We observed the cases of isolation of high genetically similar strains of B. longum from the same patients after long periods of time, however, we didn't succeed in the isolation of genetically identical bacteria: a fact, reflecting the high plasticity of microbiota in children.

  7. Intraspecies Genomic Diversity and Long-Term Persistence of Bifidobacterium longum

    Science.gov (United States)

    Chaplin, Andrei V.; Efimov, Boris A.; Smeianov, Vladimir V.; Kafarskaia, Lyudmila I.; Pikina, Alla P.; Shkoporov, Andrei N.

    2015-01-01

    Members of genus Bifidobacterium are Gram-positive bacteria, representing a large part of the human infant microbiota and moderately common in adults. However, our knowledge about their diversity, intraspecific phylogeny and long-term persistence in humans is still limited. Bifidobacterium longum is generally considered to be the most common and prevalent species in the intestinal microbiota. In this work we studied whole genome sequences of 28 strains of B. longum, including 8 sequences described in this paper. Part of these strains were isolated from healthy children during a long observation period (up to 10 years between isolation from the same patient). The three known subspecies (longum, infantis and suis) could be clearly divided using sequence-based phylogenetic methods, gene content and the average nucleotide identity. The profiles of glycoside hydrolase genes reflected the different ecological specializations of these three subspecies. The high impact of horizontal gene transfer on genomic diversity was observed, which is possibly due to a large number of prophages and rapidly spreading plasmids. The pan-genome characteristics of the subspecies longum corresponded to the open pan-genome model. While the major part of the strain-specific genetic loci represented transposons and phage-derived regions, a large number of cell envelope synthesis genes were also observed within this category, representing high variability of cell surface molecules. We observed the cases of isolation of high genetically similar strains of B. longum from the same patients after long periods of time, however, we didn’t succeed in the isolation of genetically identical bacteria: a fact, reflecting the high plasticity of microbiota in children. PMID:26275230

  8. The Science behind the Probiotic Strain Bifidobacterium animalis subsp. lactis BB-12®

    Directory of Open Access Journals (Sweden)

    Mikkel Jungersen

    2014-03-01

    Full Text Available This review presents selected data on the probiotic strain Bifidobacterium animalis subsp. lactis BB-12® (BB-12®, which is the world’s most documented probiotic Bifidobacterium. It is described in more than 300 scientific publications out of which more than 130 are publications of human clinical studies. The complete genome sequence of BB-12® has been determined and published. BB-12® originates from Chr. Hansen’s collection of dairy cultures and has high stability in foods and as freeze dried powders. Strain characteristics and mechanisms of BB-12® have been established through extensive in vitro testing. BB-12® exhibits excellent gastric acid and bile tolerance; it contains bile salt hydrolase, and has strong mucus adherence properties, all valuable probiotic characteristics. Pathogen inhibition, barrier function enhancement, and immune interactions are mechanisms that all have been demonstrated for BB-12®. BB-12® has proven its beneficial health effect in numerous clinical studies within gastrointestinal health and immune function. Clinical studies have demonstrated survival of BB-12® through the gastrointestinal tract and BB-12® has been shown to support a healthy gastrointestinal microbiota. Furthermore, BB-12® has been shown to improve bowel function, to have a protective effect against diarrhea, and to reduce side effects of antibiotic treatment, such as antibiotic-associated diarrhea. In terms of immune function, clinical studies have shown that BB-12® increases the body’s resistance to common respiratory infections as well as reduces the incidence of acute respiratory tract infections.

  9. A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis

    DEFF Research Database (Denmark)

    Nordgaard, Inge; Rumessen, Jüri Johs.; Wildt, Signe

    2011-01-01

    To investigate the clinical effect of treatment with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 (Probio-Tec AB-25) to maintain remission in patients with ulcerative colitis.......To investigate the clinical effect of treatment with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 (Probio-Tec AB-25) to maintain remission in patients with ulcerative colitis....

  10. Role of Bifidobacterium bifidum and plant food extracts in improving microflora and biochemical and cytogenetic parameters in adjuvant arthritis.

    Directory of Open Access Journals (Sweden)

    Donya, S. M.

    2011-09-01

    Full Text Available The aim of the present research was to discover plant food extracts and probiotics that may have bioactivity towards chronic inflammation. Three plant food extract mixtures expected to be rich in phenolic compounds, carotenoids and tocopherols were prepared. The anti-inflammatory activity of the different mixtures as well as probiotic bacteria (Bifidobacterium bifidum were evaluated in adjuvant arthritis in rats. The anti-inflammatory effect, mechanism of action and safety of the three mixtures and Bifidobacterium bifidum were studied by measuring the size of inflammation and the determination of inflammatory and oxidative stress biomarkers, colonic bacteria profile and specific cytogenetic parameters. The contents of tocopherols, β-carotene and phenolic compounds in the mixtures were determined. The results show that the tested mixtures and Bifidobacterium bifidum possess promising anti-inflammatory effects. The mechanism of action seems to involve a reduction in oxidative stress and inflammatory biomarkers and an effect on colonic microflora. Genotoxicity and DNA fragmentation induced by adjuvant arthritis were prevented after supplementation with the tested mixtures.El objetivo de la presente investigación fue encontrar extractos de alimentos vegetales y probióticos que puedan tener bioactividad hacía la inflamación crónica. Mezclas de tres extractos de alimentos vegetales conocidos por su riqueza en compuestos fenólicos, carotenoides y tocoferoles han sido preparadas. La actividad anti-inflamatoria de las diferentes mezclas y de bacterias probióticas (Bifidobacterium bifidum fue evaluada en artritis adyuvante en ratas. El efecto anti-inflamatorio, mecanismo de acción y salubridad de las tres mezclas y de Bifidobacterium bifidum ha sido estudiado mediante la medida del tamaño de la inflamación y la determinación de biomarcadores de inflamación y estrés oxidativo, del perfil de bacterias del colón y de parámetros citogen

  11. THE APOPTOSIS OF EXPERIMENTAL COLORECTAL CARCINOMA CELLS INDUCED BY PEPTIDOGLYCAN OF BIFIDOBACTERIUM AND THE EXPRESSION OF APOPTOTIC REGULATING GENES

    Institute of Scientific and Technical Information of China (English)

    WANG Li-sheng; PAN Ling-jia; SHI Li; SUN Yong; ZHANG Ya-li; ZHOU Dian-yuan

    1999-01-01

    Objective: To explore the antitumor mechanisms of whole peptidoglycan of bifidobacterium. Methods: The apoptotic cells and the positive expression of bcl-2 and bax oncoprotein were studied nude mice transplantation tumors of colorectal carcinoma by employing in situ end labeling technique and immunohistochemical staining. Results:The apoptotic cell density, the positive rate and the staining intensity of bax oncoprotein of the transplantation tumor of colorectal carcinoma in the whole peptidoglycan injection group were significantly higher when compared with the tumor control group. The positive rate of bcl-2 oncoprotein in the whole peptidoglycan injection group was obviously lower than that in the tumor control group (P<0.01).Conclusion: Whole peptidoglycan of Bifidobacterium bifidum could induce cell apoptosis of nude mice transplantation tumors of colorectal carcinoma by downregulating the expression of the bcl-2 gene and upregulating the expression of the bax gene.

  12. Survival of Bifidobacterium longum and its effect on physicochemical properties and sensorial attributes of white brined cheese.

    Science.gov (United States)

    Gursoy, Oguz; Gokce, Ramazan; Con, Ahmet Hilmi; Kinik, Ozer

    2014-11-01

    Survival of the probiotic adjunct culture Bifidobacterium longum and cheese starters during ripening of white brined cheese, effect of the probiotic culture on physicochemical properties and sensorial attributes of cheeses were investigated throughout 90 d of ripening. Bifidobacterium longum were able to survive at higher levels (>10(7 )cfu/g cheese) than the therapeutic minimum (10(6)-10(7 )cfu/g cheese) after 90 d and did not have any negative effect on the survival of Streptococcus spp. (including common cheese starters). Incorporation of the probiotic adjunct into white brined cheese and high levels of their survival rates during ripening had an insignificant effect on the composition of cheeses. Results indicated that white brined cheese is a suitable food matrix for the delivery of B. longum used in this study, and white brined cheeses with B. longum may be considered as a probiotic dairy product.

  13. Bifidobacterium breve reduces apoptotic epithelial cell shedding in an exopolysaccharide and MyD88-dependent manner

    Science.gov (United States)

    Hughes, K. R.; Harnisch, L. C.; Alcon-Giner, C.; Mitra, S.; Wright, C. J.; Ketskemety, J.

    2017-01-01

    Certain members of the microbiota genus Bifidobacterium are known to positively influence host well-being. Importantly, reduced bifidobacterial levels are associated with inflammatory bowel disease (IBD) patients, who also have impaired epithelial barrier function, including elevated rates of apoptotic extrusion of small intestinal epithelial cells (IECs) from villi—a process termed ‘cell shedding’. Using a mouse model of pathological cell shedding, we show that mice receiving Bifidobacterium breve UCC2003 exhibit significantly reduced rates of small IEC shedding. Bifidobacterial-induced protection appears to be mediated by a specific bifidobacterial surface exopolysaccharide and interactions with host MyD88 resulting in downregulation of intrinsic and extrinsic apoptotic responses to protect epithelial cells under highly inflammatory conditions. Our results reveal an important and previously undescribed role for B. breve, in positively modulating epithelial cell shedding outcomes via bacterial- and host-dependent factors, supporting the notion that manipulation of the microbiota affects intestinal disease outcomes. PMID:28123052

  14. Effect of repeated oral administration of Bifidobacterium longum BB536 on apomorphine-induced rearing behavior in mice

    OpenAIRE

    ORIKASA, Shuzo; NABESHIMA, Kazumi; Iwabuchi, Noriyuki; Xiao, Jin-zhong

    2016-01-01

    Schizophrenia is a chronic psychiatric illness. Disruption of the dopaminergic system has been suggested to be the pathogenic cause of this disease. The effect of Bifidobacterium longum BB536 (BB536) on schizophrenic behavior was investigated in an animal model. Daily administration of BB536 (109 CFU/mouse, p.o. for 2 weeks) was found to reduce rearing behavior augmented by the dopamine receptor agonist apomorphine and to decrease the resting level of plasma corticosterone and the ratio of ky...

  15. The influence of different polymers on viability of Bifidobacterium lactis 300b during encapsulation, freeze-drying and storage

    OpenAIRE

    Pop, Oana Lelia; Brandau, Thorsten; Schwinn, Jens; Dan Cristian VODNAR; Carmen SOCACIU

    2014-01-01

    Seven different types of natural polymers namely hydroxypropyl methylcellulose (HPMC), sodium-carboxymethyl cellulose (Na-CMC), microcrystalline cellulose (MCC), starch BR-07, starch BR-08, dextrin and pullulan were used in order to develop the optimal formula for the entrapment of Bifidobacterium lactis 300B in Ca-alginate based granules. Laminar flow drip casting with Brace-Encapsulator was used in order to prepare the granules. The results showed that alginate/pullulan and alginate/HPMC fo...

  16. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults

    OpenAIRE

    2011-01-01

    Objective. To assess the impact of Bifidobacterium lactis HN019 supplementation on whole gut transit time (WGTT) and frequency of functional gastrointestinal (GI) symptoms in adults. Material and methods. We randomized 100 subjects (mean age: 44 years; 64% female) with functional GI symptoms to consume a proprietary probiotic strain, B. lactis HN019 (Fonterra Research Centre, Palmerston North, New Zealand), at daily doses of 17.2 billion colony forming units (CFU) (high dose; n = 33), 1.8 bil...

  17. Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients

    OpenAIRE

    Chitapanarux, Imjai; Chitapanarux, Taned; Traisathit, Patrinee; Kudumpee, Sudkaneung; Tharavichitkul, Ekkasit; Lorvidhaya, Vicharn

    2010-01-01

    Background Radiation-induced diarrhea is frequently observed during pelvic radiotherapy. This study was performed to determine the ability of a probiotic containing live lactobacillus acidophilus plus bifidobacterium bifidum to reduce the incidence of radiation-induced diarrhea in locally advanced cervical cancer patients. Methods Patients who were undergoing pelvic radiotherapy concurrent with weekly cisplatin were randomly assigned to a study drug or placebo, in a double-blind study. Diarrh...

  18. Identification of Bifidobacterium Strains Isolated from Kashk-e Zard: A Traditional Iranian Fermented Cereal-Dairy Based Food

    Directory of Open Access Journals (Sweden)

    Mashak

    2016-09-01

    Full Text Available Objectives The genus Bifidobactrium enjoys considerable significance among the probiotic bacteria for having appropriately adapted to the human gastrointestinal tract. As the properties of Bifidobacteria are strain-oriented and niche-dependent, there is growing interest in studying the different sources of these probiotics. Kashk-e Zard, a traditional fermented food produced from wheat and yogurt through a two-week, two-step fermentation process, is rich in probiotics and is worthy of study in this regard. The present study aimed to identify Bifidobacterium spp. in Kashk-e Zard. Methods Twenty-three samples of Kashk-e Zard were collected and subjected to Bifidobacterium identification experiments. Polymerase chain reaction (PCR and sequencing methods were applied for bacterial identification. Results Twelve of the isolates obtained were G +, rod-shaped, and catalase-, whereas only three of them identified positive for fructose 6-phosphate phosphoketolase (F6PPK a Bifidobacterium specific test and mupirocin resistance. These three isolates were then considered for further identification using the 16SrDNA sequencing technique. Conclusions Although carbohydrate fermentation patterns specified these three isolates as B. infantis, B. bifidum, and B. longum, the molecular results did not confirm B. longum, which is still also controversial in the literature. Overall, our results demonstrated that Kashk-e Zard is a rich potential source of probiotic bacteria and further investigations should be undertaken.

  19. The effect of quercetin on genetic expression of the commensal gut microbes Bifidobacterium catenulatum, Enterococcus caccae and Ruminococcus gauvreauii.

    Science.gov (United States)

    Firrman, Jenni; Liu, LinShu; Zhang, Liqing; Arango Argoty, Gustavo; Wang, Minqian; Tomasula, Peggy; Kobori, Masuko; Pontious, Sherri; Xiao, Weidong

    2016-12-01

    Quercetin is one of the most abundant polyphenols found in fruits and vegetables. The ability of the gut microbiota to metabolize quercetin has been previously documented; however, the effect that quercetin may have on commensal gut microbes remains unclear. In the present study, the effects of quercetin on the commensal gut microbes Ruminococcus gauvreauii, Bifidobacterium catenulatum and Enterococcus caccae were determined through evaluation of growth patterns and cell morphology, and analysis of genetic expression profiles between quercetin treated and non-treated groups using Single Molecule RNA sequencing via Helicos technology. Results of this study revealed that phenotypically, quercetin did not prevent growth of Ruminococcus gauvreauii, mildly suppressed growth of Bifidobacterium catenulatum, and moderately inhibited growth of Enterococcus caccae. Genetic analysis revealed that in response to quercetin, Ruminococcus gauvreauii down regulated genes responsible for protein folding, purine synthesis and metabolism. Bifidobacterium catenulatum increased expression of the ABC transport pathway and decreased metabolic pathways and cell wall synthesis. Enterococcus caccae upregulated genes responsible for energy production and metabolism, and downregulated pathways of stress response, translation and sugar transport. For the first time, the effect of quercetin on the growth and genetic expression of three different commensal gut bacteria was documented. The data provides insight into the interactions between genetic regulation and growth. This is also a unique demonstration of how RNA single molecule sequencing can be used to study the gut microbiota.

  20. Role of Bifidobacterium bifidum and plant food extracts in improving microflora and biochemical and cytogenetic parameters in adjuvant arthritis

    Energy Technology Data Exchange (ETDEWEB)

    Al-Okbi, S. Y.; Mohamed, D. A.; Donya, S. M.; Abd El Khalek, A. B.

    2011-07-01

    The aim of the present research was to discover plant food extracts and probiotics that may have bioactivity towards chronic inflammation. Three plant food extract mixtures expected to be rich in phenolic compounds, carotenoids and tocopherols were prepared. The anti-inflammatory activity of the different mixtures as well as probiotic bacteria (Bifidobacterium bifidum) were evaluated in adjuvant arthritis in rats. The anti-inflammatory effect, mechanism of action and safety of the three mixtures and Bifidobacterium bifidum were studied by measuring the size of inflammation and the determination of inflammatory and oxidative stress biomarkers, colonic bacteria profile and specific cytogenetic parameters. The contents of tocopherols, {beta}-carotene and phenolic compounds in the mixtures were determined. The results show that the tested mixtures and Bifidobacterium bifidum possess promising anti-inflammatory effects. The mechanism of action seems to involve a reduction in oxidative stress and inflammatory bio markers and an effect on colonic microflora. Genotoxicity and DNA fragmentation induced by adjuvant arthritis were prevented after supplementation with the tested mixtures. (Author) 61 refs.

  1. Effect of triple viable bifidobacterium combined with mosapride on hemorheology and serum gastrointestinal hormone levels in patients with functional dyspepsia

    Institute of Scientific and Technical Information of China (English)

    Shun-Bin Ding; Ming-Chun Cai; Wen-Li Zhang; Tian-Hua Jiang

    2016-01-01

    Objective:To observe the effect of triple viable bifidobacterium combined with mosapride on hemorheology and serum gastrointestinal hormone levels in patients with functional dyspepsia (FD).Methods: A total of 127 patients with FD were randomly divided into the observation group (67cases) and the control group (62 cases). The control group was given mosapride, the observation group was given triple viable bifidobacterium on the base of the control group. For 2 months, to observe the efficacy and changes of hemorheology [the whole blood viscosity (high and low shear), plasma viscosity] and serum gastrointestinal hormone levels (MTL, NPY, VIP). Results: After treatment, the observation group of the whole blood viscosity (high and low shear), plasma viscosity were decreased significantly (P0.05). There was significantly difference between the two groups (P<0.05); After treatment, serum MTL, NPY were increased and VIP was increased in both groups (P<0.05), and all indexes of the observation group were improved more significant than those of the control group (P<0.05).Conclusions:Efficacy of triple viable bifidobacterium combined with mosapride is more better than single mosapride in the treatment of FD. It may be related to its effects on hemorheology and gastrointestinal hormone.

  2. Multiparametric flow cytometry and cell sorting for the assessment of viable, injured, and dead bifidobacterium cells during bile salt stress.

    Science.gov (United States)

    Amor, Kaouther Ben; Breeuwer, Pieter; Verbaarschot, Patrick; Rombouts, Frank M; Akkermans, Antoon D L; De Vos, Willem M; Abee, Tjakko

    2002-11-01

    Using a flow cytometry-based approach, we assessed the viability of Bifidobacterium lactis DSM 10140 and Bifidobacterium adolescentis DSM 20083 during exposure to bile salt stress. Carboxyfluorescein diacetate (cFDA), propidium iodide (PI), and oxonol [DiBAC4(3)] were used to monitor esterase activity, membrane integrity, and membrane potential, respectively, as indicators of bacterial viability. Single staining with these probes rapidly and noticeably reflected the behavior of the two strains during stress exposure. However, the flow cytometry results tended to overestimate the viability of the two strains compared to plate counts, which appeared to be related to the nonculturability of a fraction of the population as a result of sublethal injury caused by bile salts. When the cells were simultaneously stained with cFDA and PI, flow cytometry and cell sorting revealed a striking physiological heterogeneity within the stressed bifidobacterium population. Three subpopulations could be identified based on their differential uptake of the probes: cF-stained, cF and PI double-stained, and PI-stained subpopulations, representing viable, injured, and dead cells, respectively. Following sorting and recovery, a significant fraction of the double-stained subpopulation (40%) could resume growth on agar plates. Our results show that in situ assessment of the physiological activity of stressed bifidobacteria using multiparameter flow cytometry and cell sorting may provide a powerful and sensitive tool for assessment of the viability and stability of probiotics.

  3. A proliferative probiotic Bifidobacterium strain in the gut ameliorates progression of metabolic disorders via microbiota modulation and acetate elevation

    Science.gov (United States)

    Aoki, Ryo; Kamikado, Kohei; Suda, Wataru; Takii, Hiroshi; Mikami, Yumiko; Suganuma, Natsuki; Hattori, Masahira; Koga, Yasuhiro

    2017-01-01

    The gut microbiota is an important contributor to the worldwide prevalence of metabolic syndrome (MS), which includes obesity and diabetes. The anti-MS effects exerted by Bifidobacterium animalis ssp. lactis GCL2505 (BlaG), a highly proliferative Bifidobacterium strain in the gut, and B. longum ssp. longum JCM1217T (BloJ) were comparatively examined. BlaG treatment reduced visceral fat accumulation and improved glucose tolerance, whereas BloJ had no effect on these parameters. Gut microbial analysis revealed that BlaG exerted stronger effects on the overall bacterial structure of the gut microbiota than BloJ, including enrichment of the genus Bifidobacterium. The levels of acetate and glucagon-like peptide-1 were increased by BlaG treatment in both the gut and plasma, but not by BloJ treatment. Correlation analysis suggested that the elevation of gut acetate levels by BlaG treatment plays a pivotal role in the BlaG-induced anti-MS effects. These findings indicated that BlaG, a highly viable and proliferative probiotic, improves metabolic disorders by modulating gut microbiota, which results in the elevation of SCFAs, especially acetate. PMID:28252037

  4. Influence of probiotic strain Bifidobacterium animalis subsp. lactis lafti® b94, inulin and transglutaminase on the properties of set- style yoghurt

    Directory of Open Access Journals (Sweden)

    Maja Benković

    2008-05-01

    Full Text Available The aim of this research was to examine the influence of probiotic strain Bifidobacterium animalis subsp. lactis LAFTI® B94, inulin and transglutaminase on quality and sensory properties of set-style yoghurt. Fresh, homogenized milk with 3,3% of milk fat was used for yoghurt production, with addition of Bifidobacterium animalis subsp. lactis LAFTI® B94, inulin and transglutaminase activated during 1h 30 min at 55 °C. Enzyme inactivation was carried out by pasteurization of milk during 15 minutes at 85 °C. Control samples were prepared without addition of probiotic culture, inulin and transglutaminase. Physico-chemical parameters and sensory properties of produced set-style yoghurt have been determined. For reliable identification of probiotic strain Bifidobacterium animalis subsp. lactis LAFTI® B94, isolated from the produced yoghurt, SDS-PAGE of whole cell proteins and PCR with species specific primers for Bifidobacterium were carried out. It has been shown that produced set-style yoghurt with probiotic strain Bifidobacterium animalis subsp. lactis LAFTI® B94, inulin and transglutaminase had higher firmness, less syneresis and better sensory properties than control yoghurt samples. After 28 days of storage the viable count of Bifidobacterium animalis subsp. lactis LAFTI® B94 was higher in samples containing inulin as prebiotic. Fermentation of yoghurt samples containing inulin and transglutaminase lasted shorter than fermentation of samples without inulin and transglutaminase. The presence of high number of probiotic culture (more than 106 cells/mL in produced set yoghurts was confirmed by SDS-PAGE of whole cell proteins and PCR with species specific primers for Bifidobacterium

  5. Analysis of host-inducing proteome changes in bifidobacterium longum NCC2705 grown in Vivo.

    Science.gov (United States)

    Yuan, Jing; Wang, Bin; Sun, Zhongke; Bo, Xin; Yuan, Xitong; He, Xiang; Zhao, Hongqing; Du, Xinying; Wang, Fang; Jiang, Zheng; Zhang, Ling; Jia, Leili; Wang, Yufei; Wei, Kaihua; Wang, Jie; Zhang, Xuemin; Sun, Yansong; Huang, Liuyu; Zeng, Ming

    2008-01-01

    To investigate the molecular mechanisms underlying the adaptation of Bifidobacterium longum to the intestinal tract, we utilized a new model for rabbit intestinal culture of B. longum and reported the changes in proteomic profiles after incubation in the in vivo environment. By 2D-PAGE coupled with matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF-MS) and/or electrospray ionization tandem mass spectrometry (ESI-MS/MS) analyses, proteomic profiles of B. longum strain NCC2705 grown in the in vivo and in vitro environments were compared. Confirmed by semiquantitative RT-PCR, which exhibited at least a 3-fold change or greater, 19 up-regulated proteins, 14 down-regulated proteins, and 4 proteins with mobility changes were identified during intestinal growth. These identified proteins include key stress proteins, metabolism-related proteins, and proteins related to translation. Our results indicate that some useful proteins are expressed at higher levels in cells during intestinal growth. These proteins reflected the adaptation of B. longum NCC2705 to the intestine, such as EF-Tu which contributes to the retention or attachment as a Bifidobacterium adhesin-like factor, bile salt hydrolase (BSH) which might play an important role in the molecular mechanisms for the initial interaction of probiotic with the intestinal environment, and stress proteins which defend B. longum against the action of bile salts and other harmful ingredients of the gastrointestinal tract (GIT). The most striking fact of our observation was that four proteins GlnA1, PurC, LuxS, and Pgk exhibit clear post-translational modification. Western blot (WB) analysis and Pro-Q Diamond staining revealed that substances of the GIT trigger Pgk and LuxS phosphorylation at Ser/Thr residues for bacteria grown in vivo. These proteins were identified for the first time as bifidobacterial phosphoproteins. Our data suggest that the phosphorylated autoinducer-2 production

  6. The Effects of Bifidobacterium breve on Immune Mediators and Proteome of HT29 Cells Monolayers

    Directory of Open Access Journals (Sweden)

    Borja Sánchez

    2015-01-01

    Full Text Available The use of beneficial microorganisms, the so-called probiotics, to improve human health is gaining popularity. However, not all of the probiotic strains trigger the same responses and they differ in their interaction with the host. In spite of the limited knowledge on mechanisms of action some of the probiotic effects seem to be exerted through maintenance of the gastrointestinal barrier function and modulation of the immune system. In the present work, we have addressed in vitro the response of the intestinal epithelial cell line HT29 to the strain Bifidobacterium breve IPLA20004. In the array of 84 genes involved in inflammation tested, the expression of 12 was modified by the bifidobacteria. The genes of chemokine CXCL6, the chemokine receptor CCR7, and, specially, the complement component C3 were upregulated. Indeed, HT29 cells cocultivated with B. breve produced significantly higher levels of protein C3a. The proteome of HT29 cells showed increased levels of cytokeratin-8 in the presence of B. breve. Altogether, it seems that B. breve IPLA20004 could favor the recruitment of innate immune cells to the mucosa reinforcing, as well as the physical barrier of the intestinal epithelium.

  7. Oral treatment with Bifidobacterium longum 51A reduced inflammation in a murine experimental model of gout.

    Science.gov (United States)

    Vieira, A T; Galvão, I; Amaral, F A; Teixeira, M M; Nicoli, J R; Martins, F S

    2015-01-01

    Gout is an acute inflammatory disease characterised by the presence of uric acid crystals in the joint. This event promotes neutrophil infiltration and activation that leads to tissue damage. We investigated here whether the oral administration of the probiotic strain Bifidobacterium longum 5(1A) (BL) could ameliorate monosodium urate crystal (MSU)-induced inflammation in a murine model of gout. Mice received oral administration of BL or saline daily for 7 days and then were injected with MSU in the knee cavity. Treatment with BL significantly alleviated the inflammatory parameters, as seen by reduced hypernociception, reduced neutrophil accumulation in the joint and myeloperoxidase activity in periarticular tissue. There was inhibition of the production of CXCL1 and interleukin(IL)-1β in joints. Levels of the anti-inflammatory cytokine IL-10 were significantly higher in the knee tissue of mice treated with than control mice injected with MSU. In conclusion, oral BL treatment reduced the inflammatory response in an experimental murine model of gout, suggesting it may be useful as an adjuvant treatment in patients with gout.

  8. Plasmacytoid dendritic cells are crucial in Bifidobacterium adolescentis-mediated inhibition of Yersinia enterocolitica infection.

    Science.gov (United States)

    Wittmann, Alexandra; Autenrieth, Ingo B; Frick, Julia-Stefanie

    2013-01-01

    In industrialized countries bacterial intestinal infections are commonly caused by enteropathogenic Enterobacteriaceae. The interaction of the microbiota with the host immune system determines the adequacy of an appropriate response against pathogens. In this study we addressed whether the probiotic Bifidobacterium adolescentis is protective during intestinal Yersinia enterocolitica infection. Female C57BL/6 mice were fed with B. adolescentis, infected with Yersinia enterocolitica, or B. adolescentis fed and subsequently infected with Yersinia enterocolitica. B. adolescentis fed and Yersinia infected mice were protected from Yersinia infection as indicated by a significantly reduced weight loss and splenic Yersinia load when compared to Yersinia infected mice. Moreover, protection from infection was associated with increased intestinal plasmacytoid dendritic cell and regulatory T-cell frequencies. Plasmacytoid dendritic cell function was investigated using depletion experiments by injecting B. adolescentis fed, Yersinia infected C57BL/6 mice with anti-mouse PDCA-1 antibody, to deplete plasmacytoid dendritic cells, or respective isotype control. The B. adolescentis-mediated protection from Yersinia dissemination to the spleen was abrogated after plasmacytoid dendritic cell depletion indicating a crucial function for pDC in control of intestinal Yersinia infection. We suggest that feeding of B. adolescentis modulates the intestinal immune system in terms of increased plasmacytoid dendritic cell and regulatory T-cell frequencies, which might account for the B. adolescentis-mediated protection from Yersinia enterocolitica infection.

  9. Probiotic Bifidobacterium longum alters gut luminal metabolism through modification of the gut microbial community.

    Science.gov (United States)

    Sugahara, Hirosuke; Odamaki, Toshitaka; Fukuda, Shinji; Kato, Tamotsu; Xiao, Jin-zhong; Abe, Fumiaki; Kikuchi, Jun; Ohno, Hiroshi

    2015-01-01

    Probiotics are well known as health-promoting agents that modulate intestinal microbiota. However, the molecular mechanisms underlying this effect remain unclear. Using gnotobiotic mice harboring 15 strains of predominant human gut-derived microbiota (HGM), we investigated the effects of Bifidobacterium longum BB536 (BB536-HGM) supplementation on the gut luminal metabolism. Nuclear magnetic resonance (NMR)-based metabolomics showed significantly increased fecal levels of pimelate, a precursor of biotin, and butyrate in the BB536-HGM group. In addition, the bioassay revealed significantly elevated fecal levels of biotin in the BB536-HGM group. Metatranscriptomic analysis of fecal microbiota followed by an in vitro bioassay indicated that the elevated biotin level was due to an alteration in metabolism related to biotin synthesis by Bacteroides caccae in this mouse model. Furthermore, the proportion of Eubacterium rectale, a butyrate producer, was significantly higher in the BB536-HGM group than in the group without B. longum BB536 supplementation. Our findings help to elucidate the molecular basis underlying the effect of B. longum BB536 on the gut luminal metabolism through its interactions with the microbial community.

  10. Oral administration of Bifidobacterium longum ameliorates influenza virus infection in mice.

    Science.gov (United States)

    Iwabuchi, Noriyuki; Xiao, Jin-Zhong; Yaeshima, Tomoko; Iwatsuki, Keiji

    2011-01-01

    We investigated whether the oral administration of Bifidobacterium longum BB536 could ameliorate influenza virus (IFV) infection in a mice model. Mice were orally administrated BB536 or saline for 2 weeks and then infected with IFV. Orally administered BB536 significantly alleviated symptoms, reduced the loss of body weight, and inhibited viral proliferation in the lungs relative to the control group findings. Histopathological findings in the lungs were improved in the BB536 group compared to control group findings. There was no significant difference in the levels of interleukin-6 (IL-6), interferon-γ (IFN-γ), IL-10 and IL-12p40 in the lungs between the groups, but the levels of IL-6 and IFN-γ were lower (p=0.076, 0.103, respectively) in the BB536 group compared with those of control group. The levels of IL-6 and IL-10 correlated significantly with the values of weight loss, and the levels of IFN-γ correlated with the virus titers in the lungs. These results suggested the potential of the oral administration of BB536 in ameliorating IFV infection and the possible involvement of anti-inflammatory effects of BB536 in the anti-infection effects against IFV.

  11. Production of bacteriocin-like inhibitory substance by Bifidobacterium lactis in skim milk supplemented with additives.

    Science.gov (United States)

    Martinez, Fabio Andres Castillo; Domínguez, José Manuel; Converti, Attilio; Oliveira, Ricardo Pinheiro de Souza

    2015-08-01

    Bacteriocins are natural compounds used as food biopreservatives instead of chemical preservatives. Bifidobacterium animalis subsp. lactis (Bifid. lactis) was shown to produce a bacteriocin-like inhibitory substance (BLIS) able to inhibit the growth of Listeria monocytogenes selected as an indicator microorganism. To enhance this production by the strain Bifid. lactis BL 04, skim milk (SM) was used as a fermentation medium either in the presence or in the absence of yeast extract, Tween 80 or inulin as stimulating additives, and the results in terms of bacterial growth and BLIS production were compared with those obtained in a traditional high cost complex medium such as Man, Rogosa and Sharpe (MRS). To this purpose, all the cultivations were carried out in flasks at 200 rpm under anaerobic conditions ensured by a nitrogen flowrate of 1.0 L/min for 48 h, and BLIS production was quantified by means of a modified agar diffusion assay at low values of both temperature and concentration of List. monocytogenes. Although all these ingredients were shown to exert positive influence on BLIS production in both media, yeast extract and SM were by far the best ingredient and the best medium, respectively, allowing for a BLIS production at the late exponential phase of 2000 AU/ml.

  12. Bioaccessible Antioxidants in Milk Fermented by Bifidobacterium longum subsp. longum Strains

    Directory of Open Access Journals (Sweden)

    Mérilie Gagnon

    2015-01-01

    Full Text Available Bifidobacterium longum subsp. longum is among the dominant species of the human gastrointestinal microbiota and could thus have potential as probiotics. New targets such as antioxidant properties have interest for beneficial effects on health. The objective of this study was to evaluate the bioaccessibility of antioxidants in milk fermented by selected B. longum subsp. longum strains during in vitro dynamic digestion. The antioxidant capacity of cell extracts from 38 strains, of which 32 belong to B. longum subsp. longum, was evaluated with the ORAC (oxygen radical absorbance capacity method. On the basis of screening and gene sequence typing by multilocus locus sequence analysis (MLSA, five strains were chosen for fermenting reconstituted skim milk. Antioxidant capacity varied among the strains tested (P=0.0009. Two strains of B. longum subsp. longum (CUETM 172 and 171 showed significantly higher ORAC values than the other bifidobacteria strains. However, there does not appear to be a relationship between gene sequence types and antioxidant capacity. The milk fermented by each of the five strains selected (CUETM 268, 172, 245, 247, or PRO 16-10 did not have higher initial ORAC values compared to the nonfermented milk samples. However, higher bioaccessibility of antioxidants in fermented milk (175–358% was observed during digestion.

  13. Viability of Bifidobacterium Pseudocatenulatum G4 after Spray-Drying and Freeze-Drying

    Directory of Open Access Journals (Sweden)

    Stephenie Wong

    2010-04-01

    Full Text Available Viability of Bifidobacterium pseudocatenulatum G4 following spray-drying and freeze-drying in skim milk was evaluated. After spray-drying, the strain experienced over 99% loss in viability regardless of the air outlet temperature (75 and 85 °C and the heat-adaptation temperature (45 and 65 °C, 30 min. The use of heat-adaptation treatment to improve the thermotolerance of this strain was ineffective. On the other hand, the strain showed a superior survival at 71.65%–82.07% after freeze-drying. Viable populations of 9.319–9.487 log10 cfu/g were obtained when different combinations of skim milk and sugar were used as cryoprotectant. However, the addition of sugars did not result in increased survival during the freeze-drying process. Hence, 10% (w/v skim milk alone is recommended as a suitable protectant and drying medium for this strain. The residual moisture content obtained was 4.41% ± 0.44%.

  14. Allergic Patients with Long-Term Asthma Display Low Levels of Bifidobacterium adolescentis.

    Directory of Open Access Journals (Sweden)

    Arancha Hevia

    Full Text Available Accumulated evidence suggests a relationship between specific allergic processes, such as atopic eczema in children, and an aberrant fecal microbiota. However, little is known about the complete microbiota profile of adult individuals suffering from asthma. We determined the fecal microbiota in 21 adult patients suffering allergic asthma (age 39.43 ± 10.98 years old and compare it with the fecal microbiota of 22 healthy controls (age 39.29 ± 9.21 years old using culture independent techniques. An Ion-Torrent 16S rRNA gene-based amplification and sequencing protocol was used to determine the fecal microbiota profile of the individuals. Sequence microbiota analysis showed that the microbial alpha-diversity was not significantly different between healthy and allergic individuals and no clear clustering of the samples was obtained using an unsupervised principal component analysis. However, the analysis of specific bacterial groups allowed us to detect significantly lower levels of bifidobacteria in patients with long-term asthma. Also, in allergic individuals the Bifidobacterium adolescentis species prevailed within the bifidobacterial population. The reduction in the levels on bifidobacteria in patients with long-term asthma suggests a new target in allergy research and opens possibilities for the therapeutic modulation of the gut microbiota in this group of patients.

  15. Effects of Bifidobacterium Breve Feeding Strategy and Delivery Modes on Experimental Allergic Rhinitis Mice.

    Directory of Open Access Journals (Sweden)

    Jian-jun Ren

    Full Text Available Different delivery modes may affect the susceptibility to allergic diseases. It is still unknown whether early intervention with probiotics would counteract this effect.The effect of different delivery modes on immune status and nasal symptoms was investigated on established allergic rhinitis (AR mouse model. In addition, the immunoregulatory effects and mechanisms of different feeding manners with Bifidobacterium breve(B. breve were examined.Live lyophilized B. breve was orally administered to BALB/c mice born via vaginal delivery(VD or cesarean delivery (CD for 8 consecutive weeks, after which they were sensitized by ovalbumin(OVA to establish experimental AR. Nasal symptoms, serum immunoglobulins, cytokines, splenic percentages of CD4(+CD25(+Foxp3(+ regulatory T(Treg cells and nasal eosinophil infiltration were evaluated.Compared with VD mice, mice delivered via CD demonstrated more serious nasal symptoms, higher concentrations of OVA-specific immunoglobulin (Ig E, more nasal eosinophils and lower percentages of splenic CD4(+CD25(+Foxp3(+Treg cells after establishing experimental AR. These parameters were reversed by administering B. breves hortly after birth. However, the effect of B. breve did not differ between different delivery modes.CD aggravates the nasal symptoms of AR mice compared to VD. This is the first report that oral administration of B. breve shortly after birth can significantly alleviate the symptoms of AR mice born via both deliveries, probably via activation of the regulatory capacity of CD4(+CD25(+Foxp3(+Treg cells.

  16. Mechanisms involved in alleviation of intestinal inflammation by bifidobacterium breve soluble factors.

    Directory of Open Access Journals (Sweden)

    Elise Heuvelin

    Full Text Available OBJECTIVES: Soluble factors released by Bifidobacterium breve C50 (Bb alleviate the secretion of pro-inflammatory cytokines by immune cells, but their effect on intestinal epithelium remains elusive. To decipher the mechanisms accounting for the cross-talk between bacteria/soluble factors and intestinal epithelium, we measured the capacity of the bacteria, its conditioned medium (Bb-CM and other Gram(+ commensal bacteria to dampen inflammatory chemokine secretion. METHODS: TNFalpha-induced chemokine (CXCL8 secretion and alteration of NF-kappaB and AP-1 signalling pathways by Bb were studied by EMSA, confocal microscopy and western blotting. Anti-inflammatory capacity was also tested in vivo in a model of TNBS-induced colitis in mice. RESULTS: Bb and Bb-CM, but not other commensal bacteria, induced a time and dose-dependent inhibition of CXCL8 secretion by epithelial cells driven by both AP-1 and NF-kappaB transcription pathways and implying decreased phosphorylation of p38-MAPK and IkappaB-alpha molecules. In TNBS-induced colitis in mice, Bb-CM decreased the colitis score and inflammatory cytokine expression, an effect reproduced by dendritic cell conditioning with Bb-CM. CONCLUSIONS: Bb and secreted soluble factors contribute positively to intestinal homeostasis by attenuating chemokine production. The results indicate that Bb down regulate inflammation at the epithelial level by inhibiting phosphorylations involved in inflammatory processes and by protective conditioning of dendritic cells.

  17. Fermented inulin hydrolysate by Bifidobacterium breve as cholesterol binder in functional food application

    Science.gov (United States)

    Melanie, Hakiki; Susilowati, Agustine; Maryati, Yati

    2017-01-01

    Inulin hydrolysate is a result of inulin hydrolysis by inulinase enzyme of Scopulariopsis sp.-CBS1 fungi isolated from dahlia tuber skin in the formation of fructooligosaccharides (FOS) as dietary fiber. Inulin hydrolysate fermented by Bifidobacterium breve has a potential as cholesterol binder in digestive system due to dietary fiber content in inulin. This study was conducted to evaluate the best cholesterol binding capacity by the variation of lactic acid bacteria (LAB) culture concentration of 10%, 20% and 30% (v/v), respectively. Fermentation process were conducted with inulin hydrolysate concentration of 25% (w/v), skim milk 7,5% (w/v) and various LAB culture concentration at 40 °C for 0, 12, 24, 36 and 48 hours. The results showed that the variation of LAB culture concentrations affect the cholesterol binding ability in fermented inulin hydrolysate. The fermentation process with 10% LAB culture concentration at 40°C for 48 hours resulted in the highest cholesterol binding capacity (CBC) of 13,69 mg/g at pH 7and 14,44 mg/g at pH 2 with composition of total acids of 0,787%, soluble dietary fiber of 0,396%, insoluble dietary fiber of 5,47%, total solids of 14,476%, total sugars of 472,484 mg/mL, reducing sugar of 92 mg/mL and total plate count (TPC) of 7,278 log CFU/mL, respectively.

  18. Oligosaccharide binding proteins from Bifidobacterium longum subsp. infantis reveal a preference for host glycans.

    Directory of Open Access Journals (Sweden)

    Daniel Garrido

    Full Text Available Bifidobacterium longum subsp. infantis (B. infantis is a common member of the infant intestinal microbiota, and it has been characterized by its foraging capacity for human milk oligosaccharides (HMO. Its genome sequence revealed an overabundance of the Family 1 of solute binding proteins (F1SBPs, part of ABC transporters and associated with the import of oligosaccharides. In this study we have used the Mammalian Glycan Array to determine the specific affinities of these proteins. This was correlated with binding protein expression induced by different prebiotics including HMO. Half of the F1SBPs in B. infantis were determined to bind mammalian oligosaccharides. Their affinities included different blood group structures and mucin oligosaccharides. Related to HMO, other proteins were specific for oligomers of lacto-N-biose (LNB and polylactosamines with different degrees of fucosylation. Growth on HMO induced the expression of specific binding proteins that import HMO isomers, but also bind blood group and mucin oligosaccharides, suggesting coregulated transport mechanisms. The prebiotic inulin induced other family 1 binding proteins with affinity for intestinal glycans. Most of the host glycan F1SBPs in B. infantis do not have homologs in other bifidobacteria. Finally, some of these proteins were found to be adherent to intestinal epithelial cells in vitro. In conclusion, this study represents further evidence for the particular adaptations of B. infantis to the infant gut environment, and helps to understand the molecular mechanisms involved in this process.

  19. Growth and final product formation by Bifidobacterium infantis in aerated fermentations.

    Science.gov (United States)

    González, R; Blancas, A; Santillana, R; Azaola, A; Wacher, C

    2004-10-01

    Fermentation conditions were developed to allow Bifidobacterium infantis to grow in the presence of air. Batch fermentations in TPYG medium, starting from anoxic conditions followed by the application of low airflow rates [0.02-0.1 air volume, per liquid media volume, per minute (vvm)], were analyzed for growth, oxygen uptake, and product formation by the bacterium. Under all aerated fermentations, B. infantis showed high aerotolerance, with a maximum oxygen-specific consumption rate of 0.34 mmol oxygen per gram dry cell weight per hour in the presence of 0.06 vvm. Similar growth yields were obtained under oxic and anoxic conditions (0.11-0.13 and 0.11 g dry cell weight per mmol glucose, respectively). Oxygen also influenced metabolite formation since lactate production and its molar relation to acetate increased and formate decreased with aeration rate. Under anoxic conditions, a maximum concentration of 8.1 mM lactate and an acetate/lactate ratio of 3.5:1 were obtained, while under oxic conditions the lactate concentration increased more than two-fold and the acetate/lactate molar ratio decreased to 1.5:1. The possibility of balancing acetate/lactate molar ratios for organoleptic purposes as well as for obtaining good growth under microaerated conditions was demonstrated.

  20. Biochemical Characterization and Complete Conversion of Coenzyme Specificity of Isocitrate Dehydrogenase from Bifidobacterium longum.

    Science.gov (United States)

    Huang, Shi-Ping; Cheng, Hong-Mei; Wang, Peng; Zhu, Guo-Ping

    2016-02-26

    Bifidobacterium longum is a very important gram-positive non-pathogenic bacterium in the human gastrointestinal tract for keeping the digestive and immune system healthy. Isocitrate dehydrogenase (IDH) from B. longum (BlIDH), a novel member in Type II subfamily, was overexpressed, purified and biochemically characterized in detail. The active form of BlIDH was an 83-kDa homodimer. Kinetic analysis showed BlIDH was a NADP⁺-dependent IDH (NADP-IDH), with a 567- and 193-fold preference for NADP⁺ over NAD⁺ in the presence of Mg(2+) and Mn(2+), respectively. The maximal activity for BlIDH occurred at 60 °C (with Mn(2+)) and 65 °C (with Mg(2+)), and pH 7.5 (with Mn(2+)) and pH 8.0 (with Mg(2+)). Heat-inactivation profiles revealed that BlIDH retained 50% of maximal activity after incubation at 45 °C for 20 min with either Mn(2+) or Mg(2+). Furthermore, the coenzyme specificity of BlIDH can be completely reversed from NADP⁺ to NAD⁺ by a factor of 2387 by replacing six residues. This current work, the first report on the coenzyme specificity conversion of Type II NADP-IDHs, would provide better insight into the evolution of NADP⁺ use by the IDH family.

  1. Biochemical Characterization and Complete Conversion of Coenzyme Specificity of Isocitrate Dehydrogenase from Bifidobacterium longum

    Directory of Open Access Journals (Sweden)

    Shi-Ping Huang

    2016-02-01

    Full Text Available Bifidobacterium longum is a very important gram-positive non-pathogenic bacterium in the human gastrointestinal tract for keeping the digestive and immune system healthy. Isocitrate dehydrogenase (IDH from B. longum (BlIDH, a novel member in Type II subfamily, was overexpressed, purified and biochemically characterized in detail. The active form of BlIDH was an 83-kDa homodimer. Kinetic analysis showed BlIDH was a NADP+-dependent IDH (NADP-IDH, with a 567- and 193-fold preference for NADP+ over NAD+ in the presence of Mg2+ and Mn2+, respectively. The maximal activity for BlIDH occurred at 60 °C (with Mn2+ and 65 °C (with Mg2+, and pH 7.5 (with Mn2+ and pH 8.0 (with Mg2+. Heat-inactivation profiles revealed that BlIDH retained 50% of maximal activity after incubation at 45 °C for 20 min with either Mn2+ or Mg2+. Furthermore, the coenzyme specificity of BlIDH can be completely reversed from NADP+ to NAD+ by a factor of 2387 by replacing six residues. This current work, the first report on the coenzyme specificity conversion of Type II NADP-IDHs, would provide better insight into the evolution of NADP+ use by the IDH family.

  2. Oligosaccharide binding proteins from Bifidobacterium longum subsp. infantis reveal a preference for host glycans.

    Science.gov (United States)

    Garrido, Daniel; Kim, Jae Han; German, J Bruce; Raybould, Helen E; Mills, David A

    2011-03-15

    Bifidobacterium longum subsp. infantis (B. infantis) is a common member of the infant intestinal microbiota, and it has been characterized by its foraging capacity for human milk oligosaccharides (HMO). Its genome sequence revealed an overabundance of the Family 1 of solute binding proteins (F1SBPs), part of ABC transporters and associated with the import of oligosaccharides. In this study we have used the Mammalian Glycan Array to determine the specific affinities of these proteins. This was correlated with binding protein expression induced by different prebiotics including HMO. Half of the F1SBPs in B. infantis were determined to bind mammalian oligosaccharides. Their affinities included different blood group structures and mucin oligosaccharides. Related to HMO, other proteins were specific for oligomers of lacto-N-biose (LNB) and polylactosamines with different degrees of fucosylation. Growth on HMO induced the expression of specific binding proteins that import HMO isomers, but also bind blood group and mucin oligosaccharides, suggesting coregulated transport mechanisms. The prebiotic inulin induced other family 1 binding proteins with affinity for intestinal glycans. Most of the host glycan F1SBPs in B. infantis do not have homologs in other bifidobacteria. Finally, some of these proteins were found to be adherent to intestinal epithelial cells in vitro. In conclusion, this study represents further evidence for the particular adaptations of B. infantis to the infant gut environment, and helps to understand the molecular mechanisms involved in this process.

  3. The regulatory effects of Bifidobacterium infantis on the secretomotor activity of the enteric nervous system

    Directory of Open Access Journals (Sweden)

    Najma Javed

    2013-01-01

    Full Text Available Background: Bifidobacterium infantis (BI and other probiotics are non-pathogenic living organisms that have gained increased attention for their possible therapeutic implications on the health of the digestive tract. The mechanisms by which probiotics exert their effects are largely unknown.Aims: This study explored the protective and regulatory effect of oral BI on the enteric nervous system in the 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis rats. Materials and Methods: Electrical field stimulation and chemical stimulation by 5 hydroxytryptamine or serotonin were used to elicit changes in short-circuit current response of the colonic rat tissue. Results: BI-fed colitis rats expressed trends of higher secretomotor activity and revealed signs of decreased macroscopic inflammatory damage when compared to sham-fed colitis rats, suggesting a protective and preventative role of oral BI. Conclusion: These findings may provide additional insights for understanding the prophylactic and therapeutic value of specific probiotics in intestinal inflammatory disorders, offering the possibility of a non-invasive alternative to toxic and immune-compromising drugs.

  4. Antifungal Activity and Aflatoxin Degradation of Bifidobacterium Bifidum and Lactobacillus Fermentum Against Toxigenic Aspergillus Parasiticus

    Science.gov (United States)

    Ghazvini, Roshanak Daie; Kouhsari, Ebrahim; Zibafar, Ensieh; Hashemi, Seyed Jamal; Amini, Abolfazl; Niknejad, Farhad

    2016-01-01

    Food and feedstuff contamination with aflatoxins (AFTs) is a serious health problem for humans and animals, especially in developing countries. The present study evaluated antifungal activities of two lactic acid bacteria (LAB) against growth and aflatoxin production of toxigenic Aspergillus parasiticus. The mycelial growth inhibition rate of A. parasiticus PTCC 5286 was investigated in the presence of Bifidobacterium bifidum PTCC 1644 and Lactobacillus fermentum PTCC 1744 by the pour plate method. After seven days incubation in yeast extract sucrose broth at 30°C, the mycelial mass was weighed after drying. The inhibitory activity of LAB metabolites against aflatoxin production by A. parasiticus was evaluated using HPLC method. B. bifidum and L. fermentum significantly reduced aflatoxin production and growth rate of A. parasiticus in comparison with the controls (p≤0.05). LAB reduced total aflatoxins and B1, B2, G1 and G2 fractions by more than 99%. Moreover, LAB metabolites reduced the level of standard AFB1, B2, G1 and G2 from 88.8% to 99.8% (p≤0.05). Based on these findings, B. bifidum and L. fermentum are recommended as suitable biocontrol agents against the growth and aflatoxin production by aflatoxigenic Aspergillus species. PMID:28077976

  5. Preclinical Immunomodulation by the Probiotic Bifidobacterium breve M-16V in Early Life

    Science.gov (United States)

    Rigo-Adrover, Maria del Mar; Franch, Àngels; Castell, Margarida; Pérez-Cano, Francisco José

    2016-01-01

    This study aimed to investigate the effect of supplementation with the probiotic Bifidobacterium breve M-16V on the maturation of the intestinal and circulating immune system during suckling. In order to achieve this purpose, neonatal Lewis rats were supplemented with the probiotic strain from the 6th to the 18th day of life. The animals were weighed during the study, and faecal samples were obtained and evaluated daily. On day 19, rats were euthanized and intestinal wash samples, mesenteric lymph node (MLN) cells, splenocytes and intraepithelial lymphocytes (IEL) were obtained. The probiotic supplementation in early life did not modify the growth curve and did not enhance the systemic immune maturation. However, it increased the proportion of cells bearing TLR4 in the MLN and IEL, and enhanced the percentage of the integrin αEβ7+ and CD62L+ cells in the MLN and that of the integrin αEβ7+ cells in the IEL, suggesting an enhancement of the homing process of naïve T lymphocytes to the MLN, and the retention of activated lymphocytes in the intraepithelial compartment. Interestingly, B. breve M-16V enhanced the intestinal IgA synthesis. In conclusion, supplementation with the probiotic strain B. breve M-16V during suckling improves the development of mucosal immunity in early life. PMID:27820846

  6. Bifidobacterium lactis attenuates onset of inflammation in a murine model of colitis

    Institute of Scientific and Technical Information of China (English)

    David Philippe; Stéphanie Blum; Laurent Favre; Francis Foata; Oskar Adolfsson; Genevieve Perruisseau-Carrier; Karine Vidal; Gloria Reuteler; Johanna Dayer-Schneider; Christoph Mueller

    2011-01-01

    AIM: To assess the anti-inflammatory effect of the probiotic Bifidobacterium lactis (B. lactis ) in an adoptive transfer model of colitis. METHODS: Donor and recipient mice received either B. lactis or bacterial culture medium as control (deMan Rogosa Sharpe) in drinking water for one week prior to transfer of a mix of naive and regulatory T cells until sacrifice. RESULTS: All recipient mice developed signs of colonic inflammation, but a significant reduction of weight loss was observed in B. lactis -fed recipient mice compared to control mice. Moreover, a trend toward a diminution of mucosal thickness and attenuated epithelial damage was revealed. Colonic expression of pro-inflammatory and T cell markers was significantly reduced in B. lactis - fed recipient mice compared to controls. Concomitantly, forkhead box protein 3, a marker of regulatory T cells, was significantly up-regulated by B. lactis . CONCLUSION: Daily oral administration of B. lactis was able to reduce inflammatory and T cells mediators and to promote regulatory T cells specific markers in a mouse model of colitis.

  7. PCR monitoring of Lactobacillus and Bifidobacterium dynamics in fermentations by piglet intestinal microbiota.

    Science.gov (United States)

    Moura, Patrícia; Simões, Fernanda; Gírio, Francisco; Loureiro-Dias, Maria C; Esteves, M Paula

    2007-04-01

    A new group-specific primer (Lact71R), targeting the 16S-23S rDNA intergenic spacer region of Lactobacillus, was tested in its specificity to amplify rDNA of lactobacilli from piglet intestinal origin by polymerase chain reaction (PCR). Lact71R and Lab0677F, a Lactobacillus group-specific primer targeting the 16S rDNA, generated a common amplicon by PCR with DNA from Lactobacillus and Pediococcus reference strains, but not from Weissella strains. Sequence analysis of clones obtained by PCR amplification with Lact71R and Lab0677F and total DNA isolated from the ileal, caecal and colonic contents of one piglet resulted in Lactobacillus and Lactobacillus-like sequences mainly retrieved from intestinal environments. The primer pair was further validated in a culture independent PCR-analysis to monitor broad fluctuations of lactobacilli populations in fructo-oligosaccharides (FOS) fermentations by piglet intestinal microbiota. Bifidobacterium genus-specific primers were also used for PCR titre determination throughout FOS fermentations, in parallel with lactate and short chain fatty acids (SCFA) quantification. Increases between PCR titres were correlated with lactate detection in early stages of fermentation. Based on the obtained results, a simple monitoring PCR approach is proposed, foreseeing its application to the study of the dynamics of specific bacterial populations in complex environments.

  8. Influence of microencapsulation and spray drying on the viability of Lactobacillus and Bifidobacterium strains.

    Science.gov (United States)

    Goderska, Kamila; Czarnecki, Zbigniew

    2008-01-01

    Improved production methods of starter cultures, which constitute the most important element of probiotic preparations, were investigated. The aim of the presented research was to analyse changes in the viability of Lactobacillus. acidophilus and Bifidobacterium bifidum after stabilization (spray drying, liophilization, fluidization drying) and storage in refrigerated conditions for 4 months. The highest numbers of live cells, up to the fourth month of storage in refrigerated conditions, of the order of 10(7) cfu/g preparation were recorded for the B. bifidum DSM 20239 bacteria in which the N-Tack starch for spray drying was applied. Fluidization drying of encapsulated bacteria allowed obtaining a preparation of the comparable number of live bacterial cells up to the fourth month of storage with those encapsulated bacteria, which were subjected to freeze-drying but the former process was much shorter. The highest survivability of the encapsulated L. acidophilus DSM 20079 and B. bifidum DSM 20239 cells subjected to freeze-drying was obtained using skimmed milk as the cryoprotective substance. Stabilization of bacteria by microencapsulation can give a product easy to store and apply to produce dried food composition.

  9. Safety assessment of Bifidobacterium longum J DM301 based on complete genome sequences

    Institute of Scientific and Technical Information of China (English)

    Yan-Xia Wei; Zhuo-Yang Zhang; Chang Liu; Xiao-Kui Guo; Pradeep K Malakar

    2012-01-01

    AIM: To assess the safety of Bifidobacterium longum (B.longum) JDM301 based on complete genome sequences. METHODS: The complete genome sequences of JDM301 were determined using the GS 20 system. Putative virulence factors, putative antibiotic resistance genes and genes encoding enzymes responsible for harmful metabolites were identified by blast with virulence factors database, antibiotic resistance genes database and genes associated with harmful metabolites in previous reports. Minimum inhibitory concentration of 16 common antimicrobial agents was evaluated by E-test. RESULTS: JDM301 was shown to contain 36 genes associated with antibiotic resistance, 5 enzymes related to harmful metabolites and 162 nonspecific virulence factors mainly associated with transcriptional regulation, adhesion, sugar and amino acid transport. B. longum JDM301 was intrinsically resistant tocipro ciprofloxacin,amikacin, gentamicin and streptomycin and susceptible to vancomycin, amoxicillin, cephalothin, chloramphenicol, erythromycin, ampicillin, cefotaxime, rifampicin, imipenemandtrimethoprim and trimethoprim-sulphamethoxazol. JDM301.JDM301 was moderately resistant to bacitracin, while an earlier study showed that bifidobacteria were susceptible to this antibiotic. A tetracycline resistance gene with the risk of transfer was found in JDM301, which needs to be experimentally validated. CONCLUSION: The safety assessment of JDM301 using information derived from complete bacterial genome will contribute to a wider and deeper insight into the safety of probiotic bacteria.

  10. Coculture fermentations of Bifidobacterium species and Bacteroides thetaiotaomicron reveal a mechanistic insight into the prebiotic effect of inulin-type fructans.

    Science.gov (United States)

    Falony, Gwen; Calmeyn, Thomas; Leroy, Frédéric; De Vuyst, Luc

    2009-04-01

    Four bifidobacteria, each representing a cluster of strains with specific inulin-type-fructan degradation capacities, were grown in coculture fermentations with Bacteroides thetaiotaomicron LMG 11262, a strain able to metabolize both oligofructose and inulin. In a medium for colon bacteria with inulin as the sole added energy source, the ability of the bifidobacteria to compete for this substrate reflected phenotypical variation. Bifidobacterium breve Yakult, a strain that was not able to degrade oligofructose or inulin, was outcompeted by B. thetaiotaomicron LMG 11262. Bifidobacterium adolescentis LMG 10734, a strain that could degrade oligofructose (displaying a preferential breakdown mechanism) but that did not grow on inulin, managed to become competitive when oligofructose and short fractions of inulin started to accumulate in the fermentation medium. Bifidobacterium angulatum LMG 11039(T), a strain that was previously shown to degrade all oligofructose fractions simultaneously and to be able to partially break down inulin, was competitive from the beginning of the fermentation, consuming short fractions of inulin from the moment they appeared. Bifidobacterium longum LMG 11047, representing a cluster of bifidobacteria that shared both high fructose consumption and oligofructose degradation rates and were able to perform partial breakdown of inulin, was the dominating strain in a coculture with B. thetaiotaomicron LMG 11262. These observations indicate that distinct subgroups within the large-intestinal Bifidobacterium population will be stimulated by different groups of prebiotic inulin-type fructans, a variation that could be reflected in differences concerning their health-promoting effects.

  11. Research progress on genetically engineered vaccine of Bifidobacterium%双歧杆菌基因工程疫苗研究进展

    Institute of Scientific and Technical Information of China (English)

    高峰; 吴利先

    2009-01-01

    双歧杆菌是人类最早发现的生理性细菌之一,是能在健康人肠道内定植的益生菌.如今,随着分子生物技术的发展,双歧杆菌基因工程疫苗研究日趋受到重视.此文综述了双歧杆菌基因工程疫苗的理论基础、研究进展以及前景.%Bifidobacterium is one of the human first discovered physiological bacteria,and a beneficial bacterium that colonizing in the healthy people's intestinal canal.Today,with the development of molecular biotechnology,people pay more attention to the research on genetically engineered vaccine of Bifidobacterium.In this paper,the basic theory,research progress and the prospect about the genetically engineered vaccine of Bifidobacterium are reviewed.

  12. Discovery of proteins involved in the interaction between prebiotics carbohydrates and probiotics & whole proteome analysis of the probiotic strain Bifidobacterium animalis susp. lactis BB-12

    DEFF Research Database (Denmark)

    Gilad, Ofir

    Probiotic bacteria, which primarily belong to the genera Lactobascillus and Bifidobacterium, are live microorganisms that have been related to a variety of health-promoting effects. Prebiotics are indigestible food components that specifically stimulate the growth of probiotic organisms in the hu......Probiotic bacteria, which primarily belong to the genera Lactobascillus and Bifidobacterium, are live microorganisms that have been related to a variety of health-promoting effects. Prebiotics are indigestible food components that specifically stimulate the growth of probiotic organisms...... between the widely-used, extensively-studied probiotic strain Bifidobacterium animalis subsp. lactis BB-12 and potentially-prebiotic carbohydrates. The project was initiated with a screening phase in which more than 40 carbohydrates were tested for their ability to promote the growth of the bacterium...

  13. Modulación de la fisiología gastrointestinal mediante cepas probióticas de Lactobacillus casei y Bifidobacterium bifidum Modulation of gastrointestinal physiology through probiotic strains of Lactobacillus casei and Bifidobacterium bifidum

    OpenAIRE

    J. Barrenetxe; P. Aranguren; A. Grijalba; J.M. Martínez-Peñuela; F. Marzo; Urdaneta, E. (Elena)

    2006-01-01

    En el contexto de la alimentación y la promoción de la salud se sitúan los productos denominados alimentos funcionales que tienen diversos efectos beneficiosos en el organismo, además de los meramente nutricionales. Dentro de estos alimentos funcionales, entre otros, podemos distinguir entre compuestos probióticos y prebióticos. Los microorganismos más utilizados en alimentos probióticos pertenecen a los géneros Lactobacillus y Bifidobacterium. En el presente trabajo se ha estudiado el efecto...

  14. Initial Study on Growth Morphology of Bifidobacterium Filaments%双歧杆菌丝状体生长形态初探

    Institute of Scientific and Technical Information of China (English)

    刘艳霞; 刘蕾; 刘俊康; 邓渝

    2012-01-01

    The changes of the growth and proliferation patterns of bifidobacterium under specific culture conditions were studied. Different concentrations of VB6 and VE nicotinate of drug-sensitive paper were adopted to jointly affect the growth of bifidobacterium. The growth and proliferation of bifidobacterium were observed through scanning atomic force microscope after Cram staining. The results showed that under joint affection of VB, and VE, a phenomenon of bifidobacterium filaments cluster emerged, and the bifid proliferation pattern was inhibited. The cluster growth and proliferation of bifidobacterium could maintain in the first transferred culture, but after three consecutive transferred cultures biiidobacterium resumed to normal proliferation pattern. Therefore, different concentrations of VB6 and VE nicotinate drug sensitive paper could jointly induce bifidobacterium filaments.%研究双歧杆菌在特定培养条件下生长及增殖模式的变化.采用不同浓度维生素B6和维生素E烟酸酯药敏纸片联合影响双歧杆菌生长,通过革兰染色和原子力显微镜扫描观察双歧杆菌的生长、增殖情况.在维生素B6和维生素E联合作用下,双岐杆菌出现丝状体群集生长的现象,且二分裂增殖方式受到抑制.第1次转种于普通培养基中可保持此种生长增殖方式,但连续转种3次后会恢复常规生长增殖方式.不同浓度维生素B6和维生素E烟酸酯药敏纸片联合可诱生双歧杆菌丝状体.

  15. Physical and physicochemical stability evaluation of cosmetic formulations containing soybean extract fermented by Bifidobacterium animalis

    Directory of Open Access Journals (Sweden)

    Rafael Pinto Vieira

    2009-09-01

    Full Text Available Peel off facial masks, based on polyvinyl alcohol (PVA, are formulations that, after application and drying, form an occlusive film over the face. After removing, they provide cleanness, tensor and moisturizing effects, removing dead cells, residues and other materials deposited on the stratum corneous. The soybean extract fermented by Bifidobacterium animalis has sugars, amino acids, peptides, proteins and free isoflavonoids in high concentrations, when compared to the unfermented extract, providing benefits to the cosmetic formulations like anti-aging effect, moisture, tensor action and emollience. The cosmetic bases of peel off facial masks, added with 5.0% w/w of fermented soybean extract, were submitted to Preliminary and Accelerated Stability Studies. Eight (8 preparations were evaluated in several conditions of temperature (-10.0, 5.0, 22.0 and 45.0 ºC and time (maximum of 15 days, comparing the results with the initial condition (48 h after preparation. The variables observed were: organoleptic characteristics, pH and appearing viscosity value and film drying time. The preparation containing 17.0% w/w of PVA and 0.5% w/w of guar gum was selected between the eight preparations initially prepared, because it presented the best performance in the stability test, being recommended storage at low temperatures (5.0 ºC.As máscaras faciais peel off a base de álcool polivinílico (PVA são formulações que, após a aplicação e secagem, formam um filme oclusivo sobre a face e, após sua remoção, conferem limpeza, ação tensora e hidratação à pele, retirando células mortas do estrato córneo, resíduos e outros materiais depositados. O extrato de soja fermentado por Bifidobacterium animalis possui açúcares, aminoácidos, peptídeos, e alto teor de isoflavonas na forma livre, quando comparado ao leite não fermentado, propiciando benefícios às formulações cosméticas, como ação antienvelhecimento, hidratação, efeito tensor e

  16. Probiotic Lactobacillus acidophilus NCFM and Bifidobacterium animalis subsp lactis Bl-04 interactions with prebiotic carbohydrates using differential proteomics and protein characterization

    DEFF Research Database (Denmark)

    Hansen, Morten Ejby

    are defined as probiotics. The positive clinical effects of probiotics, mainly belonging to the Bifidobacterium and Lactobacillus genera in treatments of irritable bowel syndrome, gut infections and lifestyle diseases are well documented. Compounds that selectively stimulate the beneficial effect...... and the discovery and documentation of novel ones. In this project we set out to investigate the metabolism of carbohydrates that are prebiotic or potential prebiotic compounds utilized by the probiotic organisms Lactobacillus acidophilus NCFM (NCFM) and Bifidobacterium animalis subsp. lactis BL-04 (Bl-04). The aim...

  17. Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults

    DEFF Research Database (Denmark)

    Larsen, C.N.; Nielsen, S.; Kaestel, P.

    2006-01-01

    Objective: This study was performed to investigate the dose-response effects of supplementation with Bifidobacterium animalis subsp lactis (BB-12) and Lactobacillus paracasei subsp paracasei (CRL-431) on blood lipids, recovery from feces and bowel habits. Changes of the fecal microflora was analy......Objective: This study was performed to investigate the dose-response effects of supplementation with Bifidobacterium animalis subsp lactis (BB-12) and Lactobacillus paracasei subsp paracasei (CRL-431) on blood lipids, recovery from feces and bowel habits. Changes of the fecal microflora...

  18. Combined Transcriptome and Proteome Analysis of Bifidobacterium animalis subsp. lactis BB-12 Grown on Xylo-Oligosaccharides and a Model of Their Utilization

    DEFF Research Database (Denmark)

    Gilad, Ofir; Jacobsen, Susanne; Stuer-Lauridsen, B.

    2010-01-01

    Recent studies have demonstrated that xylo-oligosaccharides (XOS), which are classified as emerging prebiotics, selectively enhance the growth of bifidobacteria in general and of Bifidobacterium animalis subsp. lactis strains in particular. To elucidate the metabolism of XOS in the well-documente......Recent studies have demonstrated that xylo-oligosaccharides (XOS), which are classified as emerging prebiotics, selectively enhance the growth of bifidobacteria in general and of Bifidobacterium animalis subsp. lactis strains in particular. To elucidate the metabolism of XOS in the well...

  19. Increased amount of Bifidobacterium thermacidophilum and Megasphaera elsdenii in the colonic microbiota of pigs fed a swine dysentery preventive diet containing chicory roots and sweet lupine

    DEFF Research Database (Denmark)

    Mølbak, Lars; Thomsen, L.E.; Jensen, Tim Kåre

    2007-01-01

    . Methods and Results: Terminal restriction fragment length polymorphism (T-RFLP) was used to describe differences in the total colonic microbiota as well as in the populations of Bifidobacterium spp. in pigs fed with a fructan-rich diet and a diet containing resistant carbohydrates. The fructan-rich diet...... has previously been shown to prevent swine dysentery caused by Brachyspira hyodysenteriae. The T-RFLP profiling, 16S rRNA gene cloning and in situ hybridization showed that the pigs fed with the fructan-rich diet had a higher proportion of Bifidobacterium thermacidophilum subsp. porcinum...

  20. 婴儿肠道双歧杆菌种群多样性分析%Analysis of the probiotics Bifidobacterium community in infant intestinal flora

    Institute of Scientific and Technical Information of China (English)

    张和春; 倪新华; 杨国; 王劲松; 范小兵; 杭晓敏

    2006-01-01

    使用分子生物学方法,对4例出生时间为17~120 h婴儿的肠道双歧杆菌种群多样性进行分析.肠道中剖腹产婴儿在出生17 h后,双歧杆菌就已定植;另外,婴儿肠道中双歧杆菌种群有短双歧杆菌(Bifidobacterium breve)和长双歧杆菌(Bifidobacterium longum),分别占双歧杆菌种群的65%和35%.

  1. Oral administration of an immunostimulatory DNA sequence from Bifidobacterium longum improves Th1/Th2 balance in a murine model.

    Science.gov (United States)

    Takahashi, Noritoshi; Kitazawa, Haruki; Iwabuchi, Noriyuki; Xiao, Jin-Zhong; Miyaji, Kazuhiro; Iwatsuki, Keiji; Saito, Tadao

    2006-08-01

    We have reported the antiallergic activities of the immunostimulatory oligodeoxynucleotide (ODN) BL07S, identified from genomic DNA of Bifidobacterium longum BB536 from in vitro and in vivo studies. The present study evaluated the efficiency of ODN BL07S in preventing allergic responses by oral administration. Oral administration of BL07S suppressed serum ovalbumin (OVA)-specific immunoglobulin (Ig) E levels and improved the OVA-specific IgG2a/IgG1 ratio. ODN BL07S increased Th1 cytokine and decreased Th2 cytokine production in splenocytes. These results suggest that immunostimulatory ODNs are potentially associated with the antiallergic effects of probiotics.

  2. Effect of repeated oral administration of Bifidobacterium longum BB536 on apomorphine-induced rearing behavior in mice.

    Science.gov (United States)

    Orikasa, Shuzo; Nabeshima, Kazumi; Iwabuchi, Noriyuki; Xiao, Jin-Zhong

    2016-01-01

    Schizophrenia is a chronic psychiatric illness. Disruption of the dopaminergic system has been suggested to be the pathogenic cause of this disease. The effect of Bifidobacterium longum BB536 (BB536) on schizophrenic behavior was investigated in an animal model. Daily administration of BB536 (10(9) CFU/mouse, p.o. for 2 weeks) was found to reduce rearing behavior augmented by the dopamine receptor agonist apomorphine and to decrease the resting level of plasma corticosterone and the ratio of kynurenine to tryptophan. These results suggest the potential of BB536 for supplemental treatment of the symptoms of schizophrenia.

  3. [Construction and identification of the Bifidobacterium expression system pGEX-TSOL18/B. longum of Taenia solium].

    Science.gov (United States)

    Zhou, Bi-Ying; Liu, Mei-Chen; He, Li-Fang

    2014-06-01

    The TSOL18 gene of Taenia solium was synthesized and cloned into Escherichia coli-Bifidobacteria shuttle vector pGEX-1lambdaT. The recombinant plasmid pGEX-TSOL18 was transformed into Bifidobacterium longum with electroporation. The recombinant plasmid containing TSOL18 gene was identified by restriction endonuclease analysis, PCR and DNA sequencing. The length of synthesized TSOL18 gene was 393 bp. The results indicated that the Bifidobacteria expression system pGEX-TSOL18/B. longum was successfully constructed.

  4. Microbes of fermented kefir-like using combination of kefir grains and Bifidobacterium longum

    Directory of Open Access Journals (Sweden)

    Sri Usmiati

    2005-03-01

    Full Text Available The objectives of research were to find out physico-chemical characters and to detect flavor volatile compound of kefir-like. Material used was skim milk TS 9.5% which was heated at 85oC for 30 minutes and cooled at 22oC before innoculation of the starter. Microorganisms used were (a Lactobacillus acidophilus P155110, (b Lactobacillus delbrueckii subsp. Bulgaricus NCIMB 11778, (c Lactococcus lactis P155610, (d Leuconostoc mesenteroides subsp. dextranicum NCIMB 3350, (e Acetobacter aceti P154810, (f Bifidobacterium longum BF1, and (g Saccharomyces cerevisiae P156252. The treatments consist of P1 = without (b; P2 = without (a; and P3= used (a until (g. The physico-chemical characters identified were lactic acid and lactose percentages, pH, viscosity, organoleptic test for intensity of kefir-like sensory attributes. Results indicated that B. longum was potential bacterium use for starter combination on kefir-like making. The use starter P1 combination has high acidity and viscosity, low pH and lactose percentage, and high intensity on attribute creamy-white color, soft and curdle consistency, and kefir specific aroma on kefir-like. Volatile compound acid group were dominate by high acidity character on kefir-like resulted from starter P1 combination. Compound of 3-hydroxi-2-butanone (acetoin was affecting butter-like of P3 character. This compound resulted from which is a character of fermented milk flavor was not detected on P1 kefir-like.

  5. Immunostimulatory oligodeoxynucleotide from Bifidobacterium longum suppresses Th2 immune responses in a murine model.

    Science.gov (United States)

    Takahashi, N; Kitazawa, H; Iwabuchi, N; Xiao, J Z; Miyaji, K; Iwatsuki, K; Saito, T

    2006-07-01

    We have reported previously that novel immunostimulatory sequence (ISS) oligodeoxynucleotide (ODN) BL07S from a probiotic strain of Bifidobacterium longum inhibited immunoglobulin (Ig) E production in vitro. However, whether ISS-ODNs from probiotics regulate T helper type 2 (Th2)-polarized immune reactions in vivo remains unclear. To evaluate the inhibitory effects of ODN BL07S on type I allergic response, BALB/c mice were injected with or without ODN BL07S in the presence of ovalbumin (OVA) on days 0 and 14. Serum Ig levels (IgE, IgG1 and IgG2a) and cytokine levels (interferon (IFN)-gamma, interleukin (IL)-12, IL-4, IL-5, IL-10 and IL-13) were investigated in splenocyte cultures from days 14-28. Production of OVA-specific and total IgE were significantly suppressed by administration of ODN BL07S, but not by ODN BL06S, a non-ISS-ODN. Compared to controls, ODN BL07S induced significantly lower levels of Th2 cytokines (IL-4 and IL-5) in splenocyte cultures, and significantly higher levels of serum OVA-specific IgG2a. These effects of ODN BL07S on modulation of Th2 immune response were dose-dependent. The present results demonstrate that ODN BL07S from genomic DNA of B. longum BB536 prevents antigen-induced Th2 immune responses in vivo, suggesting that ISS-ODNs from probiotics might be useful in preventing allergic disease.

  6. Proteomic profiling of Bifidobacterium bifidum S17 cultivated under in vitro conditions

    Directory of Open Access Journals (Sweden)

    Xiao eWei

    2016-02-01

    Full Text Available Bifidobacteria are frequently used in probiotic food and dairy products. Bifidobacterium bifidum S17 is a promising probiotic candidate strain that displays strong adhesion to intestinal epithelial cells and elicits potent anti-inflammatory capacity both in vitro and in murine models of colitis. The recently sequenced genome of B. bifidum S17 has a size of about 2.2 Mb and encodes 1,782 predicted protein-coding genes. In the present study, a comprehensive proteomic profiling was carried out to identify and characterize proteins expressed by B. bifidum S17. A total of 1148 proteins entries were identified by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS, representing 64.4% of the predicted proteome. 719 proteins could be assigned to functional categories according to cluster of orthologous groups of proteins (COGs. The COG distribution of the detected proteins highly correlates with that of the complete predicted proteome suggesting a good coverage and representation of the genomic content of B. bifidum S17 by the proteome. COGs that were highly present in the proteome of B. bifidum S17 were Translation, Amino Acid Transport and Metabolism, and Carbohydrate Transport and Metabolism. Complete sets of enzymes for both the bifidus shunt and the Embden-Meyerhof pathway were identified. Further bioinformatic analysis yielded 28 proteins with a predicted extracellular localization including 14 proteins with an LPxTG-motif for cell wall anchoring and two proteins (elongation factor Tu and enolase with a potential moonlighting function in adhesion. Amongst the predicted extracellular proteins were five of six pilin proteins encoded in the B. bifidum S17 genome as well as several other proteins with a potential role in interaction with host structures. The presented results are the first compilation of a proteomic reference profile for a B. bifidum strain and will facilitate analysis of the molecular mechanisms of physiology, host

  7. Effect of composite yogurt enriched with acacia fiber and Bifidobacterium lactis

    Institute of Scientific and Technical Information of China (English)

    Yang Won Min; Sang Un Park; Yeon Sil Jang; Young-Ho Kim; Poong-Lyul Rhee; Seo Hyun Ko; Nami Joo

    2012-01-01

    AIM:To investigate whether composite yogurt with acacia dietary fiber and Bifidobacterium lactis (B.lactis)has additive effects in irritable bowel syndrome (IBS).METHODS:A total of 130 patients were randomly allocated to consume,twice daily for 8 wk,either the composite yogurt or the control product.The composite yogurt contained acacia dietary fiber and high-dose B.lactis together with two classic yogurt starter cultures.Patients were evaluated using the visual analog scale via a structured questionnaire administered at baseline and after treatment.RESULTS:Improvements in bowel habit satisfaction and overall IBS symptoms from baseline were significantly higher in the test group than in the control group (27.16 vs 15.51,P =0.010,64.2 ± 17.0 vs 50.4 ± 20.5,P < 0.001; respectively).In constipation-predominant IBS,improvement in overall IBS symptoms was significantly higher in the test group than in the control group (72.4 ± 18.4 vs 50.0 ± 21.8,P < 0.001).In patients with diarrhea-predominant IBS,improvement in bowel habit satisfaction from baseline was significantly higher in the test group than in the control group (32.90 vs 7.81,P =0.006).CONCLUSION:Our data suggest that composite yogurt enriched with acacia fiber and B.lactis has greater therapeutic effects in patients with IBS than standard yogurt.

  8. Microencapsulation of Bifidobacterium animalis subsp. lactis and Lactobacillus acidophilus in cocoa butter using spray chilling technology.

    Science.gov (United States)

    Pedroso, D L; Dogenski, M; Thomazini, M; Heinemann, R J B; Favaro-Trindade, C S

    2013-01-01

    In the present study, the cells of Bifidobacterium animalis subsp. lactis (BI-01) and Lactobacillus acidophilus (LAC-04) were encapsulated in cocoa butter using spray-chilling technology. Survival assays were conducted to evaluate the resistance of the probiotics to the spray-chilling process, their resistance to the simulated gastric and intestinal fluids (SGF and SIF), and their stability during 90 days of storage. The viability of the cells was not affected by microencapsulation. The free and encapsulated cells of B. animalis subsp. lactis were resistant to both SGF and SIF. The micro-encapsulated cells of L. acidophilus were more resistant to SGF and SIF than the free cells; the viability of the encapsulated cells was enhanced by 67%, while the free cells reached the detection limit of the method (10(3) CFU/g). The encapsulated probiotics were unstable when they were stored at 20 °C. The population of encapsulated L. acidophilus decreased drastically when they were stored at 7 °C; only 20% of cells were viable after 90 days of storage. The percentage of viable cells of the encapsulated B. animalis subsp.lactis, however, was 72% after the same period of storage. Promising results were obtained when the microparticles were stored at -18 °C; the freeze granted 90 days of shelf life to the encapsulated cells. These results suggest that the spray-chilling process using cocoa butter as carrier protects L. acidophilus from gastrointestinal fluids. However, the viability of the cells during storage must be improved.

  9. Bifidobacterium longum CECT 7347 modulates immune responses in a gliadin-induced enteropathy animal model.

    Directory of Open Access Journals (Sweden)

    José Moisés Laparra

    Full Text Available Coeliac disease (CD is an autoimmune disorder triggered by gluten proteins (gliadin that involves innate and adaptive immunity. In this study, we hypothesise that the administration of Bifidobacterium longum CECT 7347, previously selected for reducing gliadin immunotoxic effects in vitro, could exert protective effects in an animal model of gliadin-induced enteropathy. The effects of this bacterium were evaluated in newborn rats fed gliadin alone or sensitised with interferon (IFN-γ and fed gliadin. Jejunal tissue sections were collected for histological, NFκB mRNA expression and cytokine production analyses. Leukocyte populations and T-cell subsets were analysed in peripheral blood samples. The possible translocation of the bacterium to different organs was determined by plate counting and the composition of the colonic microbiota was quantified by real-time PCR. Feeding gliadin alone reduced enterocyte height and peripheral CD4+ cells, but increased CD4+/Foxp3+ T and CD8+ cells, while the simultaneous administration of B. longum CECT 7347 exerted opposite effects. Animals sensitised with IFN-γ and fed gliadin showed high cellular infiltration, reduced villi width and enterocyte height. Sensitised animals also exhibited increased NFκB mRNA expression and TNF-α production in tissue sections. B. longum CECT 7347 administration increased NFκB expression and IL-10, but reduced TNF-α, production in the enteropathy model. In sensitised gliadin-fed animals, CD4+, CD4+/Foxp3+ and CD8+ T cells increased, whereas the administration of B. longum CECT 7347 reduced CD4+ and CD4+/Foxp3+ cell populations and increased CD8+ T cell populations. The bifidobacterial strain administered represented between 75-95% of the total bifidobacteria isolated from all treated groups, and translocation to organs was not detected. These findings indicate that B. longum attenuates the production of inflammatory cytokines and the CD4+ T-cell mediated immune response in

  10. Crystal structure of glycoside hydrolase family 127 β-L-arabinofuranosidase from Bifidobacterium longum

    Energy Technology Data Exchange (ETDEWEB)

    Ito, Tasuku; Saikawa, Kyo [Department of Biotechnology, The University of Tokyo, Tokyo (Japan); Kim, Seonah [National Bioenergy Center, National Renewable Energy Laboratory, Golden, CO (United States); Fujita, Kiyotaka [Faculty of Agriculture, Kagoshima University, Korimoto, Kagoshima (Japan); Ishiwata, Akihiro [Synthetic Cellular Chemistry Laboratory, RIKEN (Japan); Kaeothip, Sophon [ERATO Glycotrilogy Project, JST, Wako, Saitama (Japan); Arakawa, Takatoshi; Wakagi, Takayoshi [Department of Biotechnology, The University of Tokyo, Tokyo (Japan); Beckham, Gregg T., E-mail: Gregg.Beckham@nrel.gov [National Bioenergy Center, National Renewable Energy Laboratory, Golden, CO (United States); Ito, Yukishige [Synthetic Cellular Chemistry Laboratory, RIKEN (Japan); ERATO Glycotrilogy Project, JST, Wako, Saitama (Japan); Fushinobu, Shinya, E-mail: asfushi@mail.ecc.u-tokyo.ac.jp [Department of Biotechnology, The University of Tokyo, Tokyo (Japan)

    2014-04-25

    Graphical abstract: - Highlights: • HypBA1 β-L-arabinofuranosidase belongs to glycoside hydrolase family 127. • Crystal structure of HypBA1 was determined. • HypBA1 consists of a catalytic barrel and two additional β-sandwich domains. • The active site contains a Zn{sup 2+} coordinated by glutamate and three cysteines. • A possible reaction mechanism involving cysteine as the nucleophile is proposed. - Abstract: Enzymes acting on β-linked arabinofuranosides have been unknown until recently, in spite of wide distribution of β-L-arabinofuranosyl oligosaccharides in plant cells. Recently, a β-L-arabinofuranosidase from the glycoside hydrolase family 127 (HypBA1) was discovered in the newly characterized degradation system of hydroxyproline-linked β-L-arabinooligosaccharides in the bacterium Bifidobacterium longum. Here, we report the crystal structure of HypBA1 in the ligand-free and β-L-arabinofuranose complex forms. The structure of HypBA1 consists of a catalytic barrel domain and two additional β-sandwich domains, with one β-sandwich domain involved in the formation of a dimer. Interestingly, there is an unprecedented metal-binding motif with Zn{sup 2+} coordinated by glutamate and three cysteines in the active site. The glutamate residue is located far from the anomeric carbon of the β-L-arabinofuranose ligand, but one cysteine residue is appropriately located for nucleophilic attack for glycosidic bond cleavage. The residues around the active site are highly conserved among GH127 members. Based on biochemical experiments and quantum mechanical calculations, a possible reaction mechanism involving cysteine as the nucleophile is proposed.

  11. Impact of Bifidobacterium lactis supplementation on fecal microbiota in infants delivered vaginally compared to Caesarean section

    Directory of Open Access Journals (Sweden)

    Tetty Yuniaty

    2013-03-01

    Full Text Available AbstractBackground It has been reported that infants born by Caesarean section have altered gut microbiota, with lower numbers of bifidobacteria and Bacteroides, compared to that of infants who were delivered vaginally. Probiotic supplementation has been reported to have beneficial effects on the immune response, generally in relation to allergies.Objective To assess the effect of Bifidobacterium lactis (B. lactis supplementation on the presence of B. lactis and bifidobacteria counts in stool of infants during the first 2 months of life.Methods We conducted an observational study of 122 healthy, breast-fed infants delivered vaginally or by Caesarean section. Infants assigned to the test group received breast milk and formula supplemented with the B. lactis probiotics. Infants in the control group received breast milk and formula without probiotics. The presence of B. lactis and stool bifidobacteria counts were determined at 1 month and 2 months of age. Growth, morbidity, serum immune markers, and stool immunoglobulin (Ig A were also assessed.Results B. lactis was more frequently detected in the stool of infants who received breast milk and probiotic-supplemented formula than in stool of infants who received breast milk and non-supplemented formula, both at 1 month and 2 months of age (OR 1,263; 95%CI 11 to 151,030; P=0.003. Of infants who received probiotic-supplemented formula, B. lactis was detected in 80% of those delivered by Caesarean section and in 38% of those delivered vaginally, at the 1-month mark. In infants delivered by Caesarean section, the mean stool bifidobacteria level at 1 month was significantly higher in the probiotic-supplemented group compared to that of the non-supplemented group (P=0.021.Conclusion Eearly bifidobacteria supplementation of infants, particularly those delivered by Caesarean section, is associated with higher levels of stool bifidobacteria. Anthropometric data suggests beneficial effects of bifidobacteria

  12. Impact of Bifidobacterium lactis supplementation on fecal microbiota in infants delivered vaginally compared to Caesarean section

    Directory of Open Access Journals (Sweden)

    Tetty Yuniaty

    2013-03-01

    Full Text Available Background It has been reported that infants born by Caesarean section have altered gut microbiota, with lower numbers of bifidobacteria and Bacteroides, compared to that of infants who were delivered vaginally. Probiotic supplementation has been reported to have beneficial effects on the immune response, generally in relation to allergies. Objective To assess the effect of Bifidobacterium lactis (B. lactis supplementation on the presence of B. lactis and bifidobacteria counts in stool of infants during the first 2 months of life. Methods We conducted an observational study of 122 healthy, breast-fed infants delivered vaginally or by Caesarean section. Infants assigned to the test group received breast milk and formula supplemented with the B. lactis probiotics. Infants in the control group received breast milk and formula without probiotics. The presence of B. lactis and stool bifidobacteria counts were determined at 1 month and 2 months of age. Growth, morbidity, serum immune markers, and stool immunoglobulin (Ig A were also assessed. Results B. lactis was more frequently detected in the stool of infants who received breast milk and probiotic-supplemented formula than in stool of infants who received breast milk and non-supplemented formula, both at 1 month and 2 months of age (OR 1,263; 95%CI 11 to 151,030; P=0.003. Of infants who received probiotic-supplemented formula, B. lactis was detected in 80% of those delivered by Caesarean section and in 38% of those delivered vaginally, at the 1-month mark. In infants delivered by Caesarean section, the mean stool bifidobacteria level at 1 month was significantly higher in the probiotic-supplemented group compared to that of the non-supplemented group (P=0.021. Conclusion Eearly bifidobacteria supplementation of infants, particularly those delivered by Caesarean section, is associated with higher levels of stool bifidobacteria. Anthropometric data suggests beneficial effects of bifidobacteria

  13. [Analysis of the probiotic Bifidobacterium and Lactobacillus community in child intestinal flora].

    Science.gov (United States)

    Jin, Hong-Zhi; Fan, Xiao-Bing; Hang, Xiao-Min; Li, Kun-Bao; Yang, Hong

    2005-08-01

    To investigate the distribution of child intestinal flora and the composition of its key probiotics community, study on intestinal flora of 21 Chinese children (age 2 - 5) was conducted, which included bacteria isolation and counting, 16S rDNA sequencing and homology analysis. For identification of the key probiotics such as Bifidobacterium and Lactobacillus in children feces at the species level, the specific primers Im26/Im3 and L159/L677 for PCR amplification of partial 16S rDNA were used. The results show that the composition of child intestinal flora is was relatively stable and almost same to the intestinal flora of the youth (age 20 - 25). Culture-based approaches show that the key probiotic community in feces at the species level was highly different in composition and numbers from individual to individual. B. longum and B. pseudocatenulatum, which are detected at levels of 10(7) CFU/g (wet) in samples and the detection rates are 90.48% and 85.71% respectively, are believed to be major bifidobacterial species in child intestinal microbiota. In addition, B. adolescentis, B. bifidum, B. infantis and B. thermacidophium have also been found. L. mucosae, L. fermentum, L. salivarius, L. ruminis, L. gasseri and L. plantarum are isolated from the stools. L. mucosae (3.68 log10 CFU/g (wet), detection rate 71.43%) and L. fermentum (3.97 log10 CFU/g (wet), detection rate 52.38%) are two dominant species of Lactobacillus. Study on Chinese child intestinal flora, especially on the compositions and numbers of key probiotics in the feces will be very helpful to the development of effective probiotics in future.

  14. Bifidobacterium breve attenuates murine dextran sodium sulfate-induced colitis and increases regulatory T cell responses.

    Directory of Open Access Journals (Sweden)

    Bin Zheng

    Full Text Available While some probiotics have shown beneficial effects on preventing or treating colitis development, others have shown no effects. In this study, we have assessed the immunomodulating effects of two probiotic strains, Lactobacillus rhamnosus (L. rhamnosus and Bifidobacterium breve (B. breve on T cell polarization in vitro, using human peripheral blood mononuclear cells (PBMC, and in vivo, using murine dextran sodium sulfate (DSS colitis model. With respect to the latter, the mRNA expression of T cell subset-associated transcription factors and cytokines in the colon was measured and the T helper type (Th 17 and regulatory T cell (Treg subsets were determined in the Peyer's patches. Both L. rhamnosus and B. breve incubations in vitro reduced Th17 and increased Th2 cell subsets in human PBMCs. In addition, B. breve incubation was also able to reduce Th1 and increase Treg cell subsets in contrast to L. rhamnosus. In vivo intervention with B. breve, but not L. rhamnosus, significantly attenuated the severity of DSS-induced colitis. In DSS-treated C57BL/6 mice, intervention with B. breve increased the expression of mRNA encoding for Th2- and Treg-associated cytokines in the distal colon. In addition, intervention with B. breve led to increases of Treg and decreases of Th17 cell subsets in Peyer's patches of DSS-treated mice. B. breve modulates T cell polarization towards Th2 and Treg cell-associated responses in vitro and in vivo. In vivo B. breve intervention ameliorates DSS-induced colitis symptoms and this protective effect may mediated by its effects on the T-cell composition.

  15. Microencapsulation of Bifidobacterium animalis subsp. lactis and Lactobacillus acidophilus in cocoa butter using spray chilling technology

    Directory of Open Access Journals (Sweden)

    D.L. Pedroso

    2013-09-01

    Full Text Available In the present study, the cells of Bifidobacterium animalis subsp. lactis (BI-01 and Lactobacillus acidophilus (LAC-04 were encapsulated in cocoa butter using spray-chilling technology. Survival assays were conducted to evaluate the resistance of the probiotics to the spray-chilling process, their resistance to the simulated gastric and intestinal fluids (SGF and SIF, and their stability during 90 days of storage. The viability of the cells was not affected by microencapsulation. The free and encapsulated cells of B. animalis subsp. lactis were resistant to both SGF and SIF. The micro-encapsulated cells of L. acidophilus were more resistant to SGF and SIF than the free cells; the viability of the encapsulated cells was enhanced by 67%, while the free cells reached the detection limit of the method (10³ CFU/g. The encapsulated probiotics were unstable when they were stored at 20 °C. The population of encapsulated L. acidophilus decreased drastically when they were stored at 7 °C; only 20% of cells were viable after 90 days of storage. The percentage of viable cells of the encapsulated B. animalis subsp.lactis, however, was 72% after the same period of storage. Promising results were obtained when the microparticles were stored at -18 °C; the freeze granted 90 days of shelf life to the encapsulated cells. These results suggest that the spray-chilling process using cocoa butter as carrier protects L. acidophilus from gastrointestinal fluids. However, the viability of the cells during storage must be improved.

  16. Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy.

    Science.gov (United States)

    Taipale, Teemu; Pienihäkkinen, Kaisu; Isolauri, Erika; Larsen, Charlotte; Brockmann, Elke; Alanen, Pentti; Jokela, Jorma; Söderling, Eva

    2011-02-01

    The impact of controlled administration of Bifidobacterium animalis subsp. lactis BB-12 (BB-12) on the risk of acute infectious diseases was studied in healthy newborn infants. In this double-blind, placebo-controlled study, 109 newborn 1-month-old infants were assigned randomly to a probiotic group receiving a BB-12-containing tablet (n 55) or to a control group receiving a control tablet (n 54). Test tablets were administered to the infants twice a day (daily dose of BB-12 10 billion colony-forming units) from the age of 1-2 months to 8 months with a novel slow-release pacifier or a spoon. Breastfeeding habits, pacifier use, dietary habits, medications and all signs and symptoms of acute infections were registered. At the age of 8 months, faecal samples were collected for BB-12 determination (quantitative PCR method). The baseline characteristics of the two groups were similar, as was the duration of exclusive breastfeeding. BB-12 was recovered (detection limit log 5) in the faeces of 62% of the infants receiving the BB-12 tablet. The daily duration of pacifier sucking was not associated with the occurrence of acute otitis media. No significant differences between the groups were observed in reported gastrointestinal symptoms, otitis media or use of antibiotics. However, the infants receiving BB-12 were reported to have experienced fewer respiratory infections (65 v. 94%; risk ratio 0·69; 95% CI 0·53, 0·89; P = 0·014) than the control infants. Controlled administration of BB-12 in early childhood may reduce respiratory infections.

  17. 椰汁体外促双歧杆菌生长作用的研究%Coconut juice improves Bifidobacterium proliferation in vitro

    Institute of Scientific and Technical Information of China (English)

    朱辉; 张德纯; 王春耀; 刘明方; 刘胜男

    2012-01-01

    目的 探讨椰汁体外对4株双歧杆菌生长的促进作用.方法 利用4株常见的双歧杆菌作为受试菌,以菌液D(600)值、pH值、活菌计数以及发酵牛乳凝乳时间和乳液pH值等为指标,来研究椰汁对4种双歧杆菌增殖和活性的促进作用.结果 按照25% (V/V)添加椰汁时,4株双歧杆菌菌体浓度(光密度值及活菌计数)均明显高于空白对照组(P<0.05),其中两歧双歧杆菌、青春双歧杆菌以及长双歧杆菌甚至高于双歧因子阳性对照组(P<0.05).4株双歧杆菌发酵含有椰汁的牛乳后,两歧双歧杆菌、青春双歧杆菌和长双歧杆菌的凝乳时间均较空白对照组和阳性对照组明显缩短(P<0.05),婴儿双歧杆菌却未出现凝乳现象,但4株双歧杆菌pH值均低于空白对照组和阳性对照组(P<0.05).结论 椰汁有可能成为一种良好的双歧因子,并可作为双歧杆菌的天然培养基.%Objective To determine the effect of coconut juice on the growth of 4 strains of Bifidobac-terium in vitro. Methods Four strains of common Bifidobacterium were employed as the tested bacteria. The variation of OD600values, pH values, plate counts of bacteria liquid, coagulation time of the fermented milk and its pH values were investigated for the effect of coconut juice on proliferation of 4 strains. Results Coconut juice of 25% (V/V) resulted in significantly higher light density values and live bacteria count in the 4 strains compared with blank control group (P < 0. 05 ) , with Bifidobacterium bifidum, Bifidobacterium adolescentis and Bifidobacterium longum even higher than positive control group (P < 0. 05 ). After coconut juice was added into fermenting milk with 4 strains of Bifidobacterium, coagulation time of the fermented milk of Bifidobacterium bifidum , Bifidobacterium adolescentis and Bifidobacterium longum was significantly shortened, compared with the blank control group and the positive control group (P <0. 05) , except the

  18. Autoinducer-2 plays a crucial role in gut colonization and probiotic functionality of Bifidobacterium breve UCC2003.

    Directory of Open Access Journals (Sweden)

    Steven E A Christiaen

    Full Text Available In the present study we show that luxS of Bifidobacterium breve UCC2003 is involved in the production of the interspecies signaling molecule autoinducer-2 (AI-2, and that this gene is essential for gastrointestinal colonization of a murine host, while it is also involved in providing protection against Salmonella infection in Caenorhabditis elegans. We demonstrate that a B. breve luxS-insertion mutant is significantly more susceptible to iron chelators than the WT strain and that this sensitivity can be partially reverted in the presence of the AI-2 precursor DPD. Furthermore, we show that several genes of an iron starvation-induced gene cluster, which are downregulated in the luxS-insertion mutant and which encodes a presumed iron-uptake system, are transcriptionally upregulated under in vivo conditions. Mutation of two genes of this cluster in B. breve UCC2003 renders the derived mutant strains sensitive to iron chelators while deficient in their ability to confer gut pathogen protection to Salmonella-infected nematodes. Since a functional luxS gene is present in all tested members of the genus Bifidobacterium, we conclude that bifidobacteria operate a LuxS-mediated system for gut colonization and pathogen protection that is correlated with iron acquisition.

  19. A new insight into the physiological role of bile salt hydrolase among intestinal bacteria from the genus Bifidobacterium.

    Directory of Open Access Journals (Sweden)

    Piotr Jarocki

    Full Text Available This study analyzes the occurrence of bile salt hydrolase in fourteen strains belonging to the genus Bifidobacterium. Deconjugation activity was detected using a plate test, two-step enzymatic reaction and activity staining on a native polyacrylamide gel. Subsequently, bile salt hydrolases from B. pseudocatenulatum and B. longum subsp. suis were purified using a two-step chromatographic procedure. Biochemical characterization of the bile salt hydrolases showed that the purified enzymes hydrolyzed all of the six major human bile salts under the pH and temperature conditions commonly found in the human gastrointestinal tract. Next, the dynamic rheometry was applied to monitor the gelation process of deoxycholic acid under different conditions. The results showed that bile acids displayed aqueous media gelating properties. Finally, gel-forming abilities of bifidobacteria exhibiting bile salt hydrolase activity were analyzed. Our investigations have demonstrated that the release of deconjugated bile acids led to the gelation phenomenon of the enzymatic reaction solution containing purified BSH. The presented results suggest that bile salt hydrolase activity commonly found among intestinal microbiota increases hydrogel-forming abilities of certain bile salts. To our knowledge, this is the first report showing that bile salt hydrolase activity among Bifidobacterium is directly connected with the gelation process of bile salts. In our opinion, if such a phenomenon occurs in physiological conditions of human gut, it may improve bacterial ability to colonize the gastrointestinal tract and their survival in this specific ecological niche.

  20. Effects of the Food Manufacturing Chain on the Viability and Functionality of Bifidobacterium animalis through Simulated Gastrointestinal Conditions.

    Directory of Open Access Journals (Sweden)

    Pattra Charnchai

    Full Text Available The viability and functionality of probiotics may be influenced by industrial production processes resulting in a decrease in probiotic efficiency that benefit the health of humans. This study aimed to investigate the probiotic characteristics of Bifidobacterium strains isolated from fecal samples of healthy Thai infants. In the present work, three local strains (BF014, BF052, and BH053 belonging to Bifidobacterium animalis showed a great resistance against conditions simulating the gastrointestinal tract. Among these, B. animalis BF052 possessed considerable probiotic properties, including high acid and bile tolerance, strong adhesion capability to Caco-2 cells, and inhibitory activity against pathogens including Salmonella typhimurium and Vibrio cholerae. This strain also exhibited a high survival rate compared to commercial strains during storage in a wide variety of products, including pasteurized milk, soy milk, drinking yogurt, and orange juice. The impact of food processing processes as well as the freeze-drying process, storage of freeze-dried powders, and incorporation of freeze-dried cells in food matrix on probiotic properties was also determined. The stability of the probiotic properties of the BF052 strain was not affected by food processing chain, especially its resistance in the simulated gastrointestinal conditions and its adherence ability to Caco-2 cells. It indicates that it satisfies the criteria as a potential probiotic and may be used as an effective probiotic starter in food applications.

  1. Production of conjugated linoleic acid (CLA) by Bifidobacterium breve LMC520 and its compatibility with CLA-producing rumen bacteria.

    Science.gov (United States)

    Park, Hui Gyu; Heo, Wan; Kim, Sang Bum; Kim, Hyun Seop; Bae, Gui Seck; Chung, Soo Hyun; Seo, Ho-Chan; Kim, Young Jun

    2011-02-09

    This study was performed to characterize the ability of an active Bifidobacterium strain to produce conjugated linoleic acid (CLA) and to test its possible utilization as a probiotic compatible to the ruminal condition. Bifidobacterium breve LMC520 can actively convert linoleic acid (LA) to cis-9,trans-11-CLA, which is a major isomer derived from microbial conversion. LMC520 showed reasonable tolerance under acidic conditions (pH 2.5 with 1% pepsin) and in the presence of oxgall (0-3%). The growth and CLA production of LMC520 were tested under ruminal conditions and compared with those of Butyrivibrio fibrisolvens A38, which is a major CLA producer in the rumen as an intermediate in the biohydrogenation (BH) process. LMC520 converted 15% of LA to CLA under ruminal conditions, which was 2 times higher activity than that of A38, and there was no decline in CLA level during prolonged incubation of 48 h. The BH activity of LMC520 was comparable to that of A38. When LMC520 was cocultured with A38, even with slight decrease of CLA due to high BH activity by A38, but the level of CLA was maintained by the high CLA-producing activity of LMC520. This comparative study shows the potential of this strain to be applied as a functional probiotic not only for humans but also for ruminants as well as to increase CLA production.

  2. Bifidobacterium spp. influences the production of autoinducer-2 and biofilm formation by Escherichia coli O157:H7.

    Science.gov (United States)

    Kim, Younghoon; Lee, Jae Won; Kang, Seo-Gu; Oh, Sejong; Griffiths, Mansel W

    2012-10-01

    The effect of Bifidobacterium spp. on the production of quorum-sensing (QS) signals and biofilm formation by enterohemorrhagic Escherichia coli (EHEC) O157:H7 was investigated. In an AI-2 bioassay, cell extracts of Bifidobacterium longum ATCC 15707 resulted in a 98-fold reduction in AI-2 activity in EHEC O157:H7 as well as in the Vibrio harveyi reporter strain, even though they did not inhibit the growth of EHEC O157:H7. In addition, they resulted in a 36% reduction in biofilm formation by the organism. Consistently, the virulence of EHEC O157:H7 was significantly attenuated by the presence of cell extracts of B. longum ATCC 15707 in the Caenorhabditis elegans nematode in vivo model. By a proteome analysis using two dimensional electrophoresis (2-DE), we determined that seven proteins including formation of iron-sulfur protein (NifU), thiol:disulfide interchange protein (DsbA), and flagellar P-ring protein (FlgI) were differentially regulated in the EHEC O157:H7 when supplemented with cell extracts of B. longum ATCC 15707. Taken together, these findings propose a novel function of a dairy adjunct in repressing the virulence of EHEC O157:H7.

  3. Antiobesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats

    Directory of Open Access Journals (Sweden)

    Lee Si

    2011-07-01

    Full Text Available Abstract Background Recent studies have reported the preventive effects of probiotics on obesity. Among commensal bacteria, bifidobacteria is one of the most numerous probiotics in the mammalian gut and are a type of lactic acid bacteria. The aim of this study was to assess the antiobesity and lipid-lowering effects of Bifidobacterium spp. isolated from healthy Korean on high fat diet-induced obese rats. Methods Thirty-six male Sprague-Dawley rats were divided into three groups as follows: (1 SD group, fed standard diet; (2 HFD group, fed high fat diet; and (3 HFD-LAB group, fed high fat diet supplemented with LAB supplement (B. pseudocatenulatum SPM 1204, B. longum SPM 1205, and B. longum SPM 1207; 108 ~ 109 CFU. After 7 weeks, the body, organ, and fat weights, food intake, blood serum levels, fecal LAB counts, and harmful enzyme activities were measured. Results Administration of LAB reduced body and fat weights, blood serum levels (TC, HDL-C, LDL-C, triglyceride, glucose, leptin, AST, ALT, and lipase levels, and harmful enzyme activities (β-glucosidase, β-glucuronidase, and tryptophanase, and significantly increased fecal LAB counts. Conclusion These data suggest that Bifidobacterium spp. used in this study may have beneficial antiobesity effects.

  4. Effect of Bifidobacterium breve on the Intestinal Microbiota of Coeliac Children on a Gluten Free Diet: A Pilot Study

    Directory of Open Access Journals (Sweden)

    Andrea Quagliariello

    2016-10-01

    Full Text Available Coeliac disease (CD is associated with alterations of the intestinal microbiota. Although several Bifidobacterium strains showed anti-inflammatory activity and prevention of toxic gliadin peptides generation in vitro, few data are available on their efficacy when administered to CD subjects. This study evaluated the effect of administration for three months of a food supplement based on two Bifidobacterium breve strains (B632 and BR03 to restore the gut microbial balance in coeliac children on a gluten free diet (GFD. Microbial DNA was extracted from faeces of 40 coeliac children before and after probiotic or placebo administration and 16 healthy children (Control group. Sequencing of the amplified V3-V4 hypervariable region of 16S rRNA gene as well as qPCR of Bidobacterium spp., Lactobacillus spp., Bacteroides fragilis group Clostridium sensu stricto and enterobacteria were performed. The comparison between CD subjects and Control group revealed an alteration in the intestinal microbial composition of coeliacs mainly characterized by a reduction of the Firmicutes/Bacteroidetes ratio, of Actinobacteria and Euryarchaeota. Regarding the effects of the probiotic, an increase of Actinobacteria was found as well as a re-establishment of the physiological Firmicutes/Bacteroidetes ratio. Therefore, a three-month administration of B. breve strains helps in restoring the healthy percentage of main microbial components.

  5. Exposure of Bifidobacterium longum subsp. infantis to Milk Oligosaccharides Increases Adhesion to Epithelial Cells and Induces a Substantial Transcriptional Response.

    Directory of Open Access Journals (Sweden)

    Devon W Kavanaugh

    Full Text Available In this study, we tested the hypothesis that milk oligosaccharides may contribute not only to selective growth of bifidobacteria, but also to their specific adhesive ability. Human milk oligosaccharides (3'sialyllactose and 6'sialyllactose and a commercial prebiotic (Beneo Orafti P95; oligofructose were assayed for their ability to promote adhesion of Bifidobacterium longum subsp. infantis ATCC 15697 to HT-29 and Caco-2 human intestinal cells. Treatment with the commercial prebiotic or 3'sialyllactose did not enhance adhesion. However, treatment with 6'sialyllactose resulted in increased adhesion (4.7 fold, while treatment with a mixture of 3'- and 6'-sialyllactose substantially increased adhesion (9.8 fold to HT-29 intestinal cells. Microarray analyses were subsequently employed to investigate the transcriptional response of B. longum subsp. infantis to the different oligosaccharide treatments. This data correlated strongly with the observed changes in adhesion to HT-29 cells. The combination of 3'- and 6'-sialyllactose resulted in the greatest response at the genetic level (both in diversity and magnitude followed by 6'sialyllactose, and 3'sialyllactose alone. The microarray data was further validated by means of real-time PCR. The current findings suggest that the increased adherence phenotype of Bifidobacterium longum subsp. infantis resulting from exposure to milk oligosaccharides is multi-faceted, involving transcription factors, chaperone proteins, adhesion-related proteins, and a glycoside hydrolase. This study gives additional insight into the role of milk oligosaccharides within the human intestine and the molecular mechanisms underpinning host-microbe interactions.

  6. 发酵乳中双岐杆菌种类快速识别%Rapid identification bifidobacterium in fermented milk products by PCR-DGGE analysis

    Institute of Scientific and Technical Information of China (English)

    王立平; 吴艳涛; 刘晓莉; 曹悦

    2012-01-01

    To establish a rapid identification method for bifidobacterium in fermented milk products.The use of Polymerase Chain Reaction-Denaturing Gradient Gel Electrophoresis(PCR-DGGE) technique in identifying bifidobacterium present in commercial probiotic yoghurts dealed with pronase E was evaluated.Identification was achieved comparing the PCR-DGGE patterns obtained from the analysed products with the ladder bands.PCR-DGGE assays enabled identification of the species of bifidobacterium initially present in commercial fermented milk products and their accurate quantification with a detection threshold of 105 cells per mL of product.Established PCR-DGGE analysis method is situble for detection of bifidobacterium in commercial probiotic yoghurts.%建立发酵乳制品中双歧杆菌快速识别方法。采用酶解前处理法获取样品中菌体细胞,基于PCR-DGGE技术确定发酵乳中双歧杆菌种属。该方法能准确、快速鉴别双歧杆菌,检出限为105cfu/mL。该方法可用于发酵乳中双歧杆菌的准确识别。

  7. Dynamic observation of splenocyte apoptosis in mice immunized with recombinant vaccine Bifidobacterium bifidum pGEX-Sj14-3-3 of Schistosoma japonicum

    Institute of Scientific and Technical Information of China (English)

    张宁

    2013-01-01

    Objective To investigate the effects of recombinant vaccine Bifidobacterium bifidum(Bb) pGEX-Sj14-3-3 on splenocyte apoptosis in BALB/c mice. Methods Ninety-six BALB/c mice were randomly divided into two groups according to their body mass: per os group(PO) and

  8. An ATP Binding Cassette Transporter Mediates the Uptake of α-(1,6)-Linked Dietary Oligosaccharides in Bifidobacterium and Correlates with Competitive Growth on These Substrates

    DEFF Research Database (Denmark)

    Hansen, Morten Ejby; Fredslund, Folmer; Andersen, Joakim Mark

    2016-01-01

    and lactobacilli in the human gut. Here we show that the solute binding protein (BlG16BP) associated with an ATP binding cassette (ABC) transporter from the probiotic Bifidobacterium animalis subsp. lactis Bl-04 binds -(1,6)-linked glucosides and galactosides of varying size, linkage, and monosaccharide...

  9. Inhibitory effect of honey-sweetened goat and cow milk fermented with Bifidobacterium lactis Bb-12 on the growth of Listeria monocytogenes

    Directory of Open Access Journals (Sweden)

    Mirela Lučan

    2009-06-01

    Full Text Available The aim of the study was to determine the influence of honey addition on fermentation of goat and cow milk with Bifidobacterium lactis Bb-12. Additionally, inhibitory potential of honey-sweetened fermented goat and cow milk against Listeria monocytogenes strain was examined. Two monofloral honey types, dark-colored chestnut and light-colored acacia honey were added. The basic hypothesis of this study was that addition of honey could have influence on the growth of Bifidobacterium lactis during the fermentation of goat and cow milk. Furthermore, higher inhibitory potential caused by honey addition against Listeria monocytogenes has been assumed. Compared to cow milk, higher acidity and CFU of Bifidobacterium lactis Bb-12 were noted in the fermented goat milk in all phases of the fermentation process. The results of this study show that both types of honey enhanced growth and acidity of the Bifidobacterium lactis Bb-12 in both milk types during fermentation. A disc assay has shown that development of growth inhibition zones depends on the type and concentration of honey, as well as on the milk type. The chestnut honey had generally higher inhibitory effect than acacia honey.

  10. QUANTITATIVE FLUORESCENCE IN-SITU HYBRIDIZATION OF BIFIDOBACTERIUM SPP WITH GENUS-SPECIFIC 16S RIBOSOMAL-RNA-TARGETED PROBES AND ITS APPLICATION IN FECAL SAMPLES

    NARCIS (Netherlands)

    LANGENDIJK, PS; SCHUT, F; JANSEN, GJ; RAANGS, GC; KAMPHUIS, GR; WILKINSON, MHF; WELLING, GW

    1995-01-01

    Three 16S rRNA hybridization probes were developed and tested for genus-specific detection of Bifidobacterium species in the human fecal flora. Variable regions V2, V4, and VS of the 16S rRNA contained sequences unique to this genus and proved applicable as target sites for oligodeoxynucleotide prob

  11. Evaluation of positive interaction for cell growth between Bifidobacterium adolescentis and Propionibacterium freudenreichii using a co-cultivation system with two microfiltration modules.

    Science.gov (United States)

    Kouya, Tomoaki; Ishiyama, Yohei; Tanaka, Takaaki; Taniguchi, Masayuki

    2013-02-01

    Using a co-cultivation system developed previously, positive interaction for cell growth between Bifidobacterium adolescentis and Propionibacterium freudenreichii was evaluated. The total dry cell weight (DCW) of these two strains obtained in the co-cultivation system was 1.5-1.7-fold of the sum of the DCWs obtained in two single cultivations of each bacterium.

  12. Lactobacillus rhamnosus GG and Bifidobacterium longum attenuate lung injury and inflammatory response in experimental sepsis.

    Directory of Open Access Journals (Sweden)

    Ludmila Khailova

    Full Text Available INTRODUCTION: Probiotic use to prevent nosocomial gastrointestinal and potentially respiratory tract infections in critical care has shown great promise in recent clinical trials of adult and pediatric patients. Despite well-documented benefits of probiotic use in intestinal disorders, the potential for probiotic treatment to reduce lung injury following infection and shock has not been well explored. OBJECTIVE: Evaluate if Lactobacillus rhamnosus GG (LGG or Bifidobacterium longum (BL treatment in a weanling mouse model of cecal ligation and puncture (CLP peritonitis will protect against lung injury. METHODS: 3 week-old FVB/N mice were orally gavaged with 200 µl of either LGG, BL or sterile water (vehicle immediately prior to CLP. Mice were euthanized at 24 h. Lung injury was evaluated via histology and lung neutrophil infiltration was evaluated by myeloperoxidase (MPO staining. mRNA levels of IL-6, TNF-α, MyD88, TLR-4, TLR-2, NFΚB (p50/p105 and Cox-2 in the lung analyzed via real-time PCR. TNF-α and IL-6 in lung was analyzed via ELISA. RESULTS: LGG and BL treatment significantly improved lung injury following experimental infection and sepsis and lung neutrophil infiltration was significantly lower than in untreated septic mice. Lung mRNA and protein levels of IL-6 and TNF-α and gene expression of Cox-2 were also significantly reduced in mice receiving LGG or BL treatment. Gene expression of TLR-2, MyD88 and NFΚB (p50/p105 was significantly increased in septic mice compared to shams and decreased in the lung of mice receiving LGG or BL while TLR-4 levels remained unchanged. CONCLUSIONS: Treatment with LGG and BL can reduce lung injury following experimental infection and sepsis and is associated with reduced lung inflammatory cell infiltrate and decreased markers of lung inflammatory response. Probiotic therapy may be a promising intervention to improve clinical lung injury following systemic infection and sepsis.

  13. FORMULASI PRODUK SUSU FERMENTASI KERING DENGAN PENAMBAHAN BAKTERI PROBIOTIK Lactobacillus casei DAN Bifidobacterium longum

    Directory of Open Access Journals (Sweden)

    Dida Hani Rahman

    2012-11-01

    Full Text Available ABSTRACTFermented milk is a healthy product that has many benefits especially for human digestive tract. Manufacturing of probiotic fermented milk products as a functional food with a viable long shelf life needs to be developed. The purpose of this study was to formulate a dried fermented milk product using probiotic bacterias. The experimental design study was a complete random design with 4 treatments using different lactic acid bacteria (LAB: A1 (Streptococcus lactis: 0.5%; A2 (Streptococcus lactis: 0.25% and Lactobacillus casei: 0.25%; A3 (Streptococcus lactis: 0.25%, Lactobacillus bulgaricus: 0.125%, Streptococcus thermophiles: 0.125%; and A4 (Streptococcus lactis: 0.25% and Bifidobacterium longum: 0.25%. The highest level of hardness was A2 product and the highest level of tenderness is A1 product. Results of proximate analysis showed that dried fermented milk products had high levels of the protein, calcium, and phosphorus. Microbiological test results showed that the amount of lactic acid bacteria (BAL in dried fermented milk products were eligible based on CODEX: 243 (2003. Statictical analysis using ANOVA in the hedonic quality test showed that the treatments were significantly different (p 0.05 on the attributes of color, aroma, hardness, and flavor except texture.Key words: dried fermented milk, functional food, probiotic, lactic acid bacteria (LABABSTRAKSusu fermentasi merupakan produk kesehatan yang mempunyai banyak manfaat terutama untuk saluran pencernaan manusia. Pembuatan produk susu fermentasi probiotik sebagai makanan fungsional yang mempunyai kelangsungan hidup dan daya simpan yang lama perlu dikembangan. Tujuan penelitian ini adalah untuk memformulasikan susu fermentasi kering menggunakan bakteri probiotik. Desain penelitian yang digunakan adalah rancangan acak lengkap dengan 4 perlakuan menggunakan 4 bakteri asam laktat (BAL, (Streptococcus lactis, 0.5%, A2 (Streptococcus lactis; 0.25% dan Lactobacillus casei; 0.25%, A3

  14. Improving the storage stability of Bifidobacterium breve in low pH fruit juice.

    Science.gov (United States)

    Saarela, M; Alakomi, H L; Mättö, J; Ahonen, A M; Puhakka, A; Tynkkynen, S

    2011-09-01

    Bifidobacterial food applications are limited since bifidobacteria are sensitive to e.g. acidic conditions prevalent in many food matrices. The aim of the present study was to investigate whether a low pH selection step alone or combined to UV mutagenesis could improve the viability of an acid sensitive Bifidobacterium strain, B. breve 99, in low pH food matrices. Furthermore, the potential of carriers and an oat fibre preparation to further improve the stability was studied. The best performing low pH tolerant variants in the present study were generated by UV-mutagenesis with 70-700μJ/cm(2) followed by incubation in growth medium at pH 4.5. The most promising variants regarding the low pH tolerance showed, in repeated tests with cells grown without pH control, about one Log-value better survival in pH 3.8 fruit juice after one week storage at 4°C compared to wild-type B. breve 99. Cells grown with pH control, PDX formulated and then frozen showed poorer viability in low pH fruit juice than cells grown with no pH control. For frozen concentrates pH 3.8 was too stressful and no or small differences between the variants and the wild-type strain were seen. The differences detected at pH 3.8 with the cells grown without pH control were also seen with the frozen concentrates at pH 4.5. Some improvement in the stability could be achieved by using a combination of trehalose, vitamin C and PDX as a freezing carrier material, whereas a significant improvement in the stability was seen when oat fibre was added into the fruit juice together with the frozen cells. Due to the initial very poor fruit juice tolerance of B. breve 99 the obtained improvement in the stability was not enough for commercial applications. However, the same methods could be applied to initially better performing strains to further improve their stability in the fruit juice.

  15. Inhibitory effect of Bifidobacterium infantis-mediated sKDR prokaryotic expression system on angiogenesis and growth of Lewis lung cancer in mice

    Directory of Open Access Journals (Sweden)

    Li Zhao-Jun

    2012-04-01

    Full Text Available Abstract Background To construct the Bifidobacterium infantis-mediated soluble kinase insert domain receptor (sKDR prokaryotic expression system and to observe its inhibitory effect on growth of human umbilicus vessel endothelial cells (HUVECs in vitro and Lewis lung cancer (LLC on mice in vivo. Methods The Bifidobacterium infantis-mediated sKDR prokaryotic expression system was constructed through electroporation and subsequently identified through PCR and Western blot analysis. HUVECs were added to the products of this system to evaluate the anti-angiogenesis effect through MTT assay in vitro. The LLC mice models were divided into three groups: one group treated with saline (group a; one group treated with recombinant Bifidobacterium infantis containing pTRKH2-PsT plasmid group (group b; and one group treated with recombinant Bifidobacterium infantis containing pTRKH2-PsT/sKDR plasmid group (group c. The quality of life and survival of mice were recorded. Tumor volume, tumor weight, inhibitive rate, and necrosis rate of tumor were also evaluated. Necrosis of tumor and signals of blood flow in tumors were detected through color Doppler ultrasound. In addition, microvessel density (MVD of the tumor tissues was assessed through CD31 immunohistochemical analysis. Results The positively transformed Bifidobacterium infantis with recombinant pTRKH2-PsT/sKDR plasmid was established, and was able to express sKDR at gene and protein levels. The proliferation of HUVECs cultivated with the extract of positively transformed bacteria was inhibited significantly compared with other groups (P Bifidobacterium infantis containing pTRKH2-PsT/sKDR plasmid enhanced the efficacy of tumor growth suppression and prolongation of survival, increased the necrosis rate of tumor significantly, and could obviously decrease MVD and the signals of blood flow in tumors. Conclusion The Bifidobacterium infantis-mediated sKDR prokaryotic expression system was constructed

  16. Studies on the storage stability of Bifidobacterium lactis V9 in skim milk powder%Bifidobacterium lactis V9在脱脂乳粉中贮藏稳定性的研究

    Institute of Scientific and Technical Information of China (English)

    刘彪; 张和平

    2012-01-01

    To investigate the bacterial survive stability (B. lactis V9 and Bifidobacterium B) in skim milk powder under different temperatures. Arrhenius equation was involved for evaluating the relationship between temperature and loss rate of bacterial cells in order to predict the loss of B. lactis V9 and Bifidobacterium B in skim milk powder during shelf life. The results showed drat loss rate of bacterial cells was increased as the temperature increment. After at 37 ℃ for 28 days storage, living numbers of two strains were the mosdy reduced by two order of magnitude. No significant changes of living numbers with rime variation was observed at each temperature. A prediction model of shelf life with two strains under different temperatures was established according to Arrhenius equation and bacterial decrement data.This model can predict the loss rate of bacterial cells under one temperature and shelf life of bifidobacteria skim milk powder.%研究Bifidobacterium laais V9(B.laais V9)与双歧杆菌B在脱脂乳粉中不同温度条件下存活稳定性,并以Arrhenius方程反映温度与菌体损失率之间关系,预测B.lactis V9与双歧杆菌B相关乳粉产品货架期内菌体损失情况.结果表明,B.lactis V9与双歧杆菌B随温度升高,菌体损失率增大.两菌株在37℃贮藏28 d后,活菌数下降最明显,约两个数量级,且在不同贮藏温度下活菌数随时间变化情况无显著性差异.通过Arrhenius方程和菌体递减模型,建立了B.lactis V9和双歧杆菌B在不同温度下货架期预测模型,该模型可以较好的预测含B.lactis V9和双歧杆菌B乳粉产品在某一温度下菌体损失率和货架期寿命.

  17. Experimental study on process used for producing Bifidobacterium coconut rice wine%双歧椰汁米酒实验室生产工艺的研究

    Institute of Scientific and Technical Information of China (English)

    朱辉; 张德纯; 刘明方; 王春耀; 刘胜男

    2011-01-01

    目的 以优质糯米和椰汁为原料,通过双歧杆菌和酿酒酵母共生发酵研制出一种功能性的米酒.方法 采用正交试验设计的方法得到了双歧杆菌和酿酒酵母最佳的共生发酵条件.结果 最佳的共生发酵条件是:发酵温度35℃、双歧杆菌接种量3%、酿酒酵母接种量2%、发酵时间16 h,再通过添加30%酿酒酵母单独发酵产物之后,研制出双歧椰汁米酒.结论 采用此工艺生产的功能性米酒既有椰汁的果香味又有米酒的醇香味,口感柔和,易于接受.%Objective Using high quality glutinous rice and coconut juice as raw material to develop a functional rice wine through Bifidobacterium and 5. Cerevisiae symbiotic fermentation. Method We selected orthogonal design method to get optimal symbiotic fermentation conditions of Bifidobacterium and S. cerevisiae and then added separate fermented pro-ducte by S. cerevisiae, eventually getting the process used for producing Bifidobacterium coconut rice wine. Result The best symbiotic fermentation conditions were as follows: fermentation temperature 35 t, inoculation amount of Bifidobacterium 3% , inoculation amount of 5. Cerevisiae 2% , and fermentation time 16 h. Then 30% fermented product, by S. cerevisiae alone was added to get Bifidobacterium coconut juice. Conclusion This functional rice wine produced by the said process has not only coconut juice fruit fragrance, but also rice wine's mellow taste, which tastes soft and easily acceqtable.

  18. Properties of Streptococcus thermophilus fermented milk containing variable concentrations of Bifidobacterium longum and Lactobacillus acidophilus Propriedades de leites fermentados por Streptococcus thermophilus contendo concentrações variáveis de Bifidobacterium longum e Lactobacillus acidophilus

    Directory of Open Access Journals (Sweden)

    Patrícia Blumer Zacarchenco

    2006-09-01

    Full Text Available Sensory evaluation and analysis of pH, titratable acidity and microbial counts after 1, 7, 14 and 21 days of storage of five combinations of lyophilized Bifidobacterium longum and/or Lactobacillus acidophilus added to milk fermented with Streptococcus thermophilus were studied during storage at 4ºC. The taste and acidity sensory attributes were significantly (PForam estudadas as características sensoriais, de pH e acidez de cinco combinações de leites fermentados por Streptococcus thermophilus, adicionados de Bifidobacterium longum e/ou Lactobacillus acidophilus liofilizados. Os efeitos sobre as características sensoriais tornaram-se significantes (p < 0,05 com o aumento do tempo de estocagem. As combinações favoritas continham, inicialmente, Bif. longum e L. acidophilus (10(8 e 10(7ufc/mL, respectivamente e Bif. longum apenas (10(8ufc/mL. Estas combinações não diferiram significativamente do leite fermentado padrão, nem entre si. As notas mais baixas e os maiores valores de acidez titulável foram apresentados pelo leite fermentado por Streptococcus thermophilus contendo apenas L. acidophilus (10(8ufc/mL, concentração inicial. Durante 21 dias de estocagem a 4ºC, as contagens de células viáveis de Str. thermophilus não mudaram, as de Bif. longum mantiveram-se constantes ou reduziram em um ciclo logarítmico e, as de L. acidophilus reduziram de 1 a 2 ciclos logarítmicos. Não foi observada inibição da pós-acidificação resultante da presença de bifidobactéria ou L. acidophilus.

  19. Lactobacillus casei Zhang和Bifidobacterium lactis V9在益生菌酸乳中的应用%Application of Lactobacillus casei Zhang and Bifidobacterium lactis V9 in the probiotic yoghurt

    Institute of Scientific and Technical Information of China (English)

    刘彪; 张和平

    2012-01-01

    益生菌在酸乳中的应用已非常普遍,将Lactobacillus casei Zhang单独(样品A)以及与Bifidobacterium lactis V9复合(样品B),同酸乳发酵剂(G027)共同发酵益生菌酸乳,于4℃贮藏21 d.结果表明,整个贮藏期间2组样品间的黏度和持水性差异不显著;贮藏期间2组样品间L.casei Zhang的活菌数没有差异,且L.casei Zhang和B.lactis V9的活菌数不随贮藏时间而降低;L.casei Zhang和B.lactis V9复合益生菌酸奶感官评价优于单独添加L.casei Zhang酸乳.L.casei Zhang和B.lactis V9复合添加,更适合于益生菌酸乳的生产.%Now it is common for adding probiotics in fermented yoghurt. Yoghurt was fermented by Lactobadllus casei Zhang (A) or combined with Bifidobacterium lactis V9 (B) plus with starter culture (G027) and followed with a 21 d storage at 4 t. The results showed that there was no significance between A and B concerning viscosity and syneresis. It also observed no significant difference existed in counts of L. casei 7ian% between A and B during storage and counts of two probiotics had no change as the storage passed by. However, Fermented milk by combined L. casei Zhang with B. lactis V9 possess markedly higher favorable sensory scores than L. casei Zhang fermented milk, suggesting that it is more suitable for probiotic yoghurt manufacture.

  20. 蒺藜提取液对长双歧杆菌及青春双歧杆菌生长的影响%Effects of Fructus tribuli extract on growth of Bifidobacterium longum and Bifidobacterium adolescentis

    Institute of Scientific and Technical Information of China (English)

    曹吉利; 魏莉娟; 谭源; 舒国伟

    2011-01-01

    以MRS培养基为对照,OD600及pH值为响应,研究了蒺藜提取液浓度对2株双歧杆菌——长双歧杆菌及青春双歧杆菌生长的影响.结果表明;蒺藜提取液能促进长双歧杆菌和青春双歧杆菌的生长,但最适浓度因菌而已,长双歧杆菌和青春双歧杆菌在MRS培养基中的最佳蒺藜提取液的加量分别为2.0%和1.5%,37℃培养18h后,培养液的OD600分别达到1.388和1.564.%The effects of Fructus tribuli extract on growth of Bifidobacterium longum and Bifidobacterium adolescentis were studied using MRS medium as control and taking Odm and pH as response. The results showed that the Fructus tribuli extract could promote the growth of B. Longum and B. Adolescentis, but the optimal concentration of the extract differed for different strains. The optimal concentration of the extract for B. Longum and B. Adolescentis were 2.0% and 1.5%, respectively, and the OD600 of B. Longum and B. Adolescentis reached 1.388 and 1.564 respectively after the cultivation at 37℃ for 18h.

  1. 双歧杆菌及其与龋病的相关性研究进展%Bifidobacterium and related research progress on the relationship between the bacteria and dental caries

    Institute of Scientific and Technical Information of China (English)

    相艳(综述); 杜民权(审校)

    2013-01-01

    In recent years, in-depth studies on the relationship between Bifidobacterium and dental caries have gradually attracted increasing attention. This paper summarizes the classification and determination of Bifidobacterium, discusses the relationship between Bifidobacterium and dental caries, and investigates the function of Bifidobacterium in the developmental process of dental caries.%随着分子生物学及其技术的发展,双歧杆菌属与龋病间的关系备受人们的关注。本文就双歧杆菌的分类鉴定、与龋病发生的关系及在龋病发展过程中的作用等研究进展作一综述。

  2. An immunostimulatory DNA sequence from a probiotic strain of Bifidobacterium longum inhibits IgE production in vitro.

    Science.gov (United States)

    Takahashi, Noritoshi; Kitazawa, Haruki; Shimosato, Takeshi; Iwabuchi, Noriyuki; Xiao, Jin-Zhong; Iwatsuki, Keiji; Kokubo, Sadayuki; Saito, Tadao

    2006-04-01

    The immunostimulatory oligodeoxynucleotide (ODN) BL07 (5'-GCGTCGGTTTCGGTGCTCAC-3') was identified from the genomic DNA of the probiotic strain Bifidobacterium longum BB536. ODN BL07 stimulated B-lymphocyte proliferation and induced interleukin-12 (IL-12) production in macrophage-like J774.1 cells. ODNs BL07 and BL07S (modified with phosphorothioate backbone) significantly inhibited immunoglobulin E (IgE) production and stimulated interferon-gamma (IFN-gamma) and IL-12 production, but did not affect IL-4 secretion in murine splenic cells of ovalbumin-primed BALB/c mice. These ODNs also significantly inhibited production of IgE in purified murine B cells in the presence of IL-4 and anti-CD40. The results suggest the potential of ODNs BL07 and BL07S in preventing IgE-related immune responses and the possible involvement of ODN BL07 in the antiallergic efficacy of B. longum BB536.

  3. Metabolize of Bifidobacterium and its Developmental Prospect%双歧杆菌的代谢及开发前景

    Institute of Scientific and Technical Information of China (English)

    吕耀龙; 赵春杰; 刘建军

    2008-01-01

    双歧杆菌(Bifidobacterium)是典型的益生菌,与机体的许多生理、病理现象关系密切,引起生物学、医学、免疫学、营养学、遗传学、食品学等领域的专家学者的广泛关注.综述了双歧杆菌的生物学特性、厌氧机理、有关酶系合成、分泌到菌体外的物质、质粒研究及双歧杆菌制品的开发利用.

  4. The influence of different polymers on viability of Bifidobacterium lactis 300b during encapsulation, freeze-drying and storage.

    Science.gov (United States)

    Pop, Oana Lelia; Brandau, Thorsten; Schwinn, Jens; Vodnar, Dan Cristian; Socaciu, Carmen

    2015-07-01

    Seven different types of natural polymers namely hydroxypropyl methylcellulose (HPMC), sodium-carboxymethyl cellulose (Na-CMC), microcrystalline cellulose (MCC), starch BR-07, starch BR-08, dextrin and pullulan were used in order to develop the optimal formula for the entrapment of Bifidobacterium lactis 300B in Ca-alginate based granules. Laminar flow drip casting with Brace-Encapsulator was used in order to prepare the granules. The results showed that alginate/pullulan and alginate/HPMC formulation provide high protection for the bacterial strain used for encapsulation. These two formulations were further used to obtain freeze dried granules, for which the viability in time and at different temperatures was tested. The final results showed a higher viability than the level of the therapeutic minimum (>10(7) CFU/g) after 15 days of storage. Other parameters like entrapment efficiency, production rate, sphericity, flowability were also discussed.

  5. Genomics of the Genus Bifidobacterium Reveals Species-Specific Adaptation to the Glycan-Rich Gut Environment

    Science.gov (United States)

    Milani, Christian; Turroni, Francesca; Duranti, Sabrina; Lugli, Gabriele Andrea; Mancabelli, Leonardo; Ferrario, Chiara; van Sinderen, Douwe

    2015-01-01

    Bifidobacteria represent one of the dominant microbial groups that occur in the gut of various animals, being particularly prevalent during the suckling period of humans and other mammals. Their ability to compete with other gut bacteria is largely attributed to their saccharolytic features. Comparative and functional genomic as well as transcriptomic analyses have revealed the genetic background that underpins the overall saccharolytic phenotype for each of the 47 bifidobacterial (sub)species representing the genus Bifidobacterium, while also generating insightful information regarding carbohydrate resource sharing and cross-feeding among bifidobacteria. The abundance of bifidobacterial saccharolytic features in human microbiomes supports the notion that metabolic accessibility to dietary and/or host-derived glycans is a potent evolutionary force that has shaped the bifidobacterial genome. PMID:26590291

  6. A nutritious medida (Sudanese cereal thin porridge) prepared by fermenting malted brown rice flour with Bifidobacterium longum BB 536.

    Science.gov (United States)

    Kabier, Barka M; Mustafa, Suhaimi; Kharidah, Muhammad; Suraini, Abd-Aziz; Abdul Manap, Yazid

    2004-09-01

    The nutritive value of spontaneously fermented brown rice flour medida, a Sudanese cereal thin porridge, is low. This study was carried out to improve the nutritional quality of medida. The flour was soaked and malted at 30◦C to optimise the protein content. Flour malted for two days had the highest protein content. Skim milk was added to the malted brown rice flour medida and fermented using Bifidobacterium longum BB 536. Maximum count of B. longum BB 536 up to 9 log CFU/ ml was attained at 4.6 final fermentation pH. The resultant viscosity was similar to that of the spontaneously fermented brown rice flour medida. There was significant (Pmedida have stable flowing characteristics and meet the whole protein and energy requirements for infants and children aged 1 - 10 years old.

  7. Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women

    Institute of Scientific and Technical Information of China (English)

    Yue-Xin Yang; Mei He; Gang Hu; Jie Wei; Philippe Pages; Xian-Hua Yang; Sophie Bourdu-Naturel

    2008-01-01

    AIM: To investigate the effect of a fermented milk containing Bifidobacterium lactis DN- 173010 and yogurt strains (BIO ) on adult women with constipation in Beijing. METHODS: A total of 135 adult females with constipation were randomly allocated to consume for 2 wk either 100 g of the test fermented milk or 100 g of an acidified milk containing non-living bacteria (control). Stool frequency, defecation condition scores, stool consistency and food intake were recorded at baseline and after 1 and 2 wk in an intention-to-treat population of 126 subjects. In parallel, safety evaluation parameters were performed. RESULTS: At baseline, no differences were found between groups. Following consumption of test product, stool frequency was significantly increased after 1 wk (3.5±1.5 vs 2.4±0.6, P < 0.01) and 2 wk (4.1±1.7 vs 2.4±0.6, P < 0.01), vs baseline. Similarly, after 1 and 2 wk, of test product consumption, defecation condition (1.1±0.9 vs 1.9±1.2, P < 0.01 and 0.8±1.0 vs 1.9±1.2, P < 0.01, respectively) and stool consistency (1.0±0.8 vs 1.5±1.1, P < 0.01 and 0.6±0.8 vs 1.5±1.1, P < 0.01, respectively) were significantly improved. Compared with the control group, stool frequency was also significantly increased (3.5±1.5 vs 2.5± 0.9, P <0.01 and 4.1±1.7 vs 2.6±1.0, P <0.01, respectively), and defecation condition (1.1±0.9 vs 1.6±1.1, P < 0.01 and 0.8±1.0 vs 1.6±1.1, P < 0.01, respectively) and stool consistency (1.0±0.8 vs 1.4±1.0, P < 0.05 and 0.6±0.8 vs 1.3±1.0, P < 0.01, respectively) significantly decreased after 1 and 2 wk of product consumption. During the same period, food intake did not change between the two groups, and safety parameters of the subjects were within normal ranges. CONCLUSION: This study suggests a beneficial effect of a fermented milk containing B. lactis DN-173010 on stool frequency, defecation condition and stool consistency in adult women with constipation constipated women after 1 and 2 wk of consumption.

  8. Bifidobacterium breve and Streptococcus thermophilus secretion products enhance T helper 1 immune response and intestinal barrier in mice.

    Science.gov (United States)

    Ménard, Sandrine; Laharie, David; Asensio, Corinne; Vidal-Martinez, Teresita; Candalh, Céline; Rullier, Anne; Zerbib, Frank; Mégraud, Francis; Matysiak-Budnik, Tamara; Heyman, Martine

    2005-11-01

    Lactic acid bacteria or their secretion products can modulate immune responses differently in normal and inflammatory conditions. This comparative study analyzes the effect of oral administration of living lactic acid bacteria, or their conditioned media, on the epithelial and immune functions of colitis-prone C57BL/6 IL-10-deficient mice. Mice were untreated (control) or infected with Helicobacter hepaticus with or without oral treatment with living bacteria, Bifidobacterium breve C50 and Streptococcus thermophilus 065 (LB), or their culture-conditioned media (CM). Histology, cytokine mRNA, electrical resistance, and barrier capacity of colonic samples as well as cytokine secretion by mesenteric lymph node (MLN) cells were studied. Helicobacter hepaticus mice developed only mild colitis, which was not modified in LB or CM groups. In the CM (but not the LB) group, the colonic barrier was reinforced as compared to the other groups, as evidenced by decreased horseradish peroxidase (HRP) transcytosis and mannitol fluxes and increased electrical resistance. In MLN, the percentage of CD4+ and CD8+ T cells secreting IFNgamma was significantly higher in CM (2.06% and 1.98%, respectively) mice than in H. hepaticus (1.1% and 0.47%, P secretion by MLN cells was significantly higher in the CM group as compared to the other groups. In the absence of severe colitis, Bifidobacterium breve C50- and Streptococcus thermophilus 065-conditioned media can reinforce intestinal barrier capacity and stimulate Th1 immune response, highlighting the involvement of lactic acid bacteria-derived components in host defense.

  9. Preparation of N,O-carboxymethyl chitosan coated alginate microcapsules and their application to Bifidobacterium longum BIOMA 5920

    Energy Technology Data Exchange (ETDEWEB)

    Mi, Yu; Su, Ran [Shaanxi R and D Center of Biomaterials and Fermentation Engineering, School of Chemical Engineering, Northwest University (China); Fan, Dai-Di, E-mail: fandaidi@nwu.edu.cn [Shaanxi R and D Center of Biomaterials and Fermentation Engineering, School of Chemical Engineering, Northwest University (China); Zhu, Xiao-Li [Shaanxi R and D Center of Biomaterials and Fermentation Engineering, School of Urban and Environmental Science, Northwest University, Taibai North Road 229, Xi' an, Shaanxi 710069 (China); Zhang, Wen-Ni [Shaanxi R and D Center of Biomaterials and Fermentation Engineering, School of Chemical Engineering, Northwest University (China); Shaanxi Key Laboratory of Degradable Biomedical Materials, School of Chemical Engineering, Northwest University (China)

    2013-07-01

    In order to greatly improve vitality of probiotic bacteria within the application, a novel biocompatible vehicle, N,O-carboxymethyl chitosan (NOCs) with appropriate degrees of substitution coat alginate (ALg) microparticles, was prepared by electrostatic droplet generation. The amount of chitosan (Cs) and N,O-carboxymethyl chitosan (NOCs) coated on the ALg microparticles was determined by differential scanning calorimetry. The surface morphology of ALg microparticles, Cs coated ALg microparticles and NOCs coated ALg microparticles was determined using scanning electron microscopy. The coating thickness of Cs coated ALg microparticles and that of NOCs coated ALg microparticles was directly observed with confocal laser scanning microscopy. In order to assess pH sensitivity of microparticles, the bovine serum albumin release from the microspheres was tested in acid solution (pH 2.0) for 2 h and subsequently in alkaline solution (pH 7.0) for 2 h. The survival of Bifidobacterium longum BIOMA 5920 loaded in NOCs coated with ALg microparticle was improved in simulated gastric juice (pH 2.0, for 2 h) compared to that of B. longum BIOMA 5920 loaded in ALg microparticles and Cs coated ALg microparticles. After incubation in simulated intestinal juices (pH 7.0, 2 h), the release of microencapsulated B. longum BIOMA 5920 was investigated. - Highlights: • Synthesised N,O-carboxymethyl chitosan (NOCs) coated alginate (ALg) microspheres. • Their effect on intestinal microflora was investigated in simulated gastric juices. • NOCs A coated ALg microspheres improved Bifidobacterium longum survival in SGJ. • The modified chitosan layer improved the pH-response of alginate microspheres. • NOCs A coated microspheres could be used to deliver oral bioactive compounds.

  10. Development of a luciferase-based reporter system to monitor Bifidobacterium breve UCC2003 persistence in mice

    Directory of Open Access Journals (Sweden)

    Hill Colin

    2008-09-01

    Full Text Available Abstract Background Probiotics such as bifidobacteria have been shown to maintain a healthy intestinal microbial balance and help protect against infections. However, despite these benefits, bifidobacteria still remain poorly understood at the biochemical, physiological and especially the genetic level. Herein we describe, for the first time, the development of a non-invasive luciferase-based reporter system for real-time tracking of Bifidobacterium species in vivo. Results The reporter vector pLuxMC1 is based on the recently described theta-type plasmid pBC1 from B. catenatulatum 1 and the luxABCDE operon from pPL2lux 2. Derivatives of pLuxMC1, harbouring a bifidobacterial promoter (pLuxMC2 as well as a synthetically derived promoter (pLuxMC3 3 placed upstream of luxABCDE, were constructed and found to stably replicate in B. breve UCC2003. The subsequent analysis of these strains allowed us to assess the functionality of pLuxMC1 both in vitro and in vivo. Conclusion Our results demonstrate the potential of pLuxMC1 as a real-time, non-invasive reporter system for Bifidobacterium. It has also allowed us, for the first time, to track the colonisation potential and persistence of this probiotic species in real time. An interesting and significant outcome of the study is the identification of the caecum as a niche environment for B. breve UCC2003 within the mouse gastrointestinal tract (GI tract.

  11. Exposure of Bifidobacterium longum subsp. infantis to Milk Oligosaccharides Increases Adhesion to Epithelial Cells and Induces a Substantial Transcriptional Response

    Science.gov (United States)

    Kavanaugh, Devon W.; O’Callaghan, John; Buttó, Ludovica F.; Slattery, Helen; Lane, Jonathan; Clyne, Marguerite; Kane, Marian; Joshi, Lokesh; Hickey, Rita M.

    2013-01-01

    In this study, we tested the hypothesis that milk oligosaccharides may contribute not only to selective growth of bifidobacteria, but also to their specific adhesive ability. Human milk oligosaccharides (3′sialyllactose and 6′sialyllactose) and a commercial prebiotic (Beneo Orafti P95; oligofructose) were assayed for their ability to promote adhesion of Bifidobacterium longum subsp. infantis ATCC 15697 to HT-29 and Caco-2 human intestinal cells. Treatment with the commercial prebiotic or 3′sialyllactose did not enhance adhesion. However, treatment with 6′sialyllactose resulted in increased adhesion (4.7 fold), while treatment with a mixture of 3′- and 6′-sialyllactose substantially increased adhesion (9.8 fold) to HT-29 intestinal cells. Microarray analyses were subsequently employed to investigate the transcriptional response of B. longum subsp. infantis to the different oligosaccharide treatments. This data correlated strongly with the observed changes in adhesion to HT-29 cells. The combination of 3′- and 6′-sialyllactose resulted in the greatest response at the genetic level (both in diversity and magnitude) followed by 6′sialyllactose, and 3′sialyllactose alone. The microarray data was further validated by means of real-time PCR. The current findings suggest that the increased adherence phenotype of Bifidobacterium longum subsp. infantis resulting from exposure to milk oligosaccharides is multi-faceted, involving transcription factors, chaperone proteins, adhesion-related proteins, and a glycoside hydrolase. This study gives additional insight into the role of milk oligosaccharides within the human intestine and the molecular mechanisms underpinning host-microbe interactions. PMID:23805302

  12. Biochemical and kinetic characterisation of a novel xylooligosaccharide-upregulated GH43 β-d-xylosidase/α-l-arabinofuranosidase (BXA43) from the probiotic Bifidobacterium animalis subsp. lactis BB-12

    DEFF Research Database (Denmark)

    Viborg, Alexander Holm; Sørensen, Kim Ib; Gilad, Ofir

    2013-01-01

    The Bifidobacterium animalis subsp. lactis BB-12 gene BIF_00092, assigned to encode a β-d-xylosidase (BXA43) of glycoside hydrolase family 43 (GH43), was cloned with a C-terminal His-tag and expressed in Escherichia coli. BXA43 was purified to homogeneity from the cell lysate and found to be a dual...... to xylotetraose at subsite +3 and occur only in GH43 from the Bifidobacterium genus....

  13. 影响双岐南瓜酸奶品质因素的探讨%Study on Quality of Yoghourt with Active Bifidobacterium and Pumpkin Juice

    Institute of Scientific and Technical Information of China (English)

    张丽芳

    2012-01-01

    Study on difference temperature of Yoghourt with active bifidobacterium and pumpkin Juice about quality, flavour and bifidobacterium number of changes, Compare different store temperature on pumpkin with acidity, flavour and material, bifidobacterium number of changes; the Pumpkin polysaccharides change in the storage period. Result show: at 38℃fermentation, yogurt with water, the diacetyl content, or bifidobacterium numbers,bifidobacterium number and score acidity of the senses is highest, the contents of aldehyde is 17.25mg·kg-1; In 2℃ storage acidity increased slowly, acetaldehy and diacetyl ratio is close to 3, bifidobacterium number down slowly; pumpkin polysaccharides in the storage period on the downward trend in the first 6d down, then a relatively rapid pace of decline.%研究了不同发酵温度对双岐南瓜酸奶质构、风味及菌群数量的影响,比较了不同贮藏温度下南瓜双岐酸奶酸度、风味物质、双歧杆菌数量的变化,探讨了双岐南瓜酸奶在贮藏期南瓜多糖的变化情况.结果表明:在38℃条件下发酵,酸奶的持水力、表观粘度、双乙酰含量、双歧杆菌数量、感官评分达最高,胶体收缩最小,乙醛含量为17.25mg· kg-1;在2℃条件下贮存酸度上升缓慢,乙醛与双乙酰含量比值均接近3,双歧杆菌数量下降缓慢;南瓜多糖在贮存期内呈现下降趋势,在前6d下降缓慢,随后下降较快.

  14. 荧光定量PCR法检测益生菌饮料中Lactobacillus casei Zhang和Bifidobacterium lactis V9%Lactobacillus casei Zhang Bifidobacterium lactis V9 Method of fluorescent quantitative PCR for detection of Lactobacillus casei Zhang and Bifidobacterium lactis V9

    Institute of Scientific and Technical Information of China (English)

    其木格苏都; 王记成; 张家超; 张和平

    2011-01-01

    益生菌活菌数是益生菌产品最重要的指标,而检测益生菌方法的准确性和科学性则至关重要.本文采用荧光定量PCR法同时定量检测益生菌饮料中Lactobacillus casei Zhang(L.casei Zhang)和Bifidobacterium lactis V9(B.lactis V9)的活菌数,并与平板菌落计数法进行比较.结果表明,荧光定量PCR法测得L.casei Zhang活菌数与平板菌落计数法测得活菌数差异不显著;而采用荧光定量PCR法测得B.lactis V9活菌数显著高于平板菌落计数法.荧光定量PCR法灵敏、特异、简便快速,可定量检测并真实反应L.casei Zhang和B.lactis V9的活菌数.%The viable count of probiotic is considered as the most important index and the accurate and scientific assay of probiotic viable number is essential to probiotic products. In the present study, the fluorescent quantitative PCR method and plate colony counting method were used and compared for detection of bacterial viable numbers of Lactobadllus casei Zhang and Bifidobacterium lactis V9 in probiotic fermented beverage. The result showed that there was no significant difference of L. Casei Zhang number between two methods, whereas the numbers of B. Lactis V9 detected by two methods were significant difference. It is suggested that fluorescent quantitative PCR method appear to be highly accurate, specific, fast and reliable for quantification of L. Casei Zhang and B. Lactis V9.

  15. Potencial do soro de leite líquido como agente encapsulante de Bifidobacterium Bb-12 por spray drying: comparação com goma arábica Potential of liquid whey as the encapsulating agent of Bifidobacterium Bb-12 by spray drying: comparison with arabic gum

    Directory of Open Access Journals (Sweden)

    Fabiane Picinin de Castro-Cislaghi

    2012-09-01

    Full Text Available O objetivo do trabalho foi avaliar o potencial do soro de leite líquido como agente encapsulante de Bifidobacterium Bb-12 por spray drying, comparando-o com a goma arábica, a qual é tradicionalmente utilizada na tecnologia de microencapsulação. Foram determinados o rendimento da microencapsulação e a viabilidade das microcápsulas durante o armazenamento. Quando o soro de leite foi utilizado como agente encapsulante, o rendimento da microencapsulação foi maior e a viabilidade das células manteve-se elevada e constante durante doze semanas. O soro de leite apresentou-se como um eficiente agente encapsulante de Bifidobacterium por spray drying.The objective of this study was to evaluate the potential of liquid whey as the encapsulating agent Bifidobacterium Bb-12 by spray drying, compared with arabic gum, which is typically used in microencapsulation technology. The microencapsulation yield and viability during storage were determined. When the whey was used as the encapsulating agent, the microencapsulation yield was higher, and cell viability remained high and steady for twelve weeks. The whey was shown to be an effective encapsulating agent of Bifidobacterium by spray drying.

  16. Isolation of Bifidobacterium from Direct Yoghurt Fermenter%直投式酸奶发酵剂中双歧杆菌的分离

    Institute of Scientific and Technical Information of China (English)

    陈杰; 孙翠焕; 吴英春; 陈丽媛; 冯华; 徐冲

    2011-01-01

    An easy, simple, and feasible method to isolate Bifidobacterium from direct yoghurt fennenter is introduced. After the fennenter was cultured and activated in liquid medium, it was separated on different media with scratch method. Bifidobacterium confirmed according to its colony and cell form, then to carry out the initial characterization.%介绍一种简便可行的从直投式酸奶发酵剂中分离双歧杆菌的方法.发酵剂在液体培养基中活化后,在不同选择培养基上划线分离,根据菌落及菌体形态确定双歧杆菌.然后进行初步鉴定.

  17. Cross-Feeding between Bifidobacterium longum BB536 and Acetate-Converting, Butyrate-Producing Colon Bacteria during Growth on Oligofructose▿

    OpenAIRE

    Falony, Gwen; Vlachou, Angeliki; Verbrugghe, Kristof; De Vuyst, Luc

    2006-01-01

    In vitro coculture fermentations of Bifidobacterium longum BB536 and two acetate-converting, butyrate-producing colon bacteria, Anaerostipes caccae DSM 14662 and Roseburia intestinalis DSM 14610, with oligofructose as the sole energy source, were performed to study interspecies interactions. Two clearly distinct types of cross-feeding were identified. A. caccae DSM 14662 was not able to degrade oligofructose but could grow on the fructose released by B. longum BB536 during oligofructose break...

  18. Comparative study on biochemical activity of the intestinal isolates Lactobacillus sp. V3 and Bifidobacterium sp. A71 in different substrates

    OpenAIRE

    JOSIP BARAS; SUZANA DIMITRIJEVIC-BRANKOVIC

    2001-01-01

    The two intestinal isolates Lactobacillus sp. V3 and Bifidobacterium sp. A71 were selected for soymilk fermentation according to their acidification activity in soymilk. Beetroot juice and carrot juice were chosen for soymilk supplementation as additional sources of carbohydrates and brewer's yeast as an extra source of nitrogen. The fermentation was carried out for eight hours at 42°C. The fermentation was monitored by standard analytical and microbiological tests for changes of acidity (dec...

  19. Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis

    DEFF Research Database (Denmark)

    Wildt, Signe; Munck, Lars K; Vinter-Jensen, Lars

    2006-01-01

    Probiotic treatment may be effective in diseases involving gut microflora and intestinal inflammation. In collagenous colitis (CC), a potential pathogenic role of the gut microflora has been proposed. The effect of probiotic treatment in CC is unknown. Our aim was to investigate the clinical effe...... of treatment with Lactobacillus acidophilus LA-5 and Bifidobacterium animalis subsp. lactis BB-12 (AB-Cap-10) in patients with CC....

  20. Identification and quantification of Bifidobacterium species isolated from food with genus-specific 16S rRNA-targeted probes by colony hybridization and PCR.

    Science.gov (United States)

    Kaufmann, P; Pfefferkorn, A; Teuber, M; Meile, L

    1997-01-01

    A Bifidobacterium genus-specific target sequence in the V9 variable region of the 16S rRNA has been elaborated and was used to develop a hybridization probe. The specificity of this probe, named lm3 (5'-CGGGTGCTI*CCCACTTTCATG-3'), was used to identify all known type strains and distinguish them from other bacteria. All of the 30 type strains of Bifidobacterium which are available at the German culture collection Deutsche Sammlung von Mikroorganismen und Zellkulturen, 6 commercially available production strains, and 34 closely related relevant strains (as negative controls) were tested. All tested bifidobacteria showed distinct positive signals by colony hybridization, whereas all negative controls showed no distinct dots except Gardnerella vaginalis DSM4944 and Propionibacterium freudenreichii subsp. shermanii DSM4902, which gave slight signals. Furthermore, we established a method for isolation and identification of bifidobacteria from food by using a PCR assay without prior isolation of DNA but breaking the cells with proteinase K. By this method, all Bifidobacterium strains lead to a DNA product of the expected size. We also established a quick assay to quantitatively measure Bifidobacterium counts in food and feces by dilution plating and colony hybridization. We were able to demonstrate that 2.1 x 10(6) to 2.3 x 10(7) colonies/g of sour milk containing bifidobacteria hybridized with the specific nucleotide probe. With these two methods, genus-specific colony hybridization and genus-specific PCR, it is now possible to readily and accurately detect any bifidobacteria in food and fecal samples and to discriminate between them and members of other genera. PMID:9097423

  1. Modulación de la fisiología gastrointestinal mediante cepas probióticas de Lactobacillus casei y Bifidobacterium bifidum Modulation of gastrointestinal physiology through probiotic strains of Lactobacillus casei and Bifidobacterium bifidum

    Directory of Open Access Journals (Sweden)

    J. Barrenetxe

    2006-12-01

    Full Text Available En el contexto de la alimentación y la promoción de la salud se sitúan los productos denominados alimentos funcionales que tienen diversos efectos beneficiosos en el organismo, además de los meramente nutricionales. Dentro de estos alimentos funcionales, entre otros, podemos distinguir entre compuestos probióticos y prebióticos. Los microorganismos más utilizados en alimentos probióticos pertenecen a los géneros Lactobacillus y Bifidobacterium. En el presente trabajo se ha estudiado el efecto de dietas suplementadas con Lactobacillus casei o Bifidobacterium bifidum en el desarrollo animal y en especial sobre la función intestinal, centrada en su actividad immunitaria, digestiva y absortiva de animales en crecimiento. Las cepas bacterianas utilizadas modifican la actividad del intestino delgado de los ratones sanos, afectando significativamente a su actividad enzimática (sacarasa, maltasa y aminopeptidasa y a la captación de nutrientes (galactosa y glicilsarcosina, así como a la actividad inmune intestinal (mayor número de placas de Peyer. Sin embargo, estos efectos no parecen perturbar el desarrollo de los animales en crecimiento ya que no se aprecian diferencias significativas en su peso corporal ni en sus parámetros sanguíneos. Estos resultados ponen de manifiesto los posibles efectos beneficiosos en la fisiología intestinal y contribuyen al conocimiento de los posibles mecanismos de acción de los probióticos, que se pudieran utilizar en el tratamiento preventivo de diferentes patologías relacionadas con el aparato digestivo.The products called functional foods, which besides being merely nutritional have different beneficial effects on the organism, are situated in the context of diet and health promotion. Amongst these functional foods we can distinguish, amongst others, between probiotic and prebiotic compounds. The micro-organisms most widely used in probiotic foods belong to the Lactobacillus and Bifidobacteriumtypes

  2. Human intestinal mucosa-associated Lactobacillus and Bifidobacterium strains with probiotic properties modulate IL-10, IL-6 and IL-12 gene expression in THP-1 cells.

    Science.gov (United States)

    Čitar, M; Hacin, B; Tompa, G; Štempelj, M; Rogelj, I; Dolinšek, J; Narat, M; Matijašić, B Bogovič

    2015-01-01

    Lactobacilli and bifidobacteria are considered one of the permanent genera of the physiological human intestinal microbiota and represent an enormous pool of potential probiotic candidates. Approximately 450 isolates of presumptive Lactobacillus or Bifidobacterium strains were obtained from bioptic samples of colonic and ileal mucosa from 15 adolescents aged 12 to 18 years. On the basis of randomly amplified polymorphic DNA (RAPD)-PCR analysis, 20 strains were selected for further taxonomic classification and characterisation, as well as assessment of probiotic properties and safety. Importantly, selected strains showed the capability of colonising different parts of the intestine. The most frequently isolated species was Lactobacillus paracasei followed by Lactobacillus fermentum. The majority of isolates were susceptible to antimicrobials of human and veterinary importance, however, tetracycline and/or erythromycin resistance was observed in Lactobacillus plantarum and L. fermentum strains. Thirteen strains were able to ferment more than 19 different carbon sources and three out of five tested strains exerted antagonistic activity against several different indicator strains. Two Lactobacillus isolates (L. paracasei L350 and L. fermentum L930 bb) and one Bifidobacterium isolate (Bifidobacterium animalis subsp. animalis IM386) fulfilled in vitro selection criteria for probiotic strains and exhibited strong downregulation of pro-inflammatory cytokines IL-6 and IL-12 and upregulation of anti-inflammatory IL-10. The selected strains represent suitable candidates for further studies regarding their positive influence on host health and could play an important role in ameliorating the symptoms of inflammatory bowel diseases.

  3. Cell-Free Spent Media Obtained from Bifidobacterium bifidum and Bifidobacterium crudilactis Grown in Media Supplemented with 3′-Sialyllactose Modulate Virulence Gene Expression in Escherichia coli O157:H7 and Salmonella Typhimurium

    Science.gov (United States)

    Bondue, Pauline; Crèvecoeur, Sébastien; Brose, François; Daube, Georges; Seghaye, Marie-Christine; Griffiths, Mansel W.; LaPointe, Gisèle; Delcenserie, Véronique

    2016-01-01

    Complex oligosaccharides from human milk (HMO) possess an antimicrobial activity and can promote the growth of bifidobacteria such as Bifidobacterium bifidum and Bifidobacterium longum subsp. infantis. In addition, fermentation of carbohydrates by bifidobacteria can result in the production of metabolites presenting an antivirulence effect on several pathogenic bacteria. Whey is rich in complex bovine milk oligosaccharides (BMO) structurally similar to HMO and B. crudilactis, a species of bovine origin, is able to metabolize some of those complex carbohydrates. This study focused on the ability of B. bifidum and B. crudilactis to grow in a culture medium supplemented in 3′-sialyllactose (3′SL) as the main source of carbon, a major BMO encountered in cow milk. Next, the effects of cell-free spent media (CFSM) were tested against virulence expression of Escherichia coli O157:H7 and Salmonella enterica serovar Typhimurium. Both strains were able to grow in presence of 3′SL, but B. crudilactis showed the best growth (7.92 ± 0.3 log cfu/ml) compared to B. bifidum (6.84 ± 0.9 log cfu/ml). Then, CFSM were tested for their effects on virulence gene expression by ler and hilA promoter activity of luminescent mutants of E. coli and S. Typhimurium, respectively, and on wild type strains of E. coli O157:H7 and S. Typhimurium using RT-qPCR. All CFSM resulted in significant under expression of the ler and hilA genes for the luminescent mutants and ler (ratios of −15.4 and −8.1 respectively) and qseA (ratios of −2.1 and −3.1) for the wild type strain of E. coli O157:H7. The 3′SL, a major BMO, combined with some bifidobacteria strains of bovine or human origin could therefore be an interesting synbiotic to maintain or restore the intestinal health of young children. These effects observed in vitro will be further investigated regarding the overall phenotype of pathogenic agents and the exact nature of the active molecules. PMID:27713728

  4. 婴儿源益生性双歧杆菌的筛选及肠道定殖性研究%Screening of Probiotic Bifidobacterium Strains from Infants and Study of Their Intestinal Colonization Ability

    Institute of Scientific and Technical Information of China (English)

    韩俊燕; 赵国忠; 杨波; 刘小鸣; 张灏; 陈卫

    2016-01-01

    本研究旨在从婴儿粪便中筛选出具有潜在益生特性的双歧杆菌,并探究其肠道定殖情况,为双歧杆菌的产品开发提供优良的菌株.采用MRS培养基对样品进行分离纯化,菌株经F6PPK检测及16S rDNA测序鉴定,之后进行模拟胃肠液、胆盐耐受性、对食源性致病菌(大肠杆菌、沙门氏菌、单增李斯特菌等)的抑制及对HT-29细胞的粘附能力测定,将筛选出的菌株进行动物实验,测定其肠道定殖能力.分离到的27株双歧杆菌,经分子生物学鉴定为7个不同的种:Bifidobacterium longum、Bifidobacterium breve、Bifidobacterium bifidum、Bifidobacterium pseudocatenulatum、Bifidobacterium infantis、Bifidobacterium animalis和Bifidobacterium adolescentis.体外实验表明,B.longum A9、B.breve A4、B.bifidum B6、B.longum C6、B.adolescentis F8和B.infantis H6等具有较强的潜在益生特性;动物实验表明,B.infantis H6和B.longum C6具有较强的肠道定殖能力.B.longum C6和B.infantis H6有望作为优良的益生性菌株,应用于双歧杆菌的产品开发.

  5. Long-term changes in human colonic Bifidobacterium populations induced by a 5-day oral amoxicillin-clavulanic acid treatment.

    Science.gov (United States)

    Mangin, Irène; Lévêque, Christophe; Magne, Fabien; Suau, Antonia; Pochart, Philippe

    2012-01-01

    The objective of this study was to assess the possible modifications due to amoxicillin-clavulanic acid (AMC) treatment on total bacteria and on Bifidobacterium species balance in human colonic microbiota. Eighteen healthy volunteers (19 to 36 years old) were given a 875/125 mg dose of AMC twice a day for 5 days. Fecal samples were obtained before and after antibiotic exposure. After total DNA extraction, total bacteria and bifidobacteria were specifically quantified using real-time PCR. Dominant species were monitored over time using bacterial and bifidobacterial Temporal Temperature Gradient gel Electrophoresis (TTGE). At the end of AMC exposure, total bacterial concentrations as well as bifidobacteria concentrations were significantly reduced compared to before AMC exposure:10.7±0.1 log(10) 16S rRNA gene copies/g vs 11.1±0.1 log(10) (p = 0.003) and 8.1±0.5 log(10) 16S rRNA gene copies/g vs 9.4±0.3 log(10) (p = 0.003), respectively. At the same time, the mean similarity percentages of TTGE bacteria and TTGE bifidobacteria profiles were significantly reduced compared to before AMC exposure: 51.6%±3.5% vs 81.4%±2.1% and 55.8%±7.6% vs 84.5%±4.1%, respectively. Occurrence of B. adolescentis, B. bifidum and B. pseudocatenulatum/B. catenulatum species significantly decreased. Occurrence of B. longum remained stable. Moreover, the number of distinct Bifidobacterium species per sample significantly decreased (1.5±0.3 vs 2.3±0.3; p = 0.01). Two months after AMC exposure, the mean similarity percentage of TTGE profiles was 55.6% for bacteria and 62.3% for bifidobacteria. These results clearly demonstrated that a common antibiotic treatment may qualitatively alter the colonic microbiota. Such modifications may have potential long-term physiological consequences.

  6. Long-term changes in human colonic Bifidobacterium populations induced by a 5-day oral amoxicillin-clavulanic acid treatment.

    Directory of Open Access Journals (Sweden)

    Irène Mangin

    Full Text Available The objective of this study was to assess the possible modifications due to amoxicillin-clavulanic acid (AMC treatment on total bacteria and on Bifidobacterium species balance in human colonic microbiota. Eighteen healthy volunteers (19 to 36 years old were given a 875/125 mg dose of AMC twice a day for 5 days. Fecal samples were obtained before and after antibiotic exposure. After total DNA extraction, total bacteria and bifidobacteria were specifically quantified using real-time PCR. Dominant species were monitored over time using bacterial and bifidobacterial Temporal Temperature Gradient gel Electrophoresis (TTGE. At the end of AMC exposure, total bacterial concentrations as well as bifidobacteria concentrations were significantly reduced compared to before AMC exposure:10.7±0.1 log(10 16S rRNA gene copies/g vs 11.1±0.1 log(10 (p = 0.003 and 8.1±0.5 log(10 16S rRNA gene copies/g vs 9.4±0.3 log(10 (p = 0.003, respectively. At the same time, the mean similarity percentages of TTGE bacteria and TTGE bifidobacteria profiles were significantly reduced compared to before AMC exposure: 51.6%±3.5% vs 81.4%±2.1% and 55.8%±7.6% vs 84.5%±4.1%, respectively. Occurrence of B. adolescentis, B. bifidum and B. pseudocatenulatum/B. catenulatum species significantly decreased. Occurrence of B. longum remained stable. Moreover, the number of distinct Bifidobacterium species per sample significantly decreased (1.5±0.3 vs 2.3±0.3; p = 0.01. Two months after AMC exposure, the mean similarity percentage of TTGE profiles was 55.6% for bacteria and 62.3% for bifidobacteria. These results clearly demonstrated that a common antibiotic treatment may qualitatively alter the colonic microbiota. Such modifications may have potential long-term physiological consequences.

  7. Prophylactic antiobesity effect of bifidobacterium vinegar in rats%双歧醋对大鼠预防性减肥的实验研究

    Institute of Scientific and Technical Information of China (English)

    李金玲; 张德纯; 王春耀; 郭亚楠

    2011-01-01

    目的 探讨双歧醋预防大鼠肥胖的作用及相关机制研究.方法48只SD大鼠被随机分成双歧醋低剂量组[1.8 mL/(kg·BW)]、中剂量组[3.4 mL/(kg·BW)]、高剂量组[6.8 mL/(kg·BW)]和市售醋组[3.4mL/(kg · BW)]、肥胖模型组以及基础对照组,进行预防性减肥实验,观察双歧醋在大鼠肥胖过程中对大鼠的影响,测定指标包括大鼠体重、体脂、Lee's指数、脂肪细胞直径、血瘦素、血胰岛素.结果实验结果显示,双歧醋各组所有测定指标值都较肥胖组有明显好转,特别是血瘦素和血胰岛素水平,双歧醋的高、中剂量组与市售醋组差异有统计学意义.结论双歧醋能有效预防血瘦素和血胰岛素的升高,预防体脂、Lee's指数和体重的增加也有一定作用.%Objective To discuss the prophylactic antiobesity effect of bifidobacterium vinegar and possible mechanism. Method 48 SD rats were randomly divided into 6 groups: bifidobacterium vinegar groups of three different doses, ordinary vineger group, obesity model group and control group. The effect of bifidobacterium vinegar on the rats was observed; indicators including body weight, body fat, adipocyte diameter, Lees index, leptin and insuline were determined. Result All indicator values measured were improved obviously compared with obesity model group. Particularly, the leptin and insuline levels of high and medium dosage bifidobacterium vinegar groups were improved obviously compared with those of ordinary vineger group. Conclusion Bifidobacterium vinegar can prevent the development of high leptin, insulin, and prevent the body weight, Lees index and body fat from increasing to some degree.

  8. 獭兔双歧杆菌的培养特性及抗菌活性研究%Culturing characteristics and antibacterial activity of Rex Rabbit bifidobacterium

    Institute of Scientific and Technical Information of China (English)

    史怀平; 解广勤; 史新娥; 胡沈荣; 卜书海; 郑雪莉

    2011-01-01

    【Objective】 This research studied the physiological characteristics and antimicrobial ability of Rex Rabbit bifidobacterium.【Method】 After Rex Rabbit bifidobacteria were inoculated in indicated medium,the growth characteristics were investigated.And the antimicrobial activity of Rex Rabbit bifidobacterium was detected through co-culturing with E.coli.【Result】 Rex Rabbit bifidobacteria were cladodromous and significantly proliferated in improved broth.It was found through heat-resistant assay that Rex Rabbit bifidobacterium could grow at 42 ℃.Rex Rabbit bifidobacteria were sensitive to many drugs like Erythromycin.After Rex Rabbit bifidobacterium were co-cultured with E.coli,the growth of E.coli was blocked and the metabolites from Rex Rabbit bifidobacterium also had obvious antimicrobial function.【Conclusion】 Rex Rabbit bifidobacteria grew well in vitro and had significant antimicrobial activity.%【目的】研究獭兔双歧杆菌的生理特性及抗菌能力。【方法】将獭兔双歧杆菌接种于特定的培养基后,观察其生长特性,并与大肠埃希菌共培养,研究其抗菌能力。【结果】獭兔双歧杆菌呈分枝状,在改良肉汤培养基中生长旺盛;耐温驯化后发现,獭兔双歧杆菌可在42℃下生长;獭兔双歧杆菌对许多药物如红霉素等敏感;獭兔双歧杆菌与大肠埃希菌共培养可抑制大肠埃希菌生长,其代谢产物也具有明显的抑菌能力。【结论】獭兔双歧杆菌在体外培养良好,具有很好的抗菌活性。

  9. Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus.

    Science.gov (United States)

    Ejtahed, H S; Mohtadi-Nia, J; Homayouni-Rad, A; Niafar, M; Asghari-Jafarabadi, M; Mofid, V; Akbarian-Moghari, A

    2011-07-01

    The purpose of this study was to investigate the effects of probiotic and conventional yogurt on the lipid profile in type 2 diabetic people. In a randomized double-blind controlled trial, 60 people (23 males and 37 females) with type 2 diabetes and low-density lipoprotein cholesterol (LDL-C) greater than 2.6 mmol/L were assigned to 2 groups. Participants consumed daily 300 g of probiotic yogurt containing Lactobacillus acidophilus La5 and Bifidobacterium lactis Bb12 or 300 g of conventional yogurt for 6 wk. Fasting blood samples, anthropometric measurements and 3-d, 24-h dietary recalls were collected at the baseline and at the end of the trial. Probiotic yogurt consumption caused a 4.54% decrease in total cholesterol and a 7.45% decrease in LDL-C compared with the control group. No significant changes from baseline were shown in triglyceride and high-density lipoprotein cholesterol (HDL-C) in the probiotic group. The total cholesterol:HDL-C ratio and LDL-C:HDL-C ratio as atherogenic indices significantly decreased in the probiotic group compared with the control group. Probiotic yogurt improved total cholesterol and LDL-C concentrations in type 2 diabetic people and may contribute to the improvement of cardiovascular disease risk factors.

  10. Application of central composite design to optimize the amount of carbon source and prebiotics for Bifidobacterium bifidum BB01

    Directory of Open Access Journals (Sweden)

    Shu Guowei

    2016-06-01

    Full Text Available The objective of the present study was to obtain the optimum proportion of the carbon source and prebiotics for Bifidobacterium bifidum BB01 by the central composite design (CCD. The effect of carbon source (lactose and two prebiotics (inulin and fructooligosaccharides on the BB01 were observed by measuring the OD600 value, pH value and the viable counts at 18h. The final optimized concentrations of carbon source and prebiotics were: lactose 1.6%, inulin 0.26%, and fructooligosaccharides 0.22%. The result indicates that the growth of B. bifidum BB01 shows an significant increase in the optimized culture medium (p < 0.05, the OD600 value reached 1.434 at 18h, which increased 6.58% compared to the control. And the viable counts of B. bifidum BB01 increased 24.36% and reached (2.17±0.06 ×109cfu/mL. The results show that the optimization of the carbon source and prebiotics using CCD in this study is workable and necessary.

  11. Growth Characteristics Modeling of Mixed Culture of Bifidobacterium bifidum and Lactobacillus acidophilus using Response Surface Methodology and Artificial Neural Network

    Directory of Open Access Journals (Sweden)

    Ganga Sahay Meena

    2014-12-01

    Full Text Available Different culture conditions viz. additional carbon and nitrogen content, inoculum size and age, temperature and pH of the mixed culture of Bifidobacterium bifidum and Lactobacillus acidophilus were optimized using response surface methodology (RSM and artificial neural network (ANN. Kinetic growth models were fitted for the cultivations using a Fractional Factorial (FF design experiments for different variables. This novel concept of combining the optimization and modeling presented different optimal conditions for the mixture of B. bifidum and L. acidophilus growth from their one variable at-a-time (OVAT optimization study. Through these statistical tools, the product yield (cell mass of the mixture of B. bifidum and L. acidophilus was increased. Regression coefficients (R2 of both the statistical tools predicted that ANN was better than RSM and the regression equation was solved with the help of genetic algorithms (GA. The normalized percentage mean squared error obtained from the ANN and RSM models were 0.08 and 0.3%, respectively. The optimum conditions for the maximum biomass yield were at temperature 38°C, pH 6.5, inoculum volume 1.60 mL, inoculum age 30 h, carbon content 42.31% (w/v, and nitrogen content 14.20% (w/v. The results demonstrated a higher prediction accuracy of ANN compared to RSM.

  12. Lyophilised Vegetal BM 297 ATO-Inulin lipid-based synbiotic microparticles containing Bifidobacterium longum LMG 13197: design and characterisation.

    Science.gov (United States)

    Amakiri, A C; Kalombo, L; Thantsha, M S

    2015-01-01

    This study aimed at the manufacturing and characterisation of Vegetal BM 297 ATO-inulin-Bifidobacterium longum LMG 13197 microparticles prepared by freeze drying. Emulsions containing 1%, 1.5%, 2%, 3.5% or 5% w/v inulin were prepared, with or without centrifugation before freeze drying. Morphological properties, particle size distribution, encapsulation efficiency of the microparticles and their ability to preserve viability of the enclosed B. longum LMG 13197 cells were evaluated. The microparticles produced from both formulations without a centrifugation step were irregular, porous with concavities and contained high number of bacterial cells. Formulations with or without inulin had average particle sizes of 33.4-81.0 μm with encapsulation efficiencies of 82% and 88%, respectively. Vegetal-inulin microparticles have the morphology and size that will enable their even distribution in final food products, and hence, they have the potential for use as a functional food additive because they are likely to deliver sufficient numbers of viable bacteria.

  13. Immunomodulation by Bifidobacterium infantis 35624 in the murine lamina propria requires retinoic acid-dependent and independent mechanisms.

    Directory of Open Access Journals (Sweden)

    Patrycja Konieczna

    Full Text Available Appropriate dendritic cell processing of the microbiota promotes intestinal homeostasis and protects against aberrant inflammatory responses. Mucosal CD103(+ dendritic cells are able to produce retinoic acid from retinal, however their role in vivo and how they are influenced by specific microbial species has been poorly described. Bifidobacterium infantis 35624 (B. infantis feeding to mice resulted in increased numbers of CD103(+retinaldehyde dehydrogenase (RALDH(+ dendritic cells within the lamina propria (LP. Foxp3(+ lymphocytes were also increased in the LP, while TH1 and TH17 subsets were decreased. 3,7-dimethyl-2,6-octadienal (citral treatment of mice blocked the increase in CD103(+RALDH(+ dendritic cells and the decrease in TH1 and TH17 lymphocytes, but not the increase in Foxp3(+ lymphocytes. B. infantis reduced the severity of DSS-induced colitis, associated with decreased TH1 and TH17 cells within the LP. Citral treatment confirmed that these effects were RALDH mediated. RALDH(+ dendritic cells decreased within the LP of control inflamed animals, while RALDH(+ dendritic cells numbers were maintained in the LP of B. infantis-fed mice. Thus, CD103(+RALDH(+ LP dendritic cells are important cellular targets for microbiota-associated effects on mucosal immunoregulation.

  14. Modified Vero cell induced by Bifidobacterium bifidum inhibits enterohemorrhagic Escherichia coli O157:H7 cytopathic effect

    Directory of Open Access Journals (Sweden)

    Tahamtan, Y.

    2014-11-01

    Full Text Available Enterohemorrhagic Escherichia coli (EHEC, such as E. coli O157:H7, are emerging food-borne pathogens worldwide. This micro-organism can damage the epithelial tissue of the large intestine. The cytotoxic effects can be neutralized by probiotics such as Bifidobacterium bifidum. Probiotics are viable cells that have beneficial effects on the health of the host. The preventing activity of B. bifidum against E. coli O157 was studied using a Vero cell model. Vero cell was pretreated with viable B. bifidum and incubated for either 3 h to 24 h and then collected from the cell to make modified Vero cell (MVC. Indirect antibacterial effects of B. bifidum were demonstrated by reduction of attachment of E. coli O157:H7 to MVC. The maximum reduction was resulted in pretreatment of Vero cell with B. bifidum for 24 h before infection. B. bifidum attenuated E. coli O157:H7 attachment to MVC up to 10 days of incubation. To our knowledge, MCV prevented Vero cell line injury induced by E. coli O157:H7. Therefore, B. bifidum can be used for inhibition of E. coli O157:H7 cytopathic effect (CPE in Vero cell model, even as pretreatment of the cell line.

  15. A novel gene cluster allows preferential utilization of fucosylated milk oligosaccharides in Bifidobacterium longum subsp. longum SC596

    Science.gov (United States)

    Garrido, Daniel; Ruiz-Moyano, Santiago; Kirmiz, Nina; Davis, Jasmine C.; Totten, Sarah M.; Lemay, Danielle G.; Ugalde, Juan A.; German, J. Bruce; Lebrilla, Carlito B.; Mills, David A.

    2016-01-01

    The infant intestinal microbiota is often colonized by two subspecies of Bifidobacterium longum: subsp. infantis (B. infantis) and subsp. longum (B. longum). Competitive growth of B. infantis in the neonate intestine has been linked to the utilization of human milk oligosaccharides (HMO). However, little is known how B. longum consumes HMO. In this study, infant-borne B. longum strains exhibited varying HMO growth phenotypes. While all strains efficiently utilized lacto-N-tetraose, certain strains additionally metabolized fucosylated HMO. B. longum SC596 grew vigorously on HMO, and glycoprofiling revealed a preference for consumption of fucosylated HMO. Transcriptomes of SC596 during early-stage growth on HMO were more similar to growth on fucosyllactose, transiting later to a pattern similar to growth on neutral HMO. B. longum SC596 contains a novel gene cluster devoted to the utilization of fucosylated HMO, including genes for import of fucosylated molecules, fucose metabolism and two α-fucosidases. This cluster showed a modular induction during early growth on HMO and fucosyllactose. This work clarifies the genomic and physiological variation of infant-borne B. longum to HMO consumption, which resembles B. infantis. The capability to preferentially consume fucosylated HMO suggests a competitive advantage for these unique B. longum strains in the breast-fed infant gut. PMID:27756904

  16. Yoghurt fermented by Lactobacillus delbrueckii subsp. bulgaricus H+ -ATPase-defective mutants exhibits enhanced viability of Bifidobacterium breve during storage.

    Science.gov (United States)

    Ongol, Martin Patrick; Sawatari, Yuki; Ebina, Yoshiko; Sone, Teruo; Tanaka, Michiko; Tomita, Fusao; Yokota, Atsushi; Asano, Kozo

    2007-05-30

    Persistent acid production by Lactobacillus delbrueckii subsp. bulgaricus during refrigerated storage is a major cause of reduced viability of probiotic strains such as Bifidobacterium breve in yoghurt. It was established that H+ -ATPase-defective mutants of lactic acid bacteria have reduced growth and metabolism in low pH environments. Therefore, the aim of this study was to evaluate inhibition of post-acidification and maintenance of B. breve viability in yoghurt fermented by L. delbrueckii subsp. bulgaricus mutants with reduced membrane-bound H+ -ATPase activity during refrigerated storage. Spontaneous neomycin mutants of L. delbrueckii subsp. bulgaricus that had a significantly (P bulgaricus SBT0164 No. 55-1 (mutant) starter culture had markedly reduced post-acidification and maintained viability (> or = 10(8) CFU/ml) of both Bifidobacteruim breve JCM 1192(T) and Bifidobacteruim breve JCM 7017 during storage at 10 degrees C for 21 days. These results clearly showed that yoghurt fermented by mutants of L. delbrueckii subsp. bulgaricus with reduced membrane-bound H+ -ATPase activity has reduced post-acidification that prolongs viability of B. breve in yoghurt during refrigerated storage.

  17. The substitution of a traditional starter culture in mutton fermented sausages by Lactobacillus acidophilus and Bifidobacterium animalis.

    Science.gov (United States)

    Holko, I; Hrabě, J; Šalaková, A; Rada, V

    2013-07-01

    Common starter cultures used in fermented mutton sausages were substituted by probiotic strains of Lactobacillus acidophilus CCDM 476 and Bifidobacterium animalis 241a. Technological properties of the traditional and the probiotic sausages were compared. The potential probiotic effect was evaluated by enumeration of bifidobacteria and lactobacilli in stool samples of 15 volunteers before and after a 14-day consumption period. The numbers of lactobacilli (10(7) cfu/g) and bifidobacteria (10(3) cfu/g) in the final product did not affect the technological properties. The use of L. acidophilus as a starter culture was found more beneficial than the use of B. animalis. Even after 60 days of storage, high counts of L. acidophilus (10(6) cfu/g) were detected; on the other hand, the counts of B. animalis were under the detection limit. Regarding sensory properties, the probiotic products showed better texture, and, curiously, a reduction of the typical smell of mutton. The numbers of lactobacilli in stool samples increased significantly after the consumption of the probiotic sausages.

  18. Effect of alginate and chitosan on viability and release behavior of Bifidobacterium pseudocatenulatum G4 in simulated gastrointestinal fluid.

    Science.gov (United States)

    Kamalian, Nikoo; Mirhosseini, Hamed; Mustafa, Shuhaimi; Manap, Mohd Yazid Abd

    2014-10-13

    The main aim of this study was to investigate the effect of different coating materials (i.e. Na-alginate and chitosan) on the viability and release behavior of Bifidobacterium pseudocatenulatum G4 in the simulated gastric fluid (SGF) and simulated intestinal fluid (SIF). This study reports the viability of encapsulated B. pseudocatenulatum G4 coated using different alginate (2-4 g/100mL) and chitosan (0.2-0.8 g/100mL) concentrations. The results indicated that the highest concentration of alginate (4.4142 g/100mL) along with 0.5578 g/100mL chitosan resulted in the highest viability of B. pseudocatenulatum G4. The release behavior of the encapsulated probiotics in SGF (pH 1.5) in 2h followed by 4h in SIF (pH 7.4) was also assessed. The resistance rate of alginate-chitosan capsule in SGF was higher than SIF. The alginate-chitosan encapsulated cells had also more resistance than alginate capsules. The current study revealed that alginate encapsulated B. Pseudocatenulatum G4 exhibited longer survival than its free cells (control).

  19. Crystal structure of a putative exo-β-1,3-galactanase from Bifidobacterium bifidum S17.

    Science.gov (United States)

    Godoy, Andre S; de Lima, Mariana Z T; Camilo, Cesar M; Polikarpov, Igor

    2016-04-01

    Given the current interest in second-generation biofuels, carbohydrate-active enzymes have become the most important tool to overcome the structural recalcitrance of the plant cell wall. While some glycoside hydrolase families have been exhaustively described, others remain poorly characterized, especially with regard to structural information. The family 43 glycoside hydrolases are a diverse group of inverting enzymes; the available structure information on these enzymes is mainly from xylosidases and arabinofuranosidase. Currently, only one structure of an exo-β-1,3-galactanase is available. Here, the production, crystallization and structure determination of a putative exo-β-1,3-galactanase from Bifidobacterium bifidum S17 (BbGal43A) are described. BbGal43A was successfully produced and showed activity towards synthetic galactosides. BbGal43A was subsequently crystallized and data were collected to 1.4 Å resolution. The structure shows a single-domain molecule, differing from known homologues, and crystal contact analysis predicts the formation of a dimer in solution. Further biochemical studies are necessary to elucidate the differences between BbGal43A and its characterized homologues.

  20. Microencapsulation of Bifidobacterium bifidum F-35 in whey protein-based microcapsules by transglutaminase-induced gelation.

    Science.gov (United States)

    Zou, Qiang; Liu, Xiaoming; Zhao, Jianxin; Tian, Fengwei; Zhang, He-ping; Zhang, Hao; Chen, Wei

    2012-05-01

    Bifidobacterium bifidum F-35 was microencapsulated into whey protein microcapsules (WPMs) by a transglutaminase (TGase)-induced method after optimization of gelation conditions. The performance of these WPMs was compared with that produced by a spray drying method (WPMs-A). WPMs produced by the TGase-induced gelation method (WPMs-B) had larger and denser structures in morphological examinations. Native gel and SDS-PAGE analyses showed that most of the polymerization observed in WPMs-B was due to stable covalent crosslinks catalyzed by TGase. The degradation properties of these WPMs were investigated in simulated gastric juice (SGJ) with or without pepsin. In the presence of pepsin, WPMs-A degraded more quickly than did WPMs-B. Finally, survival rates of the microencapsulated cells in both WPMs were significantly better than that of free cells and varied with the microencapsulation method. However, WPMs-B produced by TGase-induced gelation could provide better protection for microencapsulated cells in low pH conditions and during 1 mo of storage at 4 °C or at ambient temperature.

  1. Oral Feeding of Probiotic Bifidobacterium infantis: Colonic Morphological Changes in Rat Model of TNBS-Induced Colitis

    Directory of Open Access Journals (Sweden)

    Najma H. Javed

    2016-01-01

    Full Text Available Ulcerative colitis (UC is a chronic inflammatory bowel disease of unknown etiology. It has been proposed that modifying the bacterial flora in intestine with probiotics may decrease the inflammatory process and prevent relapses in UC. We investigated the possible protective and therapeutic effects of a single strand of probiotic, Bifidobacterium infantis (BI, on colonic inflammation, in rats with regular feedings. Two groups of Lewis rats were prepared (n=8. The first group was the control, sham-fed group (n=4. The other group was the experimental BI-fed group (n=4. Colitis was induced in both groups by intrarectal administration of TNBS under light anesthesia. The sham-fed colitis induced groups received a daily oral gavage feeding of 1.0 mL distilled water, whereas the B. infantis-fed group received 0.205 g of B. infantis dissolved in 1.0 mL distilled water daily. The change in body weight and food and water intake was recorded over the course of each study and analyzed. The rats were euthanized and tissues from the descending colon were harvested and analyzed microscopically and histologically. Results of our study indicated significant reduction in inflammation, mucosal damage, and preservation of goblet cells, as compared to the control animals. Modulation of gastrointestinal (GI flora suggests a promising field in developing strategies for prevention and treatment of inflammatory bowel diseases by dietary modifications.

  2. Bifidobacterium adolescentis Exerts Strain-Specific Effects on Constipation Induced by Loperamide in BALB/c Mice

    Science.gov (United States)

    Wang, Linlin; Hu, Lujun; Xu, Qi; Yin, Boxing; Fang, Dongsheng; Wang, Gang; Zhao, Jianxin; Zhang, Hao; Chen, Wei

    2017-01-01

    Constipation is one of the most common gastrointestinal complaints worldwide. This study was performed to determine whether Bifidobacterium adolescentis exerts inter-strain differences in alleviating constipation induced by loperamide in BALB/c mice and to analyze the main reasons for these differences. BALB/c mice underwent gavage with B. adolescentis (CCFM 626, 667, and 669) once per day for 17 days. The primary outcome measures included related constipation indicators, and the secondary outcome measures were the basic biological characteristics of the strains, the concentration changes of short-chain fatty acids in feces, and the changes in the fecal flora. B. adolescentis CCFM 669 and 667 relieved constipation symptoms by adhering to intestinal epithelial cells, growing quickly in vitro and increasing the concentrations of propionic and butyric acids. The effect of B. adolescentis on the gut microbiota in mice with constipation was investigated via 16S rRNA metagenomic analysis. The results revealed that the relative abundance of Lactobacillus increased and the amount of Clostridium decreased in the B. adolescentis CCFM 669 and 667 treatment groups. In conclusion, B. adolescentis exhibits strain-specific effects in the alleviation of constipation, mostly due to the strains’ growth rates, adhesive capacity and effects on the gut microbiome and microenvironment. PMID:28230723

  3. Bifidobacterium adolescentis Exerts Strain-Specific Effects on Constipation Induced by Loperamide in BALB/c Mice

    Directory of Open Access Journals (Sweden)

    Linlin Wang

    2017-02-01

    Full Text Available Constipation is one of the most common gastrointestinal complaints worldwide. This study was performed to determine whether Bifidobacterium adolescentis exerts inter-strain differences in alleviating constipation induced by loperamide in BALB/c mice and to analyze the main reasons for these differences. BALB/c mice underwent gavage with B. adolescentis (CCFM 626, 667, and 669 once per day for 17 days. The primary outcome measures included related constipation indicators, and the secondary outcome measures were the basic biological characteristics of the strains, the concentration changes of short-chain fatty acids in feces, and the changes in the fecal flora. B. adolescentis CCFM 669 and 667 relieved constipation symptoms by adhering to intestinal epithelial cells, growing quickly in vitro and increasing the concentrations of propionic and butyric acids. The effect of B. adolescentis on the gut microbiota in mice with constipation was investigated via 16S rRNA metagenomic analysis. The results revealed that the relative abundance of Lactobacillus increased and the amount of Clostridium decreased in the B. adolescentis CCFM 669 and 667 treatment groups. In conclusion, B. adolescentis exhibits strain-specific effects in the alleviation of constipation, mostly due to the strains’ growth rates, adhesive capacity and effects on the gut microbiome and microenvironment.

  4. The combination of Bifidobacterium breve with non-digestible oligosaccharides suppresses airway inflammation in a murine model for chronic asthma.

    Science.gov (United States)

    Sagar, Seil; Vos, Arjan P; Morgan, Mary E; Garssen, Johan; Georgiou, Niki A; Boon, Louis; Kraneveld, Aletta D; Folkerts, Gert

    2014-04-01

    Over the last decade, there has been a growing interest in the use of interventions that target the intestinal microbiota as a treatment approach for asthma. This study is aimed at exploring the therapeutic effects of long-term treatment with a combination of Bifidobacterium breve with non-digestible oligosaccharides on airway inflammation and remodeling. A murine ovalbumin-induced chronic asthma model was used. Pulmonary airway inflammation; mRNA expression of pattern recognition receptors, Th-specific cytokines and transcription factors in lung tissue; expression of Foxp3 in blood Th cells; in vitro T cell activation; mast cell degranulation; and airway remodeling were examined. The combination of B. breve with non-digestible oligosaccharides suppressed pulmonary airway inflammation; reduced T cell activation and mast cell degranulation; modulated expression of pattern recognition receptors, cytokines and transcription factors; and reduced airway remodeling. The treatment induced regulatory T cell responses, as shown by increased Il10 and Foxp3 transcription in lung tissue, and augmented Foxp3 protein expression in blood CD4+CD25+Foxp3+ T cells. This specific combination of beneficial bacteria with non-digestible oligosaccharides has strong anti-inflammatory properties, possibly via the induction of a regulatory T cell response, resulting in reduced airway remodeling and, therefore, may be beneficial in the treatment of chronic inflammation in allergic asthma.

  5. Inhibition of Bifidobacterium Cell Wall 51.74 kDa Adhesin Isolated from Infants Feces Towards Adhesion of Enteric Phatogen E. coli on Enterocyte Balb/C Mice

    Directory of Open Access Journals (Sweden)

    I Sukrama

    2012-01-01

    Full Text Available Objectives: To determine 51.74 kDa adhesin of Bifidobacterium sp cell wall isolated from infants feces as an anti adhesion of E. coli on enterocyte mice. Methods: Randomized Posttest-Only Control Group Design was employed to investigate adherence ability of this adhesin towards E.coli adhesion on mice entherocyte. Results: In this research, it was obtained, that the 51.74 kDa adhesin cell wall of Bifidobacterium sp has an ability to inhibit adhesion of E. coli on mice enterocyte. The ability was increased as an increase of adhsein concentration. Conclusions: that can be drawn from this research is the finding of 51.74 kDa adhesin cell wall of Bifidobacterium sp isolated from infants feces that can inhibit adhseion of E. coli on mice enterocyte. Future work that can be carried out are further researches concerning whether these protein can be applied to inhibit adherence of other pathogen bacteria

  6. Cloning, Expression and Function Analysis of Serpin Gene in Bifidobacterium bifidum%两歧双歧杆菌中serpin基因的克隆、表达与功能分析

    Institute of Scientific and Technical Information of China (English)

    叶若松; 黎鹏; 章昭琳; 万翠香; 崔佳; 魏华

    2011-01-01

    The Serpin gene has been cloned from the genomic DNA of Bifidobacterium bifidum WBBI02. A recombinant Serpin expression system in prokaryotic cells, namely, pBX2- WBBI02 was constructed, and the Serpin protein was successfully expressed and purified. An in vitro inhibition test of Serpin against intestinal proteinase and the effect of Serpin on the adherence of Bifidobacterium longum were approached. The results showed that the serpin gene of Bifidobacterium bifidum WBBI02 is 768 bp , whose similarity is 99. 9% with that of Bifidobacterium longum NCC2705. The purified Serpin was efficient to inhibit the activities of eukaryotic α-chymotrypsin and pancreatic elastase by maximum 90% and 97% , respectively, microscopical observation proved that Serpin enhanced the adherence of Bifidobacteria to HT-29 cells.%从Bifidobacterium bifidum WBB102基因组中克隆了serpin基因片段,构建了重组Serpin蛋白的原核表达体系,实现了Serpin的表达与纯化.纯化的Serpin蛋白进行了抑制肠道蛋白酶活性检测,以及对双歧杆菌粘附作用影响的显微观察研究.结果表明:WBB102中长度为768 bp的serpin基因序列,与GENEBANK中Bifidobacterium longum NCC2705 serpin序列同源性为99.9%.原核表达载体pBX2-WBB102表达的Serpin能有效地抑制糜蛋白酶和胰弹性蛋白酶的活性,最高抑制率分别为90%和97%,显微观察结果证实Serpin能促进双歧杆菌对HT-29细胞的粘附.

  7. Effect of a mixture of inulin and fructo-oligosaccharide on lactobacillus and bifidobacterium intestinal microbiota of patients receiving radiotherapy: a randomised, double-blind, placebo-controlled trial Efecto de una mezcla de inulina y fructo-oligosacárido sobre la microflora intestinal de lactobacillus y bifidobacterium de pacientes que reciben radioterapia: un ensayo aleatorio, a doble ciego y controlado con placebo

    Directory of Open Access Journals (Sweden)

    P. García-Peris

    2012-12-01

    Full Text Available Background & aims: The pathogenesis of enteritis after abdominal radiotherapy is unknown, although changes in faecal microbiota may be involved. In several studies, Lactobacillus and Bifidobacterium have proven beneficial for the host. Prebiotics stimulate the proliferation of Lactobacillus and Bifidobacterium, and this may have positive effects on the intestinal mucosa during abdominal radiotherapy. Methods: We performed a randomised double-blind, placebo-controlled trial including 31 patients with gynaecological cancer who received radiotherapy (29 sessions, 52.2 Gy after surgery. Patients were randomised to two groups: prebiotic and placebo. The first group received a mixture of fibre (50% inulin and 50% fructo-oligosaccharide and the second received 6 g of maltodextrin twice daily from one week before to three weeks after radiotherapy. Lactobacillus and Bifidobacterium counts were determined in faeces samples (day -7 before radiotherapy, day 15 of radiotherapy, at the end of treatment, and three weeks after radiotherapy by culture in selective media and fluorescent in situ hybridization (FISH using genus-specific probes. Bacterial counts by FISH were significantly higher than by culture method. Results: There were no differences in baseline microbiota between groups. At the end of radiotherapy, we observed a statistically significant decrease in Lactobacillus and Bifidobacterium counts in both groups. By cultural analysis, we observed higher numbers of Lactobacillus and Bifidobacterium three weeks after radiotherapy in the prebiotic group (5.6 vs. 6.3, p = 0.04 and 5.5 vs. 6 log cfu/g, p = 0.03. Conclusions: Abdominal radiotherapy negatively affects Lactobacillus and Bifidobacterium counts. The prebiotic mixture of inulin and fructoligosaccharide can improve the recovery of both genera after radiotherapy. Registered under ClinicalTrials.gov Identifier no. NCT01549782Antecedentes y objetivos: Se desconoce la patogenia de la enteritis tras la

  8. Selective and differential enumerations of Lactobacillus delbrueckii subsp. bulgaricus, Streptococcus thermophilus, Lactobacillus acidophilus, Lactobacillus casei and Bifidobacterium spp. in yoghurt--a review.

    Science.gov (United States)

    Ashraf, Rabia; Shah, Nagendra P

    2011-10-03

    Yoghurt is increasingly being used as a carrier of probiotic bacteria for their potential health benefits. To meet with a recommended level of ≥10(6) viable cells/g of a product, assessment of viability of probiotic bacteria in market preparations is crucial. This requires a working method for selective enumeration of these probiotic bacteria and lactic acid bacteria in yoghurt such as Streptococcus thermophilus, Lactobacillus delbrueckii subsp. bulgaricus, Lb. acidophilus, Lb. casei and Bifidobacterium. This chapter presents an overview of media that could be used for differential and selective enumerations of yoghurt bacteria. De Man Rogosa Sharpe agar containing fructose (MRSF), MRS agar pH 5.2 (MRS 5.2), reinforced clostridial prussian blue agar at pH 5.0 (RCPB 5.0) or reinforced clostridial agar at pH 5.3 (RCA 5.3) are suitable for enumeration of Lb. delbrueckii subsp. bulgaricus when the incubation is carried out at 45°C for 72h. S. thermophilus (ST) agar and M17 are recommended for selective enumeration of S. thermophilus. Selective enumeration of Lb. acidophilus in mixed culture could be made in Rogosa agar added with 5-bromo-4-chloro-3-indolyl-β-d-glucopyranoside (X-Glu) or MRS containing maltose (MRSM) and incubation in a 20% CO2 atmosphere. Lb. casei could be selectively enumerated on specially formulated Lb. casei (LC) agar from products containing yoghurt starter bacteria (S. thermophilus and Lb. delbrueckii subsp. bulgaricus), Lb. acidophilus, Bifidobacterium spp. and Lb. casei. Bifidobacterium could be enumerated on MRS agar supplemented with nalidixic acid, paromomycin, neomycin sulphate and lithium chloride (MRS-NPNL) under anaerobic incubation at 37°C for 72h.

  9. Fermentation of Soymilk and Orange Juice by Bifidobacterium bifidum%两歧双歧杆菌发酵橙汁酸豆奶的研究

    Institute of Scientific and Technical Information of China (English)

    杜林; 曾娜; 黄小丹

    2011-01-01

    In this paper, the growth of Bifidobacterium bifidum was studied in soy milk, with which a fermentation product was achieved with good flavor. Soy milk was produced via Bifidobacterium bifidum catalyzed fermentation of the mixture of soybean and orange juice with the soybean-water ratio of 1:8. Then orthogonal test was used to optimize the fermentation process and the result showed that the best culture temperature, inoculum amount, dosage of orange juice and cultivation time were 39℃, 5%, 10% and 18 hours, under which the number of Bifidobacterium bifidum can reach 7.9 × 108 CFU / mL. The fermented soymilk product was in rich of flavor and aroma of orange juice.%本文尝试研究豆奶中两歧双歧杆菌的生长情况,以得到风味良好的发酵产品.以大豆与水1∶8的比例制取豆奶,添加一定量的橙汁,并加入两歧双歧杆菌进行发酵.考察了培养温度、橙汁添加量、接种量等因素对产品pH值和活菌教的影响,并在此基础上进行正交试验优化.正交试验结果表明,培养温度为39℃、接种量为5%、橙汁添加量为10%,18 h培养后可使豆奶中的两歧双歧杆菌活菌数达到7.9× 108 CFU/mL.产品具有浓郁豆奶发酵风味和橙汁香味.

  10. Influence of live combined bifidobacterium, lactobacillus and enterococcus capsules inflammation factors and intestinal mucosal barrier function of severe acute pancreatitis patients

    Institute of Scientific and Technical Information of China (English)

    Ping-Ping Shi; Ling-Yun Wu; Jian-Jun Wang

    2015-01-01

    Objective:To explore the influence of inflammation factors and intestinal mucosal barrier function on severe acute pancreatitis patients treated with bifidobacterium triple viable capsules.Methods:88 cases severe acute pancreatitis patients were divided into observation group and control group according to admission order, 44 cases in each group, all patients were given conventional treatment, on this base, patients in observation group were treated by oral bifidobacterium triple viable capsules, they were treated for one week, detected the serum inflammatory factors: the tumor necrosis factor alpha (TNF-α), interleukin 6 (IL-6) and C-reactive protein (CRP) and intestinal mucosal barrier function index: endotoxin, diamine oxidase (DAO), D-lactic acid, urinary lactulose/mannitol (L/M) in the two groups before and after treatment.Results:The levels of TNF-α, IL-6 and CRP in two groups after treatment were significantly reduced than before treatment, and after treatment the levels of TNF-α, IL-6 and CRP in observation group was significantly lower than that of the control group, all the difference was statistically significant; The levels of endotoxin, DA, D-lactic acid, L/M in two groups after treatment were significantly reduced than before treatment, and the levels of endotoxin, DA, D-lactic acid,L/M after treatment in observation group was significantly lower than that of the control group, the difference was statistically significant.Conclusion: Based on conventional treatment combined bifidobacterium triple viable capsules can significantly reduce inflammation in patients with severe acute pancreatitis, it can protect the intestinal mucosal barrier function, and has important clinical significance.

  11. 香猪源性双歧杆菌的筛选及鉴定%Isolation and Identification of Bifidobacterium from Guizhou Xiang Pigs Feces

    Institute of Scientific and Technical Information of China (English)

    吕锡斌; 何腊平; 张汝娇; 张玲; 李翠芹

    2013-01-01

    为丰富双歧杆菌(Bifidobacterium,BF)菌种资源,对双歧杆菌保健产品的开发奠定基础,选择贵州省特色资源香猪的粪便进行了双歧杆菌的筛选及鉴定试验。结果表明:从1~6月龄香猪粪便中共分离50个菌株(BF1~BF50),其中,8株(BF15,BF21,BF23,BF28,BF33,BF34,BF37,BF42)为长双歧杆菌,其他42株为猪双歧杆菌。香猪源性双歧杆菌主要形态为表面光滑、菌落微小,乳白色凸起状,边缘整齐且为半透明或不透明状,有V形、L形(较多)、Y形(较少见)。%In order to enrich the resource of Bifidobacterium and lay the foundation for health care products of Bifidobacterium,Bifidobacterium was isolated and screened from the feces of the healthy Guizhou Xiang pigs which were the featured resource of Guizhou .The results showed that fifty strains were isolated from 1 to 6-month-old Guizhou Xiang pigs,42 strains were B.suis,and eight of them were B.longum.Their morphology were mainly as follows,such as smooth surface,tiny colonies,white convex,neat edge and translucent or opaque shape,with V-shaped,L-shaped ,Y-shaped.

  12. In Vitro Fermentation of Sugar Beet Arabino-Oligosaccharides by Fecal Microbiota Obtained from Patients with Ulcerative Colitis To Selectively Stimulate the Growth of Bifidobacterium spp. and Lactobacillus spp

    DEFF Research Database (Denmark)

    Vigsnæs, Louise Kristine; Holck, Jesper; Meyer, Anne S.

    2011-01-01

    analysis. With a few minor exceptions, AOS affected the communities similarly to what was seen for FOS. Quantitative real-time PCR revealed that Bifidobacterium spp. and Lactobacillus spp. were selectively increased after fermentation of AOS or FOS by fecal microbiota derived from UC patients....... The stimulation of growth of Lactobacillus spp. and Bifidobacterium spp. was accompanied by a high production of acetate and hence a decrease of pH. The fermentation of AOS may help improve the inflammatory conditions in UC patients through stimulation of bacteria eliciting anti-inflammatory responses and through...

  13. In vitro fermentation of sugar beet arabino-oligosaccharides by fecal microbiota obtained from patients with ulcerative colitis to selectively stimulate the growth of Bifidobacterium spp. and Lactobacillus spp

    DEFF Research Database (Denmark)

    Vigsnæs, Louise Kristine; Holck, Jesper; Meyer, Anne S.

    were monitored after 24 h by quantitative real-time PCR and short-chain fatty acid analysis. With a few minor exceptions, AOS affected the communities similarly to what was seen for FOS. Quantitative real-time PCR revealed that Bifidobacterium spp. and Lactobacillus spp. were selectively increased...... after fermentation of AOS or FOS by fecal microbiota derived from UC patients. The stimulation of growth of Lactobacillus spp. and Bifidobacterium spp. was accompanied by a high production of acetate and hence a decrease of pH. The fermentation of AOS may thus help improve the inflammatory conditions...

  14. The GH5 1,4-β-mannanase from Bifidobacterium animalis subsp. lactis Bl-04 possesses a low-affinity mannan-binding module and highlights the diversity of mannanolytic enzymes

    DEFF Research Database (Denmark)

    Morrill, Johan; Kulcinskaja, Evelina; Sulewska, Anna Maria

    2015-01-01

    β-Mannans are abundant and diverse plant structural and storage polysaccharides. Certain human gut microbiota members including health-promoting Bifidobacterium spp. catabolize dietary mannans. Little insight is available on the enzymology of mannan deconstruction in the gut ecological niche. Here......, we report the biochemical properties of the first family 5 subfamily 8 glycoside hydrolase (GH5_8) mannanase from the probiotic bacterium Bifidobacterium animalis subsp. lactis Bl-04 (BlMan5_8). BlMan5_8 possesses a novel low affinity carbohydrate binding module (CBM) specific for soluble mannan...

  15. The GH5 1,4-β-mannanase from Bifidobacterium animalis subsp. lactis Bl-04 possesses a low-affinity mannan-binding module and highlights the diversity of mannanolytic enzymes

    DEFF Research Database (Denmark)

    Morrill, Johan; Kulcinskaja, Evelina; Sulewska, Anna Maria;

    2015-01-01

    β-Mannans are abundant and diverse plant structural and storage polysaccharides. Certain human gut microbiota members including health-promoting Bifidobacterium spp. catabolize dietary mannans. Little insight is available on the enzymology of mannan deconstruction in the gut ecological niche. Here......, we report the biochemical properties of the first family 5 subfamily 8 glycoside hydrolase (GH5_8) mannanase from the probiotic bacterium Bifidobacterium animalis subsp. lactis Bl-04 (BlMan5_8). BlMan5_8 possesses a novel low affinity carbohydrate binding module (CBM) specific for soluble mannan...

  16. Preservation of functionality of Bifidobacterium animalis subsp. lactis INL1 after incorporation of freeze-dried cells into different food matrices.

    Science.gov (United States)

    Vinderola, G; Zacarías, M F; Bockelmann, W; Neve, H; Reinheimer, J; Heller, K J

    2012-05-01

    The aim of this work was to investigate how production and freeze-drying conditions of Bifidobacterium animalis subsp. lactis INL1, a probiotic strain isolated from breast milk, affected its survival and resistance to simulated gastric digestion during storage in food matrices. The determination of the resistance of bifidobacteria to simulated gastric digestion was useful for unveiling differences in cell sensitivity to varying conditions during biomass production, freeze-drying and incorporation of the strain into food products. These findings show that bifidobacteria can become sensitive to technological variables (biomass production, freeze-drying and the food matrix) without this fact being evidenced by plate counts.

  17. Genome Structure of the Symbiont Bifidobacterium pseudocatenulatum CECT 7765 and Gene Expression Profiling in Response to Lactulose-Derived Oligosaccharides

    Science.gov (United States)

    Benítez-Páez, Alfonso; Moreno, F. Javier; Sanz, María L.; Sanz, Yolanda

    2016-01-01

    Bifidobacterium pseudocatenulatum CECT 7765 was isolated from stools of a breast-fed infant. Although, this strain is generally considered an adult-type bifidobacterial species, it has also been shown to have pre-clinical efficacy in obesity models. In order to understand the molecular basis of its adaptation to complex carbohydrates and improve its potential functionality, we have analyzed its genome and transcriptome, as well as its metabolic output when growing in galacto-oligosaccharides derived from lactulose (GOS-Lu) as carbon source. B. pseudocatenulatum CECT 7765 shows strain-specific genome regions, including a great diversity of sugar metabolic-related genes. A preliminary and exploratory transcriptome analysis suggests candidate over-expression of several genes coding for sugar transporters and permeases; furthermore, five out of seven beta-galactosidases identified in the genome could be activated in response to GOS-Lu exposure. Here, we also propose that a specific gene cluster is involved in controlling the import and hydrolysis of certain di- and tri-saccharides, which seemed to be those primarily taken-up by the bifidobacterial strain. This was discerned from mass spectrometry-based quantification of different saccharide fractions of culture supernatants. Our results confirm that the expression of genes involved in sugar transport and metabolism and in the synthesis of leucine, an amino acid with a key role in glucose and energy homeostasis, was up-regulated by GOS-Lu. This was done using qPCR in addition to the exploratory information derived from the single-replicated RNAseq approach, together with the functional annotation of genes predicted to be encoded in the B. pseudocatenulatum CETC 7765 genome. PMID:27199952

  18. The effect of co-administration of lactobacillus probiotics and bifidobacterium on spatial memory and learning in diabetic rats

    Directory of Open Access Journals (Sweden)

    H Alaei

    2012-12-01

    Full Text Available Background: Diabetes mellitus affects numerous intracellular metabolic processes, which are reflected by changes in the concentration of some plasma constituents. Particularly, the disease may indirectly undermine some functions of the nervous system including learning and memory through altering oxidative stress status. On the other hand, probiotics can enhance the antioxidant capacity. This study was designed to evaluate the effects of probiotics on spatial memory, maze learning and indices of oxidative stress in diabetic rats.Methods: In this experimental study, 40 male Wistar rats were randomly allocated to 4 groups (n=10 for each: Control (CO, Control probiotic (CP, Control diabetic (DC, and Diabetic probiotic (DP. The probiotic supplement, including Lactobacillus acidophilus, Lactobacillus fermentum, Bifidobacterium lactis (334 mg of each with a CFU of ~1010, was administered through drinking water every 12 hours for 8 weeks. Using morris water maze (MWM, spatial learning and memory were evaluated. Serum insulin and oxidative stress indices, including superoxide dismutase (SOD and 8-hydroxy-2'-deoxyguanosine (8-OHdG, were measured by standard laboratory kits.Results: Oral administration of probiotics improved impairment of spatial learning (P=0.008 and consolidated memory (P=0.01 in the rats. Moreover, probiotic treatment increased serum insulin (P<0.0001 and serum superoxide dismutase activity (P=0.007 while it decreased their blood glucose (P=0.006 and 8-OHdG (P<0.0001.Conclusion: Probiotic supplementation reversed the serum concentrations of insulin and glucose along with an increase in antioxidant capacity in diabetic rats. It also improved spatial learning and memory in the animals. Relevancy of the metabolic changes and behavioral functions need to be further studied.

  19. Structural Basis on the Catalytic Reaction Mechanism of Novel 1,2-Alpha L-Fucosidase (AFCA) From Bifidobacterium Bifidum

    Energy Technology Data Exchange (ETDEWEB)

    Nagae, M.; Tsuchiya, A.; Katayama, T.; Yamamoto, K.; Wakatsuki, S.; Kato, R.

    2009-06-03

    1,2-alpha-L-fucosidase (AfcA), which hydrolyzes the glycosidic linkage of Fucalpha1-2Gal via an inverting mechanism, was recently isolated from Bifidobacterium bifidum and classified as the first member of the novel glycoside hydrolase family 95. To better understand the molecular mechanism of this enzyme, we determined the x-ray crystal structures of the AfcA catalytic (Fuc) domain in unliganded and complexed forms with deoxyfuconojirimycin (inhibitor), 2'-fucosyllactose (substrate), and L-fucose and lactose (products) at 1.12-2.10 A resolution. The AfcA Fuc domain is composed of four regions, an N-terminal beta region, a helical linker, an (alpha/alpha)6 helical barrel domain, and a C-terminal beta region, and this arrangement is similar to bacterial phosphorylases. In the complex structures, the ligands were buried in the central cavity of the helical barrel domain. Structural analyses in combination with mutational experiments revealed that the highly conserved Glu566 probably acts as a general acid catalyst. However, no carboxylic acid residue is found at the appropriate position for a general base catalyst. Instead, a water molecule stabilized by Asn423 in the substrate-bound complex is suitably located to perform a nucleophilic attack on the C1 atom of L-fucose moiety in 2'-fucosyllactose, and its location is nearly identical near the O1 atom of beta-L-fucose in the products-bound complex. Based on these data, we propose and discuss a novel catalytic reaction mechanism of AfcA.

  20. Genome Structure of the Symbiont Bifidobacterium pseudocatenulatum CECT 7765 and Gene Expression Profiling in Response to Lactulose-Derived Oligosaccharides

    Directory of Open Access Journals (Sweden)

    Alfonso eBenítez-Páez

    2016-04-01

    Full Text Available Bifidobacterium pseudocatenulatum CECT 7765 was isolated from stools of a breast-fed infant. Although this strain is generally considered an adult-type bifidobacterial species, it has also been shown to have pre-clinical efficacy in obesity models. In order to understand the molecular basis of its adaptation to complex carbohydrates and improve its potential functionality, we have analyzed its genome and transcriptome, as well as its metabolic output when growing in galacto-oligosaccharides derived from lactulose (GOS-Lu as carbon source. B. pseudocatenulatum CECT 7765 shows strain-specific genome regions, including a great diversity of sugar metabolic-related genes. A preliminary and exploratory transcriptome analysis suggests candidate over-expression of several genes coding for sugar transporters and permeases; furthermore, five out of seven beta-galactosidases identified in the genome could be activated in response to GOS-Lu exposure. Here, we also propose that a specific gene cluster is involved in controlling the import and hydrolysis of certain di- and tri-saccharides, which seemed to be those primarily taken-up by the bifidobacterial strain. This was discerned from mass spectrometry-based quantification of different saccharide fractions of culture supernatants. Our results confirm that the expression of genes involved in sugar transport and metabolism and in the synthesis of leucine, an amino acid with a key role in glucose and energy homeostasis, was up-regulated by GOS-Lu. This was done using qPCR in addition to the exploratory information derived from the single-replicated RNAseq approach, together with the functional annotation of genes predicted to be encoded in the B. pseudocatenulatum CETC 7765 genome.

  1. Functional analysis of bifidobacterial promoters in Bifidobacterium longum and Escherichia coli using the α-galactosidase gene as a reporter.

    Science.gov (United States)

    Sakanaka, Mikiyasu; Tamai, Saki; Hirayama, Yosuke; Onodera, Ai; Koguchi, Hiroka; Kano, Yasunobu; Yokota, Atsushi; Fukiya, Satoru

    2014-11-01

    Heterologous gene expression in bifidobacteria requires weak, strong, and inducible promoters depending on the objectives of different expression studies. Weak promoters in Escherichia coli can also be desirable for stable heterologous gene cloning. Here, we developed a reporter system using the Bifidobacterium longum α-galactosidase gene and investigated the activity and inducibility of seven bifidobacterial promoters in B. longum and their activities in E. coli. These studies revealed diverse promoter activities. Three promoters were highly active in B. longum, but only slightly active in E. coli. Among these, two phosphoketolase gene (xfp) promoters exhibited strong activity in B. longum cells grown on glucose. In contrast, the promoter activity of the fructose transporter operon (fruEKFG) was strongly induced by carbohydrates other than glucose, including fructose, xylose, and ribose. These promoters will allow strong or highly inducible expression in bifidobacteria and stable gene cloning in E. coli. In contrast to the functions of these promoters, the promoter of sucrose-utilization operon cscBA showed very high activity in E. coli but low activity in B. longum. Other three promoters were functional in both B. longum and E. coli. In particular, two sucrose phosphorylase gene (scrP) promoters showed inducible activity by sucrose and raffinose in B. longum, indicating their applicability for regulated expression studies. The diverse promoter functions revealed in this study will contribute to enabling the regulated expression of heterologous genes in bifidobacteria research.

  2. Mortality and translocation assay to study the protective capacity of Bifidobacterium lactis INL1 against Salmonella Typhimurium infection in mice.

    Science.gov (United States)

    Zacarías, M F; Reinheimer, J; Forzani, L; Grangette, C; Vinderola, G

    2014-12-01

    The mouse has been largely used for the study of the protective capacity of probiotics against intestinal infections caused by Salmonella. In this work we aimed at comparing the mortality and translocation assay for the study of the protective capacity of the human breast milk-derived strain Bifidobacterium animalis subsp. lactis INL1 on a model of gut infection by Salmonella enterica subsp. enterica serovar Typhimurium. Different doses of S. Typhimurium FUNED and B. animalis subsp. lactis INL 1 were administered to Balb/c mice in a mortality or a translocation assay. The survival of the control group in the mortality assay resulted to be variable along experiments, and then we preferred to use a translocation assay where the preventive administration of 109 cfu of bifidobacteria/mouse for 10 consecutive days significantly reduced the number of infected animals and the levels of translocation to liver and spleen, with enhanced secretory immunoglobulin A and interleukin 10 production in the small and large intestine, respectively. Ten days of B. animalis subsp. lactis strain INL1 administration to mice significantly reduced both the incidence and the severity of Salmonella infection in a mouse model of translocation. This work provided the first evidence that a translocation assay, compared to a mortality assay, could be more useful to study the protective capacity of probiotics against Salmonella infection, as more information can be obtained from mice and less suffering is conferred to animals due to the fact that the mortality assay is shorter than the latter. These facts are in line with the guidelines of animal research recently established by the National Centre for the Replacement, Refinement & Reduction of Animals in Research.

  3. Promotility Action of the Probiotic Bifidobacterium lactis HN019 Extract Compared with Prucalopride in Isolated Rat Large Intestine

    Science.gov (United States)

    Dalziel, Julie E.; Anderson, Rachel C.; Peters, Jason S.; Lynch, Amy T.; Spencer, Nick J.; Dekker, James; Roy, Nicole C.

    2017-01-01

    Attention is increasingly being focussed on probiotics as potential agents to restore or improve gastrointestinal (GI) transit. Determining mechanism of action would support robust health claims. The probiotic bacterium Bifidobacterium lactis HN019 reduces transit time, but its mechanisms of action and effects on motility patterns are poorly understood. The aim of this study was to investigate changes in GI motility induced by an extract of HN019 on distinct patterns of colonic motility in isolated rat large intestine, compared with a known promotility modulator, prucalopride. The large intestines from male Sprague Dawley rats (3–6 months) were perfused with Kreb's buffer at 37°C in an oxygenated tissue bath. Isometric force transducers recorded changes in circular muscle activity at four independent locations assessing contractile propagation between the proximal colon and the rectum. HN019 extract was perfused through the tissue bath and differences in tension and frequency quantified relative to pre-treatment controls. Prucalopride (1 μM) increased the frequency of propagating contractions (by 75 ± 26%) in the majority of preparations studied (10/12), concurrently decreasing the frequency of non-propagating contractions (by 50 ± 11%). HN019 extract had no effect on contractile activity during exposure (n = 8). However, following wash out, contraction amplitude of propagating contractions increased (by 55 ± 18%) in the distal colon, while the frequency of non-propagating proximal contractions decreased by 57 ± 7%. The prokinetic action of prucalopride increased the frequency of synchronous contractions along the length of colon, likely explaining increased colonic rate of transit in vivo. HN019 extract modified motility patterns in a different manner by promoting propagating contractile amplitude and inhibiting non-propagations, also demonstrating prokinetic activity consistent with the reduction of constipation by B. lactis HN019 in humans. PMID:28184185

  4. Effect of yoghurt containing Bifidobacterium lactis Bb12® on faecal excretion of secretory immunoglobulin A and human beta-defensin 2 in healthy adult volunteers

    Directory of Open Access Journals (Sweden)

    Kabeerdoss Jayakanthan

    2011-12-01

    Full Text Available Abstract Background Probiotics are used to provide health benefits. The present study tested the effect of a probiotic yoghurt on faecal output of beta-defensin and immunoglobulin A in a group of young healthy women eating a defined diet. Findings 26 women aged 18-21 (median 19 years residing in a hostel were given 200 ml normal yoghurt every day for a week, followed by probiotic yoghurt containing Bifidobacterium lactis Bb12® (109 in 200 ml for three weeks, followed again by normal yoghurt for four weeks. Stool samples were collected at 0, 4 and 8 weeks and assayed for immunoglobulin A and human beta-defensin-2 by ELISA. All participants tolerated both normal and probiotic yoghurt well. Human beta-defensin-2 levels in faeces were not altered during the course of the study. On the other hand, compared to the basal sample, faecal IgA increased during probiotic feeding (P = 0.0184 and returned to normal after cessation of probiotic yoghurt intake. Conclusions Bifidobacterium lactis Bb12® increased secretory IgA output in faeces. This property may explain the ability of probiotics to prevent gastrointestinal and lower respiratory tract infections.

  5. Comparative study on biochemical activity of the intestinal isolates Lactobacillus sp. V3 and Bifidobacterium sp. A71 in different substrates

    Directory of Open Access Journals (Sweden)

    JOSIP BARAS

    2001-09-01

    Full Text Available The two intestinal isolates Lactobacillus sp. V3 and Bifidobacterium sp. A71 were selected for soymilk fermentation according to their acidification activity in soymilk. Beetroot juice and carrot juice were chosen for soymilk supplementation as additional sources of carbohydrates and brewer's yeast as an extra source of nitrogen. The fermentation was carried out for eight hours at 42°C. The fermentation was monitored by standard analytical and microbiological tests for changes of acidity (decreasing pH and increasing acid content, the contents of soluble dry substances, sugars and a-amino acids as well as changes in the number of viable cells. The samples were collected at the beginning and subsequently every two hours until the end of the fermentation. The results showed that there were differences between the tested isolates in terms of their ability to ferment soymilk. The mix with brewer's yeast had a better stimulating effect on the growth of both strains compared to those with juices alone. In addition, the carrot juice stimulated the growth of Bifidobacterium sp. A71 better than beetroot juice, while the opposite effect was found for the growth of Lactobacillus sp. V3.

  6. Bifidobacterium breve with α-linolenic acid alters the composition, distribution and transcription factor activity associated with metabolism and absorption of fat

    Science.gov (United States)

    Patterson, Elaine; Wall, Rebecca; Lisai, Sara; Ross, R. Paul; Dinan, Timothy G.; Cryan, John F.; Fitzgerald, Gerald F.; Banni, Sebastiano; Quigley, Eamonn M.; Shanahan, Fergus; Stanton, Catherine

    2017-01-01

    This study focused on the mechanisms that fatty acid conjugating strains - Bifidobacterium breve NCIMB 702258 and Bifidobacterium breve DPC 6330 - influence lipid metabolism when ingested with α-linolenic acid (ALA) enriched diet. Four groups of BALB/c mice received ALA enriched diet (3% (w/w)) either alone or in combination with B. breve NCIMB 702258 or B. breve DPC 6330 (109 CFU/day) or unsupplemented control diet for six weeks. The overall n-3 PUFA score was increased in all groups receiving the ALA enriched diet. Hepatic peroxisomal beta oxidation increased following supplementation of the ALA enriched diet with B. breve (P CLA) was identified in adipose tissue. Furthermore, a strain specific effect of B. breve NCIMB 702258 was found on the endocannabinoid system (ECS). Liver triglycerides (TAG) were reduced following ALA supplementation, compared with unsupplemented controls (P < 0.01) while intervention with B. breve further reduced liver TAG (P < 0.01), compared with the ALA enriched control. These data indicate that the interactions of the gut microbiota with fatty acid metabolism directly affect host health by modulating n-3 PUFA score and the ECS. PMID:28265110

  7. Effects of Nisin on the Growth of Lactobacillus acidophilus La-5 and Bifidobacterium bifidum Bb-12%Nisin 对 Lactobacillus acidophilus La-5 和 Bifidobac

    Institute of Scientific and Technical Information of China (English)

    吴正钧; 周诚

    2002-01-01

    在MRS平板上,采用琼脂扩散法测定了Nisin对Lactobacillus acidophilus la-5和Bifidobacterium bifidumBb-12生长的抑制作用.当Nisin浓度≥50ug/ml时,对Lactobacillus acidophilus la-5表现出强烈的抑制作用,而Bifidobacterium bifidum Bb-12则几乎不生长,即使Nisin的浓度仅为25ug/ml;当L.acidophilus la-5和B.bifidum Bb-12单独或两者共同在37℃发酵10%(w/w)还原脱脂奶时,脱脂奶中添加的50ug/ml Nisin对B.bifidum Bb-12表现出杀菌作用,而对L.acidophilus La-5则为抑菌作用.当延长培养时间后,L.acidophilus La-5的存在可以降低Nisin对B.bifidum Bb-12的致死作用.

  8. Application of bifidobacterium in cancer gene therapy%双歧杆菌在肿瘤基因治疗中的应用

    Institute of Scientific and Technical Information of China (English)

    孙月丽; 赵擎宇

    2008-01-01

    Bifidobacterium,a kind of anaerobic and nonpathogenic bacteria,is an inherent flora of hu-man body or some mammal. It plays an important part in maintaining the stability of intestinal environment,growth promotion, and improving the immunity, etc. It attracts wide attention in nutrition and food science be-cause of these advantages. Recently, bifidobacterium is interested by medical science field because of its anti-tumor function and its anaerobic and nonpathogenic characters. It can be used as a specific gene delivery vector for cancer gene therapy.%双歧杆菌是定植于人类或某些哺乳动物肠道内的生理菌群,厌氧、无致病性,能维持肠道内环境稳定,促进机体生长,提高免疫力,具有重要的作用,受到营养学和食品学的广泛关注.近年来双歧杆菌又因重要的抗肿瘤作用和其趋厌氧性、无致病性引起医学界的重视,成为肿瘤基因治疗载体的重要研究对象.

  9. Long-Term Use of Probiotics Lactobacillus and Bifidobacterium Has a Prophylactic Effect on the Occurrence and Severity of Pouchitis: A Randomized Prospective Study

    Directory of Open Access Journals (Sweden)

    Banasiewicz Tomasz

    2014-01-01

    Full Text Available Aim. The aim of the study was to assess the impact of the long-term use of the composite probiotics in patients after restorative proctocolectomy. Method. Forty-three patients (20 females and 23 males, aged 21 to 68 years after restorative proctocolectomy were included in the study. After randomization patients were divided into placebo group and treatment group with oral intake of probiotic containing Lactobacillus acidophilus, Lactobacillus delbrueckii subsp. bulgaricus, and Bifidobacterium bifidus. Patients were investigated during initial visit and during final visit after 9 months. All patients were subjected to standard clinical and endoscopic examination with microscopic study of the specimens. Concentrations of calprotectin and pyruvate kinase isoenzyme M2-PK were determined in all cases. Results. The average severity of pouchitis and the number of patients with pouchitis significantly decrease after 9 months of the probiotic taking. The concentrations of calprotectin and pyruvate kinase isoenzyme M2-PK significantly decreased after the therapy. Conclusions. Nine months of the probiotic treatment (Lactobacillus acidophilus, Lactobacillus delbrueckii subsp. bulgaricus, and Bifidobacterium bifidus reduced the number of patients with pouchitis, decreased the PDAI score, and also decreased the fecal pyruvate kinase and calprotectin. The long-term probiotics use is safe and well accepted and can be an effective method of the pouchitis prevention.

  10. Myo-inositol hexakisphosphate degradation by Bifidobacterium pseudocatenulatum ATCC 27919 improves mineral availability of high fibre rye-wheat sour bread.

    Science.gov (United States)

    García-Mantrana, Izaskun; Monedero, Vicente; Haros, Monika

    2015-07-01

    The goal of this investigation was to develop baking products using Bifidobacterium pseudocatenulatum ATCC27919, a phytase producer, as a starter in sourdough for the production of whole rye-wheat mixed bread. This Bifidobacterium strain contributed to myo-inositol hexakisphosphate (phytate) hydrolysis, resulting in breads with higher mineral availability as was predicted by the phytate/mineral molar ratios, which remained below the inhibitory threshold values for Ca and Zn intestinal absorption. The products with sourdough showed similar technological quality as their homologous without sourdough, with levels of acetic and d/l lactic acids in dough and bread baking significantly higher with the use of sourdough. The overall acceptability scores showed that breads with 25% of whole rye flour were highly accepted regardless of the inclusion of sourdough. This work emphasises that the in situ production of phytase during fermentation by GRAS/QPS microorganisms constitutes a strategy which is particularly appropriate for reducing the phytate contents in products for human consumption.

  11. In Vitro Antibacterial Mechanism of Action of Crude Garlic (Allium sativum) Clove Extract on Selected Probiotic Bifidobacterium Species as Revealed by SEM, TEM, and SDS-PAGE Analysis.

    Science.gov (United States)

    Booyens, J; Labuschagne, M C; Thantsha, M S

    2014-06-01

    There has been much research on the effects of garlic (Allium sativum) on numerous pathogens, but very few, if any, studies on its effect on beneficial, probiotic bifidobacteria. We have recently shown that garlic exhibits antibacterial activity against bifidobacteria. The mechanism by which garlic kills bifidobacteria is yet to be elucidated. This study sought to determine the mechanism of action of garlic clove extract on selected Bifidobacterium species using scanning and transmission electron microscopy and SDS-PAGE analysis. SEM micrographs revealed unusual morphological changes such as cell elongation, cocci-shaped cells with cross-walls, and distorted cells with bulbous ends. With TEM, observed changes included among others, condensation of cytoplasmic material, disintegration of membranes, and loss of structural integrity. SDS-PAGE analysis did not reveal any differences in whole-cell protein profiles of untreated and garlic clove extract-treated cells. The current study is the first to reveal the mechanism of action of garlic clove extract on probiotic Bifidobacterium species. The results indicate that garlic affects these beneficial bacteria in a manner similar to that exhibited in pathogens. These results therefore further highlight that caution should be taken especially when using raw garlic and probiotic bifidobacteria simultaneously as viability of these bacteria could be reduced by allicin released upon crushing of garlic cloves, thereby limiting the health benefits that the consumer anticipate to gain from probiotics.

  12. DECHEMA annual conference in 1998; DECHEMA-Jahrestagungen `98. Bd. 1. 16. Jahrestagung der Biotechnologen. Kurzfassungen

    Energy Technology Data Exchange (ETDEWEB)

    Hess, C. [comp.

    1998-12-31

    In a versatile, often multidisciplinary programme the DECHEMA annual conferences in 1998 present new results from research, the state of the art, and, not least, the persons, companies, and institutions active in various disciplines. This volume contains shortened versions of the lectures and posters presented at the 16th Annual Conference of Biotechnologists. [Deutsch] Die DECHEMA-Jahrestagungen `98 stellen in einem vielseitigen, oft interdisziplinaeren Programm neue Ergebnisse aus der Forschung, den aktuellen Stand der Technik und nicht zuletzt auch die auf den jeweiligen Gebieten aktiven Personen, Firmen und Institutionen vor. In diesem Band sind die Kurzfassungen der Vortraege und Poster der 16. Jahrestagung der Biotechnologen enthalten. (orig.)

  13. Theory of nuclear reactors. Vol. 1. Theorie der Kernreaktoren. Bd. 1. Der stationaere Reaktor

    Energy Technology Data Exchange (ETDEWEB)

    Emendoerfer, D.; Hoecker, K.H.

    1982-01-01

    An introduction is given to the elements of reactor physics and reactor calculation which refers to practice from the present point of view. It is demonstrated to the reader how the reactor characteristics relevant to construction can be calculated from atomic factors by means of neutron transport and diffusion theory; these reactor characteristics are: multiplication factor, power density distribution, burn-up, plutonium build-up, xenon vibrations, short-time behaviour. The interaction between thermo- and fluid-dynamic processes is important for this calculation. On grounds of didactics the crucial point of this book is the establishment and calculation of simple models which give a clear description of all important characteristics of the events. Attempts for more exact simulation by computer are dealt with including typical solutions.

  14. Electrical engineering fundamentals. Vol. 1. 2. ed.; Allgemeine Elektrotechnik. Bd. 1

    Energy Technology Data Exchange (ETDEWEB)

    Seidel, H.U.; Wagner, E. [Technische Hochschule Ilmenau (Germany)

    1999-07-01

    This textbook provides fundamental knowledge in electrical engineering, i.e. physical laws, methodology, energy conversion elements, modules and componentry. The fundamentals of electrical engineering are presented, from the calculation of steady phenomena to a.c. circuits and to wave propagation along power lines. The book can also serve as a textbook for students at all levels. [German] Dieses Lehrbuch vermittelt allgemeines, studienuebergreifendes Grundlagenwissen des Elektrotechnikers. Dabei werden in enger Anlehnung an die physikalischen Grundgesetze der Elektrotechnik sowohl die grundlegenden Arbeitsmethoden als auch wesentliche Energieumwandlungsprozesse, Bauelemente und Baugruppen behandelt. Die Autoren behandeln die Grundgebiete der Elektrotechnik von der Berechnung stationaerer Vorgaenge ueber Wechselstromschaltungen bis zur Wellenausbreitung laengs Leitungen. Die didaktische Aufbereitung sowohl bezueglich der vorausgesetzten mathematischen Kenntnisse als auch in der gewaehlten Abfolge der Stoffdarstellung entsprechend den im Studiengang fortschreitenden mathematischen und physikalischen Faehigkeiten macht dieses Lehrbuch auch fuer Studenten von Beginn des Studiums an zu einem nuetzlichen Hilfsmittel. In die Darstellung sind die langjaehrigen Erfahrungen der Autoren zu den Grundlagen der Elektrotechnik eingegangen. (orig.)

  15. A differential medium for the enumeration bifidobacterium in fermented milk%一种发酵乳中双歧杆菌鉴别培养基计数评估

    Institute of Scientific and Technical Information of China (English)

    王立平

    2012-01-01

    Objective:To establish a quantitative method for bifidobacterium in fermented milk.Methods:A differential culture medium,which use fructose as the only source of carbohydrates,was emploied to quantitatively assess bifidobacterium,based on a morphological differentiation of colonies and a counting of bifidobacterium on the same plate.Results:Results obtained with FBM are very close to those obtained by the use of reference media(P0.05).Conclusion:FBM medium is situble for enumering Bifidobacterium in fermented milk%目的:建立发酵乳中双歧杆菌数量计数测定方法。方法:采用果糖为碳源的鉴别培养基,基于乳酸菌同型发酵和异型菌落形态的差异,借助pH指示剂确定样品中双歧杆菌数量。结果:该培养基所计双歧杆菌数量与对照培养基所计数量在同一数量级且差异不显著(P〉0.05)。结论:该培养基可用于发酵乳中双歧杆菌的准确计数。

  16. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Scientific Opinion on the substantiation of a health claim related to a combination of Bifidobacterium longum LA 101, Lactobacillus helveticus LA 102, Lactococcus lactis LA 103 and

    DEFF Research Database (Denmark)

    Tetens, Inge

    substantiation of a health claim related to a combination of Bifidobacterium longum LA 101, Lactobacillus helveticus LA 102, Lactococcus lactis LA 103 and Streptococcus thermophilus LA 104 and improves stools frequency. The food that is the subject of the health claim is a combination of B. longum LA 101, L...

  17. Scientific Opinion on the substantiation of a health claim related to Bifidobacterium bifidum CNCM I-3426 and defence against pathogens in the upper respiratory tract pursuant to Article 13(5) of Regulation (EC) No 1924/2006

    DEFF Research Database (Denmark)

    Tetens, Inge

    of a health claim related to Bifidobacterium bifidum CNCM I-3426 and defence against pathogens in the upper respiratory tract. The food constituent that is the subject of the claim is B. bifidum CNCM I-3426. The Panel considers that B. bifidum CNCM I-3426 is sufficiently characterised. The Panel considers...

  18. The optimization of lipuid fermentation conditions and the determination of growth curve for bifidobacterium longum%长双歧杆菌液态发酵条件的优化及生长曲线的测定

    Institute of Scientific and Technical Information of China (English)

    冯伟华; 常艳璐

    2012-01-01

    目的 优化长双歧杆菌的液态发酵条件.方法 通过单因素试验方法,考察长双歧杆菌液态培养基的最佳初始pH、培养温度、接种量和培养时间.结果 长双歧杆菌的最佳发酵条件为:发酵液初始pH 7.0、发酵培养温度39℃、发酵接种量6%、最佳培养时间8~10 h.结论 本课题研究确定的发酵工艺有效地提高了长双歧杆菌的培养效率.%Objective To optimize the fermentation conditions for bifidobacterium longum. Methods By the single-factor test, the best initial pH, incubation temperature, inoculum size and incubation time of the culture medium for bifidobacterium longum were investigated. Results The optimal fermentation conditions of bifidobacterium longum were as follow: the initial pH of fermentation broth was 7.0, the fermentation temperature was 39℃, the fermentation inoculation size was 6%, the best incubation time was 8-10 h. Conclusion This fermentation technology effectively improves the efficiency of the cultivation of bifidobacterium longum

  19. Comparative genomic analysis of the gut bacterium Bifidobacterium longum reveals loci susceptible to deletion during pure culture growth

    Directory of Open Access Journals (Sweden)

    Shakhova VV

    2008-05-01

    Full Text Available Abstract Background Bifidobacteria are frequently proposed to be associated with good intestinal health primarily because of their overriding dominance in the feces of breast fed infants. However, clinical feeding studies with exogenous bifidobacteria show they don't remain in the intestine, suggesting they may lose competitive fitness when grown outside the gut. Results To further the understanding of genetic attenuation that may be occurring in bifidobacteria cultures, we obtained the complete genome sequence of an intestinal isolate, Bifidobacterium longum DJO10A that was minimally cultured in the laboratory, and compared it to that of a culture collection strain, B. longum NCC2705. This comparison revealed colinear genomes that exhibited high sequence identity, except for the presence of 17 unique DNA regions in strain DJO10A and six in strain NCC2705. While the majority of these unique regions encoded proteins of diverse function, eight from the DJO10A genome and one from NCC2705, encoded gene clusters predicted to be involved in diverse traits pertinent to the human intestinal environment, specifically oligosaccharide and polyol utilization, arsenic resistance and lantibiotic production. Seven of these unique regions were suggested by a base deviation index analysis to have been precisely deleted from strain NCC2705 and this is substantiated by a DNA remnant from within one of the regions still remaining in the genome of NCC2705 at the same locus. This targeted loss of genomic regions was experimentally validated when growth of the intestinal B. longum in the laboratory for 1,000 generations resulted in two large deletions, one in a lantibiotic encoding region, analogous to a predicted deletion event for NCC2705. A simulated fecal growth study showed a significant reduced competitive ability of this deletion strain against Clostridium difficile and E. coli. The deleted region was between two IS30 elements which were experimentally

  20. Influence of Bifidobacterium longum BB536 intake on faecal microbiota in individuals with Japanese cedar pollinosis during the pollen season.

    Science.gov (United States)

    Odamaki, Toshitaka; Xiao, Jin-Zhong; Iwabuchi, Noriyuki; Sakamoto, Mitsuo; Takahashi, Noritoshi; Kondo, Shizuki; Miyaji, Kazuhiro; Iwatsuki, Keiji; Togashi, Hideo; Enomoto, Tadao; Benno, Yoshimi

    2007-10-01

    It has been reported that intake of yogurt or powder supplemented with the Bifidobacterium longum BB536 probiotic strain alleviated subjective symptoms and affected blood markers of allergy in individuals with Japanese cedar pollinosis (JCPsis) during the pollen seasons of 2004 and 2005, based on randomized, double-blind, placebo-controlled trials. Furthermore, the 2004 study found that intestinal bacteria such as the Bacteroides fragilis group significantly fluctuated during the pollen season in JCPsis individuals and intake of BB536 yogurt tended to suppress these fluctuations. The present study investigated faecal microbiota to examine whether any changes occurred during the pollen season and whether any influence was exerted by intake of BB536 powder in the 2005 pollen season, which happened to be a heavy season, to confirm the 2004 findings and to evaluate the relationship of microbiota with symptom development. In a randomized, double-blind, placebo-controlled trial, 44 JCPsis subjects received BB536 or a placebo for 13 weeks during the pollen season. Another 14 Japanese cedar pollen (JCP)-specific IgE negative healthy subjects received placebo for the same period. Faecal samples were collected before (week 0), during (weeks 4, 8 and 13) and after (week 17) intervention, and out of JCP season (week 28). Faecal microbiota were analysed using terminal-RFLP (T-RFLP) and real-time PCR methods. Principal component analysis based on T-RFLP indicated distinct patterns of microbiota between healthy subjects and JCPsis subjects in the placebo group, but an intermediate pattern in the BB536 group at week 13, the last stage of the pollen season. The coordinate of principal component 1 at week 13 correlated with composite scores of JCPsis symptoms recorded during the pollen season. Faecalibacterium prausnitzii and the Bacteroides fragilis group were identified as the main contributors to microbiotal fluctuations. Real-time PCR indicated that BB536 intake suppressed

  1. Survival of Bifidobacterium bifidum in cow- and camel-milk yogurts enriched with Cinnamomum verum and Allium sativum

    Directory of Open Access Journals (Sweden)

    Amal Bakr Shori

    2015-10-01

    Full Text Available The effects of Allium sativum and Cinnamomum verum water extracts on the survival of Bifidobacterium bifidum during 21 days of refrigerated storage and after simulated gastrointestinal digestion (SGD were investigated. Two types of yogurt (cow- and camel-milk yogurts were prepared in the presence of A. sativum or C. verum. The viable cell counts (VCC of B. bifidum in fresh A. sativum- or C. verum-cow milk yogurt (1 day were higher (8.1 × 109 cfu/ml and 6.6 × 109 cfu/ml, respectively; p < 0.05 than plain-yogurt (1.9 × 109 cfu/ml. In contrast, B. bifidum VCC in fresh plain-camel milk yogurt was 1.99 × 109 cfu/ml whereas the presence of A. sativum or C. verum in yogurt increased (p < 0.05 VCC to 19.61 × 109 cfu/ml and 25.55 × 109 cfu/ml, respectively. The VCC of B. bifidum in both herbal-yogurts decreased (p < 0.05 during refrigerated storage for both types of yogurt. The VCC of B. bifidum was ∼1.3 × 109 cfu/ml in all fresh cow milk yogurts after 1 h gastric digestion. Intestinal digestion (1 h increased VCC of B. bifidum in all fresh yogurts but not in 7 day old yogurts (plain- and A. sativum-yogurts. However, prolonged digestion to another 1 h in intestine reduced (p < 0.05 VCC of B. bifidum in all fresh and storage yogurts. In contrast, all fresh camel milk yogurts showed VCC of B. bifidum ⩽1 × 109 cfu/ml after SGD. Seven day old A. sativum – camel milk yogurt showed the lowest survival of B. bifidum after gastric digestion compared to plain- and C. verum-yogurt. The VCC reduced (p < 0.05 in all camel milk-yogurts after 2 h intestinal digestion.

  2. Catabolism of glucose and lactose in Bifidobacterium animalis subsp. lactis, studied by 13C Nuclear Magnetic Resonance.

    Science.gov (United States)

    González-Rodríguez, Irene; Gaspar, Paula; Sánchez, Borja; Gueimonde, Miguel; Margolles, Abelardo; Neves, Ana Rute

    2013-12-01

    Bifidobacteria are widely used as probiotics in several commercial products; however, to date there is little knowledge about their carbohydrate metabolic pathways. In this work, we studied the metabolism of glucose and lactose in the widely used probiotic strain Bifidobacterium animalis subsp. lactis BB-12 by in vivo (13)C nuclear magnetic resonance (NMR) spectroscopy. The metabolism of [1-(13)C]glucose was characterized in cells grown in glucose as the sole carbon source. Moreover, the metabolism of lactose specifically labeled with (13)C on carbon 1 of the glucose or the galactose moiety was determined in suspensions of cells grown in lactose. These experiments allowed the quantification of some intermediate and end products of the metabolic pathways, as well as determination of the consumption rate of carbon sources. Additionally, the labeling patterns in metabolites derived from the metabolism of glucose specifically labeled with (13)C on carbon 1, 2, or 3 in cells grown in glucose or lactose specifically labeled in carbon 1 of the glucose moiety ([1-(13)Cglucose]lactose), lactose specifically labeled in carbon 1 of the galactose moiety ([1-(13)Cgalactose]lactose), and [1-(13)C]glucose in lactose-grown cells were determined in cell extracts by (13)C NMR. The NMR analysis showed that the recovery of carbon was fully compatible with the fructose 6-phosphate, or bifid, shunt. The activity of lactate dehydrogenase, acetate kinase, fructose 6-phosphate phosphoketolase, and pyruvate formate lyase differed significantly between glucose and lactose cultures. The transcriptional analysis of several putative glucose and lactose transporters showed a significant induction of Balat_0475 in the presence of lactose, suggesting a role for this protein as a lactose permease. This report provides the first in vivo experimental evidence of the metabolic flux distribution in the catabolic pathway of glucose and lactose in bifidobacteria and shows that the bifid shunt is the only

  3. Research on development of Bifidobacterium adolescentis-containing solidified yoghurt and selective medium for strains%青春双歧杆菌凝固型酸奶研制及选择性培养基比较

    Institute of Scientific and Technical Information of China (English)

    刘韩; 关宏; 杨文钦; 张琪; 韩明宇; 刘吉成

    2011-01-01

    以鲜牛奶、白砂糖为主要原料,以青春双歧杆菌、保加利亚乳杆菌、嗜热链球菌为发酵剂,制成营养保健的青春双歧杆菌凝固型酸奶.通过试验确定了青春双歧杆菌凝固型酸奶最佳工艺为:白砂糖8%,接种量3%,保加利亚乳杆菌:嗜热链球菌:青春双歧杆菌=1:1:4,发酵4h.结合MRS培养基和LM-MRS培养基可以对青春双歧杆菌凝固型酸奶中三种乳酸分别计数.青春双歧杆凝固型酸奶中保加利亚乳杆菌活菌数为8.0x108 cfu.mL-1,嗜热链球菌活茵数为8.5x108cfu·mL-1,青春双歧杆菌活茵数为2.0x106 cfu·mL-1.%The nutritional and healthy solidified yoghurt containing Bifidobacterium adolescentic has been made, using fresh milk and sugar as the main raw materials and using Bifidobacterium adolescentic, Lactobacillus delbrueckii subsp. bulgaricus and Streptococcus thermophilus as starter cultures. The optimum technological condition of solidified yoghurt of Bifidobacterium adolescentic was determined: they are respectively 8% of sugar, 3% of inoculum and three lactic acid bacteria which are Lactobacillus delbrueckii subsp. bulgaricus, Streptococcus thermophilus and Bifidobacterium adoles centic and the percentage of these three lactic acid bacteria is 1:1:4, the time of fermentation is 4 h. The number of Lactobacillus delbrueckii subsp. bulgaricus, Streptococcus thermophilus and Bifidobacterium adolescentic could be counted in solidified Bifidobacterium adolescentic. Solidified yoghurt contain the number of viable Lactobacillus delbrueckii subsp. bulgaricus is 8.0 × 108 cfu· mL-1, the number of viable Streptococcus thermophilus is 8.5× 108 cfu· mL-1, the number of viable Bifidobacterium adolescentic is 2.0×106 cfu·mL-1.

  4. Application study on examination of Bifidobacterium in MUP-MRS medium%莫匹罗星锂盐改良MRS检测双歧杆菌的应用研究

    Institute of Scientific and Technical Information of China (English)

    蔡芷荷; 宋曼丹; 周蔼怡; 陈秋霞; 严纪文; 朱海明; 帅惠萍; 苏丽春; 何天文

    2011-01-01

    目的:探讨应用莫匹罗星锂盐改良MRS(MUP-MRS)进行双歧杆菌计数的最佳条件.方法:使用双歧杆菌和乳酸菌各4株对不同剂量MUP-MRS进行性能测试;对5份含乳双歧杆菌的市售样品进行乳双歧杆菌计数;并观察双歧杆菌在不同培养时间的生长情况.结果:当莫匹罗星锂盐(Li-MUP)为0.5 mg~1.0 mg/100 ml时,双歧杆菌生长率在0.98~1.19间,两歧双歧杆菌不生长;Li-MUP大于2.0 mg/100 ml时,双歧杆菌均不生长.5份样品中,Li-MUP在0.5 mg~0.75 mg/100 ml时,乳双歧杆菌计数1.0×10~3.9×10CFU/ml,生长良好;非目标乳酸菌完全受抑制(植物乳杆菌除外).Li-MUP在1.0 mg/100 ml时,乳双歧杆菌不生长.双歧杆菌培养48 h±2 h,菌落细少;培养72 h±2 h,形成易于计数的菌落.结论:用MUP-MRS琼脂进行双歧杆菌计数时,Li-MUP的添加剂量可选0.5 mg~0.75 mg/100 ml,培养时间选择72 h±2 h.%Objective :To investigate the optimum culture condition of enumeration of Bifidobacterium in MUP - MRS Medium.Methods: The productivity of 4 target strains of Bifidobacterium and Lactic acid bacteria were calculated in MUP - MRS Media with various doses of Li - Mupirocin. The 5 samples have Bifidobacterium lactic. The growth feature of Bifidobacterium were observed in different incubation times. Results: The productivity of Bifidobacterium were all among 0.98 ~ 1.19 in MUP - MRS Media with 0.5 mg ~ 1.0 mg/100 ml of Li - Mupirocin, but Bifidobacterium bifidum failed to growth. Bifidobacterium lactic grow with Li - Mupirocin ≥2.0 mg/100 ml. The enumeration of Bifidobacterium lactic in the commercial samples was 1.0 × 106 ~ 3.9 × 108 CFU/ml with 0.5 mg~ 0.75 mg/100 ml of Li - Mupirocin. Non - target strains could be totally inhibited except Lactobacilus plantarum. Bafidobacterium lactic failed to growth with Li - Mupirocin in 1.0 mg/100 ml. Bifidobacterium could only form the pinpoint colonies after 48 h ± 2 h incubation, but all the colonies were

  5. Bifidobacterium pseudocatenulatum CECT 7765 Reduces Obesity-Associated Inflammation by Restoring the Lymphocyte-Macrophage Balance and Gut Microbiota Structure in High-Fat Diet-Fed Mice.

    Directory of Open Access Journals (Sweden)

    Angela Moya-Pérez

    Full Text Available The role of intestinal dysbiosis in obesity-associated systemic inflammation via the cross-talk with peripheral tissues is under debate. Our objective was to decipher the mechanisms by which intervention in the gut ecosystem with a specific Bifidobacterium strain reduces systemic inflammation and improves metabolic dysfunction in obese high-fat diet (HFD fed mice.Adult male wild-type C57BL-6 mice were fed either a standard or HFD, supplemented with placebo or Bifidobacterium pseudocatenulatum CECT 7765, for 14 weeks. Lymphocytes, macrophages and cytokine/chemokine concentrations were quantified in blood, gut, liver and adipose tissue using bead-based multiplex assays. Biochemical parameters in serum were determined by ELISA and enzymatic assays. Histology was assessed by hematoxylin-eosin staining. Microbiota was analyzed by 16S rRNA gene pyrosequencing and quantitative PCR.B. pseudocatenulatum CECT 7765 reduced obesity-associated systemic inflammation by restoring the balance between regulatory T cells (Tregs and B lymphocytes and reducing pro-inflammatory cytokines of adaptive (IL-17A and innate (TNF-α immunity and endotoxemia. In the gut, the bifidobacterial administration partially restored the HFD-induced alterations in microbiota, reducing abundances of Firmicutes and of LPS-producing Proteobacteria, paralleled to reductions in B cells, macrophages, and cytokines (IL-6, MCP-1, TNF-α, IL-17A, which could contribute to systemic effects. In adipose tissue, bifidobacterial administration reduced B cells whereas in liver the treatment increased Tregs and shifted different cytokines (MCP-1 plus ILP-10 in adipose tissue and INF-γ plus IL-1β in liver. In both tissues, the bifidobacteria reduced pro-inflammatory macrophages and, TNF-α and IL-17A concentrations. These effects were accompanied by reductions in body weight gain and in serum cholesterol, triglyceride, glucose and insulin levels and improved oral glucose tolerance and insulin

  6. Effect of the consumption of a fermented dairy product containing Bifidobacterium lactis DN-173 010 on constipation in childhood: a multicentre randomised controlled trial (NTRTC: 1571

    Directory of Open Access Journals (Sweden)

    Perrin Catherine

    2009-03-01

    Full Text Available Abstract Background Constipation is a frustrating symptom affecting 3% of children worldwide. Randomised controlled trials show that both polyethylene glycol and lactulose are effective in increasing defecation frequency in children with constipation. However, in 30–50%, these children reported abdominal pain, bloating, flatulence, diarrhoea, nausea and bad taste of the medication. Two recent studies have shown that the fermented dairy product containing Bifidobacterium lactis strain DN-173 010 is effective in increasing stool frequency in constipation-predominant irritable bowel syndrome patients with a defecation frequency Methods/design It is a two nation (The Netherlands and Poland double-blind, placebo-controlled randomised multicentre trial in which 160 constipated children (age 3–16 years with a defecation frequency Bifidobacterium lactis DN-173 010 or a control product, twice a day, for 3 weeks. During the study all children are instructed to try to defecate on the toilet for 5–10 minutes after each meal (3 times a day and daily complete a standardized bowel diary. Primary endpoint is stool frequency. Secondary endpoints are stool consistency, faecal incontinence frequency, pain during defecation, digestive symptoms (abdominal pain, flatulence, adverse effects (nausea, diarrhoea, bad taste and intake of rescue medication (Bisacodyl. Rate of success and rate of responders are also evaluated, with success defined as ≥ 3 bowel movements per week and ≤1 faecal incontinence episode over the last 2 weeks of product consumption and responder defined as a subject reporting a stool frequency ≥ 3 on the last week of product consumption. To demonstrate that the success percentage in the intervention group will be 35% and the success percentage in the control group (acidified milk without ferments, toilet training, bowel diary will be 15%, with alpha 0.05 and power 80%, a total sample size of 160 patients was calculated. Conclusion This

  7. Assessment of fermented buffalo milk for Lactobacillus casei and supply with Bifidobacterium longum/ Análise de leite de búfala fermentado por Lactobacillus casei e suplementado com Bifidobacterium longum

    Directory of Open Access Journals (Sweden)

    Jean-Louis Le Guerroue

    2006-06-01

    Full Text Available It was elaborated fermented buffalo milk for L. casei utilizing skimmed milk added with 12,00% sugar and fermented by 24 hours. After fermentation, the product was supply with B. longum and storage during 30 days at 5 and 10° C, being evaluated the acidity, pH and viability of L. casei and B. longum parameters. Were does the nutritional composition, calculate the caloric value and sensorial analysis of the flavored product. The fermented milk presented initial acidity 0.69% and pH 4.86. The L. casei initial viability was 11,00 log CFU/mL and B. longum 10,46 log CFU/mL. After storage of 30 days, the acidity and pH were adequate and the L. casei and B. longum viability was above 9.00 log CFU/mL. The composition analysis resulted (% protein 3.63, carbohydrate 21.86, fat 0.10, ashes 0.56, wet 73.85 and dry substance 26.15, with caloric value 103 Kcal/100 g. There wasn’t significant difference to preference and acceptance between flavored samples, and have good acceptation by hedonic scale.Elaborou-se leite de búfala fermentado por Lactobacillus casei utilizando leite desnatado, adicionado de 12,00% de açúcar e fermentado por 24 horas. Após fermentação o produto foi suplementado com Bifidobacterium longum e estocado durante 30 dias a 5 e 10° C, sendo então avaliados os parâmetros de acidez, pH e viabilidade de L.casei e de B. longum. Realizou-se a análise de composição nutricional, cálculo do valor calórico e análise sensorial do produto saborizado. O leite fermentado suplementado com B. longum, apresentou acidez inicial de 0,69% e pH de 4,86. A viabilidade de L. casei inicial foi 11,00 log UFC/mL e de B. longum 10,46 log UFC/mL. Após 30 dias de estocagem refrigerada, a acidez e o pH estavam adequados e a viabilidade de L. casei e de B. longum ficou acima de 9,00 log UFC/mL. A análise da composição nutricional resultou nos valores (%: proteína 3,63, carboidrato 21,86, gordura 0,10, resíduo mineral fixo 0,56, umidade 73,85 e

  8. Effect of fermented milk containing Lactobacillus acidophilus and Bifidobacterium longum on plasma lipids of women with normal or moderately elevated cholesterol.

    Science.gov (United States)

    Andrade, Sara; Borges, Nuno

    2009-11-01

    This study aimed to evaluate the effect of milk fermented with Lactobacillus acidophilus 145 and Bifidobacterium longum BB536 on plasma lipids in a sample of adult women. A double-blind, placebo controlled, cross-over study (two periods of four weeks each separated by a 1-week washout period) was performed in 34 women, aged between 18 and 65 years. Group A consumed 125 g fermented milk three times a day for the first 4 weeks while group B consumed regular yoghurt under the same conditions. (Groups A and B switched products for the second treatment period). Women taking the test product with a baseline total cholesterol above 190 mg/dl showed a significant reduction in LDL cholesterol. HDL cholesterol was also reduced by the test product. We conclude that the fermented milk may help to reduce LDL levels in hypercholesterolemic adult women.

  9. Manufacture of Fermented Carrot Juice with Bifidobacterium%胡萝卜汁双歧杆菌发酵饮料的研制

    Institute of Scientific and Technical Information of China (English)

    杜小兵; 张篪; 郑海涛

    2004-01-01

    在添加5%脱脂牛乳和4%~5%蔗糖的胡萝卜汁中接种5×106/mL的长双歧杆菌(Bifidobacterium longum),发酵10~14h后或终点pH达到4.2左右时,可获得总菌数在109/mL数量级、色泽鲜艳、口感良好、风味上佳的双歧杆菌胡萝卜汁发酵饮料制品.产品低温贮运的保质期为1周左右.

  10. Study on protoplast formation in bifidobacterium%双歧杆菌原生质体制备条件的探讨

    Institute of Scientific and Technical Information of China (English)

    黎永学; 张德纯

    2003-01-01

    目的探讨Bifidobacterium(双歧杆菌)原生质体制备的条件.方法将培养至对数生长期的双歧杆菌用α-淀粉酶和溶菌酶进行酶解脱壁.结果在37℃条件下,800 μg/ml溶菌酶和500 μg/ml α-淀粉酶用于双歧杆菌联合酶解脱壁60 min,双歧杆菌原生质体形成率为80%左右.结论α-淀粉酶和溶菌酶联合酶解脱壁可用于双歧杆菌原生质体制备.

  11. Isolation and Purification of Recombinant Serine/Threonine Protein Kinases of the Strain Bifidobacterium longum B379M and Investigation of Their Activity.

    Science.gov (United States)

    Alekseeva, M G; Mavletova, D A; Kolchina, N V; Nezametdinova, V Z; Danilenko, V N

    2015-10-01

    Previously, we identified six serine/threonine protein kinases (STPK) of Bifidobacterium and named them Pkb1-Pkb6. In the present study, we optimized methods for isolation of the six STPK catalytic domains proteins of B. longum B379M: a method for isolation of Pkb3 and Pkb4 in native conditions, a method for isolation of Pkb5 in denaturing conditions, and a method for isolation of Pkb1, Pkb2, and Pkb6 from inclusion bodies. The dialysis conditions for the renaturation of the proteins were optimized. All of the enzymes were isolated in quantities sufficient for study of the protein activity. The proteins were homogeneous according to SDS-PAGE. The autophosphorylation ability of Pkb1, Pkb3, Pkb4, and Pkb6 was investigated for the first time. Autophosphorylation was detected only for the Pkb3 catalytic domain.

  12. Bifidobacterium breve B-3 exerts metabolic syndrome-suppressing effects in the liver of diet-induced obese mice: a DNA microarray analysis.

    Science.gov (United States)

    Kondo, S; Kamei, A; Xiao, J Z; Iwatsuki, K; Abe, K

    2013-09-01

    We previously reported that supplementation with Bifidobacterium breve B-3 reduced body weight gain and accumulation of visceral fat in a dose-dependent manner, and improved serum levels of total cholesterol, glucose and insulin in a mouse model of diet-induced obesity. In this study, we investigated the expression of genes in the liver using DNA microarray analysis and q-PCR to reveal the mechanism of these anti-obesity effects in this mouse model. Administration of B. breve B-3 led to regulated gene expression of pathways involved in lipid metabolism and response to stress. The results indicate that these regulations in the liver are related to the anti-metabolic syndrome effects of B. breve B-3.

  13. Bifidobacterium bifidum R0071 decreases stress-associated diarrhoea-related symptoms and self-reported stress: a secondary analysis of a randomised trial.

    Science.gov (United States)

    Culpepper, T; Christman, M C; Nieves, C; Specht, G J; Rowe, C C; Spaiser, S J; Ford, A L; Dahl, W J; Girard, S A; Langkamp-Henken, B

    2016-06-01

    Psychological stress is associated with gastrointestinal (GI) distress. This secondary analysis from a randomised, double-blind, placebo-controlled study examined whether three different probiotics could normalise self-reported stress-associated GI discomfort and reduce overall self-reported stress. Undergraduate students (n=581) received Lactobacillus helveticus R0052, Bifidobacterium longum ssp. infantis R0033, Bifidobacterium bifidum R0071, or placebo. Participants self-reported 2 outcomes for a 6-week period, which included final academic exams: daily level of stress (0=no stress to 10=extremely stressed) and weekly three diarrhoea-related symptoms (DS, 1=no discomfort to 7=severe discomfort) using the GI Symptom Rating Scale. Self-reported stress was positively related to DS (P=0.0068). Mean DS scores were lower with B. bifidum versus placebo at week 2 at the average level of stress and the average body mass index (BMI). DS scores were lower with B. bifidum at week 5 versus week 0 and 1 and with B. infantis R0033 at week 6 versus week 0. DS scores were higher when antibiotics were used in the prior week with placebo (P=0.0092). DS were not different with or without antibiotic use with the probiotics. Only B. bifidum had an effect on self-reported stress scores (P=0.0086). The self-reported stress score was also dependent on hours of sleep per day where it decreased by 0.13 for each additional hour of sleep. During a stressful period, B. bifidum R0071 decreases DS and self-reported stress scores. This trial was registered at clinicaltrials.gov as NCT01709825.

  14. 食用性壳寡糖(几丁质低聚糖)对长双歧杆菌的影响%Influence of Dietary Chito-oligosaccharide on Bifidobacterium longum

    Institute of Scientific and Technical Information of China (English)

    金律

    2005-01-01

    本研究对比了不同浓度的壳寡糖对于益生菌中的长双歧杆菌的生理影响,找到了合适的食用添加浓度的壳寡糖对于长双歧杆菌的明显促生长作用,为其作为具有减肥和保健双重功能的新兴食品添加物质奠定了理论基础.%In this project, the influence of dietary chito-oligosacchrides on bifidobacterium longum has been explored at different concentration additive. The very significant promotion to increase bifidobacterium longum has been found at the some additional level of chito-oligosacchrides. This project creates basis theory of novel foodstuff additions for dual function of weight-loss and healthy aim.

  15. Analysis of the nutritions in Bifidobacterium vinegar and its shelf life%功能性双歧醋营养成分分析及保质期观察

    Institute of Scientific and Technical Information of China (English)

    席青; 张德纯; 管晓冉

    2011-01-01

    目的 分析双歧醋的营养成分及保质期观察.方法 采用现代多种营养成分分析方法对双歧醋进行主要营养成分的分析测定.结果 双歧醋营养丰富,含有多种微量元素,含有18种氨基酸,其中8种人体必需氨基酸含量占总量的42.5%,富含醋酸、乳酸等8种有机酸成分.结论 双歧醋营养成分丰富,保质期长,作为一种功能性醋产品值得推广应用.%Objective To analyze the nutritional components of Bifidobacterium vinegar and explore its shelf life.Method The main nutritional components of Bifidobacterium vinegar were analyzed according to nutrition analysis methods. Result There were abundant nutritional components in Bifidobacterium vinegar, such as vitamins and trace elements. There were 18 kinds of amino acids in all, including 8 kinds of essential amino acids which accounted 42.5%. At least 8 kinds of organic acids such as acetic acid, lactic acid, etc. were found in it. Conclusion Bifidobacterium vinegar is rich in nutrients and have a long shelf-life, which can be promoted as a functional nutritious vinegar.

  16. 不同气体环境对益生菌Bifidobacterium lactis V9生长的影响%Effects of air condition on the viability of probiotic bacteria: Bifidobacterium lactis V9

    Institute of Scientific and Technical Information of China (English)

    其木格苏都; 白梅; 孔亚楠; 魏爱彬; 王记成; 张和平

    2012-01-01

    Bifidobacterium lactis V9(B.lactis V9)是一株具有良好益生特性且遗传稳定的益生茵,工业化生产环境中气体组成关系着益生菌活菌数量,进而影响其益生功效.[目的]研究不同气体环境对B.lactis V9生长及代谢的影响.[方法]在固体MRS培养基、液体MRS培养基及巴氏杀菌脱脂乳接种B.lactis V9,于不同的气体环境中培养.[结果]在固体MRS培养基上,B.lactis V9在混合气体(N2∶H2∶CO2=80∶10∶10)环境中菌落形成较氮气环境(N2∶99.99%)多,在空气环境(N2∶O2≈79∶21)中菌落形成极少.B.lactis V9在MRS液体中培养24 h,混合气体环境下其活菌数(9.11±0.11 log CFU/mL)显著高于空气环境下的活菌数(8.04±0.10 log CFU/mL) (P<0.01),在混合气体环境下B.lactis V9代谢生成的乙酸和乳酸量分别为12.79±0.86 mmol/L和11.99±0.73 mmol/L,显著高于在空气环境中生成量0.65±0.07 mmol/L和2.75±0.57 mmol/L (P<0.01),乙酸/乳酸比值分别为1.06∶1和0.24∶1.B.lactis V9在巴氏杀菌脱脂乳中发酵18h,混合气体环境下pH值(4.48±0.07)显著低于空气环境下的pH值(5.03±0.12) (P<0.01),混合气体环境下其活菌数(9.02±0.15 log CFU/mL)显著高于空气环境下的活菌数(8.53±0.08 log CFU/mL) (P<0.01).混合气体和空气环境下发酵脱脂乳产生的乙酸和乳酸量分别为60.52±2.30 mmol/L、5.17±1.02 mmol/L和16.86±0.34 mmol/L、5.92±0.81 mmol/L,乙酸/乳酸的值分别为11.71∶1和2.85∶1.[结论]在N2∶H2∶CO2=80∶10∶10混合气体环境下有利于B.lactis V9在液体MRS和脱脂乳中生长,其活菌数可以增加0.5-1个数量级.这一研究结果也可为B.lactis V9益生菌发酵乳的生产和产品中B.lactis V9活菌培养计数提供指导.%Bifldobacterium lactis V9 (B.lactis V9) has been demostrated as a probiotic with well properties and stable genetics.The gas composition in environment of industrial manufacturation is positively associated with viable numbers of

  17. Screening of Bifidobacterium Strains with High Stress Resistence to Gastrointestinal Environment%人体消化道高抗逆性双歧杆菌的筛选

    Institute of Scientific and Technical Information of China (English)

    郭德军; 纪振杰; 张平; 张洪薇; 张丽萍; 王长远; 唐彦军; 肖念平

    2013-01-01

    双歧杆菌是人体肠道的一种微生态调节剂,对人体消化道环境的抗逆性是其发挥抗肠道感染作用的关键。分别利用激光共聚焦显微镜,测定五株分别来源于药物和婴儿粪便的双歧杆菌对结肠癌细胞Caco-2的黏附性,再通过耐酸和耐胆汁盐初筛,模拟胃液和模拟肠液复筛,筛选出消化道高抗逆性双歧杆菌L-1,其对Caco-2的黏附数为166±21黏附菌数/细胞;在pH3.0模拟胃液中作用2 h后的存活率为72%;在胆汁盐浓度为0.2%的模拟肠液中24 h,其存活率为14%。结果表明,五株双歧杆菌肠道抗逆性有所不同,L-1菌株消化道抗逆性能力最好,可用做微生态制剂菌株。%Bifidobacteria was an important probiotics and used in the dairy industry to relieve and treat many intestinal disorders, whose stress tolerance to human gastrointestinal environment played a key role of exerting a barrier effect against enteropathogens. Five bifidobacterium strains were isolated from drugs and infant feces,whose adhesiveness on human colon cancer Caco-2 cell in vitro were examined by scanning confocal laser microscopy. The hardest stress tolerance of strains L-1 was screened and selected by preliminary screening and second selection,the adherent level was 166±21 adhering/cell on Caco-2 cell,survival rate was 72%when grown in simulated gastric fluid at pH3.0 for 2 h and was 14%when grown in simulated intestinal fluid containing 0.2%bile salt for 24 h. The results indicated that the ability to tolerate gastroenteric environment and the adhesive capacity to Caco-2 cell among Bifidobacterium strains were different. The strains L-1 had several aspects of advantages and may be regarded as potential probiotics.

  18. Bifidobacterium infantis strains with and without a combination of Oligofructose and Inulin (OFI attenuate inflammation in DSS-induced colitis in rats

    Directory of Open Access Journals (Sweden)

    Ahrne Siv

    2006-10-01

    Full Text Available Abstract Background Pathogenesis of inflammatory bowel disease is thought to be through different factors and there is a relationship between the gut flora and the risk of its development. Probiotics can manipulate the microflora in chronic inflammation and may be effective in treating inflammation. Bifidobacterium are saccharolytic and their growth in the gut can be promoted by non-absorbable carbohydrates and its increase in the colon appears to be of benefit. Methods Oligofructose and inulin (OFI alone and the two B. infantis DSM 15158 and DSM 15159 with and without OFI, were fed to Sprague-Dawley rats for 7 days prior to colitis induction and administrations continued for another 7 days with the DSS. Colitis severity assessed using a Disease Activity Index. Samples were collected 7 days after colitis induction, for intestinal bacterial flora, bacterial translocation, short chain fatty acids (SCFAs, myeloperoxidase (MPO, cytokines (IL-1β, TNF-α, IL-10 and TGF-β and malondialdehyde (MDA. Results OFI alone or the B. infantis strains with and without OFI improved significantly the DAI and decreased colonic MPO activity. Colonic tissue IL-1β decreased significantly in all treated groups except B. infantis DSM 15158. MDA decreased significantly in B. infantis DSM 15159 with and without OFI compared to colitis control. Succinic acid increased significantly in OFI group with and without DSM 15159 compared to all groups. Sum values of propionic, succinic acid and butyric acid increased significantly in all groups compare to the colitis control. Bacterial translocation to mesenteric lymph nodes decreased significantly in all groups compared to colitis control. Translocation to the liver decreased significantly in all groups compare to the colitis control and OFI + B. infantis DSM 15158 groups. Conclusion Administrations of OFI and Bifidobacterium improve DSS-induced acute colitis and have an anti-inflammatory effect. Major differences in effect

  19. 2型糖尿病患者与健康个体间肠道双歧杆菌的差异%Differences in fecal Bifidobacterium species between patients with type 2 diabetes and healthy individuals

    Institute of Scientific and Technical Information of China (English)

    许小津; 惠宏襄; 蔡德鸿

    2012-01-01

    Objective To determine the changes in fecal Bifidobacterium species in patients with type 2 diabetes in comparison with healthy individuals.Methods The bacterial DNA were extracted from the fecal samples from 50 type 2 diabetic patients and 30 healthy individuals.Real-time quantitative PCR was employed to determine the copy numbers of the bacteria in the fecal samples using 16S rRNA-targeted genus- and species-specific PCR primers for a selected group of fecal Bifidobacterium species including total Bifidobacterium,B.longum,B.breve,B.adolescentis,and B.infantis.Results The diabetic group had significantly lower copy numbers of total Bifidobacterium and B.adolescentis compared to the healthy individuals (P<0.05).Conclusion Type 2 diabetic patients have a lowered number of Bifidobacterium species in the gut microflora.%目的 研究2型精尿病患者与健康个体之间肠道双歧杆菌是否存在差异.方法 收集50例2型糖尿病患者和30例健康志愿者的粪便样品,提取样品中细菌总DNA,根据细菌的16SrRNA序列设计双歧杆菌总菌、长双歧杆菌、短双歧杆菌、青春双歧杆菌、婴儿双歧杆菌的属种特异性引物,并应用实时荧光定量PCR技术对两组人群粪便样品中的以上细菌进行定量检测和分析.结果 2型糖尿病患者组肠道双歧杆菌总菌和青春双歧杆菌的数量较健康对照组均显著减少(P<0.05).结论 2型糖尿病患者肠道双歧杆菌数量减少.

  20. The mechanism of bifidobacterium vinegar affecting the plasma lipid of rats fed with high-fat diet%双歧醋对高脂饮食大鼠血脂影响的机制探讨

    Institute of Scientific and Technical Information of China (English)

    李金玲; 张德纯; 刘永云; 陈翠竹; 王春耀

    2012-01-01

    Objective To discuss the prophylactic antiobesity effect of bifidobacterium vinegar and its possible mechanism. Methods 48 SD rats were randomly divided into 6 groups; bifidobacterium vinegar groups of three different doses, ordinary vineger group, high-fat model group and basic group. The possible mechanism of bifidobacterium vinegar affecting the plasma lipid of rats fed with high-fat diet was observed. The lipidoses in liver were measured; mRNA expression of LDLR and HMGCoA reductase in liver tissue were detected by immunohistochemistry and RT-PCR. Results The levels of HMGCoA re-ductase of bifidobacterium vinegar groups were depressed obviously compared with that of high-fat model group. Conclusion Bifidobacterium vinegar can prevent the occurance of high-fat in rats through adjusting the LDLR and HMGCoA reductase in liver to some degree.%目的 探讨双歧醋对高脂饮食大鼠血脂的影响机制.方法 48只SD大鼠被随机分成双歧醋低剂量组[1.8 mL/(kg·BW)]、中剂量组[3.4 mL/(kg· BW)]、高剂量组[6.8 mL/(kg·BW)]和市售醋组[3.4 mL/(kg·BW)]、高脂模型组以及基础对照组,观察双歧醋对高脂饮食大鼠血脂的影响作用机制,测定指标包括大鼠肝脏脂质、大鼠LDLR的免疫组化分析,HMGCoA还原酶和LDLR的RT-PCR分析.结果 双歧醋各组对于HMGCoA还原酶表达有抑制作用,但可以上调LDLR的基因和蛋白质表达.结论 双歧醋可以通过调节HMGCoA还原酶和LDLR的表达预防高脂饮食大鼠高血脂的发生.

  1. The influence of bifidobacterium vinegar on the plasama lipid of rat fed with high-fat diet%双歧醋对高脂饮食大鼠血脂的影响

    Institute of Scientific and Technical Information of China (English)

    李金玲; 张德纯; 王春耀; 郭亚楠

    2011-01-01

    目的 探讨双歧醋对高脂饮食大鼠血脂的影响作用.方法 48只SD大鼠被随机分成双歧醋低剂量组[1.8 mL/( kg·BW)]、中剂量组[3.4 mL/(kg · BW)]、高剂量组[6.8 mL/(kg · BW)]和市售醋组[3.4 mL/( kg·BW)]、高脂模型组以及正常组,观察双歧醋对高脂饮食大鼠血脂的影响作用,测定指标包括大鼠体重、肝指数、体脂指数、病理学观察肝脏脂肪变性等.结果 实验结果显示,双歧醋各组所有测定指标值都较高脂模型组有明显好转,特别是甘油三酯(TG)和高密度脂蛋白胆固醇(HDL-C)水平双歧杆菌醋的高、中量组与市售醋组比较差异有统计学意义(P<0.05).结论 双歧醋能有效预防高脂饮食大鼠的血脂水平升高,对预防体重、肝指数升高和肝脏脂肪变性也有一定作用.%Objective To discuss the prophylactic antiobesity effect of bifidobacterium vinegar and possible mechanism. Method 48 SD rats were randomly divided into 6 groups; bifidobacterium vinegar groups of three different doses, ordinary vineger group, high-fat model group and basic group. The effect of bifidobacterium vinegar on rats fed with high-fat diet was observed. Body weight, body fat index, fatty degeneration in liver were determined. Result All indicator values measured were improved obviously compared with high-fat model group. Particularly, TCHO, HDL-C levels of high and medium dosage bifidobacterium vinegar groups were improved obviously compared with ordinary vineger group. Conclusion Bifidobacterium vinegar can prevent rats fed with high-fat diet from development of high TG and HDL-C, and prevent the body weight, liver index, fatty degeneration in liver from increasing in some degree.

  2. 双歧杆菌胶囊治疗便秘型肠易激综合征的疗效%Curative Effect of Bifidobacterium Capsules on Constipation-predominant Irritable Bowel Syndrome

    Institute of Scientific and Technical Information of China (English)

    詹丽英; 彭国林; 李志晋; 马春曦; 徐红玲

    2011-01-01

    目的 探讨双歧杆菌胶囊治疗便秘型肠易激综合征(irritable bowel syndrome,IBS)的疗效和安全性.方法 50例便秘型IBS患者均采用双歧杆菌胶囊0.7g口服,每次2粒,每日3次,疗程为28 d.观察50例患者临床症状的改善及临床疗效、不良反应等情况.结果 50例患者中,治愈8例,显效28例,有效10例,无效4例,总有效率为92.0%.50例患者治疗后腹痛发生时间、腹痛发生次数、排便时腹痛、腹胀和排便性状异常比率、排便次数异常比率评分均较治疗前明显下降(P<0.05).在服药期间,发生腹泻1例,发热1例,经详细询问病史及行其他辅助检查后判定与服用双歧杆菌胶囊无关.结论 双歧杆菌可明显地改善便秘型IBS的临床症状,且安全性高、耐受性好.%Objective To evaluate the curative effect and safety of Bifidobacterium capsules in patients with constipation-predominant irritable bowel syndrome. Methods Fifty cases of constipation-predominant irritable bowel syndrome were treated with oral Bifidobacterium capsules (0. 7 g) three times per day (two capsules each time) for 28 days. The symptom improvement, curative effect,adverse reactions were observed in all patients. Results Among the 50 patients, complete cure was achieved in 8 and Bifidobacterium treatment was markedly effective in 28, effective in 10 and ineffective in 4 patients,with a total effective rate was 92. 0%. After treatment with Bifidobacterium capsules,occurrence time of abdominal pain, frequency of abdominal pain, abdominal pain during defecation,abdominal distention and abnormal defecation trait ratio,rate of abnormal defecation number decreased significantly (P<0. 05). During treatment with Bifidobacterium capsules,diarrhea occurred in 1 patient and fever in 1 patient. These two symptoms were not related to Bifidobacterium capsules through detailed history inquiry and other auxiliary examinations. Conclusion Bifidobacterium can effectively improve

  3. Myosin-cross-reactive antigen (MCRA) protein from Bifidobacterium breve is a FAD-dependent fatty acid hydratase which has a function in stress protection

    LENUS (Irish Health Repository)

    Rosberg-Cody, Eva

    2011-02-17

    Abstract Background The aim of this study was to determine the catalytic activity and physiological role of myosin-cross-reactive antigen (MCRA) from Bifidobacterium breve NCIMB 702258. MCRA from B. breve NCIMB 702258 was cloned, sequenced and expressed in heterologous hosts (Lactococcus and Corynebacterium) and the recombinant proteins assessed for enzymatic activity against fatty acid substrates. Results MCRA catalysed the conversion of palmitoleic, oleic and linoleic acids to the corresponding 10-hydroxy fatty acids, but shorter chain fatty acids were not used as substrates, while the presence of trans-double bonds and double bonds beyond the position C12 abolished hydratase activity. The hydroxy fatty acids produced were not metabolised further. We also found that heterologous Lactococcus and Corynebacterium expressing MCRA accumulated increasing amounts of 10-HOA and 10-HOE in the culture medium. Furthermore, the heterologous cultures exhibited less sensitivity to heat and solvent stresses compared to corresponding controls. Conclusions MCRA protein in B. breve can be classified as a FAD-containing double bond hydratase, within the carbon-oxygen lyase family, which may be catalysing the first step in conjugated linoleic acid (CLA) production, and this protein has an additional function in bacterial stress protection.

  4. Molecular identification and phylogenetic analysis of Lactobacillus and Bifidobacterium spp. isolated from gut of honeybees (Apis mellifera) from West Azerbaijan, Iran

    Science.gov (United States)

    Sharifpour, Mohammad Farouq; Mardani, Karim; Ownagh, Abdulghaffar

    2016-01-01

    Polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) and phylogenetic analysis were used for molecular identification of lactic acid bacteria (LABs) isolated from Apis mellifera. Eighteen honeybee workers were collected from three different apiaries in West Azerbaijan. LABs from the gut of honeybees were isolated and cultured using routine biochemical procedures. Genomic DNA was extracted from LABs and a fragment of 1540 bp in size of 16S rRNA gene was amplified. PCR products were digested using HinfI endonuclease and digested products with different RFLP patterns were subjected to nucleotide sequencing and phylogenetic analysis. The results revealed that Lactobacillus and Bifidobacteria spp. are were the most abundant LABs in honeybee gut. Phylogenetic analysis showed that both Lactobacillus and Bifidobacterium were closely clustered with high similarity percentage with the same bacteria isolated from honeybees’ gut elsewhere. It was concluded that LABs isolated from honeybees had low sequence divergence in comparison with LABs isolated from other sources such as dairy products. PMID:28144419

  5. Effective Lactobacillus plantarum and Bifidobacterium infantis encapsulation with chia seed (Salvia hispanica L.) and flaxseed (Linum usitatissimum L.) mucilage and soluble protein by spray drying.

    Science.gov (United States)

    Bustamante, Mariela; Oomah, B Dave; Rubilar, Mónica; Shene, Carolina

    2017-02-01

    Mucilage (M) and soluble protein (SP) extracted from chia seed and flaxseed were used as encapsulating material for two probiotic bacteria: Bifidobacterium infantis and Lactobacillus plantarum by spray drying. Probiotic survival and viability after spray drying and during storage were evaluated. B. infantis and L. plantarum displayed high survival (⩾98%) after encapsulation with mixtures of maltodextrin (MD) combined with M and SP from flaxseed (MD:FM:FSP - 7.5:0.2:7.5%, w/w/w) and chia seed (MD:CM:CSP - 7.5:0.6:7.5%, w/w/w), respectively. These ternary blends protected the probiotics and enhanced their resistance to simulated gastric juice and bile solution. Probiotics encapsulated with the ternary blends incorporated in instant juice powder exhibited high viability (>9Log10CFU/g) after 45days refrigerated storage. Encapsulation with the ternary blends reduced particle size of the probiotic powders thereby offering additional functional benefits. Our results reveal that chia seed and flaxseed are excellent sources of probiotic encapsulating agents.

  6. Effect of salt on cell viability and membrane integrity of Lactobacillus acidophilus, Lactobacillus casei and Bifidobacterium longum as observed by flow cytometry.

    Science.gov (United States)

    Gandhi, Akanksha; Shah, Nagendra P

    2015-08-01

    The aim of the current study was to investigate the effect of varying sodium chloride concentrations (0-5%) on viability and membrane integrity of three probiotic bacteria, Lactobacillus acidophilus, Lactobacillus casei and Bifidobacterium longum, using conventional technique and flow cytometry. Double staining of cells by carboxyfluorescein diacetate (cFDA) and propidium iodide (PI) enabled to evaluate the effect of NaCl on cell esterase activity and membrane integrity. Observations from conventional culture technique were compared with findings from flow cytometric analysis on the metabolic activities of the cells and a correlation was observed between culturability and dye extrusion ability of L. casei and B. longum. However, a certain population of L. acidophilus was viable as per the plate count method but its efflux activity was compromised. Esterase activity of most bacteria reduced significantly (P < 0.05) during one week storage at NaCl concentrations greater than 3.5%. The study revealed that L. casei was least affected by higher NaCl concentrations among the three probiotic bacteria, as opposed to B. longum where the cF extrusion performance was greatly reduced during 1 wk storage. The metabolic activity and salt resistance of L. casei was found to be highest among the bacteria studied.

  7. Effect of Lactobacillus acidophilus and Bifidobacterium bifidum supplementation to standard triple therapy on Helicobacter pylori eradication and dynamic changes in intestinal flora.

    Science.gov (United States)

    Wang, Yu-huan; Huang, Ying

    2014-03-01

    To investigate Lactobacillus acidophilus (L. acidophilus) and Bifidobacterium bifidum (B. bifidum) supplementation to triple therapy for Helicobacter pylori (H. pylori) eradication and dynamic changes in intestinal flora in children with H. pylori infection. One hundred H. pylori-infected children were randomly assigned to two groups: treatment group (n = 43), standard triple anti-H. pylori therapy plus probiotics of L. acidophilus and B. bifidum for 2 weeks followed by taking probiotics for another 4 weeks; control group (n = 45), standard triple anti-H. pylori therapy for 6 weeks. After 6-week treatment, ¹³C-urease breath test was performed and side effects were monitored during the observation period. Quantitative PCR with 16S rRNA-gene-targeted species-specific primers was carried out for the analysis of human intestinal B. bifidum, L. acidophilus, and Escherichia coli (E. coli). As expected, treatment group could significantly enhance the H. pylori eradication rate (83.7 vs. 64.4 %, P acidophilus, and E. coli showed no statistical difference before or after therapy in the treatment group. The number of B. bifidum and L. acidophilus was significantly decreased after 2-week treatment in the control group, but after 6-week treatment it significantly increased and nearly returned to the level before treatment. The number of E. coli increased significantly after 2-week treatment, while after 6-week treatment, it nearly decreased to the level before treatment. L. acidophilus and B. bifidum supplementation is effective for H. pylori eradication compared with triple therapy alone.

  8. Lactobacillus acidophilus La5 and Bifidobacterium lactis Bb12 cell surface hydrophobicity and survival of the cells under adverse environmental conditions.

    Science.gov (United States)

    Shakirova, Laisana; Grube, Mara; Gavare, Marita; Auzina, Lilija; Zikmanis, Peteris

    2013-01-01

    Changes in the cell surface hydrophobicity (CSH) of probiotic bacteria Lactobacillus acidophilus La5 and Bifidobacterium lactis Bb12 and the survival of these cells were examined in response to varied cultivation conditions and adverse environmental conditions. An inverse linear relationship (P acidophilus La5 and B. lactis Bb12 and survival of cells subjected to subsequent freezing/thawing, long-term storage or exposure to mineral and bile acids. The observed relationships were supported by significant correlations between the CSH and changes in composition of the cell envelopes (proteins, lipids and carbohydrates) of L. acidophilus La5 and B. lactis Bb12 examined using FT-IR spectroscopy and conventional biochemical analysis methods. The results also suggest that the estimates of hydrophobicity, being a generalized characteristic of cell surfaces, are important parameters to predict the ability of intact probiotic bacteria to endure extreme environments and therefore should be monitored during cultivation. A defined balance of cell components, which can be characterized by the reduced CSH values, apparently helps to ensure the resistance, improved viability and hence the overall probiotic properties of bacteria.

  9. Effect of the oral intake of yogurt containing Bifidobacterium longum BB536 on the cell numbers of enterotoxigenic Bacteroides fragilis in microbiota.

    Science.gov (United States)

    Odamaki, Toshitaka; Sugahara, Hirosuke; Yonezawa, Sumiko; Yaeshima, Tomoko; Iwatsuki, Keiji; Tanabe, Soichi; Tominaga, Tomoya; Togashi, Hideo; Benno, Yoshimi; Xiao, Jin-zhong

    2012-02-01

    Enterotoxigenic Bacteroides fragilis (ETBF) strains have been suggested to be associated with acute and persistent diarrheal disease, inflammatory bowel disease and colorectal cancer, although further epidemiological studies are needed for clarification. Here, a pilot study was performed to examine the effect of the oral administration of yogurt supplemented with a probiotic strain on the cell numbers of fecal ETBF in a healthy population. Among 420 healthy adults, 38 subjects were found to be ETBF carriers, giving a prevalence of approximately 9%. Among them, 32 subjects were enrolled in an open, randomized, parallel-group study to ingest yogurt supplemented with a probiotic strain, Bifidobacterium longum BB536 (BB536Y group), for 8 weeks, with milk provided to the control group (milk group). The cell numbers of ETBF and the dominant species of the B. fragilis group were measured by a quantitative PCR method. Compared with the baseline values, there was a significant decrease in the cell number of ETBF at week 8 in the BB536Y group but not in the milk group. Linear mixed models analysis for longitudinal data revealed a significant difference in the changes of ETBF cell number between the two groups during the intervention phase. These results imply the potential of probiotic yogurt for eliminating ETBF in the microbiota, but its clinical significance needs to be evaluated in the future. This is the first report of a possible effect of probiotic intake on ETBF in the microbiota.

  10. Suppressive effects of Bifidobacterium longum on the production of Th2-attracting chemokines induced with T cell-antigen-presenting cell interactions.

    Science.gov (United States)

    Iwabuchi, Noriyuki; Takahashi, Noritoshi; Xiao, Jin-Zhong; Yonezawa, Sumiko; Yaeshima, Tomoko; Iwatsuki, Keiji; Hachimura, Satoshi

    2009-04-01

    In human trials, Bifidobacterium longum BB536 alleviates subjective symptoms of Japanese cedar pollinosis, an IgE-mediated type I allergy caused by exposure to Japanese cedar, and significantly suppresses the increase of plasma thymus- and activation-regulated chemokine (TARC) associated with pollen dispersion. In the present study, we investigated the suppressive effects of BB536 on the production of T helper type 2 (Th2)-attracting chemokines, such as TARC and macrophage-derived chemokine (MDC), together with the mechanisms of their production. Murine splenocytes were cultured with heat-killed BB536, and the levels of Th2-attracting chemokines in the supernatants were measured. TARC and MDC were produced in cultures without stimulation, and the production was significantly suppressed by BB536. These chemokines were produced by antigen-presenting cells (APCs) of splenocytes stimulated with an anti-CD40 antibody. Furthermore, TARC production was induced with granulocyte macrophage colony-stimulating factor that was produced by T cells and dendritic cells. BB536 suppressed MDC production induced with the anti-CD40 antibody by APCs from the spleen, mesenteric lymph nodes (MLNs) and Peyer's patches, and it suppressed TARC production by APCs from the spleen and MLNs. These results indicate that BB536 suppresses the production of Th2-attracting chemokines induced by the T cell-APC interaction, suggesting a novel mechanism for alleviating symptoms of allergic disorders by probiotics.

  11. Cross-feeding between Bifidobacterium longum BB536 and acetate-converting, butyrate-producing colon bacteria during growth on oligofructose.

    Science.gov (United States)

    Falony, Gwen; Vlachou, Angeliki; Verbrugghe, Kristof; De Vuyst, Luc

    2006-12-01

    In vitro coculture fermentations of Bifidobacterium longum BB536 and two acetate-converting, butyrate-producing colon bacteria, Anaerostipes caccae DSM 14662 and Roseburia intestinalis DSM 14610, with oligofructose as the sole energy source, were performed to study interspecies interactions. Two clearly distinct types of cross-feeding were identified. A. caccae DSM 14662 was not able to degrade oligofructose but could grow on the fructose released by B. longum BB536 during oligofructose breakdown. R. intestinalis DSM 14610 could degrade oligofructose, but only after acetate was added to the medium. Detailed kinetic analyses of oligofructose breakdown by the last strain revealed simultaneous degradation of the different chain length fractions, in contrast with the preferential degradation of shorter fractions by B. longum BB536. In a coculture of both strains, initial oligofructose degradation and acetate production by B. longum BB536 took place, which in turn also allowed oligofructose breakdown by R. intestinalis DSM 14610. These and similar cross-feeding mechanisms could play a role in the colon ecosystem and contribute to the combined bifidogenic/butyrogenic effect observed after addition of inulin-type fructans to the diet.

  12. Fecal water genotoxicity is predictive of tumor-preventive activities by inulin-like oligofructoses, probiotics (Lactobacillus rhamnosus and Bifidobacterium lactis), and their synbiotic combination.

    Science.gov (United States)

    Klinder, Annett; Förster, Antje; Caderni, Giovanna; Femia, Angelo Pietro; Pool-Zobel, Beatrice L

    2004-01-01

    The measurement of fecal water genotoxicity in human colon cells could be a useful biomarker to study effects of diet in the colon. Here we assessed aqueous fecal extracts of samples from a chronic study with rats fed prebiotics, probiotics, and their combination. Treatments were maltodextrins (controls), inulin/oligofructoses (prebiotic), Lactobacillus rhamnosus, and Bifidobacterium lactis (probiotics) or both (synbiotic). Azoxymethane (AOM) was administered to initiate tumors. Rat feces were collected at 0 and 10 days and 2, 4, and 8 mo, and cecal contents were collected at 8 mo. Aqueous phases were prepared and tested for genotoxicity in HT29 colon cells using the comet assay. The studied types of intervention reduced fecal and cecal genotoxicity. DNA damage by samples from AOM-treated, tumor-free rats was significantly lower than from tumor-bearing animals, especially after 4 mo of synbiotic and prebiotic interventions. Inulin-based diets reduced exposure to genotoxins in the feces, directly reflecting the reported reduction of tumor incidence in these animals. Evidence is provided for the validity of this measurement as a biomarker of chemoprevention because 1) fecal water genotoxicity reflected genotoxic exposure in the cecum, 2) tumor incidence and fecal genotoxicity were directly related, and 3) these interventions reduced tumor risks by reducing exposure to genotoxins in the gut.

  13. Clostridium butyricum combined with Bifidobacterium infantis probiotic mixture restores fecal microbiota and attenuates systemic inflammation in mice with antibiotic-associated diarrhea.

    Science.gov (United States)

    Ling, Zongxin; Liu, Xia; Cheng, Yiwen; Luo, Yueqiu; Yuan, Li; Li, Lanjuan; Xiang, Charlie

    2015-01-01

    Antibiotic-associated diarrhea (AAD) is one of the most common complications of most types of antibiotics. Our aim was to determine the efficacy of Clostridium butyricum, Bifidobacterium infantis, and their mixture for AAD treatment in mice. AAD models were administered with single probiotic strain and probiotic mixture for short term and long term to evaluate the changes of the composition and diversity of intestinal microbiota, histopathology of the colon, and the systemic inflammation. Our data indicated that long-term probiotic therapy, but not short-term course, exerted beneficial effects on the restoration of the intestinal microbiota, the recovery of the tissue architecture, and attenuation of systemic inflammation. All predominant fecal bacteria reached normal level after the long-term probiotic mixture treatment, while IL-10, IFN-γ, and TNF-α also returned to normal level. However, the efficacy for AAD was time dependent and probiotic strain specific. Short-term administration of probiotic strains or mixture showed no apparent positive effects for AAD. In addition, the beneficial effects of C. butyricum combined with B. infantis probiotic mixture were superior to their single strain. This research showed that supplementation with C. butyricum combined with B. infantis probiotic mixture may be a simple and effective method for AAD treatment.

  14. Spray-drying process preserves the protective capacity of a breast milk-derived Bifidobacterium lactis strain on acute and chronic colitis in mice

    Science.gov (United States)

    Burns, Patricia; Alard, Jeanne; Hrdỳ, Jiri; Boutillier, Denise; Páez, Roxana; Reinheimer, Jorge; Pot, Bruno; Vinderola, Gabriel; Grangette, Corinne

    2017-01-01

    Gut microbiota dysbiosis plays a central role in the development and perpetuation of chronic inflammation in inflammatory bowel disease (IBD) and therefore is key target for interventions with high quality and functional probiotics. The local production of stable probiotic formulations at limited cost is considered an advantage as it reduces transportation cost and time, thereby increasing the effective period at the consumer side. In the present study, we compared the anti-inflammatory capacities of the Bifidobacterium animalis subsp. lactis (B. lactis) INL1, a probiotic strain isolated in Argentina from human breast milk, with the commercial strain B. animalis subsp. lactis BB12. The impact of spray-drying, a low-cost alternative of bacterial dehydration, on the functionality of both bifidobacteria was also investigated. We showed for both bacteria that the spray-drying process did not impact on bacterial survival nor on their protective capacities against acute and chronic colitis in mice, opening future perspectives for the use of strain INL1 in populations with IBD. PMID:28233848

  15. Survival of Lactobacillus acidophilus NCFM® and Bifidobacterium lactis HN019 encapsulated in chocolate during in vitro simulated passage of the upper gastrointestinal tract

    DEFF Research Database (Denmark)

    Klindt-Toldam, Stine; Larsen, Susanne K.; Saaby, Lasse

    2016-01-01

    Probiotic microorganisms are exposed to different types of stress both before and after consumption which strongly influences probiotic survival. Here the viability of 2 different probiotic bacteria incorporated in different types of chocolate was investigated during storage and passage of the up......Probiotic microorganisms are exposed to different types of stress both before and after consumption which strongly influences probiotic survival. Here the viability of 2 different probiotic bacteria incorporated in different types of chocolate was investigated during storage and passage...... of the upper gastro-intestinal tract using both a static and a dynamic gastric in vitro model. Lactobacillus acidophilus NCFM® and Bifidobacterium lactis HN019 equalling a total concentration of 2 × 108, 2 × 109 and 2 × 1010 CFU/g chocolate were added to samples of milk chocolate, 57% and 72% dark chocolate...... dairy and juice based probiotic products, chocolate was an excellent carrier for probiotic delivery, because of very good survival of probiotics during simulated passage of the upper GI tract. The viability of B. lactis was slightly higher than Lb. acidophilus and survival rates were >6.5 log CFU...

  16. Competitive inhibition of adherence of enterotoxigenic Escherichia coli,enteropathogenic Escherichia coli and Clostridium difficile to intestinal epithelial cell line Lovo by purified adhesin of Bifidobacterium adolescentis 1027

    Institute of Scientific and Technical Information of China (English)

    Shi-Shun Zhong; Zhen-Shu Zhang; Ji-De Wang; Zhuo-Sheng Lai; Qun-Ying Wang; Ling-Jia Pan; Yue-Xin Ren

    2004-01-01

    AIM: To observe competitive inhibition of adherence of enterotoxigenic Escherichia coli(ETEC), enteropathogenic Escherichia coli(EPEC) and Clostridium difficile ( C. difficile)to intestinal epithelial cell line Lovo by purified adhesin of Bifidobacterium adolescentis 1027 (B. ado 1027).METHODS: The binding of bacteria to intestinal epithelial cell line Lovo was counted by adhesion assay. The inhibition of adherence of ETEC, EPEC and C. difficile to intestinal epithelial cell line Lovo by purified adhesin of B. ado 1027was evaluated quantitatively by flow cytometry.RESULTS: The purified adhesin at the concentration of 10μg/mL, 20μg/mL and 30μg/mL except at 1μg/mL and 5μg/mL could inhibit significantly the adhesion of ETEC,EPEC and C. difficile to intestinal epithelial cell line Lovo.Moreover, we observed that a reduction in bacterial adhesion was occurred with increase in the concentration of adhesin,and MFI (Mean fluorescent intensity) was decreased with increase in the concentration of adhesin.CONCLUSION: The purified adhesin of B. ado 1027 can inhibit the adhesion of ETEC, EPEC and C. difficile to intestinal epithelial cell line Lovo in a dose-dependent manner.

  17. Genome-wide identification of small RNAs in Bifidobacterium animalis subsp. lactis KLDS 2.0603 and their regulation role in the adaption to gastrointestinal environment.

    Directory of Open Access Journals (Sweden)

    De-Quan Zhu

    Full Text Available Bifidobacteria are one of the predominant bacterial species in the human gastrointestinal tract (GIT and play a vital role in the host's health by acting as probiotics. However, how they regulate themselves to adapt to GIT of their host remains unknown.Eighteen bifidobacterial strains were used to analyze their adaptive capacities towards simulated GIT environment. The strain with highest survival rate and adhesion ability was selected for comparative genome as well as transcriptomic analysis.The Bifidobacterium animalis subsp. lactis KLDS 2.0603 strain was demonstrated to have the highest survival rate and adhesion ability in simulated GIT treatments. The comparative genome analysis revealed that the KLDS 2.0603 has most similar whole genome sequence compared with BB-12 strain. Eleven intergenic sRNAs were identified after genomes prediction and transcriptomic analysis of KLDS 2.0603. Transcriptomic analysis also showed that genes (mainly sRNAs targeted genes and sRNAs were differentially expressed in different stress conditions, suggesting that sRNAs might play a crucial role in regulating genes involved in the stress resistance of this strain towards environmental changes.This study first provided deep and comprehensive insights into the regulation of KLDS 2.0603 strain at transcription and post-transcription level towards environmental.

  18. Bifidobacterium bifidum OLB6378 Simultaneously Enhances Systemic and Mucosal Humoral Immunity in Low Birth Weight Infants: A Non-Randomized Study

    Science.gov (United States)

    Tanaka, Katsunori; Tsukahara, Takamitsu; Yanagi, Takahide; Nakahara, Sayuri; Furukawa, Ouki; Tsutsui, Hidemi; Koshida, Shigeki

    2017-01-01

    Probiotic supplementation has been part of the discussion on methods to enhance humoral immunity. Administration of Bifidobacterium bifidum OLB6378 (OLB6378) reduced the incidence of late-onset sepsis in infants. In this non-randomized study, we aimed to determine the effect of administration of live OLB6378 on infants’ humoral immunity. Secondly, we tried to elucidate whether similar effects would be observed with administration of non-live OLB6378. Low birth weight (LBW) infants weighing 1500–2500 g were divided into three groups: Group N (no intervention), Group L (administered live OLB6378 concentrate), and Group H (administered non-live OLB6378 concentrate). The interventions were started within 48 h after birth and continued until six months of age. Serum immunoglobulin G (IgG) levels (IgG at one month/IgG at birth) were significantly higher in Group L than in Group N (p food ingredient, showed a more marked effect than the viable bacteria. PMID:28245626

  19. Control of Klebsiella pneumoniae pulmonary infection and immunomodulation by oral treatment with the commensal probiotic Bifidobacterium longum 5(1A).

    Science.gov (United States)

    Vieira, Angélica T; Rocha, Victor M; Tavares, Luciana; Garcia, Cristiana C; Teixeira, Mauro M; Oliveira, Sérgio C; Cassali, Geovanni D; Gamba, Conrado; Martins, Flaviano S; Nicoli, Jacques R

    2016-03-01

    Klebsiella pneumoniae (Kp) a common cause of pneumonia leads to intense lung injury and mortality that are correlated with infective exacerbations. Probiotics are a class of microorganisms that have immunomodulatory effects to benefit health. We investigated whether the probiotic Bifidobacterium longum 5(1A) induces protection in mice against lung infection induced by Kp and the potential involved mechanisms. Kp infection induced secretion of pro-inflammatory cytokines, neutrophil recruitment, significant bacterial load in the lung and 50% lethality. However, treatment with live B. longum 5(1A) induced faster resolution of inflammation associated with an increased production of IL-10, decreased lung damage with significantly reduction of bacterial burden that contributed to rescue 100% of mice from death. We found that these effects could be attributed, at least in part, to activation of the Toll-like receptor (TLR) adapter protein Mal, since B. longum 5(1A) treatment in Mal-deficient infected mice did not show the protection observed in wild type infected mice. Thus, we propose that live B. longum 5(1A) activates TLR-signaling pathway that results in ROS production and protects the host against pneumonia-induced death by finely tuning the inflammatory response and contributing to faster return to lung homeostasis.

  20. Clostridium butyricum Combined with Bifidobacterium infantis Probiotic Mixture Restores Fecal Microbiota and Attenuates Systemic Inflammation in Mice with Antibiotic-Associated Diarrhea

    Directory of Open Access Journals (Sweden)

    Zongxin Ling

    2015-01-01

    Full Text Available Antibiotic-associated diarrhea (AAD is one of the most common complications of most types of antibiotics. Our aim was to determine the efficacy of Clostridium butyricum, Bifidobacterium infantis, and their mixture for AAD treatment in mice. AAD models were administered with single probiotic strain and probiotic mixture for short term and long term to evaluate the changes of the composition and diversity of intestinal microbiota, histopathology of the colon, and the systemic inflammation. Our data indicated that long-term probiotic therapy, but not short-term course, exerted beneficial effects on the restoration of the intestinal microbiota, the recovery of the tissue architecture, and attenuation of systemic inflammation. All predominant fecal bacteria reached normal level after the long-term probiotic mixture treatment, while IL-10, IFN-γ, and TNF-α also returned to normal level. However, the efficacy for AAD was time dependent and probiotic strain specific. Short-term administration of probiotic strains or mixture showed no apparent positive effects for AAD. In addition, the beneficial effects of C. butyricum combined with B. infantis probiotic mixture were superior to their single strain. This research showed that supplementation with C. butyricum combined with B. infantis probiotic mixture may be a simple and effective method for AAD treatment.

  1. Crystal structure of β1→6-galactosidase from Bifidobacterium bifidum S17: trimeric architecture, molecular determinants of the enzymatic activity and its inhibition by α-galactose.

    Science.gov (United States)

    Godoy, Andre Schutzer; Camilo, Cesar Moises; Kadowaki, Marco Antonio; Muniz, Heloisa Dos S; Espirito Santo, Melissa; Murakami, Mario Tyago; Nascimento, Alessandro S; Polikarpov, Igor

    2016-11-01

    In a search for better comprehension of β-galactosidase function and specificity, we solved the crystal structures of the GH42 β-galactosidase BbgII from Bifidobacterium bifidum S17, a well-adapted probiotic microorganism from the human digestive tract, and its complex with d-α-galactose. BbgII is a three-domain molecule that forms barrel-shaped trimers in solution. BbgII interactions with d-α-galactose, a competitive inhibitor, showed a number of residues that are involved in the coordination of ligands. A combination of site-directed mutagenesis of these amino acid residues with enzymatic activity measurements confirmed that Glu161 and Glu320 are fundamental for catalysis and their substitution by alanines led to catalytically inactive mutants. Mutation Asn160Ala resulted in a two orders of magnitude decrease of the enzyme kcat without significant modification in its Km , whereas mutations Tyr289Phe and His371Phe simultaneously decreased kcat and increased Km values. Enzymatic activity of Glu368Ala mutant was too low to be detected. Our docking and molecular dynamics simulations showed that the enzyme recognizes and tightly binds substrates with β1→6 and β1→3 bonds, while binding of the substrates with β1→4 linkages is less favorable.

  2. Molecular identification and phylogenetic analysis of Lactobacillus and Bifidobacterium spp. isolated from gut of honeybees (Apis mellifera) from West Azerbaijan, Iran.

    Science.gov (United States)

    Sharifpour, Mohammad Farouq; Mardani, Karim; Ownagh, Abdulghaffar

    2016-01-01

    Polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) and phylogenetic analysis were used for molecular identification of lactic acid bacteria (LABs) isolated from Apis mellifera. Eighteen honeybee workers were collected from three different apiaries in West Azerbaijan. LABs from the gut of honeybees were isolated and cultured using routine biochemical procedures. Genomic DNA was extracted from LABs and a fragment of 1540 bp in size of 16S rRNA gene was amplified. PCR products were digested using HinfI endonuclease and digested products with different RFLP patterns were subjected to nucleotide sequencing and phylogenetic analysis. The results revealed that Lactobacillus and Bifidobacteria spp. are were the most abundant LABs in honeybee gut. Phylogenetic analysis showed that both Lactobacillus and Bifidobacterium were closely clustered with high similarity percentage with the same bacteria isolated from honeybees' gut elsewhere. It was concluded that LABs isolated from honeybees had low sequence divergence in comparison with LABs isolated from other sources such as dairy products.

  3. Bifidobacterium bifidum OLB6378 Simultaneously Enhances Systemic and Mucosal Humoral Immunity in Low Birth Weight Infants: A Non-Randomized Study

    Directory of Open Access Journals (Sweden)

    Katsunori Tanaka

    2017-02-01

    Full Text Available Probiotic supplementation has been part of the discussion on methods to enhance humoral immunity. Administration of Bifidobacterium bifidum OLB6378 (OLB6378 reduced the incidence of late-onset sepsis in infants. In this non-randomized study, we aimed to determine the effect of administration of live OLB6378 on infants’ humoral immunity. Secondly, we tried to elucidate whether similar effects would be observed with administration of non-live OLB6378. Low birth weight (LBW infants weighing 1500–2500 g were divided into three groups: Group N (no intervention, Group L (administered live OLB6378 concentrate, and Group H (administered non-live OLB6378 concentrate. The interventions were started within 48 h after birth and continued until six months of age. Serum immunoglobulin G (IgG levels (IgG at one month/IgG at birth were significantly higher in Group L than in Group N (p < 0.01. Group H exhibited significantly higher serum IgG levels (p < 0.01 at one month of age and significantly higher intestinal secretory immunoglobulin A (SIgA levels (p < 0.05 at one and two months of age than Group N. No difference was observed in the mortality or morbidity between groups. Thus, OLB6378 administration in LBW infants enhanced humoral immunity, and non-live OLB6378, which is more useful as a food ingredient, showed a more marked effect than the viable bacteria.

  4. Identification of restriction-modification systems of Bifidobacterium animalis subsp. lactis CNCM I-2494 by SMRT sequencing and associated methylome analysis.

    Science.gov (United States)

    O' Connell Motherway, Mary; Watson, Debbie; Bottacini, Francesca; Clark, Tyson A; Roberts, Richard J; Korlach, Jonas; Garault, Peggy; Chervaux, Christian; van Hylckama Vlieg, Johan E T; Smokvina, Tamara; van Sinderen, Douwe

    2014-01-01

    Bifidobacterium animalis subsp. lactis CNCM I-2494 is a component of a commercialized fermented dairy product for which beneficial effects on health has been studied by clinical and preclinical trials. To date little is known about the molecular mechanisms that could explain the beneficial effects that bifidobacteria impart to the host. Restriction-modification (R-M) systems have been identified as key obstacles in the genetic accessibility of bifidobacteria, and circumventing these is a prerequisite to attaining a fundamental understanding of bifidobacterial attributes, including the genes that are responsible for health-promoting properties of this clinically and industrially important group of bacteria. The complete genome sequence of B. animalis subsp. lactis CNCM I-2494 is predicted to harbour the genetic determinants for two type II R-M systems, designated BanLI and BanLII. In order to investigate the functionality and specificity of these two putative R-M systems in B. animalis subsp. lactis CNCM I-2494, we employed PacBio SMRT sequencing with associated methylome analysis. In addition, the contribution of the identified R-M systems to the genetic accessibility of this strain was assessed.

  5. 双歧杆菌对坏死性小肠结肠炎新生鼠模型肠损伤的保护%Protection of bifidobacterium from damage to neonatal rat model of necrotizing enterocolitis

    Institute of Scientific and Technical Information of China (English)

    蔺小培; 顾志成

    2013-01-01

    【Objective】 To research bifidobacterium's effects on tumor necrosis factor-α (TNF-α) and interleukin-10 (IL-10) in intestinal tissue of neonatal SD rat model of necrotizing enterocolitis (NEC) and to investigate the protective effects of bifidobacterium against NEC. 【Method】 128 neonate Sprague-Dewley (SD) rats aged 2 days were divided into four groups at random:LPS group( A) ,LPS+bifidobacterium group(B) .normal saline group (C) and bifidobacterium group (D). After received injection of LPS for a week, eight rats, which were selected form each group at random, were killed quickly respectively at 2,6,12 and 24 hours through decollation. The intestinal tissue obtained,the ileocecal junction was for histological analysis,and the remains was used to measure the level of TNF-α and IL-10 through ELISA method. 【Results】 Compared to group A,the scores of intestinal histologic pathological injury of group B at 2,6,12,24 hours were significantly lower (P<0.05) and the levels of TNF-α in ileal tissue of group B at 2,6,12 hours were significantly lower(P< 0. 05). Also compared to group A,the levels of IL-10 in ileal tissue of group B at 2,6,12,24 hours were significantly higher (P<0. 05). Statistics showed that TNF-α level had positive correlation with the scores of neonatal rats of intestinal histologic injury (r=0. 646) and IL-10 level had negative correlation with the scores of neonatal rats of intestinal histologic injury (r = -0. 598). 【Conclusion】Bifidobacterium could reduce the level of TNF- a and increase the level of IL-10 of NEC model, bifidobacterium provides protection from NEC.%[目的]研究双歧杆菌对坏死性小肠结肠炎(necrotizing enterocolitis,NEC)模型新生SD大鼠肠组织TNF-α及IL-10水平的影响,探讨双歧杆菌对NEC的保护作用. [方法] 2日龄SD大鼠128只随机分成LPS组(A组)、LPS+双歧杆菌组(B组)、生理盐水对照组(C组)、双歧杆菌对照组(D组),一周后,腹腔注射LPS后2、6、12、24

  6. Construction of Bifidobacterium Infantis/CD Targeting Gene Therapy System%婴儿双歧杆菌/胞嘧啶脱氨酶肿瘤靶向性基因治疗系统的构建

    Institute of Scientific and Technical Information of China (English)

    易成; 黄英; 郭志英; 王树人

    2005-01-01

    目的构建婴儿双歧杆菌/胞嘧啶脱氨酶靶向性基因治疗系统.方法 PCR扩增CD基因,EcoR Ⅰ,BamH Ⅰ对CD基因和pGEX-1LamdaT质粒同时进行双酶切,获得4.9 kb、1.3 kb两个DNA片段.T4 DNA连接酶连接这两个片段构建重组的CD/pGEX-1LamdaT质粒,然后用电穿孔法将重组质粒转染婴儿双歧杆菌.从阳性转染的婴儿双歧杆菌中提取重组质粒,双酶切后检测切取片段长度,采用Sanger双脱氧链终止法对提取的重组质粒中的插入片段进行测序.结果从阳性转染的婴儿双歧杆菌中获得了6.2 kb大小的重组质粒,该质粒经双酶切后,得到了4.9 kb和1.3 kb两个长度的片段,其长度分别与pGEX-1LambdaT及CD基因的长度相同.测序结果显示,提取的重组质粒中插入的基因片段全长及核苷酸序列与CD基因完全相同.结论外源性CD基因被准确插入pGEX-1LambdaT质粒并转入婴儿双歧杆菌中,婴儿双歧杆菌/胞嘧啶脱氨酶靶向性基因治疗系统被成功构建.%Objective: To construct Bifidobacterium Infantis/CD targeting gene therapy systen. Methods:CD gene was amplified from E. Coli K12λ using PCR method. pGEX-1LamdaT plasmid and CD gene were digested with dual restriction endonucleas of EcoR I and BamH I and two segments of 4.9 kb and 1.3 kb were obtained. T4 DNA ligase was added to these two segments to make a recombinant CD/pGEX-1LamdaT plasmid. Then the recombinant plasmid was transfected into Bifidobacterium Infantis by electroporation.The recombinant plasmid was extracted from the positively transfected Bifidobacterium Infantis and digested with dual restriction endonucleases. Then the size of digested fragments was detected and sequencing of the gene segment inserted in extracted recombinant plasmid was performed according to the method of Sanger dideoxynucleotide triphosphate chain termination. Results: 6.2 kb recombinant plasmid was obtained from the positively transfected bacterial colony of Bifidobacterium

  7. Tetralogy of viable Bifidobacterium tablets combined with Methylcobalamin in treatment of diabetic diarrhea%双歧杆菌四联活菌联合甲钴胺治疗糖尿病腹泻疗效观察

    Institute of Scientific and Technical Information of China (English)

    邢云风; 龙新胜; 曾燕霞

    2013-01-01

    Objective:To observe the effect of Mecobalamin Combined with viable Bifidobacterium quadruple on diabetic diarrhea. Methods:58 cases were divided into two groups at random. 28 cases of the treatment group was treated with Tetralogy of Viable Bifidobacterium tables combined with Mecebalamin and 28 cases of the control group was treated with Mecebalamin in a 21days treatment course. Results:the effective rate of treatment group 85.7%, control group was 60.7%, there was statistical y significant difference between two groups (P<0.05). Conclusion:The tetralogy of viable Bifidobacterium tablets combined with Mecobalamin in treating diabetes diarrhea has a bet er clinical therapeutic effect than mecobalamin only.%目的:观察甲钴胺联合双歧杆菌四联活菌治疗糖尿病性腹泻的效果。方法:56例患者随机分成治疗组28例和对照组28例,治疗组采用双歧杆菌四联活菌联合甲钴胺治疗,对照组单用甲钴胺治疗,21天为1疗程;结果:治疗组有效率85.7%,对照组有效率60.7%,两组间比较差异有统计学意义(P<0.05)。结论:双歧杆菌联合甲钴胺治疗糖尿病性腹泻效果优于单用甲钴胺。

  8. Anti-inflammatory activity of probiotic Bifidobacterium:Enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells

    Institute of Scientific and Technical Information of China (English)

    Akemi Imaoka; Tatsuichiro Shima; Kimitoshi Kato; Shigeaki Mizuno; Toshiki Uehara; Satoshi Matsumoto; Hiromi Setoyama; Taeko Hara; Yoshinori Umesaki

    2008-01-01

    AIM: To determine the anti-inflammatory activity of probiotic Bifidobacteria in Bifidobacteria-fermented milk (BFM) which is effective against active ulcerative colitis (UC) and exacerbations of UC, and to explore the immunoregulatory mechanisms.METHODS: Peripheral blood mononuclear cells (PBMNC)from UC patients or HT-29 cells were co-cultured with heat-killed probiotic bacteria or culture supernatant of Bifidobacterium breve strain Yakult (BbrY) or Bifidobacterium bifidum strain Yakult (BbiY) to estimate the amount of IL-10 or IL-8 secreted.RESULTS: Both strains of probiotic Bifidobacteria contained in the BFM induced IL-10 production in PBMNC from UC patients, though BbrY was more effective than BbiY.Conditioned medium (CM) and DNA of both strains inhibited IL-8 secretion in HT-29 cells stimulated with TNF-α, whereas no such effect was observed with heatkilled bacteria.The inhibitory effect of CM derived from BbiY was greater than that of CM derived from BbrY.DNAs of the two strains had a comparable inhibitory activity against the secretion of IL-8.CM of BbiY induced a repression of IL-8 gene expression with a higher expression of IκB-ζ mRNA 4 h after culture of HT-29 cells compared to that in the absence of CM.CONCLUSION: Probiotic Bifidobacterium strains in BFM enhance IL-10 production in PBMNC and inhibit IL-8 secretion in intestinal epithelial cells, suggesting that BFM has anti-inflammatory effects against ulcerative colitis.

  9. Biological Characters and the Physiological Fuctions of Bifidobacterium in Human Body%双歧杆菌的生物学特性及对人体的生理功能

    Institute of Scientific and Technical Information of China (English)

    徐营; 李霞; 杨利国

    2001-01-01

    双歧杆菌(Bifidobacterium)是一种革兰氏阳性菌,具有革兰氏阳性菌典型的生理特征.研究发现,双歧杆菌作为一种生理性有益菌,对人体健康具有生物屏障、营养作用、抗肿瘤作用、免疫增强作用、改善胃肠道功能、抗衰老等多种重要的生理功能.

  10. Impact of Environmental Factors on Biofilm Formation by Bifidobacterium Longium CICC6069%环境因素对长双歧杆菌CICC6069生物膜生成的影响

    Institute of Scientific and Technical Information of China (English)

    徐文生; 张艳艳; 黄漫青; 艾启俊; 王晓东; 张磊; 仝其根

    2012-01-01

    Objective: The impact of different environmental factor on biofilm formation by Bifidabacterium longium CICC 6069 was studied. Methods: The nutritional and environmental conditions of Bifidobacterium longium CICC 6069 culture were changed by systematically adding or removing the medium compounds from MRS or TSB, to determine the impact of different environmental conditions on biofilm formation by Bifidobacterium longium CICC 6069. Results: Biofilm assays indicated that in vitro biofilm formation by Bifidobacterium longium CICC 6069 was modulated by environmental conditions. Glucose, osmolarity and MgS04 increased in biofilm formation, while an inhibitory effect of EDTA, soy peptone and pH on biofilm formation could be observed. MnS04 on biofilm formation was shown to be medium dependent. Conclusion: The biofilm formation by Bifidubaclermm longium CICC 6069 was dependent on environment conditions. Different environmental factors had different impact on biofilm formation by Bifidobacterium longium CICC 6069, among them, glucose, NaCl and MgSO4 were significantly affected.%目的:研究不同环境因子对长双歧杆菌CICC6069生物膜生成能力的影响.方法:通过增添或删除培养基MRS和TSB的组成成分,改变双歧杆菌培养的营养和环境条件,测定不同条件对双歧杆菌生物膜生成的影响.结果:不同环境因子对双歧杆菌生物膜生成的影响不同,葡萄糖、MgSO4及渗透压可促进长双歧杆菌CICC6069生物膜的生成;EDTA、大豆蛋白胨及pH可抑制长双歧杆菌生物膜的生成;MnSO4对双歧杆菌生物膜生成的影响有培养基依赖性.结论:长双歧杆菌CICC6069生物膜的生成依赖环境条件,不同环境因子对长双歧杆菌生物膜的生成有不同的影响.其中,MgSO4、NaCl、葡萄糖对双歧杆菌生物膜生成的影响比较显著.

  11. Effect of inulin on the growth and survival of Bifidobacterium longum BB536 in fermented goat’s and cow’s milk

    Directory of Open Access Journals (Sweden)

    Marina Šimunek

    2009-09-01

    Full Text Available Fermented dairy products were made from standardized goat and cow milk (2.9 % milk fat with addition of 3 % skimmed milk powder (control samples, or with addition of 2 % inulin and 1 % skimmed milk powder (experimental samples. Fermentation of samples was carried out at 40 °C by thermophilic yoghurt culture YC-380 and probiotic culture Bifidobacterium longum BB536. Desired acidity (pH around 4.5 was achieved in all samples in about 5.5 h. Viable count of probiotic strain (logN/m increased for all samples for on average 1.4 logarithmic units except for the sample of cow’s milk supplemented with inulin, which exhibited the highest growth of bifidobacteria for approximately 1.7 logarithmic units. During fermentation somewhat faster decrease of pH-value was observed in goat milk samples compared to cow milk samples. At the end of fermentation there was no statistically significant difference (P>0.05 in pH-values regardless of milk origin or inulin addition. During thirty days of fermented drink storage at lower temperature (about 6 °C, slightly lower pH-values were observed in cow milk samples compared to goat milk, especially in cow milk enriched with inulin. During storage, until the 15th day, an increase in the number of viable count of probiotic bacteria was observed in all samples, while from 20th to 30th day a decrease of 0.5 logarithmic units of the same parameter was recorded. In goat milk their survival was somewhat smaller compared to cow milk. The number of bifidobacteria in samples supplemented with inulin on the last day of storage, compared to control samples, was higher for 0.3 logarithmic units, regardless of the milk origin. After thirty days of refrigerated storage, recommended concentration of bifidobacteria was insured in all samples, thus directly implying that these fermented drinks can be included in probiotics.

  12. Effect of Lactobacillus rhamnosus LGG® and Bifidobacterium animalis ssp. lactis BB-12® on health-related quality of life in college students affected by upper respiratory infections.

    Science.gov (United States)

    Smith, Tracey J; Rigassio-Radler, Diane; Denmark, Robert; Haley, Timothy; Touger-Decker, Riva

    2013-06-01

    College students are susceptible to upper respiratory infections (URI) due to inadequate sleep, stress and close living quarters. Certain probiotic strains modulate immune function and may improve health-related quality of life (HRQL) during URI. The present study recruited apparently healthy college students and assessed the effect of probiotics on HRQL outcomes (i.e. self-reported duration, symptom severity and functional impairment of URI) in those who developed URI. Missed school and work days due to URI were also considered. Subjects (n 231) were apparently healthy college students living on campus in residence halls at the Framingham State University (Framingham, MA, USA), and were randomised to receive placebo (n 117) or probiotic-containing powder (daily dose of minimum 1 billion colony-forming units of each Lactobacillus rhamnosus LGG® (LGG®) and Bifidobacterium animalis ssp. lactis BB-12® (BB-12®); n 114) for 12 weeks. Subjects completed The Wisconsin Upper Respiratory Symptom Survey-21 to assess HRQL during URI. The final analyses included 198 subjects (placebo, n 97 and probiotics, n 101). The median duration of URI was significantly shorter by 2 d and median severity score was significantly lower by 34% with probiotics v. placebo (P,0·001), indicating a higher HRQL during URI. Number of missed work days was not different between groups (P=0·429); however, the probiotics group missed significantly fewer school days (mean difference = 0·2 d) compared to the placebo group (P=0·002). LGG® and BB-12® may be beneficial among college students with URI for mitigating decrements in HRQL. More research is warranted regarding mechanisms of action associated with these findings and the cost-benefit of prophylactic supplementation.

  13. Integration of genomic and proteomic data to identify candidate genes in HT-29 cells after incubation with Bifidobacterium bifidum ATCC 29521.

    Science.gov (United States)

    Wang, Bao-Gui; Wu, Yaoping; Qiu, Liang; Shah, Nagendra P; Xu, Feng; Wei, Hua

    2016-09-01

    As the predominant group inhabiting the human gastrointestinal tract, bifidobacteria play a vital role in human nutrition, therapeutics, and health by shaping and maintaining the gut ecosystem, reducing blood cholesterol, and promoting the supply of nutrients. The interaction between bacterial cells and human intestinal epithelial cell lines has been studied for decades in an attempt to understand the mechanisms of action. These studies, however, have been limited by lack of genomic and proteomic database to aid in achieving comprehensive understanding of these mechanisms at molecular levels. Microarray data (GSE: 74119) coupled with isobaric tags for relative and absolute quantitation (iTRAQ) were performed to detect differentially expressed genes and proteins in HT-29 cells after incubation with Bifidobacterium bifidum. Real-time quantitative PCR, gene ontology, and Kyoto Encyclopedia of Genes and Genomes analyses were further conducted for mRNA validation, functional annotation, and pathway identification, respectively. According to the results of microarray, 1,717 differentially expressed genes, including 1,693 upregulated and 24 downregulated genes, were selected and classified by the gene ontology database. The iTRAQ analysis identified 43 differentially expressed proteins, where 29 proteins were upregulated and 14 proteins were downregulated. Eighty-two candidate genes showing consistent differences with microarray and iTRAQ were further validated in HT-29 and Caco-2 cells by real-time quantitative PCR. Nine of the top genes showing interesting results with high confidence were further investigated in vivo in mice intestine samples. Integration of genomic and proteomic data provides an approach to identify candidate genes that are more likely to function in ubiquitin-mediated proteolysis, positive regulation of apoptosis, membrane proteins, and transferase catalysis. These findings might contribute to our understanding of molecular mechanisms regulating the

  14. Safety of Bifidobacterium animalis subsp. lactis (B. lactis) strain BB-12-supplemented yogurt in healthy adults on antibiotics: a phase I safety study.

    Science.gov (United States)

    Merenstein, Daniel J; Tan, Tina P; Molokin, Aleksey; Smith, Keisha Herbin; Roberts, Robert F; Shara, Nawar M; Mete, Mihriye; Sanders, Mary Ellen; Solano-Aguilar, Gloria

    2015-01-01

    Probiotics are live microorganisms that, when administered in sufficient doses, provide health benefits on the host. The United States Food and Drug Administration (FDA) requires phase I safety studies for probiotics when the intended use of the product is as a drug. The purpose of the study was to determine the safety of Bifidobacterium animalis subsp lactis (B. lactis) strain BB-12 (BB-12)-supplemented yogurt when consumed by a generally healthy group of adults who were prescribed a 10-day course of antibiotics for a respiratory infection. Secondary aims were to assess the ability of BB-12 to affect the expression of whole blood immune markers associated with cell activation and inflammatory response. A phase I, double-blinded, randomized controlled study was conducted in compliance with FDA guidelines for an Investigational New Drug (IND). Forty participants were randomly assigned to consume 4 ounces of either BB-12 -supplemented yogurt or non-supplemented control yogurt daily for 10 d. The primary outcome was to assess safety and tolerability, assessed by the number of reported adverse events. A total of 165 non-serious adverse events were reported, with no differences between the control and BB-12 groups. When compared to the control group, B lactis fecal levels were modestly higher in the BB-12-supplemented group. In a small subset of patients, changes in whole blood expression of genes associated with regulation and activation of immune cells were detected in the BB-12-supplemented group. BB-12-supplemented yogurt is safe and well tolerated when consumed by healthy adults concurrently taking antibiotics. This study will form the basis for future randomized clinical trials investigating the potential immunomodulatory effects of BB-12-supplemented yogurt in a variety of disease states.

  15. Development of a rapid SNP-typing assay to differentiate Bifidobacterium animalis ssp. lactis strains used in probiotic-supplemented dairy products.

    Science.gov (United States)

    Lomonaco, Sara; Furumoto, Emily J; Loquasto, Joseph R; Morra, Patrizia; Grassi, Ausilia; Roberts, Robert F

    2015-02-01

    Identification at the genus, species, and strain levels is desirable when a probiotic microorganism is added to foods. Strains of Bifidobacterium animalis ssp. lactis (BAL) are commonly used worldwide in dairy products supplemented with probiotic strains. However, strain discrimination is difficult because of the high degree of genome identity (99.975%) between different genomes of this subspecies. Typing of monomorphic species can be carried out efficiently by targeting informative single nucleotide polymorphisms (SNP). Findings from a previous study analyzing both reference and commercial strains of BAL identified SNP that could be used to discriminate common strains into 8 groups. This paper describes development of a minisequencing assay based on the primer extension reaction (PER) targeting multiple SNP that can allow strain differentiation of BAL. Based on previous data, 6 informative SNP were selected for further testing, and a multiplex preliminary PCR was optimized to amplify the DNA regions containing the selected SNP. Extension primers (EP) annealing immediately adjacent to the selected SNP were developed and tested in simplex and multiplex PER to evaluate their performance. Twenty-five strains belonging to 9 distinct genomic clusters of B. animalis ssp. lactis were selected and analyzed using the developed minisequencing assay, simultaneously targeting the 6 selected SNP. Fragment analysis was subsequently carried out in duplicate and demonstrated that the assay yielded 8 specific profiles separating the most commonly used commercial strains. This novel multiplex PER approach provides a simple, rapid, flexible SNP-based subtyping method for proper characterization and identification of commercial probiotic strains of BAL from fermented dairy products. To assess the usefulness of this method, DNA was extracted from yogurt manufactured with and without the addition of B. animalis ssp. lactis BB-12. Extracted DNA was then subjected to the minisequencing

  16. Bifidobacterium animalis subsp. lactis BB-12 administration in early childhood: a randomized clinical trial of effects on oral colonization by mutans streptococci and the probiotic.

    Science.gov (United States)

    Taipale, T; Pienihäkkinen, K; Salminen, S; Jokela, J; Söderling, E

    2012-01-01

    A randomized clinical trial studied the effects of early administration of Bifidobacterium animalis subsp. lactis BB-12 (BB-12) on oral colonization of (1) mutans streptococci (MS), and (2) BB-12. In this double-blind, placebo-controlled study, infants (n = 106) received probiotic bacteria (BB-12 group), xylitol (X group), or sorbitol (S group). Test tablets were administered twice a day (from the age of 1-2 months) with a novel slow-release pacifier or a spoon (daily dose of BB-12 10(10) CFU, polyol 200-600 mg). Samples were collected from mucosa/teeth at the age of 8 months and 2 years for BB- 12 determination (qPCR) and plate culturing of MS (MSB, TYCSB), lactobacilli (Rogosa) and yeasts (Sabouraud). The MS levels of the mothers were determined (Dentocult SM Strip Mutans). The baseline characteristics of the three groups were similar. Mean duration of tablet delivery was 14.9 ± 6.7 months. In all groups, >90% of the mothers showed high MS counts (log CFU ≥5). MS colonization percentages of the children at the age of 2 years were rather low (BB-12 group: 6%; X group: 31%; S group: 10%; p < 0.05). The levels of lactobacilli and yeasts did not differ between the groups. BB-12 cell counts barely exceeding the detection limit were found in three of the oral samples of the 8-month-old children; however, the 2-year samples did not contain BB-12. The early administration of BB-12 did not result in permanent oral colonization of this probiotic or significantly affect MS colonization in the children.

  17. Efecto bifidogénico de jalea de Lepidium meyenii Walp. “maca” en el recuento de Bifidobacterium bifidum en yogurt probiótico

    Directory of Open Access Journals (Sweden)

    María Elena León Marroú

    2011-06-01

    Full Text Available Los recuentos de Bifidobacterium bifidum en yogures probióticos tienden a disminuir de manera significativa por diferentes factores: pH, oxígeno disuelto, composición antagónica entre las especies, la composición química del medio, temperatura de almacenamiento, entre otros. Para asegurar que la eficacia de los productos que contienen B. bifidum sea máxima a menudo se incluyen factores bifidogénicos, los cuales tienen la propiedad de promover no solo el crecimiento adecuado, sino también su viabilidad durante el almacenamiento del producto final. El presente estudio investigó sobre el recuento de B. bifidum en yogurt probiótico elaborado en condiciones de laboratorio en relación a dos variables: adición de tres concentraciones diferentes de jalea de Lepidium meyenii “maca” (10 %, 20 % y 30 % y tiempo de almacenamiento. Se realizó el recuento de B. bifidum cada tres días, durante un mes. Se utilizó el método de recuento en placa por siembra en profundidad. Los resultados indicaron que todas las muestras a las que se añadieron jalea de L. meyenii “maca” en diferentes concentraciones mantuvieron recuentos de B. bifidum por encima de los valores establecidos por las normas internacionales. Se concluye que L. meyenii “maca”, en razón de algunos de sus componentes, ejerció un efecto bifidogénico y en concentración de 30 % de jalea fue mayor.

  18. Efecto bifidogénico de jalea de Lepidium meyenii Walp. “maca” en el recuento de Bifidobacterium bifidum en yogurt probiótico

    Directory of Open Access Journals (Sweden)

    María Elena León Marroú

    2011-01-01

    Full Text Available Los recuentos de Bifidobacterium bifidum en yogures probióticos tienden a disminuir de manera significativa por diferentes factores: pH, oxígeno disuelto, composición antagónica entre las especies, la composición química del medio, temperatura de almacenamiento, entre otros. Para asegurar que la eficacia de los productos que contienen B. bifidum sea máxima a menudo se incluyen factores bifidogénicos, los cuales tienen la propiedad de promover no solo el crecimiento adecuado, sino también su viabilidad durante el almacenamiento del producto final. El presente estudio investigó sobre el recuento de B. bifidum en yogurt probiótico elaborado en condiciones de laboratorio en relación a dos variables: adición de tres concentraciones diferentes de jalea de Lepidium meyenii “maca” (10 %, 20 % y 30 % y tiempo de almacenamiento. Se realizó el recuento de B. bifidum cada tres días, durante un mes. Se utilizó el método de recuento en placa por siembra en profundidad. Los resultados indicaron que todas las muestras a las que se añadieron jalea de L. meyenii “maca” en diferentes concentraciones mantuvieron recuentos de B. bifidum por encima de los valores establecidos por las normas internacionales. Se concluye que L. meyenii “maca”, en razón de algunos de sus componentes, ejerció un efecto bifidogénico y en concentración de 30 % de jalea fue mayor.

  19. Protective effect of Bifidobacterium infantis CGMCC313-2 on ovalbumin-induced airway asthma and β-lactoglobulin-induced intestinal food allergy mouse models

    Science.gov (United States)

    Liu, Meng-Yun; Yang, Zhen-Yu; Dai, Wen-Kui; Huang, Jian-Qiong; Li, Yin-Hu; Zhang, Juan; Qiu, Chuang-Zhao; Wei, Chun; Zhou, Qian; Sun, Xin; Feng, Xin; Li, Dong-Fang; Wang, He-Ping; Zheng, Yue-Jie

    2017-01-01

    AIM To determine whether oral administration of Bifidobacterium infantis CGMCC313-2 (B. infantis CGMCC313-2) inhibits allergen-induced airway inflammation and food allergies in a mouse model. METHODS Ovalbumin (OVA)-induced allergic asthma and β-lactoglobulin-induced food allergy mouse models were used in this study. Following oral administration of B. infantis CGMCC313-2 during or after allergen sensitization, histopathologic changes in the lung and intestine were evaluated by hematoxylin and eosin (HE) staining. In the allergic asthma mouse model, we evaluated the proportion of lung-infiltrating inflammatory cells. OVA-specific IgE and IgG1 levels in serum and cytokine levels in bronchoalveolar lavage fluid (BALF) were also assessed. In the food allergy mouse model, the levels of total IgE and cytokines in serum were measured. RESULTS Oral administration of B. infantis CGMCC313-2 during or after allergen sensitization suppressed allergic inflammation in lung and intestinal tissues, while the proportion of infiltrating inflammatory cells was significantly decreased in the BALF of allergic asthma mice. Moreover, B. infantis CGMCC313-2 decreased the serum levels of total IgE in food allergy mice, and reductions in IgE and IgG1 were also observed in OVA-induced allergic asthma mice. The expression of interleukin-4 (IL-4) and IL-13 in both serum and BALF was suppressed following the administration of B. infantis CGMCC313-2, while an effect on serum IL-10 levels was not observed. CONCLUSION B. infantis CGMCC313-2 inhibits the secretion of allergen-induced IgE, IL-4 and IL-13, and attenuates allergic inflammation.

  20. Intravenous Administration Is an Effective and Safe Route for Cancer Gene Therapy Using the Bifidobacterium-Mediated Recombinant HSV-1 Thymidine Kinase and Ganciclovir

    Directory of Open Access Journals (Sweden)

    Huicong Zhou

    2016-06-01

    Full Text Available The herpes simplex virus thymidine kinase/ganciclovir (HSV TK/GCV system is one of the best studied cancer suicide gene therapy systems. Our previous study showed that caspase 3 expression was upregulated and bladder tumor growth was significantly reduced in rats treated with a combination of Bifidobacterium (BF and HSV TK/GCV (BF-rTK/GCV. However, it was raised whether the BF-mediated recombinant thymidine kinase combined with ganciclovir (BF-rTK/GCV was safe to administer via venous for cancer gene therapy. To answer this question, the antitumor effects of BF-rTK/GCV were mainly evaluated in a xenograft nude mouse model bearing MKN-45 gastric tumor cells. The immune response, including analysis of cytokine profiles, was analyzed to evaluate the safety of intramuscular and intravenous injection of BF-rTK in BALB/c mice. The results suggested that gastric tumor growth was significantly inhibited in vivo by BF-rTK/GCV. However, the BF-rTK/GCV had no effect on mouse body weight, indicating that the treatment was safe for the host. The results of cytokine profile analysis indicated that intravenous injection of a low dose of BF-rTK resulted in a weaker cytokine response than that obtained with intramuscular injection. Furthermore, immunohistochemical analysis showed that intravenous administration did not affect the expression of immune-associated TLR2 and TLR4. Finally, the BF-rTK/GCV inhibited vascular endothelial growth factor (VEGF expression in mouse model, which is helpful for inhibiting of tumor angiogenesis. That meant intravenous administration of BF-rTK/GCV was an effective and safe way for cancer gene therapy.

  1. Effects of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 on hepatic steatosis in Zucker rats.

    Directory of Open Access Journals (Sweden)

    Julio Plaza-Diaz

    Full Text Available We have previously described the safety and immunomodulatory effects of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 in healthy volunteers. The scope of this work was to evaluate the effects of these probiotic strains on the hepatic steatosis of obese rats. We used the Zucker rat as a genetic model of obesity. Zucker-Lepr(fa/fa rats received one of three probiotic strains, a mixture of L. paracasei CNCM I-4034 and B. breve CNCM I-4035, or a placebo for 30 days. An additional group of Zucker-lean+/fa rats received a placebo for 30 days. No alterations in intestinal histology, in the epithelial, lamina propria, muscular layers of the ileal or colonic mucosa, or the submucosae, were observed in any of the experimental groups. Triacylglycerol content decreased in the liver of Zucker-Lepr(fa/fa rats that were fed L. rhamnosus, B. breve, or the mixture of B. breve and L. paracasei. Likewise, the area corresponding to neutral lipids was significantly smaller in the liver of all four groups of Zucker-Lepr(fa/fa rats that received probiotics than in rats fed the placebo. Zucker-Lepr(fa/fa rats exhibited significantly greater serum LPS levels than Zucker-lean+/fa rats upon administration of placebo for 30 days. In contrast, all four groups of obese Zucker-Lepr(fa/fa rats that received LAB strains exhibited serum LPS concentrations similar to those of Zucker-lean+/fa rats. Serum TNF-α levels decreased in the Zucker-Lepr(fa/fa rats that received B. breve, L. rhamnosus, or the mixture, whereas L. paracasei feeding decreased IL-6 levels in the serum of Zucker-Lepr(fa/fa rats. In conclusion, the probiotic strains reduced hepatic steatosis in part by lowering serum LPS, and had an anti-inflammatory effect in obese Zucker rats.

  2. Scientific Opinion on the safety and efficacy of Prostora Max (Bifidobacterium animalis as a feed additive for dogs

    Directory of Open Access Journals (Sweden)

    EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP

    2012-12-01

    Full Text Available Prostora Max is a feed additive based on a strain of Bifidobacterium animalis that has never been authorised in the EU. It is intended to be used in dogs at a proposed dose of 1.0 x 109 colony-forming units (CFUs/day in the form of a supplemental treat. The species B. animalis is considered by EFSA to be suitable for the qualified presumption of safety (QPS approach to safety assessment, if its identity is confirmed and the absence of resistance to antibiotics of human and veterinary clinical significance demonstrated. However, the B. animalis strain is resistant to the antibiotic clindamycin. In the view of the FEEDAP Panel the antibiotic resistance qualification of the B. animalis strain has not been met and the QPS approach cannot therefore be applied. Although the applicant, on the basis of a bioinformatic analysis, could exclude the presence of many known antibiotic resistance genes, the genetic basis of the resistance to clindamycin was not established. In the absence of information on the genetic basis of this resistance, the extent of the risk of horizontal gene transfer to other bacteria in the food chain and in the environment cannot be established. All the excipients of the additive are authorised for food or feed use or feed materials. The product is in a tablet form so exposure to the mucous membranes and respiratory system of users is unlikely. Some skin exposure might occur, as the cocoa butter would melt at body temperature, but skin exposure would be limited. Treatment with Prostora Max at least 1 x 109 CFUs/day had an effect on gastrointestinal-related parameters in dogs. In two studies this took the form of an improved faecal score. However, in one study this improvement was marginal and of questionable biological/practical value. Therefore, taking into consideration the results of all three studies assessed, the FEEDAP Panel cannot conclude on the efficacy of Prostora Max for dogs.

  3. Cell-free culture supernatant of Bifidobacterium breve CNCM I-4035 decreases pro-inflammatory cytokines in human dendritic cells challenged with Salmonella typhi through TLR activation.

    Science.gov (United States)

    Bermudez-Brito, Miriam; Muñoz-Quezada, Sergio; Gomez-Llorente, Carolina; Matencio, Esther; Bernal, Maria J; Romero, Fernando; Gil, Angel

    2013-01-01

    Dendritic cells (DCs) constitute the first point of contact between gut commensals and our immune system. Despite growing evidence of the immunomodulatory effects of probiotics, the interactions between the cells of the intestinal immune system and bacteria remain largely unknown. Indeed,, the aim of this work was to determine whether the probiotic Bifidobacterium breve CNCM I-4035 and its cell-free culture supernatant (CFS) have immunomodulatory effects in human intestinal-like dendritic cells (DCs) and how they respond to the pathogenic bacterium Salmonella enterica serovar Typhi, and also to elucidate the molecular mechanisms involved in these interactions. Human DCs were directly challenged with B. breve/CFS, S. typhi or a combination of these stimuli for 4 h. The expression pattern of genes involved in Toll-like receptor (TLR) signaling pathway and cytokine secretion was analyzed. CFS decreased pro-inflammatory cytokines and chemokines in human intestinal DCs challenged with S. typhi. In contrast, the B. breve CNCM I-4035 probiotic strain was a potent inducer of the pro-inflammatory cytokines and chemokines tested, i.e., TNF-α, IL-8 and RANTES, as well as anti-inflammatory cytokines including IL-10. CFS restored TGF-β levels in the presence of Salmonella. Live B.breve and its supernatant enhanced innate immune responses by the activation of TLR signaling pathway. These treatments upregulated TLR9 gene transcription. In addition, CFS was a more potent inducer of TLR9 expression than the probiotic bacteria in the presence of S. typhi. Expression levels of CASP8 and IRAK4 were also increased by CFS, and both treatments induced TOLLIP gene expression. Our results indicate that the probiotic strain B. breve CNCM I-4035 affects the intestinal immune response, whereas its supernatant exerts anti-inflammatory effects mediated by DCs. This supernatant may protect immune system from highly infectious agents such as Salmonella typhi and can down-regulate pro

  4. Effects of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 on Hepatic Steatosis in Zucker Rats

    Science.gov (United States)

    Plaza-Diaz, Julio; Gomez-Llorente, Carolina; Abadia-Molina, Francisco; Saez-Lara, Maria Jose; Campaña-Martin, Laura; Muñoz-Quezada, Sergio; Romero, Fernando; Gil, Angel; Fontana, Luis

    2014-01-01

    We have previously described the safety and immunomodulatory effects of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 in healthy volunteers. The scope of this work was to evaluate the effects of these probiotic strains on the hepatic steatosis of obese rats. We used the Zucker rat as a genetic model of obesity. Zucker-Leprfa/fa rats received one of three probiotic strains, a mixture of L. paracasei CNCM I-4034 and B. breve CNCM I-4035, or a placebo for 30 days. An additional group of Zucker-lean+/fa rats received a placebo for 30 days. No alterations in intestinal histology, in the epithelial, lamina propria, muscular layers of the ileal or colonic mucosa, or the submucosae, were observed in any of the experimental groups. Triacylglycerol content decreased in the liver of Zucker-Leprfa/fa rats that were fed L. rhamnosus, B. breve, or the mixture of B. breve and L. paracasei. Likewise, the area corresponding to neutral lipids was significantly smaller in the liver of all four groups of Zucker-Leprfa/fa rats that received probiotics than in rats fed the placebo. Zucker-Leprfa/fa rats exhibited significantly greater serum LPS levels than Zucker-lean+/fa rats upon administration of placebo for 30 days. In contrast, all four groups of obese Zucker-Leprfa/fa rats that received LAB strains exhibited serum LPS concentrations similar to those of Zucker-lean+/fa rats. Serum TNF-α levels decreased in the Zucker-Leprfa/fa rats that received B. breve, L. rhamnosus, or the mixture, whereas L. paracasei feeding decreased IL-6 levels in the serum of Zucker-Leprfa/fa rats. In conclusion, the probiotic strains reduced hepatic steatosis in part by lowering serum LPS, and had an anti-inflammatory effect in obese Zucker rats. PMID:24852284

  5. Are there any different effects of Bifidobacterium, Lactobacillus and Streptococcus on intestinal sensation, barrier function and intestinal immunity in PI-IBS mouse model?

    Directory of Open Access Journals (Sweden)

    Huan Wang

    Full Text Available BACKGROUND AND AIMS: Research has increasingly suggested that gut flora plays an important role in the development of post-infectious irritable bowel syndrome (PI-IBS. Studies of the curative effect of probiotics for IBS have usually been positive but not always. However, the differences of treatment effects and mechanisms among probiotic stains, or mixture of them, are not clear. In this study, we compared the effects of different probiotics (Befidobacterium, Lactobacillus, Streptococcus or mixture of the three on intestinal sensation, barrier function and intestinal immunity in PI-IBS mouse model. METHODS: PI-IBS model was induced by Trichinella spiralis infection in mice. Different probiotics were administered to mice after 8 weeks infection. Visceral sensitivity was measured by scores of abdominal withdrawal reflex (AWR and the threshold intensity of colorectal distention. Colonic smooth muscle contractile response was assessed by contraction of the longitudinal muscle strips. Plasma diamine oxidase (DAO and d-lactate were determined by an enzymatic spectrophotometry. Expression of tight junction proteins and cytokines in ileum were measured by Western blotting. RESULTS: Compared to control mice, PI-IBS mice treated either alone with Befidobacterium or Lactobacillus (but not Streptococcus, or the mixture of the three exhibited not only decreased AWR score and contractile response, but also reduced plasma DAO and D-lactate. These probiotic treatments also suppressed the expression of proinflammatory cytokine IL-6 and IL-17 and promoted the expression of major tight junction proteins claudin-1 and occludin. The mixture of the three probiotic strains performed better than the individual in up-regulating these tight junction proteins and suppressing IL-17 expression. CONCLUSIONS: Bifidobacterium and Lactobacillus, but not Streptococcus, alleviated visceral hypersensitivity and recovered intestinal barrier function as well as inflammation in PI

  6. Study on fermentation conditions of Bifidobacterium bifidum%一株双歧杆菌发酵条件的研究

    Institute of Scientific and Technical Information of China (English)

    高保军

    2011-01-01

    探讨了一株双歧杆菌WDS106的最佳发酵条件.采用平板菌落计数方法,确定最适发酵温度、接种量、pH值、搅拌速度和发酵时间.结果表明,该菌株按照质量分数为2%接种量,在37℃(pH值为6.5)、转速为200r/min条件下培养10 h后,发酵液活菌数达到最高值,为1.3×1010mL-1.经过优化发酵工艺参数,使活菌数提高了近一个数量级,为该菌株的开发和应用提供了参考.%The optimum fermentation conditions of Bifidobacterium bifidum WDS106 mutant strain for production of phenyllactic acid was investigated. Plate counting was used to determine the optimum fermentation temperature, inocula, pH, rotation rate and fermentation time. The highest number of viable cells was 1.3X1010 CFU/mL with 1% of inocula, pH6.5, a rotation rate of 200 r/min and fermentation temperature of 37 °C for 10 h. One order of magnitudes for viable cells was increased with the optimum fermentation parameters, and this provides a reference for the development and application of this strain.

  7. Effect of Bifidobacterium on expression of inflammatory cytokine in experimental colitis rats%双歧杆菌对实验性结肠炎中趋化因子的影响

    Institute of Scientific and Technical Information of China (English)

    吴正祥; 丁洁; 杨九华; 吴强; 杨枫

    2011-01-01

    Objective To observe the preventive and therapeutic effect of Bifidobacterium on experimental rats with 2,4, 6-trinitrobenzene sulfonic acid (TNBS)/ethanol induced colitis.Methods Forty rats were randomly divided into four groups (n = 10): normal control group (group N) ,model group (group M ), Bifidobacterium prevention group (group A),and Bifidobacterium treatment group (group B).The colitis model of rats was established with TNBS/ethanol.Group A was fed with Bifidobacterium 0.1 mL for 7 days before to be molded, group B was given Bifidobacterium 0.1 mL after to be molded (the solution concentration of Bifidobacterium is 1 × 108 cfu/mL), and group N and group M were given 2 mL normal saline.After continuous administration for 14 days, the colonic inflammation including disease activity index (DAI),colonic macroscopic damage index (CMDI) and tissue damage index (TDI) were observed, the expression of CCL20 and CCR6 in the colon tissues of rats were detected by immunohistochemical method, the levels of CCL20, CCR6, TNF-α and IL-10 in serum were detected by ELISA.Results Compared with group M, the scores of DAI, CMDI and TDI, and the expressions of CCL20 and CCR6 in the colon tissues and the serum levels of CCL20, CCR6 and TNF-α significantly decreased in group A and group B (P <0.01 ), while the serum level of IL-10 significantly increased (P <0.01 ).But the group A and group B had no significant difference.Conclusion Bifidobacterium possiblely produces prevention and treatment effect in experimental colitis rats by regulating the dynamic balance between proinflammatory and inflammation cytokines.Furthermore, Bifidobacterium in advance can improve the effectiveness and perform better.%目的 观察双歧杆菌在三硝基苯磺酸(TNBS)/乙醇诱导的实验性结肠炎的作用,并探讨其作用机制.方法 40只SPF级SD大鼠随机均分为正常组(N组)、模型组(M组)、双歧杆菌干预组(双歧杆菌预防性应用组:A组;双歧杆菌治疗

  8. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of a health claim related to Bifidobacterium animalis subsp. lactis LMG P-21384 and changes in bowel function (ID 2940, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

    DEFF Research Database (Denmark)

    Tetens, Inge

    Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to provide a scientific opinion on a health claim pursuant to Article 13 of Regulation (EC) No 1924/2006 in the framework of further assessment in relation to Bifidobacterium...

  9. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of a health claim related to a combination of Bifidobacterium logum LA 10, Lactobacillus helveticus LA 102, Lactococcus lactis LA 103 and Streptococcus thermophilus LA 104 and reducing

    DEFF Research Database (Denmark)

    Tetens, Inge

    substantiation of a health claim related to a combination of Bifidobacterium longum LA 101, Lactobacillus helveticus LA 102, Lactococcus lactis LA 103 and Streptococcus thermophilus LA 104 and reducing intestinal discomfort. The food that is the subject of the health claim is a combination of B. longum LA 101, L...

  10. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to a combination of Lactobacillus helveticus CNCM I-1722 and Bifidobacterium longum subsp. Longum CNCM I-3470 and alleviation of psychological stress (ID 938

    DEFF Research Database (Denmark)

    Tetens, Inge

    of Lactobacillus helveticus CNCM I-1722 and Bifidobacterium longum subsp. longum CNCM I-3470 and alleviation of psychological stress and “maintains the balance of healthy microbiota that helps to strengthen the natural defence”. The food constituent that is the subject of the health claims, a combination of L...

  11. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014. Scientific Opinion on the substantiation of a health claim related to a combination of Bifidobacterium longum LA 101, Lactobacillus helveticus LA 102, Lactococcus lactis LA 103 and Streptococcus thermophilus LA 104

    DEFF Research Database (Denmark)

    Tetens, Inge

    to a combination of Bifidobacterium longum LA 101, Lactobacillus helveticus LA 102, Lactococcus lactis LA 103 and Streptococcus thermophilus LA 104 and improvement of bowel function by increasing stool frequency. The food that is the subject of the health claim is a combination of four bacterial strains—B. longum...

  12. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014. Scientific Opinion on the substantiation of a health claim related to a combination of Bifidobacterium longum LA 101, Lactobacillus helveticus LA 102, Lactococcus lactis LA 103 and Streptococcus thermophilus LA 104

    DEFF Research Database (Denmark)

    Tetens, Inge

    to a combination of Bifidobacterium longum LA 101, Lactobacillus helveticus LA 102, Lactococcus lactis LA 103 and Streptococcus thermophilus LA 104 and reducing intestinal discomfort. The food that is the subject of the health claim is a combination of four bacterial strains—B. longum LA 101, L. helveticus LA 102...

  13. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to a combination of Lactobacillus rhamnosus CNCM I-1720, Lactobacillus helveticus CNCM I-1722, Bifidobacterium longum CNCM I-3470 and Saccharomyces cerevisiae var

    DEFF Research Database (Denmark)

    Tetens, Inge

    of Lactobacillus rhamnosus CNCM I-1720, Lactobacillus helveticus CNCM I-1722, Bifidobacterium longum subsp. longum CNCM I-3470 and Saccharomyces cerevisiae var. boulardii CNCM I-1079 and defence against pathogenic gastro-intestinal microorganisms. The food constituent that is the subject of the health claim...

  14. Mechanism analysis of acid tolerance response of bifidobacterium longum subsp. longum BBMN 68 by gene expression profile using RNA-sequencing.

    Directory of Open Access Journals (Sweden)

    Junhua Jin

    Full Text Available To analyze the mechanism of the acid tolerance response (ATR in Bifidobacterium longum subsp. longum BBMN68, we optimized the acid-adaptation condition to stimulate ATR effectively and analyzed the change of gene expression profile after acid-adaptation using high-throughput RNA-Seq. After acid-adaptation at pH 4.5 for 2 hours, the survival rate of BBMN68 at lethal pH 3.5 for 120 min was increased by 70 fold and the expression of 293 genes were upregulated by more than 2 fold, and 245 genes were downregulated by more than 2 fold. Gene expression profiling of ATR in BBMN68 suggested that, when the bacteria faced acid stress, the cells strengthened the integrity of cell wall and changed the permeability of membrane to keep the H(+ from entering. Once the H(+ entered the cytoplasm, the cells showed four main responses: First, the F(0F(1-ATPase system was initiated to discharge H(+. Second, the ability to produce NH(3 by cysteine-cystathionine-cycle was strengthened to neutralize excess H(+. Third, the cells started NER-UVR and NER-VSR systems to minimize the damage to DNA and upregulated HtpX, IbpA, and γ-glutamylcysteine production to protect proteins against damage. Fourth, the cells initiated global response signals ((pppGpp, polyP, and Sec-SRP to bring the whole cell into a state of response to the stress. The cells also secreted the quorum sensing signal (AI-2 to communicate between intraspecies cells by the cellular signal system, such as two-component systems, to improve the overall survival rate. Besides, the cells varied the pathways of producing energy by shifting to BCAA metabolism and enhanced the ability to utilize sugar to supply sufficient energy for the operation of the mechanism mentioned above. Based on these reults, it was inferred that, during industrial applications, the acid resistance of bifidobacteria could be improved by adding BCAA, γ-glutamylcysteine, cysteine, and cystathionine into the acid-stress environment.

  15. Spray drying technics of Bifidobacterium lactis%乳酸双歧杆菌喷雾干燥工艺研究

    Institute of Scientific and Technical Information of China (English)

    付博; 马齐; 王卫卫

    2011-01-01

    Spray drying of microencapsulation was used to effectively protect the activity of Bifidobacterium lactis during the production and storage, and technics parameters were also tested. Through wall material selection and orthogonal analysis of relevant parameters, the results showed that the best mass concentration of wall-material was 100 g/L, including β-cyclodextrin and gum acacia, and the mass ratio was 4:6. The mass concentration of core-material was 60 g/L, include trehalose 20 g/L, mannitol 20 g/L, bacteria mire 25 g/L and ascorbic acid 0.01 g/L. The best inlet air temperature was 108±2℃, outlet air temperature was 61±3℃, and tower wall temperature was 50±3℃. Atomizer speed was 17 000 r/min. Under the optimized conditions, the survival bacteria number were over 3.4×109cfu/g, survival rate was 72.12% and encapsulation efficiency was 75.88%.%为有效保证乳酸双歧杆菌在生产、消费及贮藏过程中的菌体活性,利用喷雾干燥法制备双歧杆菌微胶囊,深入研究了喷雾干燥过程中的工艺参数.通过壁材选择及相关工艺参数的正交分析,结果表明:喷雾干燥过程中的最佳壁材质量浓度为100 g/L,包括β-环糊精与阿拉伯树胶粉,且质量比为4∶6,芯材质量浓度60 g/L,包括海藻糖20 g/L,甘露醇20 g/L,菌泥25 g/L和抗坏血酸0.01 g/L.最佳工艺参数为进风温度(108±2)℃,排风温度(61+3)℃,塔壁温度(50+3)℃及雾化器转速17 000 r/min.在此工艺条件下菌粉的活菌数为3.4×109g-1,存活率72.12%.包埋率75.88%.

  16. The effect of Aquablend Avian probiotic ® including Lactobacillus, Streptococcus and Bifidobacterium on systemic antibody response against Newcastle and Influenza disease vaccine in broiler chickens

    Directory of Open Access Journals (Sweden)

    Talazadeh

    2016-05-01

    Full Text Available Background Finding alternatives to antibiotics for poultry production is very important because there are increasing concerns about antibiotic resistance. So, researchers have been directed to the research back to natural antimicrobial products. Some researchers stated that probiotics can stimulate the immune system and play an important role in shaping the immune system. Objectives The aim of this study was to examine the effect of a commercial probiotic mixture (Aquablend Avian® supplementation to the drinking water of broiler chickens on the immune response against Newcastle and influenza diseases vaccines. Materials and Methods In this study, 180 one-day-old broiler chickens were purchased and divided randomly into 3 groups (n = 60 for each group. Chickens in groups A and B received 300 mg of the probiotic in drinking water for first 3 days and first 7 days, respectively. Chickens in group C were kept as a control group and did not receive probiotic. All groups were vaccinated with live Newcastle vaccine (B1 strain intraocularly on 8th day, and AI-ND killed vaccine (subtype H9N2 subcutaneously at the back of the neck on 8th day. Two mL of blood samples were collected before vaccination as well as on days 14, 28 and 35 postimmunization. Ten chickens of each group were bled randomly and an antibody titer against Newcastle disease vaccine and AI-ND killed vaccine (subtype H9N2 was determined by the hemagglutination-inhibition test. Results The results of the present study showed that oral administration of the probiotic for 7 days significantly increased the specific antibody response to Newcastle vaccine compared to the control group (0.75 - 1.6 log, based on log2, while the probiotic administration had no significant effect on antibody productions against avian influenza vaccine as compared to the control group. Conclusions Oral administration of Aquablend Avian® probiotic strains including Lactobacillus, Streptococcus and Bifidobacterium

  17. Handbook on criticality. Vol. 1. Criticality and nuclear safety; Handbuch zur Kritikalitaet. Bd. 1. Kritikalitaet und nukleare Sicherheit

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2015-04-15

    This handbook was prepared primarily with the aim to provide information to experts in industry, authorities or research facilities engaged in criticality-safety-related problems that will allow an adequate and rapid assessment of criticality safety issues already in the planning and preparation of nuclear facilities. However, it is not the intention of the authors of the handbook to offer ready solutions to complex problems of nuclear safety. Such questions have to remain subject to an in-depth analysis and assessment to be carried out by dedicated criticality safety experts. Compared with the previous edition dated December 1998, this handbook has been further revised and supplemented. The proven basic structure of the handbook remains unchanged. The handbook follows in some ways similar criticality handbooks or instructions published in the USA, UK, France, Japan and the former Soviet Union. The expedient use of the information given in this handbook requires a fundamental understanding of criticality and the terminology of nuclear safety. In Vol. 1, ''Criticality and Nuclear Safety'', therefore, first the most important terms and fundamentals are introduced and explained. Subsequently, experimental techniques and calculation methods for evaluating criticality problems are presented. The following chapters of Vol. 1 deal i. a. with the effect of neutron reflectors and absorbers, neutron interaction, measuring methods for criticality, and organisational safety measures and provide an overview of criticality-relevant operational experience and of criticality accidents and their potential hazardous impact. Vol. 2 parts 1 and 2 finally compile criticality parameters in graphical and tabular form. The individual graph sheets are provided with an initially explained set of identifiers, to allow the quick finding of the information of current interest. Part 1 includes criticality parameters for systems with {sup 235}U as fissile material, while part 2 deals with systems comprising {sup 233}U, plutonium and higher actinides.

  18. 33{sup rd} international Vienna motor symposium. Vol. 1. First day; 33. internationales Wiener Motorensymposium. Bd. 1. Erster Tag

    Energy Technology Data Exchange (ETDEWEB)

    Lenz, Hans Peter (comp.)

    2012-11-01

    This two-volume report makes the presentations of the 33{sup rd} International Vienna Motor Symposium (April 26-27, 2012) available to a wider audience. The objective of the Vienna Motor Symposia is to examine current topics of particular interest. Among others, the work examines the above mentioned topics. Included is a CD-ROM containing the presentations in their original form and in English translation. Edited by Univ.-Prof. Dr. techn. Dipl.-Ing. H.P. Lenz, VDI, Chairman of the OeVK (Austrian Society of Automotive Engineers, Vienna).

  19. 26. international Vienna engine symposium. Vol. 1. First day; 26. Internationales Wiener Motorensymposium. Bd. 1. Erster Tag

    Energy Technology Data Exchange (ETDEWEB)

    Anon.

    2005-07-01

    Papers of the above symposium are presented in two volumes. The Vienna Engine Symposium is a forum for discussing current trends in internal combustion engines. Subjects: New gasoline and diesel engines; From conventional to hybrid drives; Electronic key technologies; Emission reduction today; Supercharged DI gasoline engines; DI diesel engines; Exhaust treatment; Simulation; Transmission; Acoustics; The future of mobility. (orig.)

  20. 30th international Vienna motor symposium. Vol. 1. First day; 30. Internationales Wiener Motorensymposium. Bd. 1. Erster Tag

    Energy Technology Data Exchange (ETDEWEB)

    Lenz, Hans Peter (comp.)

    2009-07-01

    This two-volume report makes the presentations of the 30{sup th} International Vienna Motor Symposium (May 7-8, 2009) available to a wider audience. The objective of the Vienna Motor Symposia is to examine current topics of particular interest. Among others, the work examines the above mentioned topics. Included is a CD-ROM containing the presentations in their original form and in English translation. Edited by Univ.-Prof. Dr. techn. Dipl.-Ing. H.P. Lenz, VDI, Chairman of the OeVK (Austrian Society of Automotive Engineers, Vienna). (orig.)

  1. 27th international Vienna engine symposium. Vol. 1. First day; 27. Internationales Wiener Motorensymposium. Bd. 1. Erster Tag

    Energy Technology Data Exchange (ETDEWEB)

    Lenz, H.P. (comp.)

    2006-07-01

    Abstract: This two-volume report makes the presentations of the 27{sup th} International Vienna Motor Symposium (April 27-28, 2006) available to a wider audience. The objective of the Vienna Motor Symposia is to examine current topics of particular interest in a concise manner. Among others, the work examines the following new developments: Effects of engine emissions on climate, new gasoline and diesel engines, diesel sound engineering, emissions reduction, hybrids, fuel injection, fuels, components, control systems, future perspectives. Included is a CD-ROM containing the presentations in their original form, with colour illustrations and English text. - Edited by Prof. Dr. H.P. Lenz, VDI, Chairman of the OeVK (Austrian Society of Automotive Engineers, Vienna). (orig.)

  2. 34{sup th} international Vienna motor symposium. Vol. 1. First day; 34. Internationales Wiener Motorensymposium. Bd. 1. Erster Tag

    Energy Technology Data Exchange (ETDEWEB)

    Lenz, Hans Peter (comp.)

    2013-08-01

    This two-volume report makes the presentations of the 34th International Vienna Motor Symposium (April 25-26, 2013) available to a wider audience. The objective of the Vienna Motor Symposia is to examine current topics of particular interest. Among others, the work examines the above mentioned topics. Included is a CD-ROM containing the presentations in their original form and in English translation. Edited by Univ.-Prof. Dr. techn. Dipl.-Ing. H. P. Lenz, VDI, Chairman of the OeVK (Austrian Society of Automotive Engineers, Vienna).

  3. 32{sup nd} international Vienna motor symposium. Vol. 1. First day; 32. internationales Wiener Motorensymposium. Bd. 1. Erster Tag

    Energy Technology Data Exchange (ETDEWEB)

    Lenz, Hans Peter (comp.)

    2011-07-01

    This two-volume report makes the presentations of the 32nd International Vienna Motor Symposium (5th-6th April, 2011) available to a wider audience. The objective of the Vienna Motor Symposia is to examine current topics of particular interest in a concise manner. Among others, the work examines the following new developments: new otto machines, new diesel engines, offroad and high performance engines, exhaust gas aftertreatment, injection systems for Otto and Diesel engines. - Included is a CD-ROM containing the presentations in their original form, with colour illustrations and English text.

  4. 29th international Vienna motor symposium. Vol. 1. First day; 29. Internationales Wiener Motorensymposium. Bd. 1. Erster Tag

    Energy Technology Data Exchange (ETDEWEB)

    Lenz, H.P. (comp.)

    2008-07-01

    This two-volume report makes the presentations of the 29{sup th} International Vienna Motor Symposium (April 24-25, 2008) available to a wider audience. The objective of the Vienna Motor Symposia is to examine current topics of particular interest in a concise manner. Among others, the work examines the following new developments: injection and combustion; sound design; materials and components; engine management; exhaust gas aftertreatment. - Included is a CD-ROM containing the presentations in their original form, with colour illustrations and English text. (orig.)

  5. 31th international Vienna motor symposium. Vol. 1. First day; 31. Internationales Wiener Motorensymposium. Bd. 1. Erster Tag

    Energy Technology Data Exchange (ETDEWEB)

    Lenz, Hans Peter (comp.)

    2010-07-01

    These two volumes contain all the lectures delivered at the 31{sup st} International Vienna Motor Symposium, which took place on 29{sup th} and 30{sup th} April, 2010. In these lectures pre-eminent automotive engineers presented various aspects of state-of-the-art of engine technology. Further to this, I would like to express my heartfelt thanks to all of these individuals, as well as the companies they represent, for their contributions to our conference. All lectures on the enclosed CD are available in their original version as well as in English translation. The word-search facility at www.oevk.at - the Austrian Society of Automotive Engineers (OEVK) website - allows a direct access to the titles of lectures, together with information on all the authors and companies that have participated in the International Vienna Motor Symposia since 1999 (German since 1981). The publications list - which is to be found on the following page - provides an anthology of all lectures delivered at the International Vienna Motor Symposia between 1979 and 2010. It is intended to provide a broader public with further information on the topics and subject matter dealt with by these conferences. The 32{sup nd} International Vienna Motor Symposium is to take place on the 5{sup th} and 6{sup th} Mai, 2011, and may I take this early opportunity to extend you an invitation. (orig.)

  6. 24. international Vienna engine symposium. Vol. 1. First day; 24. Internationales Wiener Motorensymposium. Bd. 1. Erster Tag

    Energy Technology Data Exchange (ETDEWEB)

    Lenz, H.P. (comp.)

    2003-07-01

    This two-volume publication contains the papers of the 24th International Vienna Engine Symposium of 15/16 May 2003. Among the subjects discussed are: New gasoline engines, DI gasoline engines and diesel engines, new high-performance engines, future engines and transmission systems; Diesel soot, structure and health hazards, diesel exhaust treatment, gasoline DI ignition, hydrogen, fuel injection and variable valve control; future co-operations, creativity and trademarks. [German] In diesem zweibaendigen Werk werden die Vortraege des 24. Internationalen Wiener Motorensymposiums vom 15./16. Mai 2003 wiedergegeben und damit einer breiten Oeffentlichkeit zugaenglich gemacht. Aufgabe der Wiener Motorensymposien ist es, kurzfristig und komprimiert Themen von besonderer Aktualitaet auf dem Gebiet des Verbrennungsmotors zu behandeln. Dieses Werk befasst sich u.a. mit folgenden neuen Entwicklungen: Motoren und Getriebe: neue Otto-, Otto-Direkteinspritzungs- und Diesel-Motoren; neue Hoechstleistungsmotoren; zukuenftige Motoren und Getriebe; neue Erkenntnisse auf den Gebieten: Dieselruss: Struktur und Gesundheitsgefaehrdung, Diesel-Abgasnachbehandlung, Otto-Direkteinspritzungs-Zuendung, Wasserstoff, Einspritzung und variable Ventilsteuerung; Zukunftsperspektiven: Allianzen, Kreativitaet und Marken. - Herausgeber: Univ.-Prof. Dr. techn. Dipl.-Ing. H.P. Lenz, Vorsitzender des Oesterreichischen Vereins fuer Kraftfahrzeugtechnik (OeVK), Wien. (orig.)

  7. 28th international Vienna motor symposium. Vol. 1. First day; 28. Internationales Wiener Motorensymposium. Bd. 1. Erster Tag

    Energy Technology Data Exchange (ETDEWEB)

    Lenz, H.P. (comp.)

    2007-07-01

    This two-volume report makes the presentations of the 28{sup th} International Vienna Motor Symposium (April 26,-27, 2007) available to a wider audience. The objective of the Vienna Motor Symposia is to examine current topics of particular interest in a concise manner. Among others, the work examines the following new developments: diesel injection and combustion; acoustics and sound design, materials and components; engine management,; exhaust gas aftertreatment; supercharging; hybrid drive systems. Included is a CD-ROM containing the presentations in their original form, with colour illustrations and English text. - Edited by Univ.-Prof. Dr. techn. Dipl.-Ing. H.P. Lenz VDI, Chairman of the OeKV (Austrian Society of Automotive Engineers, Vienna). (orig.)

  8. Differential diagnosis in pediatric radiology. Vol. 1. Skull, spine, skeleton; Differentialdiagnostik in der paediatrischen Radiologie. Bd. 1. Schaedel, Wirbelsaeule, Skelett

    Energy Technology Data Exchange (ETDEWEB)

    Ebel, K.D. [ed.; Willich, E. [ed.; Richter, E. [ed.; Benz-Bohm, G.; Bliesener-Harzheim, J.A.; Ebel, K.D.; Oestreich, A.E.; Reinwein, H.; Schaper, J.; Schumacher, R.; Stoever, B.

    1995-06-01

    The book presents in-depth material covering the full scope of tasks and problems of differential diagnostic radiology in children. The particular approach chosen by the authors provides information that will solve even the most difficult cases, guiding the reader on his way from radiographic findings to appropriate diagnosis. All radiographic findings have been characterized and classified and put into a tabulated system relating them to the relevant differential diagnosis. The system of reference adopted specifies a given lesion or disease by reference to the most significant diagnostic keywords obtained from anamnesis, clinical data, and further diagnostic evaluation. The tentative diagnosis is taken as the basis for further specification illustrated by the characteristic X-ray pictures and full-text descriptions. Almost all diagnoses are accompanied by a comprehensive image documentation obtained by all currently available imaging methods. (MG) [Deutsch] Das vorliegende Buch gibt einen kompletten Ueberblick ueeber die gesamte Bandbreite der Differentialdiagnostik in der Paediatrischen Radiologie und soll so auch in schwierigen Faeellen den Weg vom Roentgensymptom zur Diagnose ermoeglichen. Alle relevanten Roentgensymptome werden systematisch charakterisiert und die entsprechenden Differentialdiagnosen tabellarisch zusammengestellt. Jede Erkrankung wird durch Verweise auf die wichtigsten differentialdiagnostischen Stichworte aus Anamnese, Klinik und weiterfuehrende Diagnostik naeher eingegrenzt. Ausgehend von der Verdachtsdiagnose werden wegweisende Roentgenbefunde in Wort und Bild dargestellt. Fast alle erwaehnten Befunde werden durch Abbildungen unter Beruecksichtigung aller moderner bildgebenden Verfahren dokumentiert. (MG)

  9. BMBF status seminar: Bodies of landfills. Vol. 1. Conference report; BMBF-Statusseminar: Deponiekoerper. Bd. 1. Tagungsband

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1995-12-31

    This conference report contains the lectures presented at the BMBF status seminar on the cooperative project ``Bodies of landfills``, which took place at Wuppertal on 25th and 26th April 1995. The cooperative project was started in autumn 1993 and studies the long-term behaviour of wastes deposited at landfills in general. Inorganic and municipal wastes are studied separately. (orig./SR) [Deutsch] Der vorliegende Tagungsband enthaelt die Vortraege des BMBF-Statusseminars zum Verbundvorhaben `Deponiekoerper` vom 25. und 26. April 1995 in Wuppertal. Das Verbundvorhaben `Deponiekoerper` wurde im Herbst 1993 begonnen und befasst sich ganz generell mit dem langfristigen Deponieverhalten von Abfaellen. Es ist unterteilt in die Untersuchung von anorganischen Abfaellen und von Siedlungsabfaellen. (orig./SR)

  10. 双歧杆菌三联活菌片对婴幼儿免疫功能的影响%The effects of Triple live bacteria Bifidobacterium tablets on immune function of infants and young children

    Institute of Scientific and Technical Information of China (English)

    刘海英; 邓陈华; 黄珠能

    2014-01-01

    目的 观察双歧杆菌三联活菌片对婴幼儿免疫功能的影响.方法 将我院门诊上呼吸道感染患儿按年龄(0~月龄,6~月龄,12~月龄,24~36月龄)随机分成实验组和对照组.实验组口服双岐杆菌三联活菌片6个月,对照组为空白对照.观察患儿呼吸道、消化道感染性和过敏性疾病的情况和血清IgA、IgE的变化.结果 <24月龄,实验组服药3个月后的血清IgA值较对照组高(P<0.05),服药6个月后,差别增大.24~36月龄,实验组服药后的血清IgA值与对照组差异无统计学意义(P>0.05).实验组服药6个月后,血清IgE值超过正常范围的人数与对照组差异无统计学意义(P>0.05).观察1年6个月,患呼吸道、消化道感染性疾病5次以上的人数,实验组较对照组少(P<0.05);患过敏性疾病的人数,实验组与对照组差异无统计学意义(P>0.05).结论 口服双歧杆菌三联活菌片能提高婴幼儿免疫功能,可减少感染性疾病的发生.2岁前服用效果比较明显.服药年龄越小,疗程越长,效果越明显.本组资料未显示口服双歧杆菌三联活菌片对过敏性疾病的影响.%Objective To observe the effects of Triple live bacteria bifidobacterium tablets on immune function of infants and young children.Methods Children with upper respiratory infection at the outpatient department in our hospital were randomly divided into the experimental group and the control group by age:0 months of age,6 months of age,12 months of age,24-36 months of age.Experimental group took Triple live bacteria bifidobacterium tablets for 6 months,the control group took nothing and observed the incidence of respiratory tractinfection,digestive tract infection and allergic diseases,and the change of serum levels of IgA and IgE.Results Among the experimental groups less than 24 months of age,after 3 months taking Triple live bacteria bifidobacterium tablets,the IgA values were higher than that of the control group (P

  11. Influence of Bifidobacterium on the Intestinal Permeability in Stress Model Rats%双歧杆菌对应激模型大鼠肠道通透性的影响

    Institute of Scientific and Technical Information of China (English)

    冀建伟; 付蕾; 郑鹏远; 张军

    2012-01-01

    目的:研究双歧杆菌对应激模型大鼠肠道通透性的影响及其与蒙脱石散联用的协同作用.方法:取SD大鼠50只随机均分为正常对照组、模型对照组、双歧杆菌干预组(2× 108 cfu)、蒙脱石散干预组(0.6 g·kg-1)及其联合干预组(双歧杆菌2× 108 cfu+蒙脱石散0.6 g·kg-1),每日灌胃给药1次,连续给药7d,后4组每日给药后以避水压力模型(WAS)方法建立大鼠应激模型.第8天各组分别灌胃给予探针药物甘露醇80 mg、三氯蔗糖60 mg,检测各组大鼠给药后5、24 h尿液中甘露醇、三氯蔗糖的量及其比值,以评价肠道通透性.实验结束处死大鼠,检测各组大鼠血清中促肾上腺皮质激素释放因子(CRF)和促肾上腺皮质激素(ACTH)的含量.结果:与正常对照组比较,模型对照组大鼠24 h尿液中甘露醇的量及血清中CRF、ACTH含量均明显升高(P<0.05);与模型对照组比较,双歧杆菌干预组和联合干预组ACTH含量均明显降低(P<0.05),其余指标均有降低,但没有统计学意义.结论:双歧杆菌对应激模型大鼠的肠道通透性有影响,其与蒙脱石散联用对应激所致的肠道屏障功能紊乱无协同作用.%OBJECTIVE: To study the improvement effect of Bifidobacterium on intestinal permeability in stress model rats, and synergistic reaction of Bifidobacterium combined with Montmorillonite powders. METHODS: 50 SD rats were randomly divided into normal control group, model control group, Bifidobacterium treatment group (2×108 cfu). Montmorillonite powders treatment group (0.6 g·kg‐1) and drug combination group (Bifidobacterium 2x10" cni+Montmorillonite powders 0.6 g·kg‐1). Those rats were given medicine once a day via i.g. for consecutive 7 days. Stress model was established by WAS in the latter 4 groups. On 8th day each group was given mannitol 80 mg and sucralose 60 mg, and the amount and ratio of mannitol and sucralose in urine were determined S h and 24 h after

  12. Triple viable bifidobacterium lactobacillus tablets therapy for irritable bowel syndrome in 40 cases%双歧杆菌乳杆菌三联活菌片治疗肠易激综合征40例

    Institute of Scientific and Technical Information of China (English)

    孙铭

    2011-01-01

    目的 观察双歧杆菌乳杆菌三联活菌片治疗腹泻型肠易激综合征(IBS)临床疗效.方法 80例患者分为对照组和观察组,每组40例.对照组采用常规治疗方法;观察组在常规治疗基础上加用双歧杆菌乳杆菌三联活菌片口服治疗.2个疗程后观察疗效.结果 观察组显效18例,有效17例,无效5例,总有效率87.5%;对照组显效10例,有效16例,无效14例,总有效率65.0%,2组总有效率比较差别有统计学意义(P<0.05).结论 双歧杆菌乳杆菌三联活菌片对IBS的治疗有较好疗效.%Objective To study the effect of triple viable bifidobacterium lactobacillus tablets on diarrhea-predominant irritable bowel syndrome( IBS). Methods Eighty patients were divided into control group and observation group,and 40 cases in each group. Conventional therapy was administered in control group, while both triple viable bifidobacterium lactobacillus tablets and conventional therapy were received in observation group. The symptoms were assessed after 2 courses of therapy. Results In observation group, 18 cases were markedly effective, 17 cases effective,and 5 cases ineffective. The total effective rate was 87.5%. While in control group, 10 cases were markedly effective, 16 cases effective,and 14 cases ineffective. The total effective rate was 65. 0%. There was statistical significance in difference of total effective rate between two groups ( P < 0.05). Conclusion Triple viable bifidobacterium lactobacillus tablets is safe and effective in treatment of diarrhea-predominant IBS.

  13. THE CLINICAL STUDY OF XIYANPING COMBINED WITH BIFIDOBACTERIUM IN TREATMENT WITH INFANTILE VIRAL DIARRHEA%喜炎平联合双歧杆菌治疗小儿病毒腹泻的临床研究

    Institute of Scientific and Technical Information of China (English)

    张雪松

    2011-01-01

    [Objective] To the clinical effect of xiyanping combined with bifidobacterium in treatment with infantile viral diarrhea. [Methods] From February 2009 to February 2010, 112 cases with infantile viral diarrhea were randomly classified into two groups, 56 cases in control group was treated with ribavirin and 56 cases in observation group was treated with xiyanping combined with bifidobacterium. The curative effect, antidiarrheal time, fever clearance time, and total treatment time between the two groups were compared. [Results] The total effective rate in observation group were significantly higher than that in control group (P < 0.05). The antidiarrheal time, fever clearance time, and total treatment time in observation group were significantly shorter than those in control group (P < 0.05). [Conclusion] Xiyanping combined with bifidobacterium in treatment with infantile viral diarrhea can improve clinical curative effect, improve clinical symptom, which can be applied in clinic.%[目的]观察喜炎平联合双歧杆菌治疗小儿病毒腹泻的临床疗效.[方法]2010年2月~2011年2月,112例病毒腹泻患儿随机分为两组,对照组56例采用病毒唑治疗,观察组56例采用喜炎平联合双歧杆菌治疗,比较观察两组的临床疗效、止泻、退热时间和住院时间.[结果]观察组的总有效率明显高于对照组(P<0.05).观察组的平均止泻时间、平均退热时间和住院时间均明显短于对照组(P<0.05).[结论]喜炎平联合双歧杆菌治疗小儿病毒腹泻进行治疗,能够明显提高疗效,改善患儿临床症状,值得临床推广应用.

  14. Genome-wide and Function Analysis of the Secretory Proteins of Bifidobacterium longum NCC2705%长双歧杆菌NCC2705分泌蛋白的全基因组预测和功能分析

    Institute of Scientific and Technical Information of China (English)

    朱德全; 王茗悦; 栗金柳; 孟祥晨; 程广东; 岳丽红; 王长平; 薛勇

    2016-01-01

    With the genome proteins sequences of Bifidobacterium longum FNCC2705 as study objects,SignalP 4.0,LipoP,TMHMM 2.0 software were used to analyze the secretory proteins and types of signal peptide.Function of secretory proteins was also analyzed by COG ( Cluster of Or-thologous Groups of proteins) database.Results showed a total of 37 secretion proteins through Sec pathway which included 27 secreted proteins recognized by SPaseⅠand 10 secreted proteins recognized by SPaseⅡ.Maximum length of their signal peptide is 52 aa and minimum length is 10 aa respectively.The functions of Bifidobacterium secretory protein showed there were many hypothetical proteins.Secretory protein with annotation of COG functions were mainly involved in amino acid transport and metabolism,carbohydrate transport and metabolism,inorganic ion transport and metabolism,etc..The functions of these secretory proteins can help bifidobacterium adapt to its host environment.%以长双歧杆菌NCC2705基因组序列为研究对象,使用SignalP 4.0、LipoP、TMHMM 2.0软件分析该基因组中的分泌蛋白及其信号肽的类型,同时采用COG ( Cluster of Orthologous Groups of proteins)功能数据库对预测的分泌蛋白进行功能注释和聚类分析。结果表明,长双岐杆菌NCC2705中共有37个Sec途径分泌蛋白,其中Sec途径分泌蛋白包括27个被I型( SPaseⅠ)信号肽酶和10个Ⅱ型信号肽酶( SpaseII)识别的蛋白,Sec 途径分泌蛋白信号肽长度最多的有52个氨基酸,最少的有10个氨基酸。分泌蛋白的功能分析表明,该菌株分泌蛋白中含有大部分的假定蛋白,主要参与氨基酸代谢与转运、碳水化合物代谢转运,无机盐离子代谢转运,细胞壁和细胞膜生物合成的功能有关。

  15. Study on Biofilm Formation of Bifidobacterium Sp.on Different Materials%双歧杆菌在不同材料上形成生物膜的研究

    Institute of Scientific and Technical Information of China (English)

    徐文生; 张艳艳; 黄漫青; 陈湘宁

    2011-01-01

    Objective: Biofilm formation ability of bifidobacterium was evaluated. Methods: Biofilm formation ability of several different Bifidobacteriums was determined and identified by crystal violet and Congo red staining methods. Results: The 9 isolates exhibited different capacities of biofilm formation on hydrophilic and hydrophobic material surfaces.All isolates formed weak biofilms in polypropylene (PP) tubes. While strong, moderate or weak biofilms were detected in borosilicate (BS) tubes or polystyrene (PS) microplates. The microscopic analysis of biofilms formed on glass coverslips revealed that the biofilm contains polysaccharides exopolysaccharides. Poor correlation was observed between cell surface hydrophobicity and biofilm formation. Conclusion: Bifidobacterium sp. have biofilm formation ability to a certain degree.%目的:评价双歧杆菌生物膜生成能力.方法:采用结晶紫染色和刚果红染色等方法对几种不同双歧杆菌形成生物膜的能力进行测定和鉴定.结果:采用不同途径分离的9株双歧杆菌分别在亲水性材料和疏水性材料上展现不同的生物膜形成能力.所有菌株在聚丙烯材料上均表现出弱的生物膜形成能力,而在聚苯乙烯和硼硅酸盐材料表面均表现出不同程度的生物膜形成能力.利用盖玻片对生物膜的显微观察表明生物膜含有多糖成分.细胞表面疏水性研究表明双歧杆菌中生物膜的形成与细胞表面疏水性未见相关性.结论:双歧杆菌具有一定的生物膜生成能力.

  16. Research on the optimistic fermentation technology of the activities of Bifidobacterium%提高双歧杆菌活力的优化增菌发酵技术研究

    Institute of Scientific and Technical Information of China (English)

    何枫嫒; 葛武鹏; 卫伟; 朱红; 刘锐

    2012-01-01

    Viable counts of Bifidobacterium is one of the key criterions to improve human body health. The study adopted MRS as basic medium, and four optimal ingredients were chosen and added: Konjac Gum Hydrolyzates, Extractive Juice of Semen Coins, Extractive Juice of Yam, Inulin. Through single -factor test,3 better optimal ingredients were sifted out. To take the viable counts as index, orthogonal experiment was used to select a formula which is the best to enriching high activity bifidobacterium. The experimental result showed that in single— factor test, Konjac Gum Hydrolyzate had the best effect to enriching bifidobacterium among the above 4 factors,and the additive concentration was MRS added with Konjac Gum Hydrolyzates (35 mL/L),with the viable counts being 1.21×109 CFU/mL.Orthogonal test showed that the optimum medium was MRS added with Konjac Gum Hydrolyzates(30 mL/L).Extractive Juice of Semen Coins(25 mL/L), Inulin(20 g/L),in-cubated under anaerobic conditions for 36h at 37℃,with the viable counts being 7.4×109 CFU/mL.%以MRS为基础培养基,选取添加4种不同的增菌因子,即:魔芋胶水解物、薏苡仁浸提液、山药浸提液、菊粉,以单因素实验筛选出较优的3种增菌因子,通过正交实验以活菌数为活力评价指标,确定最佳增菌配方.结果表明,单因素实验中,魔芋胶水解物增菌效果最佳,当其在MRS培养基中添加体积分数为35 mL/L时,双歧杆菌的活菌数可达1.21×109 mL-1;正交实验所得最佳增菌配方为:MRS+魔芋胶水解物(30 mL/L)+薏苡仁浸提液(25 mL/L)+菊粉(20g/L),37℃厌氧培养36 h,活菌数可达7.4×109 mL-1.

  17. Galactosyl hydrolases from Bifidobacterium adolescentis and Bifidobacterium longum

    NARCIS (Netherlands)

    Hinz, S.W.A.

    2005-01-01

    De menselijke darm bevat veel verschillende bacteriën, waaronder bifidobacteriën. Deze kunnen een positieve invloed hebben op de gezondheid. De hoeveelheid darmbacteriën kan beïnvloed worden door hun groei te stimuleren, b.v. door het eten van voedingsvezels (prebiotica genaamd). Darmbacteriën kunne

  18. Abbot Close Nursing Home, St. Marys Terrace, Askeaton, Limerick.

    LENUS (Irish Health Repository)

    2011-08-30

    Abstract Background Cell surface pili in Gram positive bacteria have been reported to orchestrate the colonization of host tissues, evasion of immunity and the development of biofilms. So far, little if any information is available on the presence of pilus-like structures in human gut commensals like bifidobacteria. Results and discussion In this report, Atomic Force Microscopy (AFM) of various bifidobacterial strains belonging to Bifidobacterium bifidum, Bifidobacterium longum subsp. longum, Bifidobacterium dentium, Bifidobacterium adolescentis and Bifidobacterium animalis subsp. lactis revealed the existence of appendages resembling pilus-like structures. Interestingly, these microorganisms harbour two to six predicted pilus gene clusters in their genome, with each organized in an operon encompassing the major pilin subunit-encoding gene (designated fimA or fimP) together with one or two minor pilin subunit-encoding genes (designated as fimB and\\/or fimQ), and a gene encoding a sortase enzyme (strA). Quantitative Real Time (qRT)-PCR analysis and RT-PCR experiments revealed a polycistronic mRNA, encompassing the fimA\\/P and fimB\\/Q genes, which are differentially expressed upon cultivation of bifidobacteria on various glycans.

  19. 酪酸梭菌与婴儿双歧杆菌对艰难梭菌体外生物拮抗作用的研究%ANTAGONISM OF CLOSTRIDIUM BUTYRICUM AND BIFIDOBACTERIUM INFANTIS TO CLOSTRIDIUM DIFFICILE IN VITRO

    Institute of Scientific and Technical Information of China (English)

    吕存女; 邝欣; 张雪平; 邹开勇; 孟筱琦

    2001-01-01

    用酪酸梭菌(Clostridium butyricum)和婴儿双歧杆菌(Bifidobacterium infantis)单独或联合对艰难梭菌(Clost ridium difficile)进行试管内的生物拮抗作用.将酪酸梭菌、婴儿双歧杆菌单独或酪酸梭菌和婴儿双歧杆菌联合分别与艰难梭菌以一定的比例等量混合后,接种于GAM液体培养基中进行厌氧培养.实验证明酪酸梭菌和婴儿双歧杆菌能明显抑制艰难梭菌的生长,并且两菌联合比各自单独培养时显示出更强的生物拮抗作用.

  20. The GH5 1,4-β-mannanase from Bifidobacterium animalis subsp. lactis Bl-04 possesses a low-affinity mannan-binding module and highlights the diversity of mannanolytic enzymes

    DEFF Research Database (Denmark)

    Morrill, Johan; Kulcinskaja, Evelina; Sulewska, Anna Maria;

    2015-01-01

    β-Mannans are abundant and diverse plant structural and storage polysaccharides. Certain human gut microbiota members including health-promoting Bifidobacterium spp. catabolize dietary mannans. Little insight is available on the enzymology of mannan deconstruction in the gut ecological niche. Here....... Surface plasmon resonance analysis confirmed the binding of the CBM10 to manno-oligosaccharides, albeit with slightly lower affinity than the catalytic module of the enzyme. This is the first example of a low-affinity mannan-specific CBM, which forms a subfamily of CBM10 together with close homologs...... by an exceptionally low Km and the presence of an atypical low affinity CBM, which increases binding to specifically to soluble mannan while causing minimal decrease in catalytic efficiency as opposed to enzymes with canonical mannan binding modules. These features highlight fine tuning of catalytic and binding...

  1. THE EFFECT OF PROBIOTIC FERMENTED MILK THAT INCLUDES BIFIDOBACTERIUM LACTIS CNCM I-2494 ON THE REDUCTION OF GASTROINTESTINAL DISCOMFORT AND SYMPTOMS IN ADULTS: A NARRATIVE REVIEW.

    Science.gov (United States)

    Waitzberg, Dan L; Quilici, Flávio A; Michzputen, Sender; Friche Passos, Maria do Carmo

    2015-08-01

    Objetivo: determinar la eficacia de la leche fermentada con Bifidobacterium lactis CNCM I-2429 en la reducción de el malestar gastrointestinal (GI) en adultos sanos. Métodos: se realizó una búsqueda sistemática en la literatura para identificar estudios que informaron del uso de B. animalis spp. lactis para molestias/ confort GI en adultos sanos. Se identificaron un total de 5.329 registros, de estos se evaluaron 99 artículos de texto completo. Las búsquedas de ensayos adicionales se realizaron utilizando los nombres de los autores de cada estudio identificado y varias bases de datos relevantes. La selección de los estudios se llevó a cabo de acuerdo con las guías de Artículos de Información Preferidos para Revisiones Sistemáticas y Meta-Análisis (PRISMA). Los estudios eran incluidos si eran ensayos randomizados controlados, si los sujetos de estudio eran adultos sanos y si el grupo de intervención recibió B. lactis CNCM I-2494. Se excluyeron los estudios que no eran randomizados, que incluían adultos que no estaban sanos, que incluían el uso de cualquier otra intervención o si comparaban diferentes productos sin un grupo placebo. La calidad metodológica de los estudios se evaluó utilizando la Escala de Calidad de Oxford y la Evaluación Cochrane de ocultamiento. No fue posible un metaanálisis. Resultados: la estrategia de búsqueda identificó dos estudios que incluyeron un total de 538 mujeres sanas, con edades entre 18 a 60 años, de peso normal o sobrepeso (IMC de 18-30 kg/m2). En uno de los estudios las molestias GI disminuyeron significativamente en el grupo de probióticos frente al grupo control, sin diferencias en el otro. El porcentaje de respondedores para el bienestar GI fue mayor en el grupo de probióticos frente al grupo control en el primer estudio, pero no en el segundo. Los síntomas GI se redujeron significativamente en el grupo probiótico frente al grupo control en ambos estudios. La función intestinal solo se evaluó en

  2. Preparation of Bifidobacterium bifidum microcapsules by emulsification%乳化法制备两歧双歧杆菌微胶囊

    Institute of Scientific and Technical Information of China (English)

    陈合; 王野; 贾亚丽; 舒国伟

    2013-01-01

    以两歧双歧杆菌BB01和BB28为试验菌株,活菌数及包埋产率为指标,研究了海藻酸钠浓度、CaCl2浓度、乳化时间及固定化时间对乳化法制备两歧双歧杆菌微胶囊的影响.结果表明:当两歧双歧杆菌BB01微胶囊制备的条件分别为海藻酸钠浓度2%、CaCl2浓度1%、乳化时间10 min、固定化时间15 min时,对应的活菌数分别为4.9×109 cfu/mL、3.06×109 cfu/mL、2.47×109 cfu/mL和4.37×109 cfu/mL,包埋产率分别为80%、56.7%、40.9%和54.1%;当两歧双歧杆菌BB28微胶囊制备的条件分别为海藻酸钠浓度2.5%、CaCl2浓度1%、乳化时间15 min、固定化时间15 min时,对应的活菌数分别为4.0×109 cfu/mL、4.1×109 cfu/mL、1.59×109 cfu/mL和5.55×109 cfu/mL,包埋产率分别为80%、92%、87%和76.1%.%Effect of the concentration of sodium alginate and CaCl2, emulsifying time and immobilized time on preparation of Bifidobacterium bifidum microcapsules by emulsification was studied by using B. Bifidum BB01 and BBZ8 as test strains and viable counts and encapsulation yield as index. The results were as follows:when the sodium alginate concentration 2%,CaCl, concentration 1% ,emulsifying time 10 min and immobilized time 15 min, the viable counts and encapsulation yield of B. Bifidum BB01 were 4. 9×109 cfu/mL, 3. 06×109 cfu/mL, 2. 47×10s cfu/mL and 4. 37×109 cfu/mL, 80%, 56. 7%, 40. 9% and 54. 1%; when the sodium alginate concentration 2. 5% ,CaCl2 concentration 1 %,emulsifying time 15 min and immobilized time 15 min, the viable counts and encapsulation yield of B. Bifidum BB28 were 4. 0×109 cfu/mL, 4. 1×109 cfu/mL, 1.59×109 cfu/mL and 5. 55×109 cfu/mL, 80%, 92%, 87% and 76.1%.

  3. Relationship between acid tolerance and cell membrane in Bifidobacterium, revealed by comparative analysis of acid-resistant derivatives and their parental strains grown in medium with and without Tween 80.

    Science.gov (United States)

    Yang, Xu; Hang, Xiaomin; Zhang, Min; Liu, Xianglong; Yang, Hong

    2015-06-01

    The acid tolerance is particularly important for bifidobacteria to function as probiotics because they usually encounter acidic environments in food products and gastrointestinal tract passage. In this study, two acid-resistant derivatives Bifidobacterium longum JDY1017dpH and Bifidobacterium breve BB8dpH, which displayed a stable acid-resistant phenotype, were generated. The relationship between acid tolerance and cell membrane was investigated by comparing the two acid-resistant derivatives and their parental strains grown in medium with and without Tween 80. The fold increase in acid tolerance of the two acid-resistant derivatives relative to their parental strains was much higher when cells were grown in medium with Tween 80 (10(4) ~ 10(5)-fold) than without Tween 80 (181- and 245-fold). Moreover, when cells were grown in medium with Tween 80, the two acid-resistant derivatives exhibited more C18:1 and cycC19:0, higher mean fatty acid chain length, lower membrane fluidity, and higher expression of cfa gene encoding cyclopropane fatty acid synthase than their parental strains. No significant differences in cell membrane were observed between the two acid-resistant derivatives and their parental strains when cells were grown in medium without Tween 80. The present study revealed that, when cells were grown in medium with Tween 80, the significant fold increase in acid tolerance of the two acid-resistant derivatives was mainly ascribed to the pronounced changes in cell membrane compared with their parental strains. Results presented here could provide a basis for developing new strategies of cell membrane modification to enhance acid tolerance in bifidobacteria.

  4. 青春双歧杆菌对2型糖尿病模型大鼠肠道菌群和脂质代谢的影响%Influence of Bifidobacterium adolescentis on intestinal flora and lipid metabolism in type 2 diabetes mellitus rats

    Institute of Scientific and Technical Information of China (English)

    刘伯阳; 姚淑娟; 夏美玲

    2009-01-01

    目的 通过观察青春双歧杆菌对2型糖尿病模型大鼠肠道菌群的变化,和血清中总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白(HDL-C)、超氧化物歧化酶(SOD)和丙二醛(MDA)的水平,探讨青春双歧杆菌对2型糖尿病模型大鼠肠道功能和脂质代谢的影响.方法 采用青春双歧杆菌灌胃2型糖尿病模型大鼠,取粪便检查正常菌群,取血和脏器检测TC、TG、HDL-C、SOD和MDA含量.结果 青春双歧杆菌导致肠道内双歧杆菌、乳杆菌的数量增加,而肠杆菌、肠球菌数量下降;TC、TG和MDA水平下降,而HDL-C和SOD水平升高.结论 青春双歧杆菌具有改善2型糖尿病模型大鼠肠道功能和降血脂作用,与二甲双胍联合应用效果更佳.%Objective To observe the change of intestinal flora caused by Bifidobacterium adolescentis and the levels of total cholesterol, Triglyceride, high density lipoprotein, superoxide dismutase and malondialdehyde in type 2 diabetes mellitus rats,and explore the influence of Bifidobacterium adolescentis on intestinal flora and lipid metabolism in type 2 diabetes mellitus rats. Method The levels of normal flora, total cholesterol, Triglyceride, high density lipoprotein,superoxide dismutase and malondialdehyde were examined after gavaging type 2 diabetes mellitus rats by Bifidobacterium adolescentis. Result Bifidobacterium adolescentis had caused the number of bifidobacterium and lactis to increase while that of Enter-obacter and Enterococcus to decrease;The levels of total cholesterol, Triglyceride and malondialdehyde were reduced while those of high density lipoprotein and superoxide dismutase were improved. Conclusion Bifidobacterium adolescentis has the effect of improving intestinal function and lowering serum lipids in type 2 diabetes mellitus rats,the effect of which can be improved when combined with metformin.

  5. 低pH处理对两歧双歧杆菌KLDS2.0603黏附能力的影响%Influence of low pH on the adhesion ability of Bifidobacterium bifidum KLDS2.0603

    Institute of Scientific and Technical Information of China (English)

    王彦; 孟祥晨; 王丽群; 李馨

    2012-01-01

    [目的]确定低pH处理对两歧双歧杆菌KLDS2.0603黏附能力及其表面物理化学性质的影响.[方法]将两歧双歧杆菌KLDS2.0603菌体在不同低pH的PBS溶液中处理一定时间后,采用平板菌落计数法和直接镜检法,测定其经历不同pH的酸性环境后的黏附能力,及其表面疏水性和自动聚集能力.[结果]不同pH的PBS溶液处理后的双歧杆菌菌体,其黏附能力均不同程度下降,除pH 5.0的处理组外,其余处理组均显著低于空白组.此外,经不同pH的PBS溶液处理后,仅pH 3.0和3.5的两处理组,双歧杆菌表面疏水性显著提高.除pH 1.0、1.5和5.0的处理组外,其余处理组的自动聚集能力均显著下降.[结论]低pH的酸性环境会降低两歧双歧杆菌KLDS2.0603的黏附能力,并且双歧杆菌的自动聚集能力和表面疏水性也发生相应变化.除pH 3.0和3.5的处理组外,三者之间呈现一定的正相关性.%[Objective] The influence of low pH on the adhesion ability and the surface properties of Bifidobacterium bifidum KLDS2.0603 were determined in this paper. [Methods) After Bifidobaclerium bifidum KLDS2.0603 was treated by PBS of different low pH, the adhesion ability was assayed by gram staining microscopic examination and plate colony counting method. The autoaggregation ability and surface hydrophobicity of Bifidobacterium bifidum KLDS2.0603 were also assayed. [Results] The adhesion abilities of Bifidobacterium bifidum KLDS2.0603 treated by PBS with different low pH were decreased. The adhesion abilities of treatment groups were significantly lower than control group except the group of pH 5.0. The surface hydrophobicity of Bifidobacterium bifidum K.LDS2.0603 treated by PBS of pH 3.0 and 3.5 was significantly increased. Except for experimental groups of pH 1.0, 1.5 and 5.0, the autoaggregation ability of Bifidobacterium bifidum KLDS2.0603 was significantly reduced. [Conclusion] The adhesion ability of Bifidobacterium bifidum KLDS2

  6. The application prospects of probiotic Bifidobacterium in the tumor targeted therapy%双歧杆菌在肿瘤靶向性基因治疗中的应用

    Institute of Scientific and Technical Information of China (English)

    王琳; 浦寅飞; 王衣祥; 郭传瑸

    2013-01-01

    a common feature in all types of tumors and facilitates anaerobic bacteria to localize in this zone. These provide the rationale for targeted therapy by using a probiotic anaerobic bacterium including Bifidobac-terium. Probiotic Bifidobacterium can locate and growth in the hypoxic area of solid tumors. Therefore, genetic modi-fied Bifidobacterium containing target genes would be used as a very useful tool for cancer treatment, which could make the hypoxic area not be“a forbidden area”. In this review, we will discuss the reason that hypoxic area forms in the solid tumor, the way to use Bifidobacterium as cancer treatment tool, and its related issues including the biosafe-ty, targeted localization, potential application and challenges of genetic modified Bifidobacterium.

  7. Antimicrobial activity of Lactobacillus and Bifidobacterium strains against pathogenic microorganisms “in vitro”Atividade antimicrobiana de Lactobacillus e Bifodobacterium frente a microrganismos patogênicos “in vitro”

    Directory of Open Access Journals (Sweden)

    Giselle Nobre Costa

    2012-10-01

    Full Text Available Lactobacilli and bifidobacteria have a long history of safe use in foods. These bacteria have biotechnological characteristics of interest such as the inhibition of pathogens. In this work, two lactobacilli strain and a bifidobacterium strain isolated from human gut were evaluated concerning to their ability to inhibit pathogenic microorganisms in foods by diffusion agar tests. Moreover, we assessed the metabolites produced in culture broth under static and shaking growth to simulate anaerobiosis and aerobiosis conditions, respectively. L. acidophilus LA5, L. plantarum DCTA 8420 and B. lactis DCTA 8724 showed ability to inhibit S. aureus FRI 196, strains producer toxins A and D, as well as B. cereus ATCC 25923, E. coli ATCC 25922 and S. Enteritidis, whose inhibition halos reached, on average, 24 mm in diameter. In the agar diffusion method with concentrated culture medium, it was possible to observe the effect of oxygen on the production of toxic substances. This result showed that cultivation of Lactobacillus under aerobic conditions seems to exert greater inhibitory effect, whereas for Bifidobacterium strain the effect was the opposite.Lactobacilos e bifidobactérias apresentam um longo histórico de uso seguro em alimentos, além de apresentarem características de interesse biotecnológico como a inibição de patógenos. Neste trabalho duas linhagens de lactobacilos e uma de bifidobactéria, isoladas do intestino humano, foram avaliadas em testes de difusão em ágar, quanto à capacidade de inibição de microrganismos patogênicos de ocorrência comuns em toxinfecções alimentares. Adicionalmente, foram avaliados os metabólitos produzidos em caldo de cultivo estático e em agitação para simular condições de anaerobiose a aerobiose, respectivamente. As três bactérias, L. acidophilus LA5, L. plantarum DCTA 8420 e B. lactis DCTA 8724 apresentaram capacidade de inibição para S. aureus FRI 196 linhagem produtora de toxinas A e D

  8. Application of a Cholesterol-Lowering Strain of Bifidobacterium animalis in Fat-Free Yoghurt%降胆固醇双歧杆菌B菌在零脂酸奶生产中的应用

    Institute of Scientific and Technical Information of China (English)

    傅强; 周星浩; 高兴华; 欧凯; 王银娟; 刘小杰

    2012-01-01

    Bifidobacterium animalis strain B, a strain that is capable of lowering cholesterol levels in the body, was screened out and used in combination with the conventional fermentation starter (composed of L.bulgaricus and S.thermophilus) for the mixed-strain fermentation of fat-free yoghurt at 43 °C. The end point of the fermentation was reached after 5.5 - 6 hours. The total numbers of viable Bifidobacterium animalis and lactic acid bacteria reached an average of 4.8 X 106 CFU/g and 7.4 X 107 CFU/g respectively during 28 days of storage at 4 °C.The yoghurt obtained showed a protein content of 2.8 g/100 g, a fat content of 0.2 g/100 g, and an acidity value of 80 °T. All of these three indexes met the requirements of the National Food Safety Standard GB 19302--2010: Fermented Milk. Meanwhile, according to the Ministry of Health's Regulation for Food Nutrition Labeling, the yoghurt product could be labeled as fat-free fermented milk. The results of sensory evaluations revealed that it had a very gentle flavor and a strong taste of fresh cream with a smooth and exquisite texture and a good consumer acceptance. Therefore, the yoghurt developed in this study has promising commercial prospects.%研究降胆固醇益生菌在酸奶中的应用。筛选一株具有降低人体胆固醇水平的双歧杆菌B菌,采用此双歧杆菌B菌(Bifidobacterium animalis)和常规酸奶菌种A菌(L.bulgaricus和S.thermophilus)在43℃混合发酵,发酵5.5~6h可达到发酵终点,该酸奶产品在4℃、28d冷藏保质期内,功效双歧杆菌数和乳酸菌总数平均值分别达到4.8×106CFU/g和7.4×107CFU/g,成品理化指标检测为蛋白质含量2.8g/100g、脂肪含量0.2g/100g和酸度80°T,均符合食品安全国家标准GB 19302—2010《发酵乳:风味发酵乳》的要求,根据卫生部食品营养标签管理规范,本产品可标示为零脂风味发酵乳,从感官评价结果来看,此风味发酵乳具有非常柔和的风味及有较

  9. 肿瘤双自杀基因治疗系统pTRKH2-PsT/CD,pTRKH2-PsT/UPRT在厌氧婴儿双歧杆菌中的构建%Construction of dual suicide gene therapy system pTRKH2/CD and pTRKH2/UPRT in Bifidobacterium infantis and its characterization

    Institute of Scientific and Technical Information of China (English)

    Zhuhua Li; Peng Ye; Yanbiao Yang; Guangyu Ran; Shuren Wang

    2009-01-01

    Objective: We recombine the suicide gene CD, UPRT into plasmid pTRKH2 and clone the recombinant dual suicide gene therapy system into tumor-hypoxia-targeting vector Bifidobacterium infantis and characterize its function. Methods: CD gene, UPRT gene and lactic acid bacteria expression plasmid pTRKH2 were digested by restriction endonuclease BamH I and Sal I, and constructed recombinant plasmids pTRKH2/CD and pTRKH2/UPRT in E. coll. The recombinant plasmids were then transfected into Bifidobacterium Infantis by electroporation. Identification of pTRKH2/CD and pTRKH2/UPRT was processed by dual restriction endonuclease digesting and sequencing. RT-PCR and SDS-PAGE were used to examine the expression of CD and UPRT genes at RNA and protein levels. The killing effects on Melanoma B16-F10 cells by pTRKH2/CD and pTRKH2/UPRT suicide gene therapy system with 5-FC were examined by MTT assay. Results: The CD gene and UPRT gene was successfully recombined into lactic acid bacteria expression plasmid pTRKH2. After dual endonuclease digestion of plasmid purified from the positively transfected E. co/i, two fragments of 6.9 Kb and 1.3 Kb were found for CD gene and two fragments of 6.9 Kb and 620 bp were found for UPRT gene. The sequencing of CD gene and UPRT gene proved consistent sequences with Genebank published data. A fragment of 1.3 Kb for CD gene and fragment of 620 bp for UPRT gene was found in recombinant Bifidobac- terium by RT-PCR. A 52 KDa protein for CD gene was identified in whole-cell protein of recombinant Bifidobacterium and a 26 KDa protein for UPRT gene was identified in supernatant fluid of recombinant Bifidobacterium. The survival rate of tumor cells treated by extracts from culture of recombinant Bifidobacterium with 5-FC showed a strong killing effects of pTRKH2/CD and pTRKH2/UPRT dual suicide gene therapy system on Melanoma B16-F10 cells. Conclusion: CD gene and UPRT gene are suc- cessfully inserted into pTRKH2 and transfected into tumor

  10. Effect of salt stress on morphology and membrane composition of Lactobacillus acidophilus, Lactobacillus casei, and Bifidobacterium bifidum, and their adhesion to human intestinal epithelial-like Caco-2 cells.

    Science.gov (United States)

    Gandhi, Akanksha; Shah, Nagendra P

    2016-04-01

    The effects of NaCl reduction (10.0, 7.5, 5.0, 2.5, and 0% NaCl) and its substitution with KCl (50% substitution at each given concentration) on morphology of Lactobacillus acidophilus, Lactobacillus casei, and Bifidobacterium longum was investigated using transmission electron microscopy. Changes in membrane composition, including fatty acids and phospholipids, were investigated using gas chromatography and thin layer chromatography. Adhesion ability of these bacteria to human intestinal epithelial-like Caco-2 cells, as affected by NaCl and its substitution with KCl, was also evaluated. Bacteria appeared elongated and the intracellular content appeared contracted when subjected to salt stress, as observed by transmission electron microscopy. Fatty acid content was altered with an increase in the ratio of unsaturated to saturated fatty acid content on increasing the NaCl-induced stress. Among the phospholipids, phosphatidylglycerol was reduced, whereas phosphatidylinositol and cardioplipin were increased when the bacteria were subjected to salt stress. There was a significant reduction in adhesion ability of the bacteria to Caco-2 cells when cultured in media supplemented with NaCl; however, the adhesion ability was improved on substitution with KCl at a given total salt concentration. The findings provide insights into bacterial membrane damage caused by NaCl.

  11. Study on production of bifidobacterium soybean yogurt by temperature shift fermentation%变温发酵法生产双歧杆菌大豆酸奶的研究

    Institute of Scientific and Technical Information of China (English)

    丁艺雪; 夏明; 毛俊磊; 陈晶晶

    2009-01-01

    Temperature shift fermentation to produce bifidobacterium soybean yogurt was studied, according to the differences of the favorite fermented temperature between lactobacillus and bifidobacteriai. Based on orthogonality test, the optimum formula and fermentation process were conducted, and live Bifidobacteriai was counted. The raw materials were fermented 4 hr. in 40 ℃ at first, 2.5 hr. in 37℃ subsequently, and then in 4℃ refrigerate for 24 hr. In the final product, there were 107/mL living Bifidobacteriai, which was one hundred times than the product of the same formula, putting in the constant temperature.%根据乳酸菌和双歧杆菌的最适发酵温度存在差异的特点,进行变温发酵试验,生产双歧杆菌大豆酸奶.采用正交试验优化配方及发酵工艺条件,并测定其双歧杆菌活菌数.试验结果表明,在40℃下发酵4 h,然后降温到37℃发酵2.5 h,主发酵完成后在4℃条件下后发酵24 h.最终产品双歧杆菌活菌数达107个/mL,较同一配方恒温发酵产品增加了100倍.

  12. Purification, crystallization and preliminary X-ray analysis of the galacto-N-biose-/lacto-N-biose I-binding protein (GL-BP) of the ABC transporter from Bifidobacterium longum JCM1217

    Energy Technology Data Exchange (ETDEWEB)

    Wada, Jun [Graduate School of Biostudies, Kyoto University, Kitashirakawa, Sakyo-ku, Kyoto 606-8502 (Japan); Suzuki, Ryuichiro; Fushinobu, Shinya [Department of Biotechnology, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657 (Japan); Kitaoka, Motomitsu [National Food Research Institute, 2-1-12 Kannondai, Tsukuba, Ibaraki 305-8642 (Japan); Wakagi, Takayoshi; Shoun, Hirofumi [Department of Biotechnology, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657 (Japan); Ashida, Hisashi [Graduate School of Biostudies, Kyoto University, Kitashirakawa, Sakyo-ku, Kyoto 606-8502 (Japan); Kumagai, Hidehiko; Katayama, Takane, E-mail: takane@ishikawa-pu.ac.jp [Research Institute for Bioresources and Biotechnology, Ishikawa Prefectural University, Nonoichi, Ishikawa 921-8836 (Japan); Yamamoto, Kenji [Graduate School of Biostudies, Kyoto University, Kitashirakawa, Sakyo-ku, Kyoto 606-8502 (Japan)

    2007-09-01

    Preliminary X-ray analysis of the galacto-N-biose-/lacto-N-biose I-binding protein (GL-BP) of the ABC transporter from B. longum is described. A recombinant galacto-N-biose-/lacto-N-biose I-binding protein (GL-BP) from Bifidobacterium longum JCM1217 has been prepared and crystallized by the hanging-drop vapour-diffusion method using 10 mg ml{sup −1} purified enzyme, 0.01 M zinc sulfate, 0.1 M MES buffer pH 5.9–6.4 and 20–22%(v/v) PEG MME 550 in the presence of 5 mM disaccharide ligands. Suitable crystals grew after 10 d incubation at 293 K. The crystals belong to space group C222{sub 1}, with unit-cell parameters a = 106.3, b = 143.6, c = 114.6 Å for the lacto-N-biose I complex and a = 106.4, b = 143.4, c = 115.5 Å for the galacto-N-biose complex, and diffracted to 1.85 and 1.99 Å resolution, respectively.

  13. 长双歧杆菌亚种JCM1217基因组分泌蛋白的分析%Genome-wide Analysis of the Secretory Proteins of Bifidobacterium Longum Subsp. JCM 1217

    Institute of Scientific and Technical Information of China (English)

    张秀红; 王颖; 段江燕

    2012-01-01

    Objective:Bifidobaeterium are important human intestinal probiotics, analysis of their secretory proteins will help us to correctly understand its physiological function and molecular mechanisms of interaction with their host. Methods:The amino acid sequence of Bifidobacterium longitm subsp. JCM 1217 genome proteins were obtained from Gen-Bank. Using SignalP v3.0, TMHMM 2.0, TatP, LipoPl.O, GPI, DOLOP software analyze the function of secretory proteins and the type and characteristic of these secretory proteins and their signal peptides. Results;A total of 58 secretion proteins through Sec pathway (including one through Tat pathway), 142 non-classical secretory proteins were screened. The secretory proteins from Sec pathway included secreted proteins recognized by Spase Ⅰ and Spase Ⅱ. Most of their signal peptide length are 25 and 28aa, respectively; The distribution and the average length of Spase Ⅱ secretory proteins were smaller than that of Spase I secretory proteins. The usage frequencies of alanine on the cleavage site left position -3, -2 and -1 of Bifidobacterium signal peptide and the mature protein were 61.11%, 19.4% and 83.33%, respectively, belonged to typically A-X-A signal peptide recognition sites structure. About to the functions of Bifidobacterium secretory protein, there were many hypothetical proteins in every type secretory proteins. Besides that, Spase Ⅰ type secretory proteins encoded a number of enzymes related to metabolism, while the hydrolyses were little; Spase Ⅱ type of secretory proteins are mainly related to ABC transporter proteins; the functions of non-classical secretory proteins were very complex, including enzymes with regard to metabolism and cell wall synthesis, DNA replication and gene expression related protein and other functional proteins. Conclusion;The secretory protein and their signal peptide from Bifidobacterium longwn subsp. JCM 1217 are similar to that from other Gram-positive bacteria. The functions of

  14. 健康老年人肠道双歧杆菌和乳杆菌种群多样性分析%Analysis of the probiotics Bifidobacterium and Lactobacillus community in healthy elderly intestinal flora

    Institute of Scientific and Technical Information of China (English)

    张和春; 王劲松; 杨国; 倪新华; 范小兵; 杭晓敏

    2006-01-01

    从31个60岁以上的符合中华医学会老年医学分会健康老年人标准的健康老人中随机选取4例作为研究对象,使用分子生物学方法,对他们的肠道双歧杆菌和乳杆菌种群多样性进行分析.研究结果表明,健康老人肠道中双歧杆菌的优势种群为长双歧杆菌(Bifi∥dobacterium longum)和假小链双歧杆菌(Bifidobacterium pseudocatenulatum),分别占双歧杆菌种群的55%和45%;而肠道乳杆菌则有唾液乳杆菌(Lactobacillus salivarius)50%、Lactobacillus mocosae 31.1%、口腔乳杆菌(Lactobacillus oris)6.3%、鼠李糖乳杆菌(Lactobacillus rhamnosus)6.3%和瑞士乳杆菌(Lactobacillus helveticus)6.3%,其中唾液乳杆菌、Lactobacillus mocosae为健康老人肠道优势乳杆菌种群.

  15. 早期补充益生菌对早产儿喂养及肠道菌群的影响%Influence of Early Oral Bulk Triple Viable Bifidobacterium on Intestinal Flora in Preterm Infants

    Institute of Scientific and Technical Information of China (English)

    王华; 乔林霞; 黄玉香; 张海燕; 朱文英

    2014-01-01

    Objective To study the impact of early oral triple viable Bifidobacterium intestinal flora of premature infants and feeding symptoms. Methods 60 preterm infants hospitalized were randomly divided into two groups, oral triple viable Bifidobacterium group (study group) and control group, three days after birth, 1 week and 2 weeks of age, respectively stool specimens were specimens in preterm children, while recording feeding symptoms and using real-time PCR technology to measure intestinal specimens Lactobacillus and Bifidobacterium. Results Study group incidence of feeding intolerance in 4 patients (13.3%), control group of 12 patients (40.0%), the difference was statistically significant (P=0.0195). Number of study group of intestinal lactobacilli and bifidobacteria at 1 week old was 7.84±0.35, 8.52±0.23, the control group was 6.39±0.53, 7.01±0.48, the difference was statistically significant (P=0.013, P=0.024). Number of study group of intestinal lactobacilli and bifidobacteria at 2 weeks of age was 8.62±0.28, 9.45±0.64, the control group was 7.34±0.59, 7.85±0.43, the difference was statistically significant (P=0.036, P=0.007). Conclusion Early oral bifidobacteria in preterm hospitalized triple viable group of intestinal bifidobacteria and lactobacilli was higher than oral triple viable Bifidobacterium group, while the incidence of feeding intolerance was significantly lower.%目的:研究早期口服双歧杆菌三联活菌对早产儿肠道菌群和喂养症状的影响。方法选择60例符合条件的住院早产儿并随机分为2组,分别为口服双歧杆菌三联活菌组(研究组)及对照组,在生后3d、1周及2周龄时分别留取早产儿大便标本,同时记录喂养症状,采用实时荧光定量PCR技术检测标本中的肠道乳酸杆菌及双歧杆菌。结果研究组喂养不耐受的发生率为4例(13.3%),对照组为12例(40.0%),2组比较差异具有统计学意义(P=0.0195)。研究组在1周

  16. Probiotic therapy using live combined bifidobacterium, lactobacillus and enterococcus for experimental colitis in rats model%微生态制剂对实验性大鼠结肠炎的治疗

    Institute of Scientific and Technical Information of China (English)

    万岳梦; 朱尤庆; 夏冰; 罗峻

    2010-01-01

    Objective To evaluate the effect of live combined bifidobacterium, lactobacillus and enterococcus capsules for colitis in rats induced by trinitrobenzenesulfonic acid (TNBS), so as to explore a new therapy for inflammatory bowel diseases (IBD). Methods 50 female adult Sprague-Dawley rats were randomly divided into 5 groups i. e. normal control group(G1) ,untreated TNBS-induced colitis(G2) ,TNBS-induced colitis treated with live combined bifidobacterium, lactobacillus and enterococcus (G3), TNBS-induced colitis treated with olsalazine (G4) and TNBS-induced colitis treated with both live combined bifidobacterium, lactobacillus and enterococcus and olsalazine at the same dose and duration (G5). Each group received its respective treatment. Serum levels of C-reactive protein (CRP), TNFα and IL-10 were measured with ELISA, colonic myeloperoxidase (MPO) activity was determined with spectrophotometric method, histopathologic picture of the colon of each rat was studied with microscope and colonic mucosa damage index(CMDI) was recorded. Results Serum CRP,TNFα,IL-10,CMDI and colonic MPO in G1 were significantly lower than those in G2 (P < 0. 001) with normal colonic architecture. G2 exhibited the most severe colonic inflammation and the highest levels of CRP,TNFα, IL-10, CMDI and colonic MPO with stastical significance. Treatment groups G3, G4 and G5 showed more obvious colonic inflammatory remission and lower levels of serum CRP,TNFα , IL-10 and colonic MPO, G5 being most notable when compared to G2 with stastical significance. In G2, serum levels of CRP, TNFα, IL-10 and colonic MPO activity each correlated positively with CMDI (P < 0. 001). Conclusions Live combined bifidobacterium, lactobacillus and enterococcus can effectively ameliorate colitis in rats induced by TNBS; the underlying mechanism may possibly be associated with the serum levels of cytokines.%目的 评价微生态制剂双歧三联活菌对三硝基苯磺酸钠(TNBS)诱导的大鼠结肠炎的疗

  17. 双歧杆菌对实验性末端回肠炎肠组织TLR2、TLR4的表达影响及干预机制%Bifidobacterium influences the expression of TLR 2 and TLR4 on the intestinal tissue of experimental terminal ileitis and its intervention mechanism

    Institute of Scientific and Technical Information of China (English)

    龚家顺; 林义办; 梁景星; 张艳

    2015-01-01

    [Objective]To investigate the expression of TLR2 and TLR4 and intervention mechanism in experimental terminal ileitis with bifidobacterium treatment. [Methods]Ninety healthy male SD rats were randomly divided into control group ,model group ,bifidobacterium intervention group. The model of termi‐nal ileitis was induced by ileum‐cecum side‐to‐side anastomosis in the model group and bifidobacterium in‐tervention group. The rats in bifidobacterium intervention group were given 1 mL bifidobacterium suspen‐sion of 108cfu/ml concentration postoperatively.The rats in control group and model group were daily giv‐en 1 ml of 10% skimmed milk. Euthanasia was performed 2 or 8 weeks postoperative ,and the terminal ile‐um tissues were collected. The pathological changes of the terminal ileum tissues were investigated by gross and microscopic observation ,and the expression of TLR2 and TLR4 in intestinal epithelial cells was detec‐ted. [Results]At 2 weeks ,the gross and microscopic observation showed acute inflammation in terminal ile‐um in model group and bifidobacterium intervention group.Inflammatory score of model group increased when comparing with control group(P<0.05 ,P<0.01) ,and the mucosa in control group was normal.At 8 weeks ,the inflammation score of bifidobacterium intervention group decreased significantly when compa‐ring with model group(P< 0.01).The tissues of bifidobacterium intervention group and control group were normal. The expression of TLR2 and TLR4 in the intestinal epithelium of model group and bifidobac‐terium intervention group were higher than control group (P<0.01 ,P<0.05). At 8 weeks ,the expression of TLR2 and TLR4 in model group were higher than control group(P<0.01) ,whereas they were reduced in bifidobacterium intervention group (P< 0.05). The control group had no significant changes. [Conclu‐sion]The expression of TLR2 and TLR4 increased in the process of experimental terminal ileitis ,and the expression intensity of

  18. 双歧杆菌四联活菌片治疗婴幼儿抗生素相关性腹泻的临床研究%Clinical research of bifidobacterium tetravaccine tablet in treatment of infantile antibiotic-associated diarrhea

    Institute of Scientific and Technical Information of China (English)

    吴雄基; 陆俏群

    2014-01-01

    目的:探讨双歧杆菌四联活菌片治疗婴幼儿抗生素相关性腹泻的疗效和安全性。方法120例抗生素相关性腹泻的患儿随机分为治疗组和对照组,每组60例,两组均采用基础治疗,治疗组加服双歧杆菌四联活菌片。观察两组患儿的大便次数、量和性状。结果治疗组和对照组的总有效率分别为88.3%和66.6%,两组比较差异有统计学意义(P<0.05)。结论双歧杆菌四联活菌片治疗婴幼儿抗生素相关性腹泻疗效明显,安全性高,适合临床推广应用。%Objective To investigate the curative effect and safety of bifidobacterium tetravaccine tablet in treatment of infantile antibiotic-associated diarrhea.Methods A total of 120 cases with infantile antibiotic-associated diarrhea were randomly divided into treatment group and control group, and each group contained 60 cases. All cases received basic treatment, and the treatment group was treated by bifidobacterium tetravaccine tablet in addition. The frequency, quantity and characteristics of the cases’ stools were recorded.Results The total effective rate of the treatment group and the control group were 88.3% and 66.6%, and the difference had statistical significant (P<0.05).Conclusion Bifidobacterium tetravaccine tablet in treatment of infantile antibiotic-associated diarrhea has clear effect and high safety. It is worthy of clinical application.

  19. 双歧杆菌对过敏性哮喘儿童DC成熟及其分泌细胞因子的影响%The effect of bifidobacterium on the maturation and the secretion of cytokine in dendritic cells from the children with allergic asthma

    Institute of Scientific and Technical Information of China (English)

    马红玲; 王和平; 祖莹; 王莉; 谭卫群; 郑跃杰

    2011-01-01

    目的 研究青春型双歧杆菌对过敏性哮喘儿童外周血单个核细胞(PBMC)来源的树突状细胞(DC)表达CD86和HLA-DR及其分泌IL-1β、IL-6、IL-10、IL-12、IL-23和IFN-γ的影响.方法 从15名过敏性哮喘儿童和15名非哮喘儿童的外周血单个核细胞诱导生成未成熟DC,分别加入青春型双歧杆菌或脂多糖(LPS)后继续培养DC 2天,①每天于倒置显微镜下观察DC形态;②用流式细胞仪检测各组DC表面CD86和HLA-DR的分子表达;③用ELISA方法检测培养上清中IL-1β、IL-6、IL-10、IL-12、IL-23和IFN-γ的水平.结果 ①DC经双歧杆菌和LPS分组处理后第2天,于倒置显微镜下观察到双歧杆菌组和LPS组的DC突起均较空白组明显,具有突起的细胞数量较空白组增多,而双歧杆菌组与LPS组比较,LPS组有突起的细胞数量明显增多,提示DC过度生长.②双歧杆菌刺激后,哮喘儿童DC表面CD86表达明显增高,HLA-DR表达无明显变化,非哮喘儿童CD86和HLA-DR表达均无明显变化;LPS刺激可明显增加哮喘儿童和非哮喘儿童CD86和HLA-DR的表达.③双歧杆菌刺激哮喘儿童DC分泌IL-12、IFN-γ、IL-1β及IL-6水平增高,刺激非哮喘儿童DC分泌IL-12、IL-10、IL-1β及IL-23水平增高.结论 ①过敏性哮喘儿童DC表面CD86的表达可能存在缺陷,双歧杆菌能适度上调其表达,在DC的成熟过程中可能起调节作用.②双歧杆菌能刺激过敏性哮喘儿童DC分泌IL-12和IFN-γ,从而改变Th2优势分化,纠正Th1/Th2失衡.③过敏性哮喘儿童DC分泌IL-10可能存在缺陷,从而影响免疫耐受的形成.④双歧杆菌可能通过刺激哮喘儿童DC分泌IL-1β及IL-6增高,达到促进Th17细胞分化的作用.%Objective ①To study the effects of bifidobacterium on the expression of CD 86 and HLA-DR、 secretion of IL-1β、IL- 6、IL-10、 IL-12、IL-23 and IFN-γin dendritic cells (DCs) derived from peripheral blood mononuclear cells (PBMC ) of the children with

  20. 蒙脱石散与双歧杆菌三联活菌散治疗小儿腹泻的效果对比%Effect Contrast of Montmorillonite Powder and Bifidobacterium Triple Powder in the Treatment of Pediatric Diarrhea

    Institute of Scientific and Technical Information of China (English)

    陈淑平; 付秀扬

    2016-01-01

    目的:探讨蒙脱石散与双歧杆菌三联活菌散治疗小儿腹泻的效果。方法选取我院诊断为的腹泻的患儿400例,随机分为:200例研究组(接受双歧杆菌三联活菌散治疗)和200例对照组(接受蒙脱石散治疗)。对比两组腹泻治疗疗效及不良反应发生情况。结果研究组和对照组腹泻有效率分别为91%、80%,结果比较有差异(P<0.05);两组服用药物期间均无严重不良反应,无死亡病例。结论本次研究认为双歧杆菌三联活菌散治疗小儿腹泻疗效肯定,安全性好。%Objective To explore the effects of Montmorillonite powder and Bifidobacterium triple powder in the treatment of pediatric diarrhea. Methods 400 cases of children diagnosed with diarrhea in our hospital were selected and randomly divided into:200 cases in the study group (receiving Bifidobacterium triple powder therapy) and 200 cases in the control group (receiving montmorillonite powder therapy). Results The effective rate of study group and control group were 91%and 80%, there was a difference (P<0.05). Study group and control group both had no serious side effects during medication, nor no death cases. Conclusion This study suggests that Bifidobacterium triple powder is effective in the treatment of diarrhea in children, and has good safety.

  1. Development of Microcapsule Containing Bifidobacterium and Lactobacillus acidophilus%双歧杆菌和嗜酸乳杆菌二联活菌微胶囊的研制

    Institute of Scientific and Technical Information of China (English)

    张玉华; 凌沛学; 籍保平; 张天民

    2009-01-01

    Objective To prepare the microcapsule containing Bifidobacterium and Lactobacillus acidophilus in order to improve the oral survival rate and shelf life at room temperature. Methods According to the acid-resistance in artificial gastric juice and collapse in artificial intestinal juice of microcapsule, the optimal technological conditions were ascertained for the preparation of microcapsule with air suspension. The shape and size of microcapsule were observed with scanning electron microscope. The storage stability of bacteria was studied according to the survival rate of microencapsulated bacteria after storage for 3 months at 37℃ and RH 60%-65%. Results Bacteria trapped in the microcapsule survived well in artificial gastric juice and collapsed easily in artificial intestinal juice.The encapsulation yield of microcapsule was 56.49 %, and the encapsulation efficiency was 87.45 %. The surface of microcapsule was covered with a smooth film. The particle diameter was 400-500 μm. The survival rate of microencapsulated bacteria in the presence of protectants after storage for 3 months at 37℃ and RH 60%-65% was over 10 % ,which was higher than that of lyophilized powder and microencapsulated bacteria in the absence of protectants. Conclusion The optimal technological conditions can be obtained for the preparation of microcapsule containing Bifidobacterium and Lactobacillus acidophilus with air suspension. The stability of microencapsulated bacteria can be improved.%目的 制备长双歧杆菌和嗜酸乳杆菌二联活菌微胶囊,以期提高口服时的存活率和常温下的保存期.方法 根据微胶囊在人工胃液中的耐酸性和在人工肠液中的崩解性,确定空气悬浮法制备微胶囊的最佳工艺条件.扫描电镜观察微胶囊形态与大小.根据恒温37℃、相对湿度60%~65%条件下贮存3个月后菌体存活率,考察其贮存稳定性.结果 制备的微胶囊具有良好的耐酸性和肠溶性.微胶囊包囊产率56

  2. 儿泻停颗粒联合双歧杆菌乳杆菌三联活菌片治疗小儿急性腹泻的疗效分析%Efficacy of Child Diarrhea Stops Particles Joint Triple Viable Bifidobacterium Lactobacillus in the Treatment of Children With Acute Diarrhea

    Institute of Scientific and Technical Information of China (English)

    刘文霞; 张晓

    2015-01-01

    目的:研究分析儿泻停颗粒联合双歧杆菌乳杆菌三联活菌片治疗小儿急性腹泻的临床效果。方法选取2013年2月~2015年2月我院收治的小儿急性腹泻患儿82例,随机分为对照组、观察组,各41例。对照组给予蒙脱石散联合双歧杆菌乳杆菌三联活菌片治疗,观察组给予儿泻停颗粒联合双歧杆菌乳杆菌三联活菌片治疗,对比两组临床治疗效果。结果观察组治疗3d后总有效率高于对照组,差异具有统计学意义(P0.05);观察组不良反应情况与对照组相比,无差异(P>0.05)。结论儿泻停颗粒联合双歧杆菌乳杆菌三联活菌片治疗小儿急性腹泻能够迅速缓解患儿临床症状,提高临床效果。%Objective To analysis the clinical effect of child diarrhea stops particles joint triple viable bifidobacterium lactobacil us in the treatment of children with acute diarrhea. Methods Children with acute diarrhea in children chosen from February 2013 to February 2015 in our hospital 82 cases,randomly divided into two groups,the observation group,41 cases each. The control group received montmorillonite joint triple viable bifidobacterium lactobacil us tablets in the treatment,the observation group were children diarrhea stops particles joint triple viable bifidobacterium lactobacil us tablets in the treatment,compared two groups of clinical effect. Results Total effective observation group was significantly higher than after 3 d,the difference was significant(P0.05). Adverse reactions observed group compared with the control group,no significant difference(P>0.05). Conclusion Child diarrhea stops particles joint triple viable bifidobacterium lactobacil us tablets in the treatment of children with acute diarrhea can quickly relieve symptoms in children, improve clinical results.

  3. Effect of probiotic Bifidobacterium longum BB536 [corrected] in relieving clinical symptoms and modulating plasma cytokine levels of Japanese cedar pollinosis during the pollen season. A randomized double-blind, placebo-controlled trial.

    Science.gov (United States)

    Xiao, J Z; Kondo, S; Yanagisawa, N; Takahashi, N; Odamaki, T; Iwabuchi, N; Iwatsuki, K; Kokubo, S; Togashi, H; Enomoto, K; Enomoto, T

    2006-01-01

    Probiotic microorganisms have been shown to be effective in the treatment of allergic inflammation and food allergy, but their efficacy remains controversial. This study tested the effect of a yogurt supplemented with a probiotic strain Bifidobacterium longum BB536 in the treatment of Japanese cedar pollinosis (JCPsis). Forty subjects with a clinical history of JCPsis were given yoghurt either containing BB536 (BB536 yoghurt) or without BB536 (placebo yoghurt) at 2 X 100 g per day for 14 weeks, in a randomized, double-blind, placebo-controlled trial. Subjective symptoms and self-care measures were recorded daily and blood samples were taken before and during the intervention (at weeks 4, 9, and 14) to measure the blood parameter levels related to JCPsis. Yoghurt supplemented with BB536 significantly alleviated eye symptoms compared with placebo yoghurt (odds ratio 0.31; 95% confidence interval 0.10-0.97; p = 0.044). Although no statistically significant differences were detected, nasal symptoms such as itching, rhinorrhea, and blockage, as well as throat symptoms tended to be relieved with the BB536 yoghurt. BB536 tended to suppress the decreasing blood levels of interferon-gamma (IFN-y) and the increasing blood eosinophil rates; a significantly higher IFN-gamma level was observed for the difference from baseline at week 4. A decreased trend in the difference from baseline levels of JCP-specific IgE levels was also observed at week 4 in the BB536 group compared with the placebo group. In conclusion, these results suggest that intake of BB536-supplemented yoghurt may relieve JCPsis symptoms, probably through a modulating effect on Th balance.

  4. Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: a randomised, double-blind, parallel, controlled study.

    Science.gov (United States)

    Guyonnet, Denis; Schlumberger, Armelle; Mhamdi, Leila; Jakob, Stefan; Chassany, Olivier

    2009-12-01

    The ability of probiotics to improve bowel habits or transit time has been shown in healthy populations. Additional data are required to support the use of specific probiotics to improve gastrointestinal (GI) well-being. The present study was designed to investigate the effect of consuming fermented milk (FM) on GI well-being, digestive symptoms and health-related quality of life (HRQoL) amongst women without diagnosed GI disorders. In this double-blind, controlled, parallel-design study, subjects were randomised to ingest daily either 2 x 125 g FM containing Bifidobacterium lactis DN-173 010 and yoghurt strains or a control non-fermented dairy product for 4 weeks followed by a 4-week wash-out period. GI well-being and digestive symptoms were assessed weekly. HRQoL was measured every 4 weeks. Data were analysed using analysis of covariance and logistic regression, correcting for baseline values on the full analysis set population of 197 women (aged 18-60 years). The percentage of women reporting an improvement in their GI well-being was significantly (P < 0.01) higher in the FM group v. the control group (OR 1.69; 95 % CI 1.17, 2.45). A significantly (P < 0.05) more pronounced decrease in the composite score of digestive symptoms was observed in the FM group when comparing with the control group (least squares mean - 0.57; 95 % CI - 1.12, - 0.02). Among HRQoL dimensions, the digestive comfort score was significantly (P < 0.05) improved in the FM group compared with the control group. The present study showed that the daily consumption of a specific FM is able to improve GI well-being and digestive symptoms in adult women without GI disorders.

  5. Screening and optimization of the formulation of cryoprotectants for the lyophilized Bifidobacterium infantis%婴儿双歧杆菌冻干保护剂配方的筛选与优化

    Institute of Scientific and Technical Information of China (English)

    沈颐涵

    2014-01-01

    Objective:To develop a better technique for the production of probioticBifidobacterium infantisand improve the survival rate of the lyophilized powder.Methods:In this improved technique, The types of cryoprotectants added in the lyophilization ofBiifdobacterium infantis and their optimized formulations were studied by orthogonal test.Results:The survival rate of the lyophilized powder ofBiifdobacterium infantiscould be signiifcantly improved from about 43% to 85.42%and the viable cell counts maintained at above 4.1×1010cfu/g when a formulation of cryoprotectant consisting of 10% skim milk powder, 3% mannitol, 1% Vc-Na and 0.5% monosodium glutamate was used.Conclusion:This formulation will have a good beneift when applied to the probiotic production.%目的:构建一种更好的婴儿双歧杆菌微生态制剂生产工艺,提高冻干菌粉的活菌存活率。方法:通过正交试验,对婴儿双歧杆菌冻干过程中加入的保护剂种类及其最佳配比进行研究。结果:以脱脂奶粉10%,甘露醇3%, Vc-Na 1%,味精0.5%作为冻干保护剂,可使婴儿双歧杆菌冻干菌粉的活菌存活率由43%左右提高到85.42%、活菌量保持在4.1×1010 cfu/g。结论:该配方用于微生态制剂的生产将有较好的效益。

  6. Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial.

    Science.gov (United States)

    Eskesen, Dorte; Jespersen, Lillian; Michelsen, Birgit; Whorwell, Peter J; Müller-Lissner, Stefan; Morberg, Cathrine M

    2015-11-28

    The aim of the present study was to investigate the effect of Bifidobacterium animalis subsp. lactis, BB-12®, on two primary end points - defecation frequency and gastrointestinal (GI) well-being - in healthy adults with low defecation frequency and abdominal discomfort. A total of 1248 subjects were included in a randomised, double-blind, placebo-controlled trial. After a 2-week run-in period, subjects were randomised to 1 or 10 billion colony-forming units/d of the probiotic strain BB-12® or a matching placebo capsule once daily for 4 weeks. Subjects completed a diary on bowel habits, relief of abdominal discomfort and symptoms. GI well-being, defined as global relief of abdominal discomfort, did not show significant differences. The OR for having a defecation frequency above baseline for ≥50% of the time was 1·31 (95% CI 0·98, 1·75), P=0·071, for probiotic treatment overall. Tightening the criteria for being a responder to an increase of ≥1 d/week for ≥50 % of the time resulted in an OR of 1·55 (95% CI 1·22, 1·96), P=0·0003, for treatment overall. A treatment effect on average defecation frequency was found (P=0·0065), with the frequency being significantly higher compared with placebo at all weeks for probiotic treatment overall (all PEffects on defecation frequency were similar for the two doses tested, suggesting that a ceiling effect was reached with the one billion dose. Overall, 4 weeks' supplementation with the probiotic strain BB-12® resulted in a clinically relevant benefit on defecation frequency. The results suggest that consumption of BB-12® improves the GI health of individuals whose symptoms are not sufficiently severe to consult a doctor (ISRCTN18128385).

  7. 思连康改善抗生素相关性腹泻患儿菌群失调随机对照研究%Bifidobacterium Tetravaccine Tablets in Treating Dysbacteriosis of Children with Antibiotic Associated Diarrhea

    Institute of Scientific and Technical Information of China (English)

    王妍妍; 关晶; 温韬雪

    2016-01-01

    Objective To study effect and nursing of Bifidobacterium Tetravaccine Tablets to improve dysbacteriosis of children with an-tibiotic associated diarrhea. Methods 174 cases children with antibiotic associated diarrhea were divided into observation group and control group, 87 cases in each group. The control group was given conventional rehydration, gastrointestinal mucosa protectant treatment etc., and the observation group was added with Bifidobacterium Tetravaccine Tablets. All patients were given the ADD nursing. The dys-bacteriosis, anti-diarrhea effect, diamine oxidase, therapy effect were compared between two groups. Results The total effective rate of the observation group was 97. 70%, which was significantly higher than 86. 21% of the control group(χ2=7. 768, P < 0. 05);the shit ball/stem ratio in the observation group was 8. 05%, the bacteria culture dysbacteriosis rate was 0, which were significantly lower than those of the control group ( 35. 63%, 20. 69%)(χ2=19. 393, 20. 077, P < 0. 05);the diarrhea frequency, diarrhoea time, length of hospital stay of the observation group were significantly lower than those of the control group( t=17. 331, 10. 313, 3. 997,P < 0. 05);3, 7 d af-ter treatment, the diamine oxidase level of the observation group was significantly lower than the control group( t=20. 556, 20. 427, P <0. 05). Conclusion Bifidobacterium Tetravaccine Tablets can help alleviate the antibiotic associated diarrhea with clinical symptoms, im-prove the intestinal mucosal barrier function and therapy effect. Targeted nursing can help children recover at an early date.%目的:观察思连康用于抗生素相关性腹泻(antibiotic associated diarrhea,AAD)患儿菌群失调的效果及护理措施。方法选择抗生素相关性腹泻患儿174例,采用随机数字表法分为观察组和对照组,各87例。对照组给予常规补液、胃肠黏膜保护剂等治疗,观察组在此基础上联合应用思连康口服,两组均给

  8. Antimicrobial activity of human β-defensins against lactic acid bacteria.

    Science.gov (United States)

    Wang, Xiao-Fang; Tian, Fei; Cao, Rui-Ming; Li, Jing; Wu, Sheng-Mei; Guo, Xiao-Kui; Chen, Tong-Xin

    2015-01-01

    In this study, we evaluated the antimicrobial activity of human β-defensin-1 (hBD-1), human β-defensin-2 (hBD-2) and human β-defensin-3 (hBD-3) against three internationally common probiotic strains of lactic acid bacterium. Our results indicated that hBD-1, hBD-2 and hBD-3 at the range of 0.08-10 μg/mL do not have obvious antimicrobial activity against these strains. Viability of Bifidobacterium longum JDM301 (B. longum JDM301), Bifidobacterium lactis HN019 (B. lactis HN019) and Lactobacillus rhamnosus GG (LGG) were still very high even at concentration of 10 μg hBD/mL. Then, we explored the mechanism of resistance by using carbonyl cyanide 3-chlorophenylhydrazone (CCCP) to inhibit efflux pumps. In the presence of CCCP, hBD-1, hBD-2 and hBD-3 exhibited enhanced antibacterial effect against B. longum JDM301 and B. lactis HN019, but not against LGG. Efflux pumps in B. longum JDM301 and B. lactis HN019 may partly contribute to their resistance to hBD-1, hBD-2, and hBD-3.

  9. Lab-Test® 4: Dental caries and bacteriological analysis

    Directory of Open Access Journals (Sweden)

    Francesca Cura

    2012-01-01

    The main factors predisposing the onset of the carious process are: 1 the presence of bacterial species able to lower the pH until critical values of 5.5, 2 the absence of adequate oral hygiene, 3 an inefficient immune response anti-caries, 4 the type of alimentary diet and 5 the structure of the teeth. Among the 200 bacterial species isolated from dental plaque the most pathogenic for dental caries are: Streptococcus mutans, Streptococcus sobrinus, Lactobacillus acidophilus, Actinomices viscusus and Bifidobacterium dentium. Our laboratory (LAB® s.r.l., Codigoro, Ferrara, Italy has developed a test for absolute and relative quantification of the most common oral cariogenic bacteria. The test uses specific primers and probes for the amplification of bacteria genome sequences in Polymerase Chain Reaction Real Time. The results provide a profile of patient infection, helpful for improving the diagnosis and planning of preventive treatment to reduce the bacterial load.

  10. Influence of Live Combined Bifidobacterium and Lactobacillus Tablet for Intestinal Microflora and Serum IFN-γ、IL-4 in Children with Type 1 Diabetes Mellitus%双歧杆菌乳杆菌三联活菌片对1型糖尿病肠道菌群和血清 IFN-γ、IL-4的影响

    Institute of Scientific and Technical Information of China (English)

    牛文忠; 丁显春

    2016-01-01

    Objective To explore the influence of live combined bifidobacterium and lactobacillus tablet for intestinal microflora and serum IFN-γ and IL-4 in children with type 1 diabetes mellitus (T1DM). Methods 25 children with T1DM were selected as observation group from February 2014 to January 2015 in pediatrics department of Nanyang Central Hospital,and 25 healthy children undergoing physical examination at the same time period were selected as control group.All children aged from 3 to 8 years old.The observation group were treated with insulin and live combined bifidobacterium and lactobacillus tablet,0.5 g per time and three times per day for 1 month.The control group were without any treatment.The changes of intestinal microflora,serum IFN-γand IL-4 levels were compared between observation group and control group.In observation group,the changes were compared between pre-treatment and 1 month post-treatment. Results The quantity of bifidobacterium and lactobacillus in observation group was lower than the control group,the level of IFN-γ and IFN-γ/IL-4 in observation group was higher than the control group (P <0.05 );In observation group,the quantity of bifidobacterium and lactobacillus in pre-treatment was lower than post-treatment,the level of IFN-γand IFN-γ/IL-4 in pre-treatment was higher than post-treatment(all P <0.05). Conclusion Live combined bifidobacterium and lactobacillus tablet may improve the intestinal microflora and restore the balance of Th1 /Th2 in children with T1DM.%目的:观察双歧杆菌乳杆菌三联活菌片对1型糖尿病(T1DM)患儿肠道菌群及血清 IFN-γ和 IL-4的影响。方法选取25例南阳市中心医院儿科2014年2月至2015年1月 T1DM患儿为观察组,选取同时期健康体检儿童25例为对照组。入选对象年龄3~8岁。观察组给予胰岛素治疗,同时给予双歧杆菌乳杆菌三联活菌片,每次0.5 g,每日3次,口服,疗程1个月;对照组未予任何治疗措施。

  11. 婴儿双歧杆菌的耐氧驯化及应用特性研究%Studies on oxygen tolerance test and application characteristics of Bifidobacterium infantis

    Institute of Scientific and Technical Information of China (English)

    吴敏; 胡颖; 罗爱平; 朱秋劲; 何腊平; 朱建荣; 胡萍

    2012-01-01

    This paper screened specifically Bifidobacterium infantis, and researched the activation method of inoculating culture on oxygen resistance strains, groped for the strain the application in mixing of peanut yoghourt. Results indicated that the yeast leaching solution for the strain activation had the biggest influence, and then in proper order were respectively casein peptone, dipotassium phosphate, and three best combinations were obtained that yeast leaching solution 0.4% casein peptone 0. 2%, dipotassium phosphate 0. 1%. The milk coagulation time stability to 3. 5 h after the strains was continuously activation three generations. Through the four factors on the influence growth of Bifido bacterium infantis found;ratio of milk and peanut-milk existed the biggest influence, followed by sucrose, once again, was the inoculation amount, and finally the glucose. When milk and peanut-milk ratio 1;I, sucrose2%, glucose6%, inoculation quantity 5%, Bifidohacterium infantis got to achieve the best growth state, living bacterium number reached 2. 5 X 109 CFU/mL.%研究婴儿双歧杆菌的生长促进剂,并对活化菌种进行耐氧驯化培养,探讨婴儿双歧杆菌在搅拌花生酸奶加工中的应用.结果表明:酵母浸出液对婴儿双歧杆菌活化影响最大,酪蛋白胨次之,磷酸氢二钾最小,三者最佳水平组合:酵母浸出液0.4%,酪蛋白胨0.2%,磷酸氢二钾0.1%.菌种被连续活化三代后凝乳时间稳定至3.5h.通过对4种因素婴儿双歧杆菌生长的影响研究发现:鲜牛奶与花生乳配比的影响最大,其次是蔗糖,再次是接种量,最后是葡萄糖.当鲜牛奶与花生乳配比1∶1,蔗糖6%,葡萄糖2%,接种量5%,婴儿双歧杆菌达到最佳生长状态,活菌数达到2.5×109 CFU/mL.

  12. A Specific Mixture of Fructo-Oligosaccharides and Bifidobacterium breve M-16V Facilitates Partial Non-Responsiveness to Whey Protein in Mice Orally Exposed to β-Lactoglobulin-Derived Peptides

    Science.gov (United States)

    Kostadinova, Atanaska I.; Meulenbroek, Laura A. P. M.; van Esch, Betty C. A. M.; Hofman, Gerard A.; Garssen, Johan; Willemsen, Linette E. M.; Knippels, Léon M. J.

    2017-01-01

    Oral tolerance is a promising approach for allergy prevention in early life, but it strongly depends on allergen exposure and proper immune environment. Small tolerance-inducing peptides and dietary immunomodulatory components may comprise an attractive method for allergy prevention in at-risk infants. This study aimed to investigate whether early oral exposure to β-lactoglobulin-derived peptides (BLG-peptides) and a specific synbiotic mixture of short- and long- chain fructo-oligosaccharides (scFOS/lcFOS, FF) and Bifidobacterium breve (Bb) M-16V (FF/Bb) can prevent cow’s milk allergy (CMA). Three-week-old female C3H/HeOuJ mice were orally exposed to phosphate buffered saline (PBS), whey protein, or a mixture of four synthetic BLG-peptides combined with a FF/Bb-enriched diet prior to intragastric sensitization with whey protein and cholera toxin. To assess the acute allergic skin response and clinical signs of allergy, mice were challenged intradermally with whole whey protein. Serum immunoglobulins were analyzed after a whey protein oral challenge. Cytokine production by allergen-reactivated splenocytes was measured and changes in T cells subsets in the spleen, mesenteric lymph nodes, and intestinal lamina propria were investigated. Pre-exposing mice to a low dosage of BLG-peptides and a FF/Bb-enriched diet prior to whey protein sensitization resulted in a significant reduction of the acute allergic skin response to whey compared to PBS-pretreated mice fed a control diet. Serum immunoglobulins were not affected, but anaphylactic symptom scores remained low and splenocytes were non-responsive in whey-induced cytokine production. In addition, preservation of the Th1/Th2 balance in the small intestine lamina propria was a hallmark of the mechanism underlying the protective effect of the BLG-peptides–FF/Bb intervention. Prior exposure to BLG-peptides and a FF/Bb-enriched diet is a promising approach for protecting the intestinal Th1/Th2 balance and reducing the

  13. 长双歧杆菌N-乙酰氨基己糖1-位激酶的活性位点%Active sites of N-acetylhexosamine 1-kinase from Bifidobacterium longum

    Institute of Scientific and Technical Information of China (English)

    关婉怡; 白静; 周天惠; 赵宝华

    2016-01-01

    [目的]研究长双歧杆菌(Bifidobacterium longum) JCM1217的N-乙酰氨基己糖1-位激酶(N-acetylhexosamine 1-kinase,NahK)中对催化活性有影响的位点.[方法]利用点突变试剂盒,获得NahK的4个位点的共10种单点突变体表达菌株.诱导表达并纯化野生型和突变体酶,用DNS法和NADH偶联的微孔板分光光度法检测野生型及突变体酶的最适pH和最适Mg2+浓度,并测定酶促反应动力学参数.[结果]D208A、D208N、D208E和I24A四种突变体的催化活性几乎丧失.突变体H31A、H31V、F247A和I24V的最适pH由野生型的7.5变为7.0,突变体H31A和F247A的最适Mg2+浓度由野生型的5 mmol/L变为10 mmol/L.反应动力学参数测定结果表明,突变体F247Y对底物GlcNAc/GalNAc及ATP的催化活性均高于野生型.[结论]通过定点突变,确定了对NahK催化活性有影响的4个位点,并且获得了一个催化效率提高的突变体(F247Y),为进一步对NahK进行分子改造奠定了一定基础.

  14. Xylo-oligosaccharides alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis induce bifidogenesis and modulate markers of immune function in healthy adults: a double-blind, placebo-controlled, randomised, factorial cross-over study.

    Science.gov (United States)

    Childs, Caroline E; Röytiö, Henna; Alhoniemi, Esa; Fekete, Agnes A; Forssten, Sofia D; Hudjec, Natasa; Lim, Ying Ni; Steger, Cara J; Yaqoob, Parveen; Tuohy, Kieran M; Rastall, Robert A; Ouwehand, Arthur C; Gibson, Glenn R

    2014-06-14

    Prebiotics, probiotics and synbiotics are dietary ingredients with the potential to influence health and mucosal and systemic immune function by altering the composition of the gut microbiota. In the present study, a candidate prebiotic (xylo-oligosaccharide, XOS, 8 g/d), probiotic (Bifidobacterium animalis subsp. lactis Bi-07, 109 colony-forming units (CFU)/d) or synbiotic (8 g XOS+109 CFU Bi-07/d) was given to healthy adults (25-65 years) for 21 d. The aim was to identify the effect of the supplements on bowel habits, self-reported mood, composition of the gut microbiota, blood lipid concentrations and immune function. XOS supplementation increased mean bowel movements per d (P= 0·009), but did not alter the symptoms of bloating, abdominal pain or flatulence or the incidence of any reported adverse events compared with maltodextrin supplementation. XOS supplementation significantly increased participant-reported vitality (P= 0·003) and happiness (P= 0·034). Lowest reported use of analgesics was observed during the XOS+Bi-07 supplementation period (P= 0·004). XOS supplementation significantly increased faecal bifidobacterial counts (P= 0·008) and fasting plasma HDL concentrations (P= 0·005). Bi-07 supplementation significantly increased faecal B. lactis content (P= 0·007), lowered lipopolysaccharide-stimulated IL-4 secretion in whole-blood cultures (P= 0·035) and salivary IgA content (P= 0·040) and increased IL-6 secretion (P= 0·009). XOS supplementation resulted in lower expression of CD16/56 on natural killer T cells (P= 0·027) and lower IL-10 secretion (P= 0·049), while XOS and Bi-07 supplementation reduced the expression of CD19 on B cells (XOS × Bi-07, P= 0·009). The present study demonstrates that XOS induce bifidogenesis, improve aspects of the plasma lipid profile and modulate the markers of immune function in healthy adults. The provision of XOS+Bi-07 as a synbiotic may confer further benefits due to the discrete effects of Bi-07 on the gut

  15. Pocket book of the metal trade. Vol. 1. Metals and trading conditions. 11. rev. ed.; Taschenbuch des Metallhandels. Bd. 1. Metalle und Handelsbedingungen

    Energy Technology Data Exchange (ETDEWEB)

    Schmitz, Ralf (ed.); Dietz, Ferdinand; Kammer, Catrin; Mohr, Heinz; Zocher, Nadine

    2008-07-01

    Vol. 1 of the pocket book on metals and trading conditions comprises the following chapters: 1. Metal, a raw material; 2. Metal stock exchanges; 3. Trading conditions and standards; 4. Addresses, organisations, associations; 5. Metals dictionary D-E-F; 6. List of commodities for external trading; 7. Statistics (prices, production, consumption). [German] Der erste Band ueber Metalle und Handelsbedingungen ist in folgende Kapitel unterteilt: 1. Der Rohstoff Metall; 2. Die Metallboersen; 3. Handelsbedingungen/Normen; 4. Anschriften, Organisationen, Verbaende; 5. Metall Woerterbuch: Deutsch-Englisch Franzoesisch; 6. Warenverzeichnis fuer den Aussenhandel und 7. Statistik (Preis-, Produktions- und Verbrauchsstatistik).

  16. Substituting environmentally relevant flame retardants: assessment fundamentals. Vol. 1: results and summary overview; Erarbeitung von Bewertungsgrundlagen zur Substitution umweltrelevanter Flammschutzmittel. Bd. 1: Ergebnisse und zusammenfassende Uebersicht

    Energy Technology Data Exchange (ETDEWEB)

    Leisewitz, A.; Kruse, H.; Schramm, E.

    2001-04-01

    The study examines the status, trends and alternatives (substitution and reduction potentials) in the use of flame retardants in selected product sectors: construction; electronics and electrical engineering; rail vehicles; textiles/upholstery. In addition, the study characterises thirteen flame retardants in terms of material flows, applications and toxicology/ecotoxicology. Vol. I: Summary overview of flame retardant applications in Germany in 1999/2000; characterisation of 13 flame retardants in terms of substance properties and application-specific characteristics, range of applications and quantities; derivation of assessment fundamentals for flame retardants, focussing on toxicology/ecotoxicology, suitability for closed-loop substance management, and potential for substitution and reduction; summary assessment of 13 flame retardants; summary overview of flame retardant applications. Vol. II: Analysis of flame retardant applications (state of the art, trends, alternatives) in: unsaturated polyester (UP) resins (rail vehicles); polyurethane (PU) insulating foams and one component foams (OCF) (construction sector); plastics for generic uses in electronic and electrical equipment, in casings for electronic and electrical equipment and in printed circuit boards (electronics/electrical engineering); and in upholstery and mattresses (textile applications). Vol. III: Toxicological/ecotoxicological profiles of substances: Decabromodiphenyl oxide; Tetrabromobisphenol A; Bis[pentabromophenyl]ethane; Hexabromocyclodo-decane, Tris[chloropropyl]phosphate, Resorcinol-bis-diphenylphosphate; N-Hydroxymethyl-3-dimethylphosphonopropionamide, Red phosphorus, Ammonium polyphosphate, Melamin cyanurate, Aluminiumtrihydroxide, Sodium borate decahydrate, Antimony trioxide. (orig.) [German] Untersucht werden Stand, Trends und Alternativen (Substitutions- und Minderungspotentiale) beim Einsatz von Flammschutzmitteln (FSM) in ausgewaehlten Produkten aus: Baubereich, Elektrotechnik/Elektronik, Schienenfahrzeugbereich, Textil-/Polstermoebelindustrie. Parallel dazu werden dreizehn Flammschutzmittel hinsichtlich Mengenstrom, Anwendungen und Toxikologie/Oekotoxikologie charakterisiert. Bd. I: Ergebniszusammenfassung zu Flammschutzmitteleinsatz in Deutschland 1999/2000; Charakterisierung von 13 FSM nach Stoff- und Anwendungseigenschaften, Einsatzspektrum, Mengen; Ableitung von Bewertungsgrundlagen fuer FSM mit Schwergewicht auf Toxikologie/Oekotoxikologie, Kreislauffaehigkeit, Substitutions- und Minderungspotentialen; zusammenfassende Stoffbewertung zu 13 FSM; zusammenfassende Uebersicht zu FSM-Anwendungen. Bd. II: Anwendungsuntersuchungen (Stand der Technik, Trend, Alternativen) zu FSM bei UP-Harzen (Schienenfahrzeuge), bei PU-Daemm- und Montageschaeumen (Baubereich); bei Kunststoffen fuer E+E-Geraete insgesamt, Aussengehaeusen fuer E+E-Geraete und Leiterplatten (Elektro/Elektronikindustrie); bei Polstermoebeln/Matratzen (Textilanwendungen). Bd. III: Toxikologisch/oekotoxikologische Stoffprofile Decabromdiphenylether, Tetrabrombisphenol A; Bis[pentabromphenyl]ethan; Hexabromcyclododecan, Tris[chlorpropyl]phosphat, Resorcinol-bis-diphenyl-phosphat; N-Hydroxymethyl-3-dimethylphosphonpropionamid, roter Phosphor, Ammoniumpolyphosphat, Melamincyanurat, Aluminiumtrihydroxid, Borax, Antimontrioxid. (orig.)

  17. Renewable energies in the primary school. Vol. 1. Energy (conservation). Solar energy. 2. rev. ed.; Erneuerbare Energien in der Grundschule. Bd. 1. Energie(sparen). Sonnenenergie

    Energy Technology Data Exchange (ETDEWEB)

    Kaiser, Astrid; Lueschen, Iris; Reimer, Monika [Oldenburg Univ. (Germany)

    2012-11-01

    The rearrangement of the energy supply to renewable energies is an issue of central importance for the future of our society. This rearrangement has to be supported by broad segments of the population in order to achieve the intended impact. Under this aspect, the authors of the contribution under consideration report on the item of renewable energy sources in primary schools. This contribution consists of the following chapters: (1) Why ''Renewable Energies'' in knowledge lessons? (Didactical orientation); (2) Aspects of science especially for girls (Didactical potentials); (3) Hints for the handling of the practice material; (4) Factual information and practice materials for the modules ''Energy conservation'' and ''Solar energy''.

  18. Lexicon of optics. Vol.1: A to L. Vol.2: M to Z; Lexikon der Optik. Bd. 1: A bis L. Bd. 2: M-Z

    Energy Technology Data Exchange (ETDEWEB)

    Paul, H. (ed.)

    2003-07-01

    This lexicon contains the actual knowledge for all aspects in optical sciences and technology. More than 4.000 headings are leading through the whole science of optics in two volumes together with more than 800 figures. More than 70 high-ranked authors guarantee the uptodate knowledge.

  19. Efficacy comparison between saccharomyces boulardii sachets and tetragenous viable bifidobacterium tablets in the treatment of rotaviral gastroenteritis%布拉酵母菌与双歧杆菌四联活菌治疗小儿轮状病毒性胃肠炎疗效比较

    Institute of Scientific and Technical Information of China (English)

    吴立强; 陈建平; 何念海

    2015-01-01

    目的:比较布拉酵母菌散与双歧杆菌四联活菌片在治疗小儿轮状病毒性胃肠炎的临床疗效。方法选择2012年1月至2014年5月在第三军医大学西南医院儿科门诊及住院部就诊患儿,年龄在2个月至8岁的轮状病毒性胃肠炎患儿191例,按随机数字表法分为对照组(蒙脱石散及常规对症治疗,n=62)、双歧杆菌四联活菌片组(常规治疗+双歧杆菌四联活菌片,n=64)、布拉酵母菌散组(常规治疗+布拉酵母菌散,n=65),治疗第3天及第5天后比较各组的治疗效果。结果双歧杆菌四联活菌片组、布拉酵母菌散组的显效、有效和总有效率均明显高于对照组,差异有统计学意义(P<0.05)。而布拉酵母菌散组的显效和总有效率指标稍高于双歧杆菌四联活菌片组,但差异无统计学意义(P>0.05)。双歧杆菌四联活菌片组、布拉酵母菌组在治疗第3天、第5天大便次数及腹泻持续时间均明显低于对照组,差异有统计学意义(P<0.05)。布拉酵母菌散组腹泻持续时间较双歧杆菌四联活菌片组明显缩短,差异有统计学意义(P<0.05)。结论布拉酵母菌散与双歧杆菌四联活菌片两种益生菌治疗儿童轮状病毒性胃肠炎的疗效相似,布拉酵母菌散较双歧杆菌四联活菌片可以缩短腹泻持续时间。%Objective To compare the effect between Saccharomyces boulardii sachets and tetragenous viable bifidobacterium tablets in the treatment of rotaviral gastroenteritis of children .Methods A total of 191 patients (below 2 months to 8 years old) with rotaviral gastroenteritis admitted to this hospital from January 2012 to May 2014 were divided randomly into control groups (smectite ,conventional treatment ,number=62) ,tetragenous viable bifidobacterium tablets group (conventional treatment combined with tetragenous viable bifidobacterium tablets ,number= 64) ,saccharomyces

  20. Clinical Evaluation of Mesalamine Combined with Live Bacterial Agent of Bifidobacterium, Lactobacillus, Enterococcus and Bacillus Cereus for Ulcerative Colitis%美沙拉嗪联合双歧杆菌四联活菌治疗溃疡性结肠炎的临床效果评价

    Institute of Scientific and Technical Information of China (English)

    歧红阳; 王云溪; 肖占宇

    2011-01-01

    目的 研究美沙拉嗪联合双歧杆菌四联活菌在治疗溃疡性结肠炎中的临床效果。方法 选取50例溃疡性结肠炎病人,分为2组,试验组27例,给予美沙拉嗪及双歧杆菌四联活菌;对照组23例,给予美沙拉嗪。观察2组患者治愈率及治疗前后的患者血清中自细胞介素-8(IL-8)水平。结果 试验组治愈率(92.6%)明显高于对照组(78.3%),经比较差异有统计学意义(P<0.05),试验组和对照组治疗14 d后,IL-8水平明显低于治疗前,两者相比,差异有统计学意义(P<0.05)。结论 美沙拉嗪联合双歧杆菌四联活菌可提高溃疡性结肠炎的治愈率,且不良反应少,为临床治疗提供思路。%[Objective]To study the clinical effect of mesalamine combined with live bacterial agent of bifidobacterium, lactobacil-lus, enterococcus and bacillus cereus for ulcerative colitis. [ Methods ] 50 patients with ulcerative colitis were randomly divided into the research group (27 cases) and the control group (23 cases). The research group was given mesalamine combined with live bacterial agent of bifidobacterium, lactobacillus, enterococcus and bacillus cereus, and the control group was treated with mesalamine. The cure rate and IL-8 level in serum of patients before and after treatment were observed. [ Results ] The cure rate of the research group (92.6% ) was higher than that of the control group (78.3% ) significantly (P<0.05). After 14 days of treatment, and the IL-8 level of two groups was significantly lower than before treatment (P <0.05). [ Conclusion] Mesalamine combined with live bacterial agent of bifidobacterium, lactobacillus, enterococcus and bacillus cereus can improve the cure rate of ulcerative colitis, and with less adverse reaction, which provides a new idea for clinical therapy.

  1. The effect of Combined Bifidobacterium,Lactobacillus,Enterococcus and Bacillus cereus Tablets,Live and Montmorillonite powder in breast milk jaundice%四连康及蒙托石散治疗母乳性黄疸的疗效研究

    Institute of Scientific and Technical Information of China (English)

    符榕

    2014-01-01

    目的:探讨四连康(双歧杆菌四联活菌)、蒙脱石散治疗婴儿黄疸的疗效分析。方法:将85例母乳性黄疸病例随机分为4组,A组对照组(20例),B组四连康组(25例),C组蒙脱石组(20例),D组四连康联合蒙脱石组(20例),四组均停母乳。观察其黄疸消退情况,治疗前后胆红素水平变化。结果:5d后监测血胆红素水平,B组、C组、D组均较对照组血胆红素下降明显,差异有统计学意义( P﹤0.01),黄疸消退平均时间较对照组明显提前,差异有统计学意义( P﹤0.01)。不同治疗组间黄疸消退时间及胆红素下降值亦不相同。结论:四连康和蒙脱石散治疗婴儿母乳性黄疸均有显著效果,可促进胆红素排泄,缩短患儿住院治疗时间,且两者疗效相当,联合用药效果更明显。%Objective To observe and analyze the effects of Combined Bifidobacterium,Lactobacillus,Enterococcus and Bacillus cereus Tablets,Live and Montmorillonite powder in the therapy of jaundice. Method 85 patients with breast milk jaundice were divided randomly into four groups:A( control group)、B( the group of Combined Bifidobacterium,Lactobacillus,Enterococcus and Bacillus cereus Tablets, Live)、C( the group of Montmorillonite powder )and D( the group of Combined Bifidobacterium,Lactobacillus,Enterococcus and Bacillus cereus Tablets,Live combined with Montmorillonite powder),the four groups all stopped breastfeeding. Detected the bilirubin concentration in the blood and jaundice time after the four treatments. Results Compared to control group and observation groups,the observation groups in the reduction of time were fast and reduction of bilirubin levels were higher than the control group. But the effects were different among the observation groups. Conclusion Combined Bifidobacterium,Lactobacillus,Enterococcus and Bacillus cereus Tablets,Live and Montmo-rillonite powder could advance the

  2. 双歧杆菌LTA上调ICAM-1表达及其在LAK抗肿瘤中的作用%Upregulation of ICAM-1 expression enhances cytotoxic sensitivity of tumor cells to LAK by LTA from bifidobacterium

    Institute of Scientific and Technical Information of China (English)

    蒋虹; 胡宏; 魏启欧

    2000-01-01

    目的 探讨双歧杆菌脂磷壁酸(lipoteichoic acid,LTA)作用于LoVo细胞后是否能增强LAK对该细胞的识别 阳杀伤,以及ICAM-1在其中的作用。方法 采用MTT方法观察了LAK对LoVo细胞的识别和杀伤作用,并用流式细胞仪和 ELISA的方法检测了LoVo细胞表面ICAM-1的表达。结果 50 μg/ml LTA作用3 d,LAK对LoVo细胞的粘附率由9.62%增 加到24.42%,LoVo细胞对LAK的杀伤敏感性增加了2倍。并且使表达ICAM-1的细胞数由2.42%增加到27.9%,LoVo细胞 上ICAM-1的表达量增加10倍。结论 LTA增强了LoVo细胞对LAK的杀伤敏感性,其机制可能在于LTA通过上调LoVo细 胞上ICAM-1的表达,增强了效靶细胞之间的识别和结合。LTA与LAK相结合可能增强对大肠癌的治疗效果。%Objective To investigate whether the recognizing and cytotoxic abilities of LAK can be intensified by bifi- dobacterial lipoteichoic acid(LTA) and the possible role of ICAM-1 in this process. Methods Standard MTT assay was used to evaluate the binding rate and cytotoxic capability of LAK to LoVo cells. Flow cytometric assay and ELISA were used to deter- mine the expression of ICAM-1 on these cells. Results LAK cells bound much easier to LoVo cells with an increase from 9. 62% to 24.42% as well as a double increase of the anti-tumor sensitivity of LoVo cells to LAK after challenge with 50 μg/ml LTA of Bifidobacterium bffidum 1101. Compared with the control group,both the percentage of ICAM-1 positive cells and the amount of ICAM-1 expression on LoVo cells were greatly increased directly after the challenge of LTA. Conclusion The pos- sible mechanism of the increase of antitumor activity lies in that Bifidobacterial LTA can intensify the binding and recognizing capability of LAK to tumor cells by promoting the expression of ICAM-1 on the surface of LoVo cells. The therapeutic effect on intestinal cancer may be enhanced by the combined treatment of bifidobacterial LTA and LAK.

  3. 双歧杆菌三联活菌联合美沙拉嗪治疗溃疡性结肠炎临床研究%Clinical Study of Bifidobacterium Triple Viable Bacteria with Mesalamine on Treating Ulcerative Colitis

    Institute of Scientific and Technical Information of China (English)

    许春进; 南君; 葛大赫

    2016-01-01

    目的:探讨双歧杆菌三联活菌联合美沙拉嗪治疗溃疡性结肠炎的临床效果。方法选取我院2014年2月~2016年2月收治的溃疡性结肠炎患者94例,随机分为两组,各47例。对照组给予美沙拉嗪治疗,观察组给予双歧杆菌三联活菌联合美沙拉嗪治疗,对比两组治疗有效率、治疗前后细胞因子水平和氧化应激水平。结果观察组总有效率高于对照组,差异有统计学意义(P<0.05);观察组治疗后TNF-α、IL-6、IL-8低于对照组,IL-10高于对照组,差异有统计学意义(P<0.05);观察组治疗后SOD高于对照组,MDA低于对照组,差异有统计学意义(P<0.05)。结论双歧杆菌三联活菌联合美沙拉嗪治疗溃疡性结肠炎可明显提高疗效,改善细胞因子水平和氧化应激水平。%Objective To investigate the clinical effect of triple viable Bifidobacterium combined with the Mesalamine in the treatment of ulcerative colitis.Methods 94 patients with ulcerative colitis in our hospital from February 2014 to February 2016 were randomly divided into two groups, 47 cases in each. The control group was given the salad diazoxide treatment, the observation group was given Biifd Triple Viable combined beauty The treatment of salad. Treatment efficiency, cytokine levels and oxidative stress levels before and after treatment were compared.Results The total effective rate of observation group was higher than the control group, the difference was significant (P< 0.05).The observation group after treatment, TNF-α,IL-6, IL-8 were lower than the control group, IL-10 was higher than the control group, signiifcant difference (P< 0.05). SOD in the observation group were higher than the control group, MDA was signiifcantly lower than that of the control group (P < 0.05).Conclusion Biifdobacterium triple viable combined Mesalamine on treating ulcerative colitis can significantly improve the curative effect, improve the level

  4. Proteinaceous molecules mediating Bifidobacterium-host interactions

    Directory of Open Access Journals (Sweden)

    Lorena Ruiz

    2016-08-01

    Full Text Available Bifidobacteria are commensal microoganisms found in the gastrointestinal tract.Several strains have been attributed beneficial traits at local and systemic levels, through pathogen exclusion or immune modulation, among other benefits. This has promoted a growing industrial and scientific interest in bifidobacteria as probiotic supplements. However, the molecular mechanisms mediating this cross-talk with the human host remain unknown. High-throughput technologies, from functional genomics to transcriptomics, proteomics and interactomics coupled to the development of both in vitro and in vivo models to study the dynamics of the intestinal microbiota and their effects on host cells, have eased the identification of key molecules in these interactions. Numerous secreted or surface-associated proteins or peptides have been identified as potential mediators of bifidobacteria-host interactions and molecular cross-talk, directly participating in sensing environmental factors, promoting intestinal colonization or mediating a dialogue with mucosa-associated immune cells. On the other hand, bifidobacteria induce the production of proteins in the intestine, by epithelial or immune cells, and other gut bacteria, which are key elements in orchestrating interactions among bifidobacteria, gut microbiota and host cells. This review aims to give a comprehensive overview on proteinaceous molecules described and characterized to date, as mediators of the dynamic interplay between bifidobacteria and the human host, providing a framework to identify knowledge gaps and future research needs.

  5. Bifidobacterium glycoside hydrolases and (potential) prebiotics

    NARCIS (Netherlands)

    Broek, van den L.A.M.; Voragen, A.G.J.

    2008-01-01

    Carbohydrates occur in food as natural constituents or are added as ingredients. In the last decade a number of novel dietary carbohydrates have been introduced as ingredients for food applications, responding to the growing awareness among consumers of the link between health and diet. One importan

  6. 拉克替醇和婴儿双歧杆菌对便秘大鼠AQP3及ICC的影响%Effects of lactitol and Bifidobacterium infantis on AQP3 and ICC in a rat model of constipation

    Institute of Scientific and Technical Information of China (English)

    丁一芮; 郑鹏远; 李付广; 梅璐; 黄煌; 白利梅; 刘思濛

    2015-01-01

    Objective To analyze the roles and mechanisms of lactitol and Bifidobacterium infantis in the treatment of rat constipation and to investigate their effects on aquaporin3 (AQP3) and interstitial cells of Cajal (ICC) in colon tissues.Methods Thirty SD male rats were recruited in this study,6 of which were randomly selected as the control and the rest were given 4 mg/kg.d of loperamide for 5 consecutive days to construct the rat model of constipation.The rats with constipation were randomly divided into four groups including model group,lactitol treatment group,Bifidobacterium infantis treatment group and lactitol in combination with Bifidobacterium infantis treatment group.General indexes including food intake,water intake,body weight,fecal water content and intestinal transit rate of each rat were measured after receiving corresponding treatments for 7 consecutive days.The levels of substance P (SP) and vasoactive intestinal peptide (VIP) in serums samples were detected by ELISA.The expression of protein kinase A (PKA) and neurokinin-1 receptor (NK-1) at mRNA level in colon tissues were detected by real-time polymerase chain reaction (real-time PCR).Western blot assay and real-time PCR analysis were used to detect the expression of AQP3 and c-kit at protein and mRNA levels,respectively.Results Compared with the rats in model group,the levels of fecal water content and intestinal transit rate,the concentrations of SP and VIP in serums samples,the expression of PKA and NK-1 at mRNA level and the expression of AQP3 and c-kit at mRNA and protein levels were significantly increased in rats from the three treatment groups (P<0.05).The most effective treatment was lactitol in combination with Bifidobacterium infantis,followed by the lactitol treatment and then the Bifidobacterium infantis treatment.Conclusion The combination therapy with lactitol and Bifidobacterium infantis increased the serum levels of SP and VIP in rats with constipation.SP could enhance the

  7. Correlation of Lactobacillus and Bifidobacterium treatment for hyperlipidemia%乳酸杆菌与双歧杆菌对高脂血症治疗的相关性研究

    Institute of Scientific and Technical Information of China (English)

    闫志辉; 崔立红; 王晓辉; 贺星; 李超; 弓三东; 罗哲; 季梦辰

    2015-01-01

    Objective To investigate the correlation between clinical outcomes in patients with hyperlipidemia and the distribution of Lactobacillus and Bifidobacterium. Methods From March 2012 to June 2014, 120 cases with hyperlipidemia (85 males, 35 females, average age of (48.1±11.6) years) in our hospital were randomly divided into four groups, and they were provided with one-month treatment. Group A were treated with low fat diet + exercise; group B were treated with lipid-lowering drug therapy;group C were treated with intestinal flora regulator treatment; group D were treated with lipid-lowering drugs + modulators. The serum lipids and intestinal flora detections were given in all patients separately before admission, 1 month after treatment, and 3 months after treatment. The lipid levels of patients in four groups, the changes of intestinal microflora and the blood lipid sustainment after treatment in different periods were analyzed and compared. Results The total cholesterol (TC) of group C before treatment, 1 month and 3 months after treatment was (6.69±1.29) mmol/L, (6.18±1.04) mmol/L and (6.78±1.14) mmol/L, triglyceride (TG) was (1.91±0.32) mmol/L, (1.87±0.46) mmol/L, (1.93±0.28) mmol/L; high density lipoprotein cholesterol (HDL-C) was (0.91±0.35) mmol/L, (0.97±0.33) mmol/L, (0.97±0.36) mmol/L; while TC in group D was (6.79±1.39) mmol/L, (4.11±1.07) mmol/L, (4.27±1.03) mmol/L, TG: (1.90±0.55) mmol/L, (1.36±0.41) mmol/L, (1.39±0.29) mmol/L, HDL-C: (0.88±0.30) mmol/L, (1.32±0.39) mmol/L, (1.24±0.35) mmol/L. The effect of lowering blood lipid in group C was the worst (1 month 30%; 3 months 16.7%), in group D was the best (1 month 76.6%; 3 months 70%). There was rebound phenomenon of HDL-C level in group D as time changed [HDL-C: before treatment (0.88±0.30) mmol/L, 1 month (1.32±0.39) mmol/L, 3 months (0.97±0.36) mmol/L]. The Lactobacillus and Bifidobacteria in group C at 1 month after treatment was significantly higher than before treatment and

  8. Effect of in vitro gastrointestinal tract environment on adhesion ability of Bifidobacterium adolescentis KLDS2.0003%消化道环境胁迫对青春双歧杆菌KLDS2.0003粘附能力影响

    Institute of Scientific and Technical Information of China (English)

    孟祥晨; 李馨; 朱德全; 范修海

    2013-01-01

    To determine the impact of the digestive tract environment on the adhesion ability,surface property of bacteria and bacterial cell membrane fatty acid composition of Bifidobacterium adolescentis KLDS2.0003.Method:in vitro gastrointestinal model was established to simulate in vivo gastrointestinal environment and Bifidobacterium adolescentjs KLDS2.0003 were treated under in vitro gastrointestinal environment Caco-2 cells were used as adhesion models,bacterial survival rate and adhesion ability before and after treatment was measured in vitro by direct microscopic examination and colony counting method,at the same time the bacterial cell morphology,automatic aggregation ability and surface hydrophobicity were analyzed.GS-MS was used to determinate changes of membrane fatty acid composition of bacteria before and after treatment.Results showed that the adhesion ability decreased,bacterial cell morphology changed,bacterial surface hydrophobicity and the automatic aggregation ability of bacteria declined,the ratio between bacteria membrane unsaturated fatty acids and saturated fatty acid was increased,and a new long-chain unsaturated fatty acid C18:2n6c generated after Bifidobacterium adolescentis KLDS2.0003 was stressed by in vitro gastrointestinal environment.Conclusion:the adhesion ability of Bifidobacterium adolescentis KLDS2.0003,automatic bacterial aggregation ability and surface hydrophobicity decreased after gastrointestinal environment stress and there was a certain correlation among the three changes.In addition,it was speculated that Bifidobacterium adolescentis KLDS2.0003 adapted to gastrointestinal environment by adjusting the bacterial cell membrane fatty acid composition.%确定消化道环境胁迫对青春双歧杆菌KLDS2.0003粘附能力、菌体表面性质及菌体细胞膜脂肪酸组成影响.采用体外方法模拟消化道环境,以Caco-2细胞作为粘附模型,青春双歧杆菌KLDS2.0003相继经过模拟唾液、模拟胃液以及模拟肠

  9. 双歧杆菌防治极低出生体重儿坏死性小肠结肠炎的作用研究%A research on the effect of bifidobacterium in the field of preventing and curing the NEC of very low birth weight children

    Institute of Scientific and Technical Information of China (English)

    黄柏枝; 刘仿

    2011-01-01

    目的:观察应用双歧杆菌预防极低出生体重儿坏死性小肠结肠炎(NEC)的有效性.方法:回顾性分析2005年1月~2008年5月在我院NICU住院治疗的生后存活7 d并且开始胃肠道喂养的极低出生体重儿183例的临床资料.结果:预防组NEC发病率为2.10%(2/95),对照组NEC发生率为11.36%(10/88),两组比较差异有统计学意义(P<0.01).住院期间预防组每日体质量增加(8.108±2.205)g,对照组为(6.256±2.298)g,两组比较差异有统计学意义(P<0.01).治疗后7 d两组患儿肠道细菌总数、杆菌、球菌总数及杆球菌比值差异均有统计学意义(P0.05).治疗前两组患儿大便双歧杆菌数的比较差异均无统计学意义(P>0.05);治疗后7 d两组患儿大便双歧杆菌数的比较差异有统计学意义(P0.05).结论:给予极低出生体重儿预防性口服双歧杆菌能够降低NEC发病率,促进其体质量增长.其机制与口服双歧杆菌后促进新生儿肠道正常菌群的定植和优势化、维持肠道正常菌群比率有关.%Objective: To observe the preventing effectiveness of applying bifidobacterium to very low birth weight children with NEC. Methods: The clinical data of 183 patients of NICU hospitalization survival 7 d after birth and fed the gastrointestinal tract of very low birth weight children in our hospital from January 2005 to May 2008 were retrospectively analyzed. Results: From the results, the NEC incidence rate of the preventive group was 2.10% (2/95), while the control group was 11.36% (10/88); the daily weight increase of the preventive group was (8.108±2.205) g, while the control group Was (6.256±2.298) g There were statistical significance in the comparison of both groups (all Pbifidobacterium from patients of both

  10. 酪酸梭菌二联活菌散剂预防肺炎儿童抗生素相关性腹泻的多中心随机对照临床试验%Multicenter, randomized, controlled clinical trial on preventing antibiotic-associated diarrhea in children with pneumonia using the live Clostridium butyricum and Bifidobacterium combined Powder

    Institute of Scientific and Technical Information of China (English)

    酪酸梭菌二联活菌散剂预防肺炎儿童抗生素相关性腹泻研

    2012-01-01

    Objective Many previous meta-analysis have shown that the probiotics can lower the incidence of antibiotic-associated diarrhea (AAD) in children.However,the function and efficacy of probiotics drugs showed obvious strains specificity and dose dependence.Currently,most of the reported meta-analysis regarding probiotics AAD prevention have adopted Saccharomyces,Lactobacilleae,Streptococcus and Bifidobacterium.This study aimed to evaluate the efficacy and safety of the live Clostridium butyricum and Bifidobacterium Powder to prevent AAD in hospitalized children with pneumonia.Method This study was a multicenter,randomized,controlled clinical trial; 380 hospitalized children with pneumonia aged from 3 months to 3 years were enrolled from April to Dec.2011.Totally 372 children completed the study,179 children in control group received antibiotics as routine treatment for pneumonia;193 children in treatment group received 5 × 109 colony-forming units of Clostridium butyricum and Bifidobacterium combined Powder daily for 7 days during the antibiotics treatment.The stool frequency and consistency (assessed according to the Bristol Excrement Assessment Scale) were observed for 7 consecutive days; the incidence of diarrhea and adverse drug reactions were recorded.Result Both treatment and control groups were similar in age distribution,sex,type of antibiotics,route of administration,and time of antibiotics used.During the 7 days period,the rate of AAD was 7.8% (13/193) in treatment group and 16.8% (30/179) in control group,there was significant differeuce; compared with the control group,the treatment with Clostridium butyricum and Bifidobacterium combined Powder can lead to 53.6% reduction in AAD risk (RR =0.419,95 % CI 0.217-0.808;P =O.008).The severity of diarrhea was comparable in both study groups,as evidenced by similar stool frequency,dehydration,fever and vomiting.There was significant difference (P =0.008) in the AAD occurrence time distribution between the

  11. Anti-tumor effect of Bifidobacterium infantis-mediated sFlt-1 eukaryotic expression system on Lewis lung cancer in mice%婴儿双歧杆菌介导的sFlt-1真核表达系统对Lewis肺癌小鼠的抑瘤效果

    Institute of Scientific and Technical Information of China (English)

    邓丽聪; 许士叶; 毛淑华; 易成; 黄英

    2011-01-01

    OBJECTIVE To observe the anti - tumor effect of Bifidobacleriian infantis - mediated sFlt - 1 eukaryotic expression system on the Lewis lung cancer (LLC) in mice as well as its safety and tumor - targeting effect. METHODS 24 C57BL/6 mice implanted with LLC were randomized into the pcDNA3. 1 Bifidobacterium irtfantis group (group A) , pcDNA3. 1 - sFlt - 1 recombinant Bifidobacterium infantis group (group B ) and normal saline control group (group C ). The quality of mice of life ( QOF), tumor volume, tumor weight and inhibitive rate of tumor were observed. Blood, tumor tissues and the other tissues were cultured under anaerobic environment. In addition,the survival rate of another 45 tumor - bearing mice was observed. RESULTS The tumor volume and weight in group B were much smaller than those of group A and group C,and the inhibition rate of tumor in group B was higher than that in the group A. In addition, lots of white bacteria colonies of tumor tissues grew in group A and B under anaerobic culture, whereas the other tissues showed no bacteria colony,only a few bacteria colonies formed on blood culture in group A and B. The cumulative survival rate and QOF of mice in group B were significantly improved than these of the group A and group C. CONCLUSION The Bifidobacterium infantis - mediated sFlt -1 eukaryotic expression system could not only significantly inhibit the tumor growth and prolong survival time of tumor - bearing mice,but also had good security and tumor targeting effect.%目的 观察婴儿双歧杆菌介导的sFlt-1真核表达系统对Lewis肺癌(LLC)小鼠的抑瘤效果.方法 将24只C57BL/6LLC小鼠随机分为pcDNA3.1婴儿双歧杆菌组(A组)、pcDNA3.1-sFlt-1重组婴儿双歧杆菌组(B组)及生理盐水对照组(C组).观察小鼠的生存质量、肿瘤体积、肿瘤重量及抑瘤率,并取血、肿瘤组织及其他组织进行厌氧培养;另取45只荷瘤鼠观察生存率.结果 B组小鼠的肿瘤体积及重量明显小于A、C

  12. The Regulated Effect of Lactobacillus and Bifidobacterium Preparation of Mice Intestinal Flora Disequilibrium Model%乳酸菌和双歧杆菌制剂对小鼠肠道菌群失调模型的调节作用

    Institute of Scientific and Technical Information of China (English)

    伍静; 苏春萍; 王显超; 杨静谊; 贺超; 李维国

    2013-01-01

    Use of antibiotics interference mice intestinal bona fide flora,the establishment of your degree of flora imbalance mice model.Use of lactobacillus and bifidobacterium to intestinal dysbacteriosis mice regulation.Observation lactic acid bacteria and bifidobacteria on intestinal flora disequilibrium model regulation effect.Different concentration of ceftriaxone,the mice lavage is Choosed.Cecum content culture main flora changes is take.After the success of the model for the preparation of using lactic acid bacteria and bifidobacteria in flora of therapeutic adjustment,oral 6 weeks after the test,the flora number is detected.Different dosages ceftriaxone lavage in mice have been cecum volume increases.The advantage of the model group was significantly reduced in the number of bacteria.Through oral lactobacillus and bifidobacterium preparation,can proper recovery lactobacillus and bifidobacterium quantity.Significant difference compared with controls.It is conclused that experiment successful preparation mouse intestinal flora imbalance simulation model,long-term use of antibiotics,the function of the environment through the external supplement lactic acid bacteria and bifidobacteria,to keep the balance of the intestinal flora has regulation and repair action.%利用抗生素干扰小鼠肠道原籍菌群,建立小鼠肠道菌群失衡模型;并利用乳酸菌和双歧杆菌制剂对肠道菌群失调小鼠模型进行调节治疗.观察乳酸菌和双歧杆菌对肠道菌群失调模型的调节效果.选用不同浓度的头孢曲松钠,对小鼠进行灌胃.取盲肠和结肠内容物培养主要菌群变化.模型制备成功后利用乳酸菌和双歧杆菌进行菌群的治疗性调节,口服6周后,检测被检菌群的数量.结果不同剂量头孢曲松钠灌胃的小鼠盲肠体积均有所增大,模型组的优势菌的数量显著减少.通过口服乳酸菌和双歧杆菌制剂,可以适当的恢复乳酸菌和双歧杆菌的数量.与对照组比较

  13. 真空冷冻干燥与喷雾干燥长双歧杆菌的工艺比较研究%Comparison of Vacuum Freeze-Drying and Spray-Drying Processes for Active Bifidobacterium longum Powder Production

    Institute of Scientific and Technical Information of China (English)

    付博; 马齐; 王卫卫; 炯力

    2012-01-01

    为有效延长双歧杆菌的保存期和耐受性,利用真空冷冻干燥及喷雾干燥法制备活性菌粉。研究两种干燥方法的工艺参数,并对干燥得到的活性菌粉性能进行比较。真空冷冻干燥法制备的长双歧杆菌活性菌粉的活菌数为7.98×10^9CFU/g、存活率90.9%、含水量3.8%,4℃保藏90d后活菌数为2.5×10^8CFU/g,菌粉的水溶性好;喷雾干燥法制备的活性菌粉的活菌数为4.4×10^9CFU/g、存活率82.2%、包埋率71.9%、含水量5.6%,4~C保藏90d后活菌数为4×10^8CFU/g,菌粉在水中的溶解时间较长。真空冷冻干燥成本较高、操作时间长、菌粉的保藏期较短;而喷雾干燥工艺简单、生产成本低、工作效率高,包埋的菌粉保藏期较长。%For long term storage and to improve its stress resistance, Bifidobacterium longum was made into active bacteria powder by vacuum freeze-drying or spray-drying. In this study, we first optimized the technological conditions for active Bifidobacterium longum powder production and then compared these two processes in term of bacterial survival rate, cost, and ease of operation. The viable count, survival rate, moisture and viable count after storage for 90 days at 4 ℃ of vacuum freezedried active Bifidobacterium longum powder were 7.98 × 10^9 CFU/g, 90.9%, 3.8%, and 2.5 ×10^8 CFU/g, respectively. The powder dissolved easily in water: In contrast, the viable count, survival rate, encapsulation efficiency, moisture and viable count after storage for 90 days at 4 ℃ of spray-dried Bifutobacterium longum powder were 4.4× 10^9 CFU/g, 82.2%, 71.9%, 5.6% and 4× 10^8 CFU/g, respectively. It took longer time to dissolve in water when compared to vacuum-freeze dried powder. Vacuum freeze-drying was more complicated to operate, time-consuming and expensive than spray-drying. In conclusion, these two processes have both their advantages and disadvantages, which make

  14. Scientific Opinion on the substantiation of a health claim related to a combination of Bifidobacterium longum LA 101, Lactobacillus helveticus LA 102, Lactococcus lactis LA 103 and Streptococcus thermophilus LA 104 and improves stool frequency pursuant to Article 13(5 of Regulation (EC No 1924/2006

    Directory of Open Access Journals (Sweden)

    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA

    2013-02-01

    Full Text Available Following an application from PiLeJe submitted for authorisation of a health claim pursuant to Article 13(5 of Regulation (EC No 1924/2006 via the Competent Authority of France, the Panel on Dietetic Products, Nutrition and Allergies (NDA was asked to deliver an opinion on the scientific substantiation of a health claim related to a combination of Bifidobacterium longum LA 101, Lactobacillus helveticus LA 102, Lactococcus lactis LA 103 and Streptococcus thermophilus LA 104 and improves stools frequency. The food that is the subject of the health claim is a combination of B. longum LA 101, L. helveticus LA 102, L. lactis LA 103 and S. thermophilus LA 104. The information provided was insufficient to establish that the strain L. lactis LA 103 was sufficiently characterised. The Panel considers that if in a combination of several microorganisms and/or ingredients one microorganism or ingredient used in the combination is not sufficiently characterised, then the combination is considered to be not sufficiently characterised. A combination of B. longum LA 101, L. helveticus LA 102, L. lactis LA 103, and S. thermophilus LA 104 is not sufficiently characterised. The Panel concludes that a cause and effect relationship cannot be established between the consumption of a combination of B. longum LA 101, L. helveticus LA 102, L. lactis LA 103 and S. thermophilus LA 104 and improves stool frequency.

  15. 双歧杆菌四联活菌片联合用药对小儿非感染性腹泻的疗效及血清中IL-6、IL-17表达影响研究%Effect of viable bifidobacterium quadruple combination use in treating children non-infectious diarrhea and its influence on serum IL-6,IL-17 expression

    Institute of Scientific and Technical Information of China (English)

    吴立新; 张声生

    2013-01-01

    目的 探讨双歧杆菌四联活菌片联合用药对小儿非感染性腹泻的疗效及血清中白细胞介素(IL)-6、IL-17表达的影响.方法 选择重庆市开县人民医院儿科收治的非感染性腹泻患儿100例,采用双歧杆菌四联活菌片联合用药治疗50例为观察组;采用常规治疗50例为对照组.比较两组患儿的疗效及血清中IL-6、IL-17表达水平.结果 观察组总有效率与对照组比较,差异有统计学意义(P0.05).结论 双歧杆菌四联活菌片联合用药治疗小儿非感染性腹泻疗效显著,且血清中IL-6、IL-17表达水平恢复正常相对更快,而且服用方便,无明显不良反应,适宜应用于临床.%Objective To investigate the effect of viable bifidobacterium quadruple combination use in treating children non-infectious diarrhea and its influence on serum IL-6,IL-17 expression. Methods 100 children with non-infectious diarrhea in this hospital were selected .The observation group (50 cases) was treated by viable bifidobacterium quadruple combination use and the con -trol group (50 cases) by the conventional therapy .The effects and serum expression levels of IL-6 and IL-17 were compared between the two groups .Results The total effective rates had statistical differences between the two groups (P0 .05) .Conclusion Viable bifidobacterium quadruple combination use has significant effect in treating children non-infectious diarrhea ,serum IL-6 ,IL-17 expression returning to normal rapidly ,which is easy to take without significant adverse reactions and suitable for clinical application .

  16. 变异链球菌、乳酸杆菌、双岐杆菌在不同龋患指数儿童唾液中分布情况的比较观察%Distribution of Streptococcus mutans, Bifidobacterium and Lactobacillus among preschool children with different caries status

    Institute of Scientific and Technical Information of China (English)

    林彬; 周磊; 胡轶; 郭静; 王胜朝

    2011-01-01

    目的:比较无龋儿童和高龋患儿唾液中益生菌和变异链球菌的分布情况.方法:根据WHO 1997年《口腔健康调查基本方法》中龋病诊断标准,分别选取dmft≥4(高龋组)和dmft =0(无龋组)的5~6岁儿童各30人,于上午9:00 - 11:00取所有儿童的非刺激性唾液,分别接种于变异链球菌、双歧杆菌、乳酸杆菌的选择性培养基,在37℃厌氧条件下培养48 h后,取各选择培养基HE染色后倒置显微镜观察进行形态学鉴定.进而对各组各菌种菌落单位进行统计学分析.结果:5 ~6岁儿童口腔中均含有大量变异链球菌,明显高于其他两菌种(P<0.05),但高龋病组与无龋组之间无显著性差异(P>0.05);乳酸杆菌、双歧杆菌均以无龋组最高,与高龋组相比有显著性差异(P<0.05).结论:乳酸杆菌、双歧杆菌是无龋儿童口腔中的优势菌,可能对降低该年龄段儿童的龋易感性有作用.%AIM: To quantitatively determine the composition of probiotics and Streptococcus mutans in sali-va among preschool children. METHODS: Thirty preschool children with dmft >4 and thirty preschool children with dmft =0, designated as high-caries and non-caries group respectively, were enrolled in this clinical study. Stimulatory saliva was collected from all children. The saliva was then inoculated into selective culture medium of Streptococcus mutans, Bifidobacterium and Lactobacillus, cultured under anaerobic conditions at 37 "C for 48 h. The bacteria were observed under microscope after HE staining. RESULTS: The number of Streptococcus mutans in all saliva samples was significantly higher than that of Lactobacillus or Bifidobacteria ( P 0.05). The number of Lactobacillus or Bifidobacteria was significantly higher in non-caries group than in high-caries group ( P < 0. 05 ). CONCLUSION; The number of Lactobacillus or Bifidobacteria is higher in non-caries preschool children. Increasing the number of Bifidobacterium and Lactobacillus

  17. Scientific Opinion on the substantiation of a health claim related to a combination of Bifidobacterium longum LA 101, Lactobacillus helveticus LA 102, Lactococcus lactis LA 103 and Streptococcus thermophilus LA 104 and reducing intestinal discomfort pursuant to Article 13(5 of Regulation (EC No 1924/2006

    Directory of Open Access Journals (Sweden)

    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA

    2014-05-01

    Full Text Available Following an application from PiLeJe, submitted pursuant to Article 13(5 of Regulation (EC No 1924/2006 via the Competent Authority of France, the Panel on Dietetic Products, Nutrition and Allergies (NDA was asked to deliver an opinion on the scientific substantiation of a health claim related to a combination of Bifidobacterium longum LA 101, Lactobacillus helveticus LA 102, Lactococcus lactis LA 103 and Streptococcus thermophilus LA 104 and reducing intestinal discomfort. The food that is the subject of the health claim is a combination of four bacterial strains—B. longum LA 101, L. helveticus LA 102, L. lactis LA 103 and S. thermophilus LA 104. The Panel considers that the food, a combination of B. longum LA 101, L. helveticus LA 102, L. lactis LA 103 and S. thermophilus LA 104, which is the subject of the health claim is sufficiently characterised. The claimed effect proposed by the applicant is "improves intestinal comfort". The Panel considers that reduction of gastro-intestinal discomfort is a beneficial physiological effect. The Panel considers that the only human study provided for the substantiation of the claim (with limitations did not find an effect of a combination of the bacterial strains being the subject of the claim on gastrointestinal discomfort. The Panel concludes that a cause and effect relationship has not been established between the consumption of a combination of B. longum LA 101, L. helveticus LA 102, L. lactis LA 103 and S. thermophilus LA 104 and reducing gastro-intestinal discomfort.

  18. 一名肥胖儿童营养干预后肠道内假小链双歧杆菌碳水化合物利用能力的探究%Exploring Carbohydrate Utilization Capacity of Bifidobacterium pseudocatenulatum Isolated from a Morbidly Obese Child after Dietary Intervention

    Institute of Scientific and Technical Information of China (English)

    吴欢; 王睿瑞; 赵宇峰; 庞小燕; 申剑; 张晨虹

    2015-01-01

    双歧杆菌被认为是肠道内的有益菌,可以利用膳食中的多种植物多糖或寡糖,能够被人体无法消化的复杂碳水化合物选择性富集.本研究采用序列引导的分离策略,于厌氧条件下采用MRS琼脂培养基,得到了一名肥胖儿童营养干预后肠道内优势的双歧杆菌.采用ERIC指纹图谱技术对分离物进行基因水平上的分型,并通过16S rRNA基因测序鉴定分离株的分类地位.73个双歧杆菌分离物分为5种ERIC类型,均为假小链双歧杆菌.与Bacteroides thetaiotaomicron ATCC 29148、Eschrichia coli D45和Anaerostipes hadrus BPB5这些肠道中常见共生菌的代表菌株相比,丰度最高的ERIC类型代表菌株Bifidob acte rium pse udoc ate nulatum C95利用复杂碳水化合物的能力更强.Bifidobacterium pseudocatenulatum C95被膳食中的复杂碳水化合物和益生元显著富集,成为该儿童营养干预后肠道内的优势菌.菌株自身较强的碳水化合物利用能力可能是其生长优于肠道中其他共生细菌的原因.

  19. 双歧杆菌乳杆菌三联活菌防治小儿抗生素相关性腹泻的临床观察%The clinical observation of pediatric antibiotic associated diarrhea prevented and treated by bifidobacterium lactobacillus triple living bacterium tablet

    Institute of Scientific and Technical Information of China (English)

    尹立岩

    2014-01-01

    Objective To explore the clinical effect of bifidobacterium lactobacillus triple living bacterium tablet in the prevention and treatment of pediatric antibiotic associated diarrhea(AAD).Methods 300 children with respiratory tract infection were selected,firstly they were divided into group A(1 month-lyear old) 140 cases and group B(1-3years old) 160 cases according to the age;secondly,they were randomly divided into observation group (group A:70 cases and group B:80 cases) and control group 150 cases (group A:70 cases and group B:80 cases)within the A,B groups.Control group was given antibiotics to treat respiratory tract infection,and received conventional treatment after diarrhea appeared.Observation group was given bifidobacterium lactobacillus triple living bacterium tablet combined with antibiotics,continued to receive this drug on the basis of conventional treatment after diarrhea appeared.The incidence rate of diarrhea,total effective rate,duration of diarrhea were observed.Results The incidence rate of diarrhea of observation group was obviously lower than the control group,diarrhea treatment overall effective rate obviously higher than control group,the duration of diarrhea significantly shorter than the control group,with significant difference(P < 0.05) ;The incidence rate of diarrhea of observation group in group B was obviously lower than the observation group in group A,with significant difference (P < 0.05).Conclusion The clinical effect of bifidobacterium lactobacillus triple living bacterium tablet in the prevention and treatment of pediatric AAD is significant,especially for 1-3 years old children,it is worth clinical promotion.%目的 探讨双歧杆菌乳杆菌三联活菌防治小儿抗生素相关性腹泻(AAD)的临床疗效.方法 选取300例呼吸道感染患儿,首先按照年龄大小分为A组(1个月至1岁)140例,B组(>1~3岁)160例,A、B两组内再分成观察组150例(A组:70例,B组:80例)与对照组150例(A组:70

  20. Clinical curative effect of bifidobacterium tetravaccine tablets in the treatment of cirrhotic patients with diarrhea and influence on sIgA levels and cellular immune function%双歧杆菌四联活菌片治疗肝硬化腹泻患者的疗效及其机理探讨

    Institute of Scientific and Technical Information of China (English)

    单宝珍; 李胜保; 徐柳

    2015-01-01

    Objective To explore the clinical efficacy of bifidobacterium tetravaccine tablets in the treat-ment of cirrhotic patients with diarrhea and its influence on sIgA levels and cellular immune function. Methods One hundred and twenty cirrhotic patients with diarrhea in our hospital were randomly divided into two groups. The patients in control group was treated with antiviral medication, diuresis, nutritional support as well as oth-er conventional treatments, and patients in observation group was treated with bifidobacterium tetravaccine tablets on the basis of the control group. The treatment effect and the changes of intestinal sIgA levels and cel-lular immune function of the two groups were observed and compared. Results After treatment, the total effec-tive rate of observation group was 96.67%, significantly higher than 78.33%in the control group (P<0.05). The levels of ALT, AST, TBIL were significantly decreased than before the treatment, and the level of sIgA was significantly increased when compared with those before the treatment (P<0.05). There was also a signif-icant difference concerning the levels of ALT, AST, TBIL, and sIgA between two groups after the treatment. Levels of CD4+and CD4+/CD8+in the observation group were significantly higher than that in control group (P<0.05). Conclusion Bifidobacterium tetravaccine tablets in the treatment of cirrhotic patients with diarrhea had significant clinical efficacy, could improve the intestinal sIgA level and enhance the cellular immune func-tion of the patients effectively.%目的:探讨双歧杆菌四联活菌片治疗肝硬化腹泻患者的临床疗效以及对肠道sIgA水平和细胞免疫功能的影响。方法选取120例肝硬化腹泻的患者,将其随机分为两组。对照组给予抗病毒、护肝利尿、消炎、解痉和营养支持等常规肝硬化腹泻治疗,观察组则在对照组的基础上减消炎、解痉药加用双歧杆菌四联活菌片治疗。疗程均为4周。观察

  1. 益生菌预防儿童抗生素相关性腹泻的随机对照临床试验:酪酸梭菌二联活菌及布拉氏酵母菌疗效比较%Comparison between combined clostridium butyricum and bifidobacterium living powders and saccha-romyces boulardii for prevention of antibiotic-associated diarrhea in children:a randomized,controlled clinical trial

    Institute of Scientific and Technical Information of China (English)

    许玲芬; 关竹; 王洋; 王立云; 郭晓丽; 赵蕴卿; 毛志芹

    2015-01-01

    Objective To evaluate the protection of combined clostridium butyricum and bifidobac-terium living powders for antibiotic-associated diarrhea ( AAD ) with all kinds of infections in hospitalized children,and to compare the therapeutic effect with saccharomyces boulardii. Methods This study was a prospective,randomized case-control clinical trial which collected the data of the hospitalized children with all kinds of infections in Pediactric Department of Shengjing Hospital of China Medical University between May 2011 to May 2012. A total of 552 cases were enrolled and 480 cases completed the study. A total of 240 chil-dren were in experimental group,80 cases received combined clostridium butyricum and bifidobacterium liv-ing powders 840 mg per time,twice a day and the other 160 cases received saccharomyces boulardii 250 mg per time,twice a day,for one week; the control group took none of probiltics. Two groups received routine antibiotic therapy. Everyday′s defecate frequency was recorded, the traits of excrement according to bristol stool assessment scale were evaluated,the incidence of diarrhea and drug related adverse reactions were coun-ted. Results During the studied 7 days,the AAD incidence was 4. 2%(10/240) in experimental group and 20. 4%(49/240) in control group,there was significant difference between two groups. The risk of AAD in experimental group decreased 58. 5%. Compared to saccharomyces boulardii,combined clostridium butyricum and bifidobacterium living powders decreased 38. 2% (RR=0. 728, 95%CI 0. 257~0. 784, P=0. 009). Compared to control group,the average defecate frequency decreased in experimental group,diarrhea duration contracted,there was statistic difference between two groups ( P<0. 01 ) . No drug related adverse reactions happened during the trial. Conclusion Both combined clostridium butyricum and bifidobacterium living powders and saccharomyces boulardii could effectively reduce the risk of AAD in hospitalized children with

  2. 双歧杆菌四联活菌片联合用药治疗小儿非感染性腹泻的效果及对血清IL-6、IL-17表达的影响%Effect of combined Bifidobacterium,Lactobacillus,Enterococcus and Bacil-lus cereus tablets,live in the treatment of non-infectious diarrhea in chil-dren and influence study on serum IL-6,IL 17 expression

    Institute of Scientific and Technical Information of China (English)

    周慧恩; 梁斐; 周运南; 黎惠章

    2015-01-01

    Objective To investigate the clinical effect of combined Bifidobacterium,Lactobacillus,Enterococcus and Bacillus cereus tablets,live in the treatment of non-infectious diarrhea in children and influence on serum IL-6,IL 17 expression. Methods 120 children with non-infectious diarrhea in our hospital from February 2013 to June 2014 were selected and randomly divided into observation group and control group,each group of 60 cases.Conventional method was used in control group,combined Bifidobacterium,Lactobacillus,Enterococcus and Bacillus cereus tablets,live were applied in observation group on the basis of control group.Total effective rate,diarrhea stopped time,hospital admission time,level of IL-6 and IL-17 in two groups were compared. Results Total effective rate in observation group was 96.67%,higher than that in control group(85.00%),with statistical difference(P<0.05).Diarrhea stopped time,hospital ad-mission time in observation group was shorter than that in control group respectively,with statistical difference(P<0.05). After treatment of 72 hours,level of IL-6 and IL-17 was lower than that in control group respectively (P<0.05). Con-clusion Combined Bifidobacterium,Lactobacillus,Enterococcus and Bacillus cereus tablets,live in the treatment of non-infectious diarrhea in children can shorten diarrhea stopped time,hospital admission time,reduce level of IL-6 and IL-17,has a substantial clinical curative effect and is worthy of promotion and application.%目的:探讨双歧杆菌四联活菌片治疗小儿非感染性腹泻的临床效果及对血清IL-6、IL-17表达的影响。方法选取2013年2月~2014年6月本院收治的120例非感染性腹泻小儿,将其随机分为观察组和对照组,各60例,对照组采用常规方法治疗,观察组在对照组基础上采用双歧杆菌四联活菌片治疗,比较两组的总有效率、腹泻停止时间、住院时间和IL-6、IL-17水平。结果观察组总有效率为96.67%,

  3. Determination and calculation of hazardous incident scenarios in accordance with the 3rd hazardous incident administrative instruction. Vol. 1; Ermittlung und Berechnung von Stoerfallablaufszenarien nach Massgabe der 3. Stoerfallverwaltungsvorschrift. Bd. 1: Methodischer Teil zum Erarbeiten von Stoerfallablaufszenarien

    Energy Technology Data Exchange (ETDEWEB)

    Kaiser, W.; Rogazewski, P.; Schindler, M. [TUeV Anlagentechnik GmbH, Berlin-Schoeneberg (Germany). Unternehmensgruppe TUeV Rheinland/Berlin-Brandenburg; Acikalin, A.; Albrecht, M.; Lambert, M.; Steinbach, J. [Technische Univ. Berlin (Germany)

    2000-07-01

    At present there are used various procedures, calculation methods, models and model equations for hazardous incident scenarios. The procedure on principle is varying often. This guideline explains in one main part and six appendixes the methodical procedure to select specifications and assumptions on hazardous incident scenarios and their processing. Hazardous incident scenarios lead to information on emergency preparedness planning. Both general viewpoints and possibilities are shown, how to find necessary basic assumptions on a hazardous incident scenario from information on hazardous substances, on comparable hazardous incidents and on conditions of the site and the plant. Appendixes deal with precise instructions distinguished between substance release, explosion and fire (App. 1: Assessment of source terms, App. 2: Assessment of dispersion, App. 3: Assessment of effects). Appendix 4 gives explanations to appendixes 1, 2 and 3. Appendix 5 contains a collection of 15 examples of hazardous incident scenarios, which illustrate and comment the methodical procedure. Appendix 6 describes and comments software available on German market which assists the calculating of hazardous incidents. Volume 2 determines procedures with regard to methods of calculation, current models and model equations from scientists' point of view. (orig.) [German] Derzeit wird eine Vielzahl von Vorgehensweisen, Berechnungsmethoden, Modellen und Modellgleichungen fuer Stoerfallablaufszenarien verwendet. Das prinzipielle Vorgehen ist haeufig unterschiedlich. Dieser Leitfaden enthaelt in einem Hauptteil und sechs Anhaengen das methodische Vorgehen zur Auswahl von Angaben und Annahmen fuer Stoerfallablaufszenarien sowie deren Bearbeitung. Stoerfallablaufszenarien fuehren zu Angaben fuer die Gefahrenabwehrplanung. Fuer das Ableiten von Stoerfallablaufszenarien sind sowohl allgemeine Gesichtspunkte als auch Moeglichkeiten dargelegt, wie man aus Angaben zu Gefahrstoffen, zu vergleichbaren Stoerfaellen sowie zu Bedingungen des Standortes und der Anlage die erforderlichen Grundannahmen zum Stoerfallablauf gewinnen kann. Unterschieden nach Stofffreisetzungen, Explosionen und Braenden wird jeweils auf die konkreteren Hinweise im Anhang 1 zur Abschaetzung von Quelltermen, im Anhang 2 zur Abschaetzung der Ausbreitung und im Anhang 3 zur Abschaetzung der Auswirkungen verwiesen. Der Anhang 4 enthaelt einige Erlaeuterungen zu den Anhaengen 1 bis 3. Mit einer Sammlung von 15 Beispielen fuer Stoerfallablaufszenarien wird im Anhang 5 das im Leitfaden beschriebene methodische Vorgehen veranschaulicht und erlaeutert. Im Anhang 6 werden die auf dem deutschen Markt erhaeltlichen DV-Programme (Software) zur Berechnung von Stoerfallablaufszenarien beschrieben und kommentiert. Der Band 2 untermauert das Vorgehen im Hinblick auf Berechnungsmethoden, aktuelle Modelle und Modellgleichungen aus wissenschaftlicher Sicht. (orig.)

  4. Mictrostructured sensor systems for chemical gas analysis - 'MISCHGAS'. Vol. 1: Reports 1 - 6. Final report; Mikrostrukturierte Sensorsysteme fuer die chemische Gasanalyse - 'MISCHGAS'. Bd. 1: Teilberichte 1 - 6. Abschlussbericht

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1999-07-01

    The project MISCHGAS was aimed at low-power microstructured multisensor systems for analyses of complex gas mixtures. This comprised 1. the development of the sensor chip (sensor layout, sandwich sensor systems, ultrathin carrier materials, and sol-gel technologies), 2. investigation of atomistic and electrical sensor mechanism, 3. design and construction (glues, materials, noble metal free contact systems), 4. generation and reading of the sensor signal, 5. investigation of the analytical properties of the sensors, 6. user-oriented specialised gas analysis systems. [German] Ziel des Projektes MISCHGAS sind leistungsarme, mikrostrukturierte, multisensor-geeignete Systeme fuer die Analyse sowohl einzelner als auch mehrerer Kompoenten komplexer Gasgemische. Dazu wurden die notwendigen Teilbereiche: technologische Entwicklungen des Sensorchips, Klaerung atomistischer sowie elektrischer Sensormechanismen, Aufbau und Verbindungstechnik, Generierung und Auslesung des Sensorsignals, Ermittlung der analytischen Eigenschaften der Sensoren, anwenderorientierte spezialisierte Gasmesssysteme von den Verbundpartnern bearbeitet. Hauptpunkte neuer technologischer Entwicklungen waren Sensorlayout, Sensorschichtsysteme sowie ultraduenne Traegermaterialien ueber die 'porous silicon sacrificial layer'-Technik sowie Sol-Gel-Technologien. Damit konnten leistungsarme Traeger hergestellt werden. Materialien waren SnO{sub 2} und V{sub 2}O{sub 5}. Der Einfluss von Pt auf die Sensorreaktion konnte beschrieben werden. Das Verstaendnis phaenomenologischer Zusammenhaenge von Sensormechanismen und deren physikalisch-chemisch-analytischer Erfassung sowie der festkoerperphysikalischen Beschreibung wurde deutlich verbessert. Technologie und Prozesstechnik wurden auf Gesichtspunkte wie Qualitaetssicherung, und Transferierbarkeit ausgerichtet. Weitere Arbeitsbereiche sind die Gehaeuseentwicklung und Fixierung im Gehaeuse. In der AVT gab es Fortschritte bei Kleber und Aufbauhilfsstoffen sowie edelmetallfreien Kontaktsystemen. Fuer technische Einsatzbedingungen wurden entsprechende Filter weiterentwickelt. Weitere Fortschritte gab es im Bereich Sensormesstechnik. Alle Verbundpartner wurden mit den jeweils aktuellen technologischen Sensorqualitaeten fuer ihre Qualifizierungsmessungen versorgt. Durch eine Standardisierung des Messprotokolls wurde eine Vergleichbarkeit der Qualifizierungsergebnisse ermoeglicht. Um die Aussagefaehigkeit der Sensoren weiter auszunutzen, wurde der Thermopulsbetrieb als Messmethode ausgebaut. Dies ermoeglicht es u.a., die temperaturabhaengige Empfindlichkeit eines Sensors zu nutzen und kann einen Beitrag zur Verringerung der Leistungsaufnahme des Sensors leisten. Abhaengig vom Anwendungsfall evaluierten Verbundpartner in Pilotsystemen die technologischen Entwicklungen. Dies gilt insbesondere fuer die Bereiche Brandfrueherkennung und Rauchgaserkennung. (orig.)

  5. Analysis and comparison. Bd. 1 - Longlife. Report on the analysis of state of technology, administrative and legal procedures, financial situation, demographic needs, similarities and differences in the participating countries Denmark, Germany, Lithuania, Poland and Russia. Formulations and benchmarks

    Energy Technology Data Exchange (ETDEWEB)

    Rueckert, Klaus (ed.)

    2010-07-01

    Environmental considerations are becoming one of the key features in the design when it comes to constructing modern, sustainable residential buildings. In an effort to streamline procedures and practices, the project Longlife has conducted a comparative review of these among the countries Denmark, Germany, Lithuania, Poland and Russia (associated organizations). The countries involved have shared knowledge and experiences with each other about how their respective building processes operate. These are collated and analysed. There are differences and commonness in the state of technology, administrative and legal procedures, financial situation, demographic needs, and how a 'housing project' functions. With this exercise Longlife has started to ensure that differences across the Baltic Sea Region will be minimised as regards environmentally-friendly residential constructions. This initial comparative stage covers planning, building permit and tendering procedures, practices for developing and operating housing and construction technologies. The report reflects the currently most applicable features of the participating countries' processes. Longlife project partners work in three competence teams to use the special know how and experiences and to cooperate in the public private partnership composition. The report analyses in the competence team 1 - Engineering and building technology, design standards - the engineering and technology standards in the countries Denmark, Germany, Lithuania, Poland and Russia. The report shows for the competence team 2 - Administration procedures, licensing rules, tendering rules, laws - the comparison and investigations of administration procedures, building permit rules, tendering rules and laws in the participating countries. The report provides for competence team 3 - Economical and financial basis - a general and a specific overview about economical and financial issues, sustainability and quality aspects in the involved countries. This report is basis for the next work package: development of standards, criteria and specifications for a sustainable, resource saving residential building. (orig.)

  6. Scenarios for an integrated sustainability policy - using the example of the ''Sustainable City 2030''. Vol. 1; Szenarien fuer eine integrierte Nachhaltigkeitspolitik - am Beispiel: Die nachhaltige Stadt 2030. Bd. 1. Ueberblick und Fazit

    Energy Technology Data Exchange (ETDEWEB)

    Gassner, Robert [Institut fuer Zukunftsstudien und Technologiebewertung gGmbH (IZT), Berlin (Germany)

    2013-04-15

    On behalf of the German Federal Environment Agency, this project was supposed to enhance the further development of an integrated sustainability policy in Germany. Focus of the project was the design of sustainable urban living environments, as everyday life related views of for example citizens, consumers, employees, traffic participants etc. can serve as a consistency check for an integrated sustainability policy. Political topics and stakeholders within the German environment department and beyond were analyzed in order to enhance an effective integrated sustainability policy and to identify potential synergies. For this as well as for the resolution of possible trade-offs a systematic and empirically based scenario process has been used. In the introductory empirical and planning phase the fundamentals were elaborated: Desk research, interviews and workshops were conducted to identify political topics and strategic fields, which then were checked for trade-offs and potential cooperations. For this first phase of the project stakeholders, as well as their motivations and underlying expectations for the future were identified. In the main phase of the project two complementary topics (''Recycling City'' and ''Sustainable Economy in the City'') were jointly selected and elaborated in two parallel conducted systematic and participatory scenario processes to generate integrated images of the future in 2030. Furthermore, options for action, strategic elements and potentials for networking were derived and concretized with regard to practical cooperation in the German Department of the Environment.

  7. Scientific measurement and evaluation programme (WMEP). Phase 3. Vol. 1 and 2. Final report; Wissenschaftliches Mess- und Evaluierungsprogramm (WMEP) zum Breitentest ''250 MW Wind''. Phase 3. Bd. 1 und 2. Abschlussbericht

    Energy Technology Data Exchange (ETDEWEB)

    Doepfer, R.; Durstewitz, M.; Ensslin, C. [and others

    2000-07-01

    The Federal Ministry for Economics and Technology (BMWi) funds the '250 MW Wind' test programme. This programme is designed to acquire statistically relevant data concerning the practical use of wind energy converters (WEC) in the Federal Republic of Germany. The technological and scientific areas of this supportive measure, the so called 'Wissenschaftliches Mess- und Evaluierungsprogramm' (WMEP - Scientific Measurement and Evaluation Programme), are implemented by the Institut fuer Solar Energieversorgungstechnik (ISET - Institute for Solar Energy Supply Technology) in Kassel. The WMEP acquires performance data concerning all funded WECs for a ten year period. The final report on hand describes the results of the 3rd project phase (01/07/96 - 30/06/00) of the WMEP including four annual reports and a summary of the most important fields of work. In this phase, for the first time all evaluations could be based upon the complete plant stock since all funded projects were represented in the programme. As of 30/06/00, a total of 1,497 wind turbines with an installed capacity of 349.5 MW at approx. 1,100 different locations are under supervision. During the whole project phase a maximum of 1,557 turbines was supervised. The rated power of the turbines ranges from 2.5 kW up to 1.5 MW. Evaluations regarding the economy, the estimated lifetime and long-term reliability as well as the power performance of widely dispersed wind turbine systems could be initiated in this project phase. It should also be mentioned, that the WMEP evaluations do now include all wind turbines operated in Germany. (orig.) [German] Das Bundesministerium fuer Wirtschaft und Technologie (BMWi) foerdert mit dem Breitentest '250 MW Wind' die Einfuehrung der Windenergienutzung in Deutschland. Zur Gewinnung statistisch relevanter Erfahrungswerte aus dem praktischen Einsatz von Windenergieanlagen (WEA) wurde das Institut fuer Solare Energieversorgungstechnik e.V. (ISET), Kassel, mit der begleitenden Durchfuehrung des 'Wissenschaftlichen Mess- und Evaluierungsprogramms' (WMEP) beauftragt. Im Rahmen dieses Programms werden von allen gefoerderten WEA fuer einen Zeitraum von zehn Jahren ausgewaehlte Betriebsdaten und -ergebnisse erfasst und ausgewertet. Der vorliegende Abschlussbericht beschreibt die Ergebnisse der 3. Durchfuehrungsphase (01.07.1996 - 30.06.2000) des WMEP in vier Jahresberichten und einer Zusammenfassung der wichtigsten Arbeitsschwerpunkte. In der dritten Projektphase konnten erstmals Jahresauswertungen mit dem vollstaendigen Anlagenbestand druchgefuehrt werden, da alle bewilligten Projekte ins WMEP aufgenommen werden konnten. Zum 30.06.2000 betraegt der Anlagenbestand 1497 WEA mit einer installierten Nennleistung von insgesamt 349,5 MW, der an ca. 1.100 unterschiedlichen Standorten installiert ist. Insgesamt wurden im WMEP bis zu 1557 WEA messtechnisch begleitet. Das Leistungsspektrum der einzelnen WEA reicht dabei von 2,5 kW bis 1,5 MW. In der Projektphase III des WMEP standen besonders erste Auswertungen zur Wirtschaftlichkeit, zum Langzeitverhalten sowie zum Leistungsbeitrag der Windenergie im Vordergrund. Besonders hervorzuheben sind noch die ebenfalls in dieser Phase begonnenen Auswertungen zur zeitlichen Entwicklung der Windenergienutzung, die nunmehr alle in Deutschland betriebenen WEA umfassen. (orig.)

  8. Climate protection by reducing the emissions of greenhouse gases in households and the tertiary sector through climate-conscious behaviour. Vol. 1; Klimaschutz durch Minderung von Treibhausgasemissionen im Bereich Haushalte und Kleinverbrauch durch klimagerechtes Verhalten. Bd. 1. Private Haushalte

    Energy Technology Data Exchange (ETDEWEB)

    Brohmann, B.; Cames, M.

    2000-06-01

    The aim of the project was to identify areas in households and the tertiary sector in which changes in behaviour could result in energy conservation and thus a reduction of greenhouse gas emissions, and to quantify the potentials for 1995, 2005 and 2020. A second focus was on the analysis and evaluation of programmes and instruments to realise the potentials. With literature evaluation, expert interviews, and a household servey potentials and further technical development have been identified. In sum, behavioural measures can contribute to the CO2 reduction by 64 million tons in 1995 in households and 27 in the commercial sector in which the potential decreases to 18 million tons in 2020 due to the autonomous technical development. Adequate promotion programmes can help to realise 20-30% of the potential by 2020. (orig.) [German] Ziel des Vorhabens war, im Sektor private Haushalte und Kleinverbrauch Bereiche zu identifizieren, in denen Verhaltensaenderungen zur Energieeinsparung fuehren koennen, und diese Potenziale fuer 1995, 2005 und 2020 zu quantifizieren. Darauf aufbauend waren Programme und Instrumente zur Umsetzung aufzuzeigen und zu bewerten. Gestuetzt auf Literaturrecherchen und Expertengespraeche wurden Einzelpotenziale, Rahmenbedingungen, Entwicklungstrends in der Technik und im Ausstattungsgrad ermittelt. Insgesamt koennten Verhaltensmassnahmen im Haushaltssektor die CO2-Emissionen im Basisjahr 1995 um 64 Mio, im Kleinverbrauch um 27 Mio t vermindern. Bis 2020 bleibt dieses Potenzial im Haushaltssektor in etwa gleich. Im Kleinverbrauch sinkt es infolge der autonomen Technikentwicklung auf 18 Mio t ab. Durch geeignete Programme koennen bis 2020 etwa 20-30% des Potenzials erreicht werden. (orig.)

  9. Screening for and identification of starch-, amylopectin-, and pullulan-degrading activities in bifidobacterial strains.

    Science.gov (United States)

    Ryan, Sinéad M; Fitzgerald, Gerald F; van Sinderen, Douwe

    2006-08-01

    Forty-two bifidobacterial strains were screened for alpha-amylase and/or pullulanase activity by investigating their capacities to utilize starch, amylopectin, or pullulan. Of the 42 bifidobacterial strains tested, 19 were capable of degrading potato starch. Of these 19 strains, 11 were able to degrade starch and amylopectin, as well as pullulan. These 11 strains, which were shown to produce extracellular starch-degrading activities, included 5 strains of Bifidobacterium breve, 1 B. dentium strain, 1 B. infantis strain, 3 strains of B. pseudolongum, and 1 strain of B. thermophilum. Quantitative and qualitative enzyme activities were determined by measuring the concentrations of released reducing sugars and by high-performance thin-layer chromatography, respectively. These analyses confirmed both the inducible nature and the extracellular nature of the starch- and pullulan-degrading enzyme activities and showed that the five B. breve strains produced an activity that is consistent with type II pullulanase (amylopullulanase) activity, while the remaining six strains produced an activity with properties that resemble those of type III pullulan hydrolase.

  10. Crystal structure of sucrose phosphorylase from Bifidobacterium adolescentis.

    NARCIS (Netherlands)

    Sprogoe, D.; Broek, van den L.A.M.; Mirza, O.; Kastrup, J.S.; Voragen, A.G.J.; Gajhede, M.; Skov, L.K.

    2004-01-01

    Around 80 enzymes are implicated in the generic starch and sucrose pathways. One of these enzymes is sucrose phosphorylase, which reversibly catalyzes the conversion of sucrose and orthophosphate to d-Fructose and a-d-glucose 1-phosphate. Here, we present the crystal structure of sucrose phosphoryla

  11. 日粮添加不同水平的奶牛专用霉菌毒素吸附剂对粪中双歧杆菌数量和乳中黄曲霉毒素含量的影响%The Effect of Different Mycotoxin Binder Levels Supplementation on Feces Bifidobacterium Bifidum Number and Milk AFM1 Content in Lactating Dairy Cows

    Institute of Scientific and Technical Information of China (English)

    汤月明; 黄谢江; 刘仕军

    2011-01-01

    Mycotoxin in feed can bring negative effect on dairy health and decrease production of lactating dairy cows. The objective of this study was to evaluate changes of feces bifidobacterium bifidum number and milk AFM1 concentration when dietary different levels mycotoxin binder was supplemented in lactating dairy cattle. Eighty Chinese Holstein dairy cows were randomly assigned to control group with 20g powdered zeolite for a cow per day. The three experimental group received supplementation of 10g mycotoxin binder and 10g powdered zeolite for a cow per day, 15g mycotoxin binder and 5g powdered zeolite, or 20g mycotoxin binder. Meantime, all cows were fed the same basal diets. It was shown that dietary different levels of mycotoxin binder adding can decline bifidobacterium bifidum number of feces, but there was no significant difference. In contrast with before the experiment, aflatoxin M1 of raw milk in experimental treatment declined(P<0.05 ), and aflatoxin M1 residues was in less with mycotoxin binder enhancing. Milk aflatoxin M1 concentration in control treatment did not change compared with start of experiment. Therefore, the study indicated that different levels mycotoxin binder may improve raw milk quality.%奶牛饲料原料中霉菌毒素广泛存在,并严重地威胁着奶牛健康,影响着奶牛生产性能的发挥.本试验选择年龄、胎次、产奶量、泌乳天数相近的荷斯坦牛80头探讨日粮添加4种剂量(0、10、15、20g)的霉菌毒素吸附剂对奶牛粪便中双歧杆菌数量和原料奶中黄曲霉毒素残留量的影响.与对照组(添加霉菌毒素吸附剂0g)相比,试验组奶牛粪便中双歧杆菌的外排量明显降低,但各实验组之间差异不显著,仅有数值上的变化.同时,随着霉菌毒素吸附剂含量的增加,原料奶中体细胞数呈现下降的趋势.与试验前相比,原料奶中黄曲霉毒素含量显著降低(P<0.05),且随着添加剂量的增加其黄曲霉毒素残留量

  12. 灌饲干扰素-α2b重组双岐杆菌对柯萨奇B3病毒诱导BLAB/c小鼠心肌炎的影响%Bifidobacterium as an oral delivery carrier of interferon-alpha2b for the treatment of coxsackievirus B3-induced myocarditis in the BALB/c mice

    Institute of Scientific and Technical Information of China (English)

    赖春霞; 刘宝兰; 余世强; 邓丽丽; 邓启文

    2014-01-01

    目的 构建干扰素(IFN)-α2b基因重组双歧杆菌(pBAD-SPIFN转化双歧杆菌),观察重组菌是否对小鼠柯萨奇B3病毒(CVB3)诱导的小鼠心肌炎具有治疗作用.方法 体外扩增前期研究中构建的IFN-α2b重组双岐杆菌.选取BLAB/c小鼠40只,腹腔内注射CVB3感染剂量,2周后形成病毒性心肌炎,将感染的小鼠随机分成IFN、BIFN、B、生理盐水组予以干预:IFN组给予肌肉注射干扰素,BIFN组小鼠予灌饲干扰素-α2b重组双岐杆菌;B组给予灌饲pBAD-gIIIA转化双歧杆菌;生理盐水组给予肌肉注射生理盐水.所有小鼠均在治疗14d后取心脏标本观察心肌组织病理变化,检测心肌病毒滴度,实时荧光定量聚合酶链反应(FQ-PCR)分析Th1细胞因子和IFN-α诱导黏液病毒抗性蛋白1(Mx1)基因转录水平.结果 CVB3诱导的心肌炎小鼠干预治疗2周后,BIFN组小鼠心肌炎症程度(0.16±0.10)较B组及生理盐水组明显减轻(P<0.01);BIFN组心肌的病毒滴度水平(3.03 ±0.02)较B组及生理盐水组显著下降(P <0.01);BIFN组Th1细胞因子和IFN-α诱导基因Mx1基因转录水平(分别为1.48±0.08、3.56±0.02、2.13 ±0.01)较B组及生理盐水组显著升高(P<0.01).结论 灌饲给药IFN-α2b重组双岐杆菌对CVB3病毒诱导的小鼠心肌炎具有较好疗效.%Objective To investigate a novel oral delivery system for interferon-alpha2b using genetically engineered Bifidobacterium longum as the carrier and further evaluate the efficacy of interferon (IFN)-α2b-expressed B.longum on the coxsackie B3 virus (CVB3)-induced myocarditis in mice.Methods IFN-α2b recombinant B.longum was amplified in vivo and subsequently,BLAB/c mice were inoculated intraperitoneally with infectious dose of CVB3 for two weeks to produce the models of CVB3-induced myocarditis.Then,the murine models were divided into four groups.The "BIFN group" was orally administered with IFN-α2b-transformed B.longum for two weeks respectively after the

  13. The effect of Live Combined Bifidobacterium and Lactobacillus Tablets and probiotic yogurt on lipid metabolism in critical patients%金双歧和益生菌酸奶对危重患者脂代谢影响的研究

    Institute of Scientific and Technical Information of China (English)

    刘瑞芳; 程青虹; 李建华; 刘颖; 彭冲; 葸英博

    2016-01-01

    目的:探讨添加益生菌制剂(金双歧)与添加益生菌酸奶对危重患者血脂水平的影响,及二者对患者血脂水平的交互作用。方法60例危重症患者按照随机数字表法分为A组(对照组)、B组(金双歧组)、C组(益生菌酸奶组)和D组(联合治疗组)各15例。以三酰甘油( TG)、总胆固醇(TC)、高密度脂蛋白胆固醇( HDL-C)、低密度脂蛋白胆固醇(LDL-C)及TC/HDL-C、LDL-C/HDL-C比值为检测指标,分析14 d后各组间的血脂水平是否存在差异,并采用析因设计研究两因素间的交互作用。结果治疗第14天,四组患者的TG、LDL-C、HDL-C、TC/HDL-C、LDL-C/HDL-C水平差异有统计学意义(P<0.05);析因设计显示金双歧对TG和HDL-C值有主效应(P<0.05),益生菌酸奶对TG、LDL-C、HDL-C、TC/HDL-C、LDL-C/HDL-C值有主效应(P<0.05);金双歧和益生菌酸奶对TG水平存在交互作用(F=4.64,P<0.05)。结论金双歧和益生菌酸奶可以改善危重症患者的脂代谢紊乱,为后期采取饮食调节患者的血脂水平提供理论依据,有利于患者的恢复和预后。%Objective To explore the effect of Live Combined Bifidobacterium and Lactobacillus Tablets(Jin Shuangqi)and probiotic yoghurt supplementation on lipid profile in critically ill patients, as well as to study interaction effects of Jin Shuangqi and probiotic yoghurt existing or not. Methods Sixty critically ill patients were randomly divided into four groups:A, control group(n=15);B, Jin Shuangqi group(n=15);C, probiotic yoghurt group(n=15);D, combination group(n=15). Triglyceride(TG), total cholesterol(TC), high-density lipoprotein cholesterol(HDL-C), low density lipoprotein cholesterol (LDL-C)as well as total cholesterol levels:HDL-C ratio and LDL-C:HDL-C ratio were adopted as the observation indexes on day 14, to conduct a two-factor(Jin Shuangqi, probiotic yoghurt)2 × 2 factorial design. Results

  14. mRNA expression of three kinds of recombinant bifidobacterium vaccines of Taenia solium in domestic pigs%3种猪带绦虫重组双歧杆菌候选疫苗在家猪体内的mRNA表达

    Institute of Scientific and Technical Information of China (English)

    周必英; 刘美辰; 杨凤娇

    2015-01-01

    Objective To detect the expression of three kinds of recombinant bifidobacterium(Bb) vaccines of Taenia solium in domestic pigs.Methods Healthy domestic pigs of 40 days old were orally administrated with 1011 (colony forming units,CFU) recombinant Bb-TSO45W-4B,Bb-TSOL18 and Bb-TSO45W-4B-TSOL18 vaccines.Two weeks after the first immunization,these domestic pigs were strengthened immunized.56 days after the first immunization,these domestic pigs were killed.The liver,lung and spleen were collected to detect the expression of three kinds of recombinant Bb vaccines of Taenia solium in domestic pigs using reverse transcription-polymerase chain reaction (RT-PCR).Results The TSO45W-4B gene of Taenia solium could be expressed in liver,lung and spleen of domestic pigs.The relative expression was 3.3,3.3,1,respectively.The relative expression in liver and lung was higher than that in spleen;The TSOL18 gene of Taenia solium could be expressed in liver and spleen of domestic pigs.The relative expression was 2.6,1,respectively.The relative expression in liver was higher than that in spleen.The TSO45W-4B-TSOL18 fusion gene of Taenia solium could be expressed in liver,lung and spleen of domestic pigs.The relative expression was 0.2,2.4,2.1,respectively.Conclusion Three kinds of recombinant Bb vaccines of Taenia solium could be expressed in domestic pigs,which would contribute to playing a role in immune effect of vaccines.%目的 检测3种猪带绦虫重组双歧杆菌候选疫苗在家猪体内的表达情况. 方法 将40日龄健康家猪分别用1011克隆形成单位(colony forming units,CFU)的猪带绦虫Bb-TSO45W-4B、Bb-TSOL18和Bb-TSO45W-4B-TSOL18重组候选疫苗对家猪口服灌胃.首次免疫2周后加强免疫1次.于首免后56 d,剖杀家猪,无菌取肝、肺、脾,采用RT-PCR方法检测上述3种候选疫苗在家猪体内的mRNA表达情况. 结果 在家猪肝脏、肺脏和脾脏中均检测到猪带绦虫TSO45W-4B基因的mRNA,其中肝脏和